data_2jts_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jts _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.1 m80 -132.53 150.17 52.2 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.135 166.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.498 ' CH2' ' CE ' ' A' ' 80' ' ' MET . 23.6 m95 -123.98 142.65 50.97 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.065 -1.879 . . . . 0.0 109.252 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 mm -140.0 123.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -79.86 121.7 25.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 163.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -112.28 21.35 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.937 0.79 . . . . 0.0 112.324 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HD2' ' H ' ' A' ' 49' ' ' ASN . 7.4 ttt180 -106.3 -175.47 2.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.687 -1.258 . . . . 0.0 110.105 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 m -60.11 151.71 65.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.358 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.76 -17.14 28.12 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.221 2.614 . . . . 0.0 113.964 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -54.08 -39.87 66.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.607 1.163 . . . . 0.0 113.528 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.45 -41.74 69.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.866 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -57.54 -37.41 73.02 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.192 0.997 . . . . 0.0 111.814 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -59.96 -39.08 84.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.975 0.91 . . . . 0.0 112.319 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -87.9 -44.69 10.87 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 117.816 -1.087 . . . . 0.0 111.293 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -162.86 150.11 13.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 167.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -139.98 152.77 46.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.5 t -54.17 128.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.578 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.32 113.29 2.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -13.29 25.39 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.34 164.05 27.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 117.491 0.646 . . . . 0.0 110.346 171.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.58 138.25 54.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 127.084 2.154 . . . . 0.0 106.95 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.12 115.66 16.06 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 123.935 0.772 . . . . 0.0 109.592 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.41 82.78 15.96 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 126.102 1.761 . . . . 0.0 106.511 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.39 153.49 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.502 2.802 . . . . 0.0 113.791 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -49.42 -36.92 23.61 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.166 1.386 . . . . 0.0 112.457 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -67.02 -15.35 63.67 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 32' ' ' ARG . 23.9 mt-10 -130.81 -13.61 3.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 O-C-N 124.586 1.179 . . . . 0.0 110.867 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.62 -34.15 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.342 1.057 . . . . 0.0 111.328 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -56.85 -31.36 64.7 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -105.24 -35.96 7.39 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.015 0.912 . . . . 0.0 110.482 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.479 ' HD2' ' HB3' ' A' ' 28' ' ' GLU . 5.8 mtp180 -81.2 -17.26 50.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.03 -34.39 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.56 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.48 -32.02 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.897 0.771 . . . . 0.0 111.726 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.64 -28.62 21.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.305 0.642 . . . . 0.0 111.438 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.45 -40.05 44.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.447 0.567 . . . . 0.0 111.613 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 t -142.67 82.58 12.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.41 -25.41 70.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.354 2.036 . . . . 0.0 113.84 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -101.4 100.68 11.18 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -69.34 -6.87 32.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -176.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -18.42 58.98 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 170.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -66.76 150.75 48.67 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -72.08 131.73 43.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.93 124.42 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HD2' ' NE1' ' A' ' 4' ' ' TRP . 88.5 mttt -110.34 121.04 44.33 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.04 147.02 12.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.47 163.89 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 107.975 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.706 ' HG ' ' HB2' ' A' ' 53' ' ' GLN . 19.8 p -154.39 -176.34 5.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.438 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 61.9 t30 -60.14 -30.68 69.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.11 1.0 7.19 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.211 -0.931 . . . . 0.0 113.101 -168.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.1 -26.57 3.79 Favored Glycine 0 C--O 1.225 -0.466 0 CA-C-O 122.611 1.117 . . . . 0.0 113.339 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.321 2.3 tpt85 -69.96 -48.16 59.43 Favored 'General case' 0 N--CA 1.426 -1.641 0 O-C-N 120.449 -1.618 . . . . 0.0 112.117 -176.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.706 ' HB2' ' HG ' ' A' ' 48' ' ' CYS . 38.6 mt-30 -71.9 -29.73 64.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.227 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -35.51 79.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.252 0.478 . . . . 0.0 111.796 167.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.86 -47.28 72.79 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -63.74 -46.01 87.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.864 0.832 . . . . 0.0 110.608 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.192 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -61.42 -41.44 97.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.86 -42.04 90.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.108 0.867 . . . . 0.0 111.255 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.3 -48.78 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 mt -64.7 -47.97 76.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.5 m -52.93 -36.26 59.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 121.761 2.073 . . . . 0.0 112.258 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -66.61 -37.93 85.92 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 41.9 mmm -68.0 -6.59 23.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.015 1.326 . . . . 0.0 113.529 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.31 28.91 13.36 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.706 -1.246 . . . . 0.0 113.866 167.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CG ' ' CG2' ' A' ' 69' ' ' VAL 0.333 49.4 m-85 -68.2 151.5 46.87 Favored 'General case' 0 CA--C 1.469 -2.169 0 C-N-CA 123.686 0.794 . . . . 0.0 110.057 173.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.57 -24.44 11.77 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.711 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -138.77 47.35 1.94 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.911 1.339 . . . . 0.0 111.571 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG2' ' CG ' ' A' ' 66' ' ' TYR . 2.1 t -90.32 148.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -147.05 134.5 20.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.629 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -78.14 110.6 13.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 163.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.53 -31.65 72.82 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.76 -147.51 19.26 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -100.52 165.56 19.26 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.3 tp -50.06 -32.81 16.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.971 1.367 . . . . 0.0 112.864 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.272 59.9 mttt -69.22 -28.45 66.36 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -86.32 -40.38 15.53 Favored 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 126.178 2.174 . . . . 0.0 107.58 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -60.92 126.28 18.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.179 . . . . 0.0 108.806 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.85 34.24 3.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.231 1.012 . . . . 0.0 110.264 -174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.498 ' CE ' ' CH2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -91.24 161.47 34.85 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 123.459 0.704 . . . . 0.0 109.553 170.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -51.22 150.91 13.52 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.535 2.157 . . . . 0.0 111.519 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -133.84 153.32 51.81 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 157.6 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.71 162.7 19.56 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.443 173.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.346 0 O-C-N 127.502 3.001 . . . . 0.0 111.29 170.133 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -135.28 110.98 9.26 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 107.959 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -75.95 133.02 40.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.3 mm -132.86 122.53 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -78.51 129.39 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.93 31.34 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.691 0.678 . . . . 0.0 111.991 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 5.7 ttt180 -120.02 -173.42 2.55 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.424 -0.797 . . . . 0.0 109.788 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 2.9 m -65.21 157.46 77.05 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.458 0.703 . . . . 0.0 110.01 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.62 -14.43 39.83 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.918 2.412 . . . . 0.0 113.649 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -47.37 -47.87 25.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.957 1.303 . . . . 0.0 111.087 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -70.61 -42.0 71.53 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 118.529 0.604 . . . . 0.0 109.957 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -57.05 -38.56 73.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.952 0.901 . . . . 0.0 111.18 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.7 -45.03 88.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.772 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -73.54 -47.26 42.16 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.542 1.065 . . . . 0.0 110.771 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.83 149.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 109.729 166.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -138.6 151.24 47.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.081 1.752 . . . . 0.0 107.991 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.96 131.55 16.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 119.18 3.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.567 1.147 . . . . 0.0 110.346 -171.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.05 76.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.626 -1.097 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.9 55.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.372 1.586 . . . . 0.0 109.424 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 mt -78.83 129.17 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -78.36 118.59 20.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.164 0.893 . . . . 0.0 109.498 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.9 mt -141.16 84.57 12.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.23 151.03 9.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.94 3.093 . . . . 0.0 113.895 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.2 tp -46.74 -42.65 17.14 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.539 1.536 . . . . 0.0 112.575 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -66.82 -12.55 59.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.745 0.818 . . . . 0.0 112.992 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.39 -9.15 4.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.739 1.216 . . . . 0.0 112.389 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 p -49.37 -42.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.735 1.152 . . . . 0.0 112.238 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -57.92 -34.95 70.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.969 0.908 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -92.77 7.57 43.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.062 0.945 . . . . 0.0 111.585 -168.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -140.94 -27.84 0.7 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.274 -0.891 . . . . 0.0 112.116 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.36 -34.81 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.687 1.131 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.39 23.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.482 1.113 . . . . 0.0 113.676 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -121.42 -27.94 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.902 1.281 . . . . 0.0 111.156 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.98 -38.54 76.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.807 0.731 . . . . 0.0 111.04 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -140.26 75.78 27.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.63 -32.88 18.21 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.34 2.026 . . . . 0.0 112.37 -172.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -79.03 97.71 6.2 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.14 -10.31 39.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -78.68 -18.99 53.52 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.686 1.13 . . . . 0.0 111.563 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.38 147.06 54.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.056 0.843 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -70.98 137.79 49.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.1 t -127.87 141.17 47.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -130.33 128.45 41.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.29 154.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.149 0.979 . . . . 0.0 108.925 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -155.92 161.76 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.593 1.957 . . . . 0.0 107.077 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.2 171.49 20.1 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.376 0.67 . . . . 0.0 109.638 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -48.32 -30.62 5.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.361 1.864 . . . . 0.0 114.545 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.75 2.05 8.17 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.52 -31.81 0.85 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.687 1.613 . . . . 0.0 113.918 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -63.57 -52.37 61.31 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.783 1.291 . . . . 0.0 111.507 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.94 -35.56 80.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.05 0.841 . . . . 0.0 110.892 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.9 p -72.04 -33.15 67.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.53 -0.732 . . . . 0.0 111.651 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.62 77.46 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -64.66 -49.2 71.92 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 117.516 0.658 . . . . 0.0 110.04 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.14 -36.63 70.94 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.443 0.297 . . . . 0.0 110.873 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.06 -42.12 97.13 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.44 -34.72 72.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.877 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -58.66 -50.45 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.323 0.965 . . . . 0.0 108.927 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.28 -34.44 78.36 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.753 -0.592 . . . . 0.0 110.825 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -63.16 -40.6 98.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.562 0.345 . . . . 0.0 110.687 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.99 -35.57 80.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.55 0.74 . . . . 0.0 110.677 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.05 -6.46 28.26 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.969 0.908 . . . . 0.0 112.415 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.631 -1.094 . . . . 0.0 113.159 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -65.93 119.26 11.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.381 1.591 . . . . 0.0 107.081 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 p -81.54 -19.86 41.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.01 76.81 1.67 Allowed 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.313 1.045 . . . . 0.0 108.441 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.76 141.99 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.25 140.87 35.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -91.74 102.99 15.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.74 76.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.743 -171.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.12 -168.3 27.1 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.53 153.63 51.78 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.8 tp -45.25 -45.09 11.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.861 1.664 . . . . 0.0 113.289 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -67.15 -25.36 66.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.13 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.56 -34.53 46.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.716 0.689 . . . . 0.0 111.574 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.77 123.93 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.06 22.9 12.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.12 0.968 . . . . 0.0 112.324 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.7 mmm -73.63 153.21 89.56 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.81 157.37 12.93 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.276 2.651 . . . . 0.0 110.948 167.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -136.43 158.0 45.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.128 0.571 . . . . 0.0 110.055 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.27 164.55 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.213 2.205 . . . . 0.0 105.186 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -147.56 172.18 14.4 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.805 -1.184 . . . . 0.0 110.648 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -173.579 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.236 0.387 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -140.61 163.99 31.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.574 1.55 . . . . 0.0 107.427 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -128.26 136.18 50.68 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -131.04 127.76 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -94.53 121.38 36.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 168.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.46 13.97 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -93.93 179.49 5.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.7 1.136 . . . . 0.0 110.366 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -51.9 148.09 11.17 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.76 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.56 -27.15 24.35 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.332 2.688 . . . . 0.0 113.533 171.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.73 -39.55 65.37 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.667 0.787 . . . . 0.0 111.391 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -69.83 -41.64 74.67 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.122 0.874 . . . . 0.0 110.501 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -58.1 -39.62 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.096 1.359 . . . . 0.0 110.486 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.88 -10.66 60.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.006 . . . . 0.0 113.696 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -81.69 -71.29 0.49 Allowed 'General case' 0 C--N 1.341 0.202 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 168.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.68 158.29 28.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.63 1.572 . . . . 0.0 107.702 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -143.44 152.75 41.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.527 1.131 . . . . 0.0 108.41 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.74 131.5 14.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.36 120.4 5.99 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.06 90.38 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.511 -1.161 . . . . 0.0 113.884 173.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.38 142.21 57.94 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.227 1.513 . . . . 0.0 110.005 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -87.9 127.33 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -77.18 115.33 16.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.56 81.56 23.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.133 1.773 . . . . 0.0 106.561 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.16 148.87 23.27 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.255 2.636 . . . . 0.0 112.625 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.88 -29.72 42.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.782 1.233 . . . . 0.0 112.722 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -60.08 -20.36 57.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.696 0.798 . . . . 0.0 113.049 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -128.41 -17.44 4.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.534 1.134 . . . . 0.0 112.096 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.87 -36.44 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.341 . . . . 0.0 112.765 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.65 -30.46 68.75 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.468 0.707 . . . . 0.0 112.073 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.92 -47.78 4.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.368 0.667 . . . . 0.0 109.514 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -63.89 -18.76 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.112 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -52.58 -40.55 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.43 1.014 . . . . 0.0 111.04 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.79 90.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.828 0.74 . . . . 0.0 110.917 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -71.72 -37.02 70.68 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.487 0.715 . . . . 0.0 111.063 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.87 62.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.217 0.462 . . . . 0.0 111.738 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.24 98.19 6.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 108.128 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.18 -9.76 7.01 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.088 3.192 . . . . 0.0 116.253 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -134.83 111.29 9.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.834 1.197 . . . . 0.0 110.155 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.0 -12.37 60.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.701 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -86.54 -4.17 59.13 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.151 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.74 151.03 47.9 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.362 -0.836 . . . . 0.0 108.9 168.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 m -79.62 70.21 6.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.73 0.776 . . . . 0.0 109.758 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 t -74.01 97.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -79.58 141.26 36.75 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.99 126.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -171.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.06 169.67 17.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.23 1.412 . . . . 0.0 109.307 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 p -150.11 178.45 8.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.78 -23.36 67.33 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.01 -6.81 11.97 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.63 30.13 77.08 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.661 1.119 . . . . 0.0 114.627 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -137.26 -45.8 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.012 0.906 . . . . 0.0 110.235 170.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.98 -22.38 65.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.726 0.239 . . . . 0.0 110.614 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 p -64.36 -42.21 96.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.05 -1.031 . . . . 0.0 110.95 168.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.77 -43.27 96.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.14 -40.07 96.51 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.147 1.474 . . . . 0.0 111.315 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.53 76.06 Favored 'General case' 0 C--O 1.227 -0.087 0 O-C-N 121.376 -0.828 . . . . 0.0 110.685 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.03 -39.65 83.06 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.488 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.97 -44.02 97.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.37 0.987 . . . . 0.0 109.714 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.41 -50.38 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.921 0.889 . . . . 0.0 109.688 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.05 -18.65 62.55 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.441 -0.787 . . . . 0.0 111.502 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -68.22 -36.73 79.96 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.54 -0.725 . . . . 0.0 110.126 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.12 -36.49 83.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.299 0.954 . . . . 0.0 110.052 171.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.1 mmm -73.23 -1.87 19.49 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.064 0.945 . . . . 0.0 112.796 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.08 46.05 17.78 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 119.849 1.204 . . . . 0.0 111.659 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -46.24 158.41 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.501 1.121 . . . . 0.0 113.299 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.83 -26.67 1.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.893 -1.051 . . . . 0.0 112.217 173.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -147.92 23.86 1.08 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.585 1.539 . . . . 0.0 113.845 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 144.58 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.2 128.33 16.64 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.856 0.862 . . . . 0.0 109.002 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.63 108.17 10.63 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 168.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.73 73.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.0 0.52 . . . . 0.0 110.957 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.54 -139.36 7.23 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.22 166.34 15.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.5 tp -51.03 -40.16 57.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -168.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.91 -27.61 66.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.642 0.377 . . . . 0.0 111.677 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -86.71 -36.28 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.884 0.874 . . . . 0.0 111.658 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.95 119.66 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.46 22.87 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.05 0.94 . . . . 0.0 112.468 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mmm -81.3 158.35 69.41 Favored Pre-proline 0 C--O 1.24 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 109.462 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.65 154.92 11.19 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.441 2.761 . . . . 0.0 111.754 168.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -134.41 154.34 51.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 t -130.54 141.04 47.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.59 161.0 24.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.09 0.556 . . . . 0.0 110.281 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.032 169.355 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.373 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -82.8 158.07 22.94 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.22 141.66 49.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.621 1.168 . . . . 0.0 107.998 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -139.84 136.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.89 122.24 36.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.64 20.21 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 15.8 ttt85 -109.56 -162.84 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.238 -0.914 . . . . 0.0 108.766 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.557 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 11.1 m -77.98 156.13 79.83 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.343 0.657 . . . . 0.0 109.588 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.41 -23.77 19.75 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.364 2.709 . . . . 0.0 114.029 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -26.08 64.2 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.688 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -86.2 -51.34 6.34 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 119.95 1.25 . . . . 0.0 109.142 167.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -53.25 -37.81 62.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.871 1.269 . . . . 0.0 112.992 -170.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -66.59 -45.59 78.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 0.0 111.52 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.38 -30.36 60.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.953 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.74 153.37 2.21 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.616 1.566 . . . . 0.0 109.667 166.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -146.02 146.51 31.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 t -60.15 132.67 25.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.4 149.43 16.83 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.577 0.751 . . . . 0.0 111.529 -172.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.93 -14.87 46.43 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.462 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.82 171.39 7.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.889 1.345 . . . . 0.0 111.797 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.8 mt -135.4 134.22 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -73.92 115.65 13.63 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.162 0.892 . . . . 0.0 109.031 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 mt -141.29 87.55 10.52 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.22 149.83 11.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.009 3.139 . . . . 0.0 114.027 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.49 -36.37 14.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.883 1.673 . . . . 0.0 113.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -63.88 -20.45 65.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -129.29 -11.3 4.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.93 0.892 . . . . 0.0 111.865 -169.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -50.26 -34.65 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 111.51 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.69 -33.83 56.74 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 112.609 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.54 -36.72 4.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.485 0.584 . . . . 0.0 111.211 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -69.26 -15.67 63.41 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.597 -0.689 . . . . 0.0 112.317 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.67 -35.35 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.056 169.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.08 99.43 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.385 0.993 . . . . 0.0 111.184 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -35.94 59.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.405 0.682 . . . . 0.0 111.158 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.74 75.02 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -140.66 82.47 15.78 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.994 1.718 . . . . 0.0 107.062 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.46 3.71 4.53 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.381 2.72 . . . . 0.0 114.256 -173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.06 103.88 5.99 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.801 1.24 . . . . 0.0 107.863 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -15.78 52.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.98 -25.15 63.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.468 0.577 . . . . 0.0 111.876 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -63.66 154.7 32.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.63 0.65 . . . . 0.0 111.773 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -73.2 142.67 47.34 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.22 140.59 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -120.67 139.93 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.19 144.6 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -143.57 160.59 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.46 1.104 . . . . 0.0 109.109 170.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -130.01 -139.34 0.22 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 125.034 1.334 . . . . 0.0 107.423 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -80.53 -45.15 17.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.789 1.631 . . . . 0.0 111.89 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.87 -26.44 3.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -169.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.35 2.41 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.073 0.851 . . . . 0.0 113.933 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -66.08 -44.21 85.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.984 1.392 . . . . 0.0 112.517 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.2 -33.03 71.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.868 0.758 . . . . 0.0 110.648 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -33.39 74.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.251 -0.906 . . . . 0.0 110.648 170.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.96 -49.18 68.34 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -60.47 -46.91 88.37 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.529 0.664 . . . . 0.0 110.655 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.51 75.25 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.474 0.579 . . . . 0.0 110.791 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -65.4 -42.79 92.22 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -42.34 98.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.876 0.762 . . . . 0.0 111.111 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.84 -51.21 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.88 -24.56 59.74 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.733 -0.604 . . . . 0.0 111.858 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 m -67.38 -38.95 85.52 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.321 0.51 . . . . 0.0 110.248 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -67.26 -37.21 83.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.831 0.741 . . . . 0.0 110.256 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mmm -67.39 -12.98 61.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.688 0.795 . . . . 0.0 112.289 170.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.89 14.6 66.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.349 -1.25 . . . . 0.0 113.955 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -64.26 122.87 17.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.522 1.661 . . . . 0.0 107.716 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -68.19 -30.88 70.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -165.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.27 42.9 2.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.271 0.942 . . . . 0.0 112.213 -166.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.83 146.67 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -142.65 137.76 30.18 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.144 1.378 . . . . 0.0 108.356 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -78.5 114.37 17.35 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.38 63.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.637 0.775 . . . . 0.0 112.031 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.58 -145.7 17.71 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.93 168.99 16.02 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.98 -25.48 67.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.142 0.977 . . . . 0.0 112.234 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -78.25 -6.02 53.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.353 172.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.58 -35.09 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.311 1.044 . . . . 0.0 112.471 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.61 146.19 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 120.264 1.393 . . . . 0.0 108.615 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.97 67.14 1.34 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.471 1.508 . . . . 0.0 108.427 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.2 ptm -140.23 166.1 25.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.9 1.28 . . . . 0.0 108.543 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 147.1 33.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.231 2.621 . . . . 0.0 113.561 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.87 160.06 24.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.5 1.12 . . . . 0.0 109.029 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.56 155.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -134.86 155.86 49.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.124 0.97 . . . . 0.0 109.089 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 174.642 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -134.72 98.67 4.11 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.626 1.571 . . . . 0.0 107.149 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -72.64 147.08 46.12 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mm -140.34 124.69 18.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -79.79 114.35 18.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.4 m -106.42 18.55 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.49 -171.93 2.22 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 120.946 -1.096 . . . . 0.0 109.288 173.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.74 154.9 64.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.02 -11.11 25.7 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.059 2.506 . . . . 0.0 114.1 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -54.27 -37.26 64.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.575 1.55 . . . . 0.0 112.275 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.38 -41.85 75.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.141 0.882 . . . . 0.0 110.296 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -58.75 -31.44 68.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.945 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -64.66 -14.63 59.07 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -132.08 -36.47 1.17 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.536 1.062 . . . . 0.0 112.709 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.91 139.74 6.4 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.865 1.211 . . . . 0.0 108.256 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -141.71 154.7 45.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 170.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.39 128.8 14.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -29.68 65.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.046 0.539 . . . . 0.0 112.235 -169.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.94 22.77 36.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.241 -1.311 . . . . 0.0 113.12 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.57 163.69 17.62 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.173 1.487 . . . . 0.0 112.319 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 pt -137.36 144.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 127.053 2.141 . . . . 0.0 107.33 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.3 117.23 20.1 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.113 0.565 . . . . 0.0 109.805 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.0 mt -141.21 83.45 13.7 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.222 1.809 . . . . 0.0 106.268 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.32 152.83 24.3 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.769 2.979 . . . . 0.0 114.555 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -47.38 -36.57 9.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.651 1.981 . . . . 0.0 113.016 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -64.14 -20.06 65.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.29 -11.75 4.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.852 0.861 . . . . 0.0 112.105 -169.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -51.4 -33.75 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.763 1.225 . . . . 0.0 112.058 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -54.43 -35.75 63.28 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.577 1.151 . . . . 0.0 111.974 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.96 -42.17 5.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -66.96 -14.31 62.71 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 tp -52.18 -38.62 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.467 1.031 . . . . 0.0 111.204 170.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.76 98.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.131 0.878 . . . . 0.0 111.041 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.14 -35.63 69.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.531 0.732 . . . . 0.0 111.201 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.46 -46.27 67.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 0.0 111.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 t -143.66 101.32 5.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -171.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.17 -22.92 34.1 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.57 2.847 . . . . 0.0 115.53 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -144.43 116.63 8.44 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.305 1.042 . . . . 0.0 108.849 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -66.74 -4.56 9.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 113.088 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.62 -23.58 62.58 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.146 0.579 . . . . 0.0 111.087 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.13 150.0 45.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.07 130.17 41.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.685 -0.634 . . . . 0.0 109.416 -173.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -125.74 134.49 66.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.34 86.65 2.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.87 144.44 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -152.18 163.63 38.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.559 1.544 . . . . 0.0 108.379 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.71 170.46 21.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.466 1.106 . . . . 0.0 109.147 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -54.79 -14.98 1.6 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 -3.4 4.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.51 -30.26 0.59 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.447 1.499 . . . . 0.0 114.137 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -64.97 -49.71 69.22 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.438 1.095 . . . . 0.0 111.525 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.67 -31.35 71.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.399 0.545 . . . . 0.0 110.638 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -71.57 -30.89 66.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.173 -0.954 . . . . 0.0 111.289 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.2 -48.97 70.81 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 167.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -61.36 -44.42 97.19 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.974 -0.721 . . . . 0.0 111.166 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.06 75.46 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 118.372 0.533 . . . . 0.0 110.572 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.39 -40.38 85.66 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -64.12 -41.39 97.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.361 0.982 . . . . 0.0 110.842 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.11 -53.01 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -69.78 -23.19 63.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.927 -0.483 . . . . 0.0 111.829 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.411 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 34.9 m -63.12 -44.28 96.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.558 0.617 . . . . 0.0 110.128 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -67.22 -28.92 68.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.313 0.506 . . . . 0.0 110.884 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mmm -76.7 6.59 5.74 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.142 0.977 . . . . 0.0 112.73 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 42.51 8.55 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 119.677 1.126 . . . . 0.0 112.525 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.2 OUTLIER -53.3 161.85 0.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 175.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.33 -40.72 0.65 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 110.622 168.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -135.23 33.36 3.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.818 1.19 . . . . 0.0 112.537 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.4 t -82.42 140.67 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -147.16 143.6 28.36 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.075 0.95 . . . . 0.0 108.875 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -79.35 107.46 12.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.21 -29.29 70.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.059 0.544 . . . . 0.0 111.958 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.95 -162.12 25.21 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.05 30.83 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -58.19 -34.06 69.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 110.565 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.13 -14.66 63.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.92 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -110.7 -39.26 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.114 0.966 . . . . 0.0 111.33 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 mt -64.42 139.79 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.721 1.146 . . . . 0.0 109.498 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.06 27.39 7.18 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.022 1.329 . . . . 0.0 111.508 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.0 162.51 45.44 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.05 144.26 46.92 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.285 1.99 . . . . 0.0 110.547 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.14 153.09 51.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.609 0.764 . . . . 0.0 109.261 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.77 160.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.458 1.903 . . . . 0.0 106.725 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.47 157.05 23.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 173.508 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -141.12 153.37 45.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.091 1.757 . . . . 0.0 106.906 169.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -123.08 150.44 43.15 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 mm -140.04 123.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -80.87 111.18 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -103.3 20.69 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.451 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 11.6 ttt-85 -106.94 -175.48 2.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.194 -0.942 . . . . 0.0 109.61 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 4.4 m -69.14 156.86 90.72 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.185 0.594 . . . . 0.0 109.868 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.53 -14.2 4.62 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.107 3.205 . . . . 0.0 115.759 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -48.65 -38.02 19.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.099 1.36 . . . . 0.0 112.058 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.43 -48.52 12.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.227 0.467 . . . . 0.0 110.305 173.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -55.81 -38.99 70.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.129 0.971 . . . . 0.0 112.02 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -65.4 -7.8 15.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.259 1.424 . . . . 0.0 113.637 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -130.23 -29.68 2.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.657 1.117 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -167.04 143.15 4.35 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.062 1.301 . . . . 0.0 108.797 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -143.75 153.36 42.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.337 1.055 . . . . 0.0 108.217 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.44 131.58 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -33.64 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.373 0.669 . . . . 0.0 111.54 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.37 12.94 67.81 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.048 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.03 166.05 13.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.128 1.464 . . . . 0.0 112.169 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.45 142.16 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.022 2.129 . . . . 0.0 107.373 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -80.0 114.79 19.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.877 0.471 . . . . 0.0 110.231 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 mt -139.04 80.4 24.01 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.811 1.644 . . . . 0.0 107.034 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.62 153.86 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.669 2.912 . . . . 0.0 113.912 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 tp -46.61 -38.96 10.37 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 113.114 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -69.23 -13.14 62.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -126.98 -18.84 4.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.164 0.986 . . . . 0.0 111.989 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.55 -34.48 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.018 1.327 . . . . 0.0 112.813 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -57.11 -29.88 63.9 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.356 1.062 . . . . 0.0 112.476 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.18 -41.29 3.33 Favored 'General case' 0 C--N 1.334 -0.065 0 C-N-CA 123.374 0.67 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.12 -16.85 63.94 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.3 -35.16 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.662 1.119 . . . . 0.0 110.85 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.24 -7.15 28.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.931 0.893 . . . . 0.0 113.145 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 p -120.91 15.79 11.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.732 1.613 . . . . 0.0 110.512 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.74 -51.08 0.79 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.266 1.026 . . . . 0.0 110.733 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.21 67.51 21.34 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.726 1.21 . . . . 0.0 108.142 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.98 -28.92 75.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.331 2.021 . . . . 0.0 112.211 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.65 81.09 3.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -52.47 -26.4 12.78 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.934 1.294 . . . . 0.0 113.092 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -66.64 -24.33 66.28 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.172 0.989 . . . . 0.0 112.743 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.43 150.61 44.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.29 0.95 . . . . 0.0 109.8 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.35 137.78 54.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.546 -0.721 . . . . 0.0 110.221 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.7 131.57 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -125.34 90.94 3.32 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.7 144.46 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.08 162.22 38.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.706 1.202 . . . . 0.0 109.115 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.6 p -153.35 172.45 17.03 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.214 1.006 . . . . 0.0 109.603 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -51.28 -25.96 6.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.621 1.568 . . . . 0.0 115.232 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.77 -0.68 6.05 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 -36.64 0.96 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.594 1.569 . . . . 0.0 113.811 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -63.35 -44.3 95.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.902 1.351 . . . . 0.0 111.425 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -72.94 -29.07 62.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.098 0.408 . . . . 0.0 110.412 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -69.93 -32.41 70.67 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.945 -1.097 . . . . 0.0 109.961 168.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.38 -47.96 66.62 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.48 -41.8 98.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.261 1.03 . . . . 0.0 111.095 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.48 76.31 Favored 'General case' 0 CA--C 1.526 0.035 0 CA-C-N 118.802 0.728 . . . . 0.0 110.491 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.63 -41.43 79.47 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.95 -44.34 94.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.47 1.032 . . . . 0.0 110.53 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.5 -52.12 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.97 0.908 . . . . 0.0 109.431 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.09 -26.75 65.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.989 -0.444 . . . . 0.0 110.954 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 m -61.38 -39.39 90.5 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.551 -0.718 . . . . 0.0 110.627 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.91 -41.8 77.69 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.263 0.483 . . . . 0.0 110.424 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -74.41 -16.2 60.89 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.54 46.07 0.19 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.01 168.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.05 157.48 3.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.639 1.219 . . . . 0.0 112.752 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.9 -44.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 109.491 168.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.99 35.47 2.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.394 1.078 . . . . 0.0 111.359 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.76 135.68 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -140.22 146.86 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.385 1.074 . . . . 0.0 108.963 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -80.15 113.9 18.67 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.6 -31.34 71.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.469 0.708 . . . . 0.0 111.685 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.88 -165.39 24.27 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.9 160.41 31.1 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.3 tp -49.6 -34.08 16.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.014 1.725 . . . . 0.0 111.944 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -66.68 -9.8 39.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 112.53 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.88 -27.39 3.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.223 1.409 . . . . 0.0 112.751 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.03 89.88 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.572 1.533 . . . . 0.0 107.037 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.57 27.39 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.358 1.463 . . . . 0.0 113.15 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -73.13 156.37 89.48 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 123.51 0.724 . . . . 0.0 109.226 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.24 155.24 12.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.458 2.772 . . . . 0.0 111.643 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -132.87 154.64 50.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.036 0.534 . . . . 0.0 110.518 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -133.02 173.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.298 2.239 . . . . 0.0 105.652 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -125.41 146.04 49.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.986 -1.071 . . . . 0.0 109.217 -172.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 172.701 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 C--O 1.236 0.343 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -140.38 169.92 16.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.534 1.134 . . . . 0.0 108.264 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -131.11 138.39 49.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -169.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.1 mm -137.84 129.75 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.71 120.61 26.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.97 19.42 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 118.199 0.454 . . . . 0.0 111.617 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -98.77 -177.62 3.71 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.347 -0.846 . . . . 0.0 109.601 176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.43 154.46 54.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.16 -19.67 12.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.568 2.846 . . . . 0.0 114.899 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -47.45 -44.83 25.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -73.0 -45.86 55.46 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.747 0.703 . . . . 0.0 110.719 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -55.29 -37.15 66.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.41 1.484 . . . . 0.0 111.37 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -67.64 -16.31 64.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.73 1.212 . . . . 0.0 113.119 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -92.51 -59.74 2.0 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -159.95 158.85 31.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.363 1.465 . . . . 0.0 107.755 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -140.19 154.36 46.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.38 141.31 13.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.49 121.56 4.61 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.385 1.074 . . . . 0.0 110.132 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.26 2.91 68.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.536 -1.147 . . . . 0.0 114.14 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 154.51 35.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.505 1.652 . . . . 0.0 110.964 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.02 127.93 73.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.39 114.36 9.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.754 0.706 . . . . 0.0 109.501 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -140.54 79.7 19.79 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.325 1.85 . . . . 0.0 106.508 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.54 151.24 24.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.951 3.1 . . . . 0.0 114.731 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -47.92 -38.92 17.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.881 2.072 . . . . 0.0 112.863 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -64.4 -20.45 66.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -129.71 -3.49 4.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.047 0.939 . . . . 0.0 112.045 -169.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 p -49.97 -40.98 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.476 1.111 . . . . 0.0 111.691 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -56.93 -38.01 72.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.802 0.841 . . . . 0.0 112.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -90.31 -3.76 57.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.591 0.757 . . . . 0.0 111.399 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -132.12 -26.54 1.91 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -59.56 -35.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.855 0.752 . . . . 0.0 110.739 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.12 96.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.559 0.618 . . . . 0.0 111.26 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -36.14 65.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.157 0.583 . . . . 0.0 111.143 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.19 -42.27 72.61 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.476 0.58 . . . . 0.0 111.705 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.28 82.36 13.16 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.37 1.468 . . . . 0.0 108.247 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.44 -37.78 93.19 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.014 2.476 . . . . 0.0 113.133 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -79.2 96.02 5.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -69.51 -3.28 13.98 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -7.12 25.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.732 1.213 . . . . 0.0 111.108 174.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.11 150.56 49.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.668 1.122 . . . . 0.0 109.327 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -73.88 131.81 41.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -130.48 96.31 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -74.62 134.36 42.07 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.01 146.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -146.25 163.16 36.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.003 1.321 . . . . 0.0 108.162 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 m -159.99 -178.59 7.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.801 1.641 . . . . 0.0 109.695 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -63.03 132.35 51.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 166.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.85 0.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.162 2.185 . . . . 0.0 116.413 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.03 -8.0 40.39 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.836 1.208 . . . . 0.0 114.252 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -63.06 -56.89 13.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.545 1.672 . . . . 0.0 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.74 -29.49 70.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.948 -170.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -76.19 -33.23 59.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.204 -0.935 . . . . 0.0 111.28 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.37 -47.4 75.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.32 -46.53 88.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.643 0.777 . . . . 0.0 110.533 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.3 73.96 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 121.719 -0.613 . . . . 0.0 111.058 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -64.39 -44.75 90.35 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.24 -33.07 72.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.105 0.866 . . . . 0.0 111.215 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.32 -49.9 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.204 0.911 . . . . 0.0 108.938 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.88 -31.29 70.98 Favored 'General case' 0 C--O 1.231 0.123 0 O-C-N 121.54 -0.725 . . . . 0.0 111.378 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.94 -41.04 99.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.38 -35.91 80.28 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.78 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.86 -7.09 25.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.192 0.997 . . . . 0.0 112.318 171.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.51 12.42 59.64 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.155 -0.966 . . . . 0.0 113.328 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -68.35 148.07 51.23 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.068 1.434 . . . . 0.0 108.106 168.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.5 t -128.0 -10.29 5.4 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -128.51 34.27 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.31 1.044 . . . . 0.0 110.109 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.1 143.06 13.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -146.94 128.74 15.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -76.75 104.56 7.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.21 66.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.589 0.755 . . . . 0.0 111.872 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.3 -166.54 24.96 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.983 0.801 . . . . 0.0 111.227 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.76 48.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.2 tp -44.94 -49.7 10.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 -25.35 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.305 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.74 -28.35 30.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.007 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.56 120.33 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.611 1.096 . . . . 0.0 108.884 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.5 55.54 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.563 1.545 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.0 mtp -134.53 156.14 79.04 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 124.792 1.237 . . . . 0.0 108.673 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.81 157.3 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.073 2.515 . . . . 0.0 111.434 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -134.69 128.97 34.05 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.09 139.58 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.65 155.78 28.82 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.993 -0.442 . . . . 0.0 110.805 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 168.504 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -84.32 158.39 21.19 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -133.97 122.13 22.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -123.57 126.46 73.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.04 117.19 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.275 21.5 m -114.6 52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 12.9 ttt180 -141.44 -169.92 2.97 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.508 -1.37 . . . . 0.0 110.144 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.442 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 12.0 m -58.62 153.95 37.88 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.34 -22.15 15.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.157 2.572 . . . . 0.0 114.124 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.69 -25.49 64.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.101 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -78.37 -49.86 12.78 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 120.22 1.373 . . . . 0.0 109.43 169.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.55 -40.71 75.6 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.469 1.107 . . . . 0.0 111.691 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.14 -4.76 11.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.027 1.331 . . . . 0.0 113.599 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -126.27 -34.6 2.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.941 1.246 . . . . 0.0 111.912 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -163.79 145.77 9.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.852 1.206 . . . . 0.0 109.243 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -146.75 154.87 41.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.78 1.232 . . . . 0.0 107.944 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.92 131.24 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.95 -36.5 49.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -166.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.18 2.11 83.3 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.601 0.637 . . . . 0.0 113.672 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' CB ' ' HH ' ' A' ' 47' ' ' TYR . . . -72.3 157.72 37.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.255 1.026 . . . . 0.0 113.636 -169.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.3 pt -131.52 134.44 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.14 120.87 25.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.802 0.441 . . . . 0.0 109.981 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -143.72 94.46 6.0 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.69 151.24 11.01 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.053 3.168 . . . . 0.0 114.86 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.52 -50.06 33.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.962 1.305 . . . . 0.0 112.272 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -71.75 -5.65 35.58 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -124.1 -18.95 5.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.608 1.163 . . . . 0.0 111.96 -167.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.34 -31.93 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.813 1.645 . . . . 0.0 112.452 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -52.73 -40.48 63.1 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.5 1.12 . . . . 0.0 111.802 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.26 -45.97 8.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.898 0.317 . . . . 0.0 110.543 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -73.05 -20.35 61.0 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.624 -0.672 . . . . 0.0 112.207 -168.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.54 -33.6 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.391 0.996 . . . . 0.0 110.642 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.04 -17.01 61.77 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 p -116.81 -29.31 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 110.984 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.06 72.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.68 0.673 . . . . 0.0 111.271 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.52 74.34 28.44 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.894 1.677 . . . . 0.0 106.507 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.19 -29.41 39.35 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.09 1.86 . . . . 0.0 112.435 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -79.68 95.14 5.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -62.47 -10.62 12.29 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -81.99 -19.94 39.51 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.839 1.199 . . . . 0.0 111.795 173.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.49 146.21 54.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.877 0.762 . . . . 0.0 110.635 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -70.68 145.98 50.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.139 0.976 . . . . 0.0 110.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.06 141.88 40.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -117.03 144.01 45.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.787 1.235 . . . . 0.0 107.928 171.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.75 144.34 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.367 1.067 . . . . 0.0 108.762 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.473 ' HH ' ' CB ' ' A' ' 21' ' ' ALA . 5.0 p90 -157.58 149.11 21.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.406 1.483 . . . . 0.0 109.19 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 t -149.01 174.64 12.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.989 1.716 . . . . 0.0 108.427 -168.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.13 -25.07 60.96 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.604 0.761 . . . . 0.0 112.92 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.65 140.81 41.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.596 1.159 . . . . 0.0 108.836 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.97 -28.87 72.74 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.213 0.911 . . . . 0.0 113.054 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -55.55 -46.11 77.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.483 1.141 . . . . 0.0 110.035 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -71.86 -36.89 70.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.633 0.651 . . . . 0.0 110.095 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -56.9 -44.63 82.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.268 0.485 . . . . 0.0 110.038 169.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.99 -43.04 98.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.95 1.262 . . . . 0.0 111.859 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -62.08 -43.01 99.76 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 118.445 1.123 . . . . 0.0 110.509 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.36 76.79 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-N 119.008 0.822 . . . . 0.0 110.651 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -64.07 -45.83 87.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.03 -39.45 94.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.269 0.486 . . . . 0.0 111.014 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.61 -48.04 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.975 0.807 . . . . 0.0 109.621 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.02 -29.04 66.0 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.7 m -67.11 -38.52 85.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.04 0.536 . . . . 0.0 110.61 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.1 -37.74 88.46 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.147 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.23 -3.82 18.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.841 0.856 . . . . 0.0 112.708 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.29 22.91 76.97 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.217 172.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 10.9 m-85 -65.36 124.09 21.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.175 1.487 . . . . 0.0 107.728 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -27.3 67.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.311 0.644 . . . . 0.0 112.364 -169.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -139.27 107.64 5.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.7 t -141.99 144.15 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.92 125.74 25.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -71.16 109.14 5.04 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.98 -25.09 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.862 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.04 -166.61 23.63 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.21 157.55 40.95 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 168.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.44 -41.96 86.28 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.767 -0.843 . . . . 0.0 110.462 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.3 -29.78 69.46 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.281 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.36 -39.91 31.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.15 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.0 137.79 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.579 0.627 . . . . 0.0 109.631 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.2 23.73 14.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.419 1.088 . . . . 0.0 112.296 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -72.84 154.4 91.09 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.79 152.35 17.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.715 2.943 . . . . 0.0 112.137 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -140.17 152.92 46.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.688 0.795 . . . . 0.0 109.448 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.3 158.17 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.337 1.855 . . . . 0.0 107.242 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.69 154.14 38.57 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.668 -0.645 . . . . 0.0 110.251 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 171.134 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.236 0.353 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -137.3 156.66 47.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.257 1.823 . . . . 0.0 106.773 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -128.94 139.21 52.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.4 mm -130.93 121.18 49.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -81.3 110.42 16.74 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 166.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 m -99.11 21.46 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -111.26 -172.25 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.004 -1.06 . . . . 0.0 110.381 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.75 152.59 95.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.105 0.562 . . . . 0.0 110.181 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.72 -19.63 11.05 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.625 2.883 . . . . 0.0 114.836 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.43 -28.82 67.29 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.286 -0.864 . . . . 0.0 112.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -77.41 -46.43 22.72 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.841 1.2 . . . . 0.0 109.39 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -56.43 -40.82 75.38 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.858 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -62.4 -46.99 86.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.1 0.96 . . . . 0.0 111.381 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.51 -48.23 17.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.58 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.02 142.51 7.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.125 0.875 . . . . 0.0 110.185 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -135.38 155.32 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.917 1.287 . . . . 0.0 108.198 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.68 130.18 20.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.39 114.74 3.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.58 -12.97 18.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.888 1.232 . . . . 0.0 111.942 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 164.0 24.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.307 1.054 . . . . 0.0 111.751 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.6 pt -138.84 140.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 126.53 1.932 . . . . 0.0 106.921 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.09 114.18 18.8 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.62 83.77 16.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.49 153.55 13.57 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.034 3.156 . . . . 0.0 113.378 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.9 tp -50.41 -35.6 29.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.213 1.405 . . . . 0.0 112.555 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -66.47 -15.43 63.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.672 0.789 . . . . 0.0 113.021 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -129.01 -18.44 3.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.279 1.031 . . . . 0.0 112.111 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.52 -34.05 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.014 1.326 . . . . 0.0 111.969 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.63 -11.69 46.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.125 0.97 . . . . 0.0 113.384 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -122.06 -53.42 1.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.093 0.957 . . . . 0.0 108.481 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.51 -23.19 67.29 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -56.01 -36.35 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.453 1.024 . . . . 0.0 110.884 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.68 51.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.775 0.83 . . . . 0.0 112.802 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -119.95 12.31 11.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.866 1.666 . . . . 0.0 110.813 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.08 -38.14 1.44 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.618 1.167 . . . . 0.0 111.433 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.94 71.99 48.25 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.54 -29.36 52.82 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.506 2.137 . . . . 0.0 112.607 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -78.58 96.78 5.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.65 -11.01 21.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -76.86 -17.49 58.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.258 0.935 . . . . 0.0 111.879 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.1 157.79 36.92 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.773 0.715 . . . . 0.0 111.826 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -73.79 133.67 43.29 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.76 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.78 96.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -79.01 132.28 36.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.12 135.27 64.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 123.735 0.814 . . . . 0.0 109.57 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.91 162.22 39.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.851 1.66 . . . . 0.0 108.736 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -154.64 165.81 35.36 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.399 1.48 . . . . 0.0 107.594 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -54.57 -31.98 57.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 113.009 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.87 -15.89 43.09 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.67 35.08 61.5 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.977 1.262 . . . . 0.0 112.752 -170.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -144.15 -53.87 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.666 1.186 . . . . 0.0 109.919 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.76 -27.89 68.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.27 0.628 . . . . 0.0 110.461 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -66.33 -40.06 89.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.955 1.302 . . . . 0.0 112.519 170.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.68 96.13 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -64.02 -47.12 81.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.971 0.885 . . . . 0.0 110.399 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.94 72.68 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 122.203 -0.311 . . . . 0.0 110.986 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -62.81 -45.45 92.59 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -64.05 -40.18 95.73 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.852 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.32 -53.18 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 118.947 0.794 . . . . 0.0 109.235 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.3 mt -69.31 -29.14 66.93 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.961 -0.462 . . . . 0.0 110.93 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -65.52 -40.57 93.13 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.241 0.473 . . . . 0.0 110.697 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.07 -36.67 84.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.884 0.766 . . . . 0.0 110.094 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -71.94 -3.25 21.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.04 0.936 . . . . 0.0 112.712 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 16.92 72.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.56 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -67.12 127.41 32.5 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 p -86.5 -21.83 26.75 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -131.49 35.99 3.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.763 0.825 . . . . 0.0 111.197 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.44 146.3 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.15 125.68 15.8 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -75.13 97.99 3.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.09 72.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.033 0.533 . . . . 0.0 110.679 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 -115.07 0.94 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.09 172.69 25.14 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.22 -34.46 77.69 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.002 0.521 . . . . 0.0 111.297 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.35 -36.03 80.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.823 0.449 . . . . 0.0 110.537 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.48 -41.98 31.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.509 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.91 142.91 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.859 0.754 . . . . 0.0 109.686 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.89 24.53 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.828 1.251 . . . . 0.0 111.923 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.39 165.37 49.19 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.495 1.118 . . . . 0.0 108.85 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -52.49 149.29 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.844 2.363 . . . . 0.0 111.359 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.97 148.94 45.7 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.55 149.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.42 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.1 165.02 22.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.661 0.384 . . . . 0.0 110.94 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.785 1.183 . . . . 0.0 110.625 173.355 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.237 0.404 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -140.33 161.75 36.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.849 2.06 . . . . 0.0 106.98 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -119.15 143.34 47.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -138.62 131.68 39.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.46 125.09 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.03 14.32 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -91.9 -169.18 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.397 1.453 . . . . 0.0 109.695 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -57.91 150.4 49.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.089 0.555 . . . . 0.0 109.637 167.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.47 -19.22 67.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.306 2.004 . . . . 0.0 112.624 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.08 -24.89 67.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.919 -1.113 . . . . 0.0 112.145 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -68.61 -41.18 79.92 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.517 1.053 . . . . 0.0 109.913 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -59.85 -37.34 79.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.736 1.615 . . . . 0.0 110.269 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.01 -43.49 81.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.515 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -66.39 -58.2 5.79 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -174.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -167.02 151.27 6.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.959 1.704 . . . . 0.0 107.114 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -138.53 153.61 48.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.61 126.92 12.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 96.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.51 -18.71 4.1 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.82 1.2 . . . . 0.0 111.63 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.42 162.8 25.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.146 0.973 . . . . 0.0 110.202 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -135.66 147.16 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.787 1.635 . . . . 0.0 106.831 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -80.87 116.55 20.91 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -136.92 81.52 33.36 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.48 150.45 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.5 2.8 . . . . 0.0 114.078 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -47.49 -41.54 20.99 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.671 1.989 . . . . 0.0 111.933 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.97 -15.77 57.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -129.55 -13.36 4.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.471 1.108 . . . . 0.0 112.053 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.15 -35.04 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.966 1.306 . . . . 0.0 111.735 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -56.6 -34.5 67.26 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.744 0.818 . . . . 0.0 112.234 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.4 -47.09 4.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -65.57 -22.2 66.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.673 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.66 -32.79 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.658 1.117 . . . . 0.0 111.267 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.74 60.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 112.899 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -111.39 -28.72 8.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.661 1.184 . . . . 0.0 111.01 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.55 -43.78 68.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.817 0.735 . . . . 0.0 111.546 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.94 77.11 18.89 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.036 1.334 . . . . 0.0 107.403 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.44 -36.03 93.26 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.102 2.535 . . . . 0.0 114.368 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -77.55 98.66 5.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.212 0.605 . . . . 0.0 109.484 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.15 -6.65 18.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -85.45 -14.74 45.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.184 0.902 . . . . 0.0 111.929 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.913 0.885 . . . . 0.0 110.427 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -77.98 96.44 5.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.968 0.907 . . . . 0.0 110.17 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.51 93.28 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -73.36 129.74 38.65 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -115.18 143.31 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -142.13 168.12 20.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.216 1.006 . . . . 0.0 108.355 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.3 p -153.19 178.3 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -60.31 -25.43 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.76 5.76 4.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -29.67 2.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.987 1.279 . . . . 0.0 114.532 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.5 -51.95 67.28 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.535 1.168 . . . . 0.0 111.481 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -69.01 -33.83 74.29 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.889 -171.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -68.28 -34.93 77.06 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.156 0.889 . . . . 0.0 110.974 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.3 -50.92 57.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -62.93 -46.28 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.388 0.594 . . . . 0.0 110.864 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.51 -34.38 70.88 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 110.581 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.5 94.32 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.52 -43.24 77.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.287 0.494 . . . . 0.0 110.301 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -56.93 -49.16 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.474 0.71 . . . . 0.0 109.302 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.34 -30.67 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.709 0.804 . . . . 0.0 111.313 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 m -69.81 -37.51 76.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.682 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.72 -36.66 84.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.98 0.809 . . . . 0.0 110.162 174.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mmm -69.48 -3.78 15.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.34 1.056 . . . . 0.0 112.702 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.54 78.99 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.531 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -64.54 123.56 19.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.909 1.354 . . . . 0.0 107.599 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -29.78 69.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.157 0.583 . . . . 0.0 112.362 -169.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.01 111.81 7.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -146.7 149.57 15.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.76 128.39 9.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -80.19 113.38 18.32 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.3 69.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.95 -26.23 7.6 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.368 0.985 . . . . 0.0 112.335 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.96 167.79 16.04 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.89 1.233 . . . . 0.0 110.324 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.9 tp -54.77 -33.15 60.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.129 0.972 . . . . 0.0 112.313 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.12 -29.04 69.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.599 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.79 -40.83 54.43 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.48 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -53.27 117.24 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 123.441 0.697 . . . . 0.0 111.359 -168.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 50.67 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.353 1.461 . . . . 0.0 109.72 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.1 mmm -133.42 154.48 80.92 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.477 1.511 . . . . 0.0 108.143 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.72 145.94 29.15 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.684 2.256 . . . . 0.0 110.677 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.08 147.56 33.95 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.66 154.6 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.984 0.914 . . . . 0.0 108.835 -167.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -63.46 150.19 44.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.85 0.46 . . . . 0.0 110.08 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 173.861 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -148.41 126.71 12.23 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -76.14 143.67 41.04 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -140.36 128.95 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.97 124.95 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.05 16.35 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.525 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 35.0 ttt85 -89.46 -176.17 4.95 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.757 -1.214 . . . . 0.0 108.636 169.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 10.9 m -63.9 154.34 81.64 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 121.813 -0.554 . . . . 0.0 109.51 170.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.3 -12.99 35.59 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.314 2.676 . . . . 0.0 114.25 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.05 -37.83 69.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.824 0.849 . . . . 0.0 111.573 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.67 -43.29 84.91 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.854 0.752 . . . . 0.0 110.128 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -57.74 -30.5 65.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.955 1.302 . . . . 0.0 111.269 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -65.87 -50.79 63.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.305 0.642 . . . . 0.0 110.856 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.97 -49.88 40.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.868 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.85 150.81 13.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.824 0.738 . . . . 0.0 110.49 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -139.07 156.03 47.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.947 1.299 . . . . 0.0 108.289 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.75 130.85 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.69 105.97 0.73 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.67 -13.48 9.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.045 1.307 . . . . 0.0 112.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.08 155.05 41.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.342 1.071 . . . . 0.0 110.191 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mm -120.09 135.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.98 116.15 16.39 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.54 81.06 17.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.611 . . . . 0.0 106.77 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.4 151.4 23.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.778 2.985 . . . . 0.0 114.31 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.8 tp -48.6 -41.66 31.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.29 1.836 . . . . 0.0 113.001 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.75 -12.0 61.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -126.15 -15.28 5.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.938 1.295 . . . . 0.0 112.051 -169.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.06 -39.79 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.769 1.627 . . . . 0.0 113.252 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -55.26 -40.93 71.52 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.575 0.75 . . . . 0.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -91.07 -2.4 57.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.219 0.607 . . . . 0.0 111.272 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.32 -15.32 1.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.79 -40.37 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.052 1.296 . . . . 0.0 111.262 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.22 -32.55 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.405 0.548 . . . . 0.0 112.13 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -10.3 58.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.909 0.883 . . . . 0.0 113.175 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 -30.4 4.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.356 0.98 . . . . 0.0 111.992 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.42 79.69 41.37 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.571 1.149 . . . . 0.0 107.994 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.98 -37.75 91.73 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.415 2.077 . . . . 0.0 112.131 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -77.51 96.76 4.81 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.134 0.974 . . . . 0.0 109.841 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.37 8.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -107.8 -6.99 16.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.671 1.188 . . . . 0.0 111.769 170.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.39 145.34 52.95 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 m -80.14 97.36 6.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 109.676 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -72.03 104.7 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -83.16 84.65 7.4 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 m -69.34 140.17 19.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -145.12 164.04 32.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.178 0.991 . . . . 0.0 108.936 171.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.02 171.25 18.66 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.281 1.432 . . . . 0.0 107.717 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -49.94 -33.22 16.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.02 -6.73 10.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.12 -31.44 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.792 1.178 . . . . 0.0 113.949 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.78 -56.48 21.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.852 1.326 . . . . 0.0 111.303 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.03 -32.4 74.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.674 0.39 . . . . 0.0 110.824 -169.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 p -71.66 -35.53 70.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.339 0.972 . . . . 0.0 111.405 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.27 -48.52 59.27 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.94 -48.4 76.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.671 0.788 . . . . 0.0 110.576 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.95 69.2 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.891 -0.506 . . . . 0.0 111.814 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -60.83 -45.0 96.18 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.92 -41.59 91.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.142 0.428 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.88 -50.53 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.6 mt -70.31 -29.01 65.64 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.554 -0.717 . . . . 0.0 111.395 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.386 0.539 . . . . 0.0 109.953 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.95 -35.78 78.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.282 0.633 . . . . 0.0 110.968 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.5 mmm -64.98 -15.48 62.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.851 0.86 . . . . 0.0 112.118 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.37 14.43 55.74 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.074 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -66.25 121.67 15.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.235 1.517 . . . . 0.0 107.37 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.5 p -75.08 -23.81 58.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.497 0.319 . . . . 0.0 111.522 -171.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -134.98 104.81 6.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.819 1.248 . . . . 0.0 107.67 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -142.16 143.33 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.39 127.17 17.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.14 111.98 9.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 166.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.55 66.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.29 -26.84 10.69 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 125.026 1.298 . . . . 0.0 110.765 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.3 174.68 13.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 124.524 1.059 . . . . 0.0 111.481 168.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 tp -60.45 -30.33 69.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 110.067 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -61.55 -18.82 60.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.748 1.619 . . . . 0.0 113.271 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -118.12 -36.93 3.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.027 0.83 . . . . 0.0 112.021 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 82.4 mt -57.52 141.2 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.029 0.831 . . . . 0.0 109.538 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.88 24.5 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.011 1.324 . . . . 0.0 111.959 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.2 mmm -69.52 164.16 52.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.506 1.123 . . . . 0.0 108.596 167.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.77 147.78 30.71 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.612 2.208 . . . . 0.0 110.904 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -134.78 142.86 46.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.27 149.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.131 1.372 . . . . 0.0 108.486 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -69.08 162.19 27.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.769 0.428 . . . . 0.0 111.093 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 124.883 1.23 . . . . 0.0 110.611 172.725 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.314 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -82.69 100.66 10.36 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -73.01 145.45 46.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.9 mt -147.16 139.26 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -96.93 124.97 41.05 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.45 12.74 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.77 -174.34 4.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.172 1.351 . . . . 0.0 108.159 167.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 m -57.29 156.04 16.38 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.656 0.782 . . . . 0.0 110.358 167.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.48 -14.35 43.83 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.081 2.521 . . . . 0.0 113.511 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -46.15 -49.44 16.79 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 110.82 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -69.75 -37.81 76.59 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.308 -0.245 . . . . 0.0 110.383 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -58.46 -31.22 67.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.119 1.368 . . . . 0.0 111.314 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -67.12 -39.67 86.7 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.23 0.468 . . . . 0.0 110.73 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -68.73 -54.21 17.46 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.27 152.53 4.99 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.015 1.726 . . . . 0.0 106.907 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.65 147.98 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 108.952 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.6 t -54.09 125.77 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -56.34 -24.11 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -166.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.59 -8.07 41.05 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.885 0.755 . . . . 0.0 112.764 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.81 170.3 15.61 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.223 1.011 . . . . 0.0 111.094 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.6 pt -142.95 138.92 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.661 2.384 . . . . 0.0 105.213 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.38 116.43 18.79 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.3 mt -140.67 86.98 11.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.95 153.47 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.638 2.892 . . . . 0.0 113.9 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.7 tp -51.21 -35.81 38.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.065 1.746 . . . . 0.0 112.943 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.22 -16.49 63.59 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.501 0.721 . . . . 0.0 112.775 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.76 -22.26 3.59 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.553 1.141 . . . . 0.0 111.911 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -47.42 -37.19 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.641 1.576 . . . . 0.0 112.377 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.75 -33.12 60.79 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.416 1.086 . . . . 0.0 112.301 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.52 -45.24 4.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.0 0.52 . . . . 0.0 109.951 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.91 -19.64 65.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.311 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -54.97 -34.99 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.104 0.866 . . . . 0.0 111.133 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.16 96.64 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.19 0.904 . . . . 0.0 111.273 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -37.04 45.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.463 0.705 . . . . 0.0 111.133 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.7 72.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.369 0.531 . . . . 0.0 112.057 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -139.55 79.42 24.53 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.771 1.628 . . . . 0.0 107.179 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.91 10.68 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.766 2.978 . . . . 0.0 114.502 -171.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -138.21 107.88 6.24 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.272 1.429 . . . . 0.0 107.163 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -63.25 -15.08 55.99 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.64 -15.51 58.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.73 0.695 . . . . 0.0 111.957 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -67.94 150.19 48.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.027 0.83 . . . . 0.0 110.672 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -70.24 141.87 52.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.969 0.907 . . . . 0.0 109.674 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.85 145.33 31.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -130.72 135.33 47.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.92 137.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -136.68 168.57 19.27 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 p -152.55 -175.89 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 170.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -59.18 -29.55 67.54 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.65 10.33 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -168.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.52 -29.36 2.29 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.795 1.188 . . . . 0.0 114.304 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -62.34 -50.85 69.99 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.374 1.087 . . . . 0.0 111.418 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -69.49 -31.97 70.57 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.537 0.608 . . . . 0.0 110.569 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -36.22 82.45 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 119.381 0.991 . . . . 0.0 110.734 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.24 -52.0 50.33 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -62.4 -46.24 89.48 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.486 -0.42 . . . . 0.0 111.176 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.32 74.84 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 118.222 0.465 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -63.05 -43.45 98.62 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.98 -44.78 91.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.662 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.56 -52.51 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.976 0.807 . . . . 0.0 109.072 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.15 -28.4 64.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.987 -0.446 . . . . 0.0 111.221 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.0 m -65.23 -42.16 93.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.353 0.524 . . . . 0.0 110.397 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.12 -33.92 76.49 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.879 0.763 . . . . 0.0 110.91 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -69.46 -8.75 49.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.845 0.858 . . . . 0.0 112.303 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.97 60.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.972 -0.904 . . . . 0.0 113.467 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.98 120.81 19.12 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -84.6 -17.22 39.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -167.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -133.24 38.77 3.3 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.873 0.869 . . . . 0.0 111.037 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -80.6 145.81 8.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -140.91 137.91 33.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.715 0.806 . . . . 0.0 109.139 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -72.32 106.73 4.59 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.89 79.18 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.39 -148.22 19.83 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.73 167.26 13.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.35 -34.17 66.36 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.533 1.133 . . . . 0.0 112.552 -170.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.36 -11.44 57.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.114 0.966 . . . . 0.0 113.168 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -117.1 -34.87 4.24 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.796 1.238 . . . . 0.0 111.982 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.4 127.14 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.23 24.31 8.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.484 1.113 . . . . 0.0 111.869 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.1 165.36 48.56 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 167.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.31 149.9 21.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.484 2.122 . . . . 0.0 111.688 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -131.91 158.47 41.31 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.878 0.871 . . . . 0.0 109.118 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -128.72 169.05 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -131.68 167.77 18.89 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.949 -1.094 . . . . 0.0 109.685 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 173.562 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.55 152.27 43.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.442 1.497 . . . . 0.0 107.806 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -130.04 136.13 49.03 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.591 1.156 . . . . 0.0 108.78 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.96 131.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.21 117.05 23.27 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.84 23.12 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 5.6 ttt180 -111.24 -175.5 2.72 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.8 -1.188 . . . . 0.0 110.74 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 2.7 m -60.64 150.41 75.4 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.875 0.87 . . . . 0.0 109.971 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -53.81 -23.98 29.09 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.573 2.849 . . . . 0.0 115.118 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.92 -26.35 68.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 117.428 -1.272 . . . . 0.0 113.283 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.01 -50.82 45.39 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 120.818 1.645 . . . . 0.0 109.5 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -55.91 -37.28 68.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.164 1.386 . . . . 0.0 111.373 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -61.77 -11.05 10.48 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.379 1.471 . . . . 0.0 113.985 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.16 -38.76 1.77 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.513 1.506 . . . . 0.0 112.153 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -156.48 145.32 20.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.042 1.292 . . . . 0.0 110.754 168.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -142.06 154.77 45.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 107.49 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.21 132.61 20.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -55.88 120.45 7.4 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.27 -13.51 61.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.298 0.951 . . . . 0.0 112.984 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.02 161.17 30.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.474 1.137 . . . . 0.0 111.067 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.58 137.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.9 1.68 . . . . 0.0 107.338 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.27 117.15 19.25 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -143.2 87.93 8.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -54.12 155.6 15.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.1 3.2 . . . . 0.0 114.382 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 tp -48.49 -41.93 31.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.2 1.8 . . . . 0.0 112.979 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.18 -8.38 54.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.5 -17.1 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.104 1.362 . . . . 0.0 111.829 -169.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.29 -30.42 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.314 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.6 -47.66 73.12 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.732 1.213 . . . . 0.0 111.623 -169.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -88.95 -41.82 12.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.93 0.332 . . . . 0.0 110.241 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -70.28 -15.36 62.89 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.59 -33.22 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.071 0.85 . . . . 0.0 110.851 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.11 -40.69 98.35 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.42 1.009 . . . . 0.0 111.043 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.28 -36.73 66.37 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.26 0.624 . . . . 0.0 111.168 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.43 72.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.478 0.581 . . . . 0.0 111.968 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.08 83.66 11.0 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.719 1.607 . . . . 0.0 107.425 -171.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.6 -38.12 96.17 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.875 2.383 . . . . 0.0 113.845 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -85.37 99.96 11.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.224 0.609 . . . . 0.0 109.677 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 48.6 pttt -62.81 -15.32 53.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -82.86 -11.9 57.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.024 0.829 . . . . 0.0 111.912 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.07 155.48 40.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.878 0.763 . . . . 0.0 111.191 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 140.01 54.25 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.38 140.5 43.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -123.75 147.46 28.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -150.07 164.72 34.82 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.894 1.677 . . . . 0.0 107.231 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.479 ' HG ' ' HB2' ' A' ' 53' ' ' GLN . 48.8 t -161.09 157.19 25.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.572 0.349 . . . . 0.0 110.167 -172.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.93 -23.62 19.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.13 0.972 . . . . 0.0 112.72 168.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.06 105.12 7.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 170.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.99 -23.77 57.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.622 1.106 . . . . 0.0 114.215 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -57.6 -36.9 72.36 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.433 1.116 . . . . 0.0 111.778 171.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.479 ' HB2' ' HG ' ' A' ' 48' ' ' CYS . 38.2 mt-30 -71.53 -37.67 71.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.567 0.747 . . . . 0.0 110.685 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p -68.24 -26.99 65.97 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 110.824 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.36 -46.24 93.25 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -61.02 -48.7 80.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.865 0.833 . . . . 0.0 110.242 175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.14 77.13 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.819 0.282 . . . . 0.0 110.706 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.77 -39.57 92.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.42 -35.32 73.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.174 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.05 -47.99 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.749 1.159 . . . . 0.0 108.786 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.68 -33.82 76.49 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.668 -0.645 . . . . 0.0 110.861 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 m -65.56 -39.21 91.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.828 0.451 . . . . 0.0 110.656 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.12 -36.22 82.56 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.504 0.721 . . . . 0.0 110.241 175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mmm -69.17 -3.92 15.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.189 0.995 . . . . 0.0 112.595 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.4 14.75 65.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.359 170.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 20.9 m-85 -70.0 129.14 38.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.936 1.368 . . . . 0.0 107.552 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -91.59 -18.74 23.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -167.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.88 40.47 3.36 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.323 1.049 . . . . 0.0 110.387 -169.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.78 149.45 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -143.93 142.06 30.56 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -86.33 106.8 17.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.75 66.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.872 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.53 -165.64 14.47 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.968 0.794 . . . . 0.0 112.238 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.48 151.7 52.33 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.92 30.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.255 1.822 . . . . 0.0 113.134 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -64.14 -33.19 75.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.607 0.763 . . . . 0.0 111.825 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.41 -30.03 64.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.371 0.532 . . . . 0.0 111.705 -172.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.76 91.28 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 26.43 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.851 1.261 . . . . 0.0 113.507 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.8 mtp -77.64 158.89 77.91 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.42 153.97 12.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.582 2.855 . . . . 0.0 111.703 167.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -138.97 153.9 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 108.864 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.7 p -151.84 156.69 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -68.16 152.17 45.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.796 0.839 . . . . 0.0 109.134 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.074 174.725 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.39 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -77.17 151.67 35.17 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -126.23 135.32 51.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -136.68 125.63 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.67 120.99 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.3 21.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.7 -173.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.943 -1.098 . . . . 0.0 110.216 173.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.84 152.06 77.46 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.03 -13.4 35.03 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.626 2.217 . . . . 0.0 113.371 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -55.22 -39.09 69.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.284 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -66.29 -47.85 72.31 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 120.405 1.457 . . . . 0.0 109.909 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -56.46 -37.31 70.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.948 1.299 . . . . 0.0 111.293 -172.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -58.87 -52.99 63.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.2 1.8 . . . . 0.0 110.949 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -72.32 -49.1 37.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.265 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.05 151.46 14.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.331 0.968 . . . . 0.0 111.029 167.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -139.03 153.06 48.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 170.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.44 128.4 15.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.92 106.85 1.32 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -17.69 7.49 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.933 1.254 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.18 164.75 25.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.777 0.788 . . . . 0.0 110.71 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 pt -139.88 139.0 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.263 1.825 . . . . 0.0 106.939 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -77.38 115.8 17.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.872 0.469 . . . . 0.0 109.941 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -141.2 84.09 13.13 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.11 150.73 18.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.999 3.133 . . . . 0.0 113.806 -171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.82 -41.01 22.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.159 1.784 . . . . 0.0 112.58 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.06 -14.68 61.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.432 0.693 . . . . 0.0 112.832 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.15 -7.82 3.84 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.328 1.051 . . . . 0.0 112.369 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.8 -38.62 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.098 1.317 . . . . 0.0 110.695 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.2 -26.36 64.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.694 1.197 . . . . 0.0 112.669 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -105.48 -2.24 23.92 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.378 1.071 . . . . 0.0 111.385 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -131.48 -23.58 2.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -168.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tp -57.94 -33.94 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.355 0.979 . . . . 0.0 110.576 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -16.62 52.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 113.357 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -114.96 -28.63 6.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.657 1.183 . . . . 0.0 111.028 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.03 -38.67 72.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.733 0.697 . . . . 0.0 111.459 173.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -140.37 72.83 31.4 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.094 1.758 . . . . 0.0 107.289 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.0 -37.96 93.86 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.812 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.94 88.88 5.88 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.288 0.635 . . . . 0.0 109.84 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -65.37 -4.95 6.23 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.84 -18.69 58.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.408 1.003 . . . . 0.0 111.486 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.96 152.29 41.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.154 -0.966 . . . . 0.0 110.327 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -71.51 149.57 45.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.0 146.81 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -129.22 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.89 148.6 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -174.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -150.83 166.72 29.65 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.775 1.63 . . . . 0.0 107.379 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.0 p -161.34 172.55 16.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.563 0.745 . . . . 0.0 109.623 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.96 -52.52 62.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.7 1.2 . . . . 0.0 112.192 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.28 -35.52 61.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.337 0.255 . . . . 0.0 111.389 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.43 8.91 55.89 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.034 -0.87 . . . . 0.0 113.498 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -124.08 -23.68 4.53 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.117 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.46 -33.59 71.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.762 1.619 . . . . 0.0 110.031 169.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 p -65.99 -37.88 87.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.703 0.801 . . . . 0.0 111.587 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.41 -47.88 73.2 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 169.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -61.91 -50.97 70.03 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.872 0.869 . . . . 0.0 109.992 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.07 79.27 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.05 0.54 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -61.45 -39.76 92.01 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -35.09 69.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.068 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.19 -49.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.604 1.093 . . . . 0.0 108.648 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -66.16 -34.71 78.66 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.907 -0.495 . . . . 0.0 110.5 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -64.3 -41.56 96.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 110.746 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.12 -37.13 86.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.322 0.649 . . . . 0.0 110.195 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mtp -71.39 -3.05 18.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 112.792 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.89 16.01 68.81 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.458 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.2 124.97 22.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.217 1.509 . . . . 0.0 107.177 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.7 p -68.81 -29.05 67.31 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -166.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -150.09 106.87 3.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -173.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.22 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.19 145.94 32.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.472 0.709 . . . . 0.0 109.123 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -90.4 114.27 26.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.87 69.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.669 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.48 -158.27 14.56 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.615 1.102 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.09 162.32 35.91 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.737 0.684 . . . . 0.0 111.72 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -30.22 64.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.347 1.059 . . . . 0.0 112.869 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.66 -27.76 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.475 -0.766 . . . . 0.0 111.939 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.03 -44.73 62.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.841 0.746 . . . . 0.0 112.971 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 78' ' ' ILE . 3.1 mp -55.85 119.59 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.346 0.658 . . . . 0.0 110.276 -169.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.56 52.75 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.294 1.438 . . . . 0.0 110.669 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -136.69 154.74 76.75 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.295 1.438 . . . . 0.0 109.169 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.89 155.7 10.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.644 2.896 . . . . 0.0 112.096 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -138.97 146.1 40.55 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.16 152.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.908 1.283 . . . . 0.0 108.566 -169.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.37 161.73 26.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.05 0.54 . . . . 0.0 110.149 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 124.596 1.094 . . . . 0.0 110.887 170.595 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--O 1.235 0.32 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -140.28 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.011 1.324 . . . . 0.0 107.701 168.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -134.43 137.91 44.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.3 133.19 58.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.28 134.21 38.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.84 33.67 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.442 1.019 . . . . 0.0 113.569 -168.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -125.15 -179.21 4.48 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.659 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.07 160.97 80.81 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.559 1.144 . . . . 0.0 111.005 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.7 -16.78 11.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.273 3.315 . . . . 0.0 116.108 175.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -50.89 -37.86 46.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.756 1.223 . . . . 0.0 112.296 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.25 -45.16 15.39 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -56.69 -37.09 70.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.919 1.288 . . . . 0.0 111.424 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -67.81 -5.36 16.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.056 1.343 . . . . 0.0 114.095 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -131.76 -33.82 1.37 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.782 1.174 . . . . 0.0 112.147 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.24 139.96 8.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.731 1.151 . . . . 0.0 108.819 166.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -142.6 148.81 38.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 166.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.57 132.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 -35.48 80.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.874 0.47 . . . . 0.0 111.124 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 -4.16 90.47 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.3 -0.722 . . . . 0.0 113.06 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.01 166.86 23.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.515 1.157 . . . . 0.0 111.075 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.6 pt -135.75 131.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -82.89 115.43 21.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.2 81.09 38.92 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.977 1.711 . . . . 0.0 106.726 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 152.81 7.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 113.706 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.23 -44.58 8.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.953 1.701 . . . . 0.0 112.359 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -67.15 -15.69 63.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -122.0 -18.86 6.83 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.405 1.082 . . . . 0.0 111.893 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.46 -32.39 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.61 1.164 . . . . 0.0 111.457 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -64.76 -8.68 15.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.14 -48.91 1.33 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.255 0.934 . . . . 0.0 109.83 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.64 -23.53 67.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.12 -32.58 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.868 0.758 . . . . 0.0 111.32 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.53 96.67 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.253 0.933 . . . . 0.0 110.655 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.67 -35.89 67.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.4 -44.58 64.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.526 0.603 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.77 85.25 9.31 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 108.018 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.63 -29.57 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.135 1.89 . . . . 0.0 112.25 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -79.68 96.63 6.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -68.84 -7.23 32.49 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.08 -6.06 39.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.664 0.786 . . . . 0.0 110.673 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.23 151.67 47.11 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -72.4 129.74 39.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.65 95.38 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -77.26 133.82 38.74 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.84 143.61 36.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.76 0.824 . . . . 0.0 108.958 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.42 159.51 44.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 109.036 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.5 p -155.52 169.6 23.91 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.728 1.611 . . . . 0.0 107.918 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -48.24 -26.2 1.86 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.24 -1.0 8.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.99 -46.75 1.52 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.413 1.482 . . . . 0.0 112.557 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 tpt85 -59.55 -45.95 90.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.234 1.017 . . . . 0.0 112.46 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -70.43 -31.82 69.15 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.239 0.472 . . . . 0.0 110.005 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -33.68 75.85 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.97 -1.081 . . . . 0.0 110.775 168.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -46.62 85.62 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -62.46 -43.53 98.6 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.571 1.186 . . . . 0.0 110.648 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 -39.61 80.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.271 0.487 . . . . 0.0 109.734 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -66.8 -38.81 87.23 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.853 -0.53 . . . . 0.0 109.867 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.06 -45.04 95.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 110.073 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.8 mt -57.99 -50.39 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.783 0.833 . . . . 0.0 109.084 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.1 -31.56 72.11 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.826 -0.546 . . . . 0.0 111.058 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -64.4 -40.63 96.17 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.492 0.587 . . . . 0.0 110.358 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.36 -36.95 85.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.751 0.705 . . . . 0.0 110.477 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -71.26 -5.1 29.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.077 0.951 . . . . 0.0 112.834 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.65 56.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.215 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -68.89 146.01 53.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.208 1.504 . . . . 0.0 107.708 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 p -125.06 -1.19 7.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 31.58 1.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.911 0.862 . . . . 0.0 111.007 175.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.11 146.99 7.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.803 0.841 . . . . 0.0 108.975 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.12 141.85 19.98 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -84.04 110.61 18.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -30.98 72.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.316 0.247 . . . . 0.0 111.483 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.15 -163.19 29.13 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.294 1.426 . . . . 0.0 109.982 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.12 159.26 32.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 169.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.5 tp -55.69 -33.03 63.8 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.86 1.264 . . . . 0.0 112.295 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -68.48 -28.68 67.24 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.112 0.565 . . . . 0.0 111.527 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.61 -39.44 22.18 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.043 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.17 134.13 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.96 26.4 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.775 1.23 . . . . 0.0 111.531 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -66.94 159.55 75.32 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 143.19 43.71 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.915 2.41 . . . . 0.0 111.707 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.14 155.76 47.6 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.96 0.904 . . . . 0.0 109.674 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.97 160.44 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.257 1.823 . . . . 0.0 108.026 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -73.4 150.03 42.03 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 169.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.104 -1.386 . . . . 0.0 110.306 172.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.235 0.32 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -131.0 95.4 3.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.213 1.805 . . . . 0.0 106.313 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -77.95 136.94 38.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.99 122.53 52.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -81.45 113.68 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.5 20.7 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -110.27 -169.12 1.41 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.256 -0.902 . . . . 0.0 109.714 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.62 149.49 61.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.46 -14.44 44.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.305 2.003 . . . . 0.0 112.899 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -55.22 -38.39 68.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.753 0.821 . . . . 0.0 111.372 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -69.28 -46.27 67.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.553 1.07 . . . . 0.0 109.826 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -58.65 -34.38 71.14 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 111.473 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -62.63 -39.78 94.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.507 1.123 . . . . 0.0 110.677 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -67.95 -49.67 60.43 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.385 0.993 . . . . 0.0 108.704 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.81 152.58 4.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.334 1.853 . . . . 0.0 107.548 167.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -136.95 152.38 50.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.704 1.201 . . . . 0.0 108.577 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.77 126.51 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -55.92 121.71 9.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.112 0.565 . . . . 0.0 109.682 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.67 70.64 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.222 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.25 163.14 13.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.79 1.295 . . . . 0.0 111.549 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.2 138.99 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.276 1.43 . . . . 0.0 108.394 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.82 114.86 18.11 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.037 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.72 80.94 20.45 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.639 1.575 . . . . 0.0 107.095 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.81 154.34 12.91 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.725 2.95 . . . . 0.0 113.819 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.4 tp -47.46 -36.19 9.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 113.039 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.77 -17.94 65.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.809 0.844 . . . . 0.0 113.116 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -127.75 -17.43 4.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.983 0.913 . . . . 0.0 112.174 -169.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.41 -33.03 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.119 1.368 . . . . 0.0 112.686 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.05 -25.0 65.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 112.877 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.21 -41.34 2.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.667 0.667 . . . . 0.0 110.392 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -63.53 -17.47 62.82 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.02 -37.24 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.24 0.927 . . . . 0.0 111.22 171.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.7 90.26 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.972 0.805 . . . . 0.0 111.528 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -79.41 -38.25 35.27 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.082 0.553 . . . . 0.0 110.352 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.71 78.98 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.961 0.504 . . . . 0.0 112.211 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 83.28 21.58 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.81 1.244 . . . . 0.0 107.962 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.86 -21.18 32.05 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.63 2.887 . . . . 0.0 115.129 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -131.63 95.57 3.76 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.549 1.14 . . . . 0.0 108.674 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -65.82 -5.52 9.22 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.496 1.119 . . . . 0.0 113.251 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -71.13 -21.43 62.2 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.113 0.87 . . . . 0.0 111.09 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 147.73 52.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -62.91 127.43 31.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.233 0.47 . . . . 0.0 109.765 -172.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.06 134.99 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.14 103.28 6.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.43 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.33 158.55 43.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.531 1.533 . . . . 0.0 108.562 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.5 p -144.22 -175.52 4.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.105 1.362 . . . . 0.0 107.667 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -56.76 -32.13 65.3 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.8 7.36 4.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -167.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.13 2.28 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.74 1.162 . . . . 0.0 113.416 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -59.51 -48.13 82.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.372 1.086 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.78 -24.91 58.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.052 0.842 . . . . 0.0 111.514 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -33.1 67.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 120.973 -1.08 . . . . 0.0 110.16 168.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -47.09 84.15 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.25 -45.17 95.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.166 0.983 . . . . 0.0 110.459 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.09 74.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.103 0.411 . . . . 0.0 110.797 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.84 -44.28 77.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.198 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.66 -39.5 88.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.274 1.397 . . . . 0.0 110.58 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.73 -51.18 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.866 0.866 . . . . 0.0 109.557 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.89 -34.2 76.19 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.894 -0.504 . . . . 0.0 111.147 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.7 m -66.09 -35.88 81.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.636 0.775 . . . . 0.0 110.0 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.85 -47.69 65.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.759 0.424 . . . . 0.0 110.152 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -68.65 -35.94 77.91 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.713 -0.661 . . . . 0.0 112.174 -170.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.88 45.18 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 CA-C-O 119.021 -0.877 . . . . 0.0 114.177 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.48 159.48 2.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.661 1.23 . . . . 0.0 112.742 175.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.5 p -137.95 -37.01 0.6 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.893 0.877 . . . . 0.0 110.942 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -142.67 34.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.364 0.983 . . . . 0.0 111.523 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.82 141.02 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.34 144.85 38.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.601 1.561 . . . . 0.0 107.316 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -87.06 105.64 17.3 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.13 75.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.444 0.298 . . . . 0.0 111.275 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.87 -136.27 5.78 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.14 170.76 20.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 169.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.93 -39.92 91.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.728 0.811 . . . . 0.0 109.915 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -67.95 -3.69 10.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.919 1.287 . . . . 0.0 113.669 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.37 -37.33 2.03 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.289 0.949 . . . . 0.0 112.245 -169.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 mt -58.96 144.3 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.602 1.092 . . . . 0.0 110.519 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 75.42 1.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.751 1.62 . . . . 0.0 107.775 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.2 mtp -140.21 162.86 47.65 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 126.68 1.992 . . . . 0.0 107.669 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.03 143.48 40.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.965 2.444 . . . . 0.0 111.653 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -138.52 147.44 43.13 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.05 154.29 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.253 1.421 . . . . 0.0 108.408 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.6 155.92 39.53 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.006 -0.434 . . . . 0.0 110.576 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.235 0.342 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -135.26 107.61 7.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -73.57 149.1 42.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mm -138.12 131.59 41.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.87 94.49 8.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.85 35.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -166.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.37 -179.78 6.88 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.465 -1.397 . . . . 0.0 108.635 -172.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -53.4 146.72 22.17 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.406 0.548 . . . . 0.0 111.999 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -10.1 14.04 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 114.465 -172.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.69 -42.6 71.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 110.939 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -35.76 69.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.941 -0.474 . . . . 0.0 111.462 178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -58.02 -28.73 64.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.904 1.281 . . . . 0.0 110.953 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.69 -46.67 81.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.061 0.544 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.21 -45.0 43.24 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.152 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.15 152.06 12.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.074 0.852 . . . . 0.0 110.934 167.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -146.78 160.53 42.14 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.131 1.373 . . . . 0.0 108.94 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -55.65 125.82 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.052 1.341 . . . . 0.0 108.66 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -29.54 69.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 111.818 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.06 17.27 57.42 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.167 -1.352 . . . . 0.0 113.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.28 170.58 10.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.216 1.508 . . . . 0.0 112.018 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.0 pt -142.47 142.8 26.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 127.207 2.203 . . . . 0.0 107.023 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.21 116.1 19.27 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.162 0.585 . . . . 0.0 109.919 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -137.73 73.3 47.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.26 150.61 14.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.652 2.902 . . . . 0.0 113.733 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 tp -45.84 -36.16 5.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.973 1.709 . . . . 0.0 112.916 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -63.34 -18.45 63.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.018 0.927 . . . . 0.0 113.03 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -127.49 -24.17 3.37 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.293 1.037 . . . . 0.0 111.13 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -44.66 -35.63 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.407 1.883 . . . . 0.0 113.431 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -53.84 -36.48 62.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.273 0.942 . . . . 0.0 112.47 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.45 -39.14 4.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.412 0.551 . . . . 0.0 109.729 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -67.74 -16.41 64.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.686 0.795 . . . . 0.0 112.352 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.12 -32.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.478 1.035 . . . . 0.0 111.024 169.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.02 98.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.103 . . . . 0.0 110.765 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.25 -35.75 74.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.4 0.68 . . . . 0.0 111.247 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -45.3 66.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.096 0.558 . . . . 0.0 111.968 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.25 88.12 8.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.47 1.508 . . . . 0.0 107.761 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.55 -40.87 70.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.917 2.412 . . . . 0.0 113.18 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -81.22 99.08 8.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 28.5 mtmm -66.2 -8.09 22.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.62 -7.39 22.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.136 0.88 . . . . 0.0 111.597 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.92 151.17 48.09 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.941 0.791 . . . . 0.0 109.718 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 131.49 46.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.464 0.575 . . . . 0.0 109.84 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.87 129.39 75.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -126.61 86.32 2.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.04 154.72 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.54 158.5 41.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 108.08 168.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 p -133.52 -139.56 0.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.409 0.684 . . . . 0.0 110.241 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -74.32 -37.94 63.46 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.141 -0.974 . . . . 0.0 111.229 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.83 -39.31 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.52 -26.08 0.14 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.77 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.27 -62.75 1.55 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.177 1.488 . . . . 0.0 111.813 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.08 -32.64 73.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.977 0.353 . . . . 0.0 111.17 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -76.19 -33.85 59.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.582 -0.699 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.97 -46.52 93.57 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -60.4 -50.35 73.94 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.664 0.786 . . . . 0.0 109.784 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.75 78.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.68 -38.7 87.35 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.84 -39.31 87.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.313 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.48 -46.29 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.34 0.973 . . . . 0.0 109.356 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.74 -36.86 85.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.85 0.75 . . . . 0.0 110.462 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -64.44 -42.36 96.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.067 0.547 . . . . 0.0 110.305 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.63 -33.91 76.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.758 0.708 . . . . 0.0 111.126 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.3 mmm -71.28 -3.18 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.74 18.68 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.373 -0.829 . . . . 0.0 112.975 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 23.0 m-85 -66.95 157.2 33.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.719 1.259 . . . . 0.0 109.23 169.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 p -135.17 164.78 26.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.269 1.428 . . . . 0.0 108.242 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 51.99 35.34 15.78 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.4 1.08 . . . . 0.0 111.932 -169.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.18 143.54 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.48 154.04 41.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.005 1.322 . . . . 0.0 107.49 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -109.51 116.0 30.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.75 61.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.533 0.733 . . . . 0.0 111.96 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.51 -92.27 0.58 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.2 175.22 28.52 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 tp -47.95 -35.67 11.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 113.672 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -65.27 -27.62 68.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.263 0.625 . . . . 0.0 112.146 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.42 -45.65 37.57 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.831 0.741 . . . . 0.0 111.726 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.546 ' H ' HD12 ' A' ' 78' ' ' ILE . 4.9 mp -58.78 115.46 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.978 0.911 . . . . 0.0 110.162 -170.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.19 53.57 2.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 110.399 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.0 ptm -137.54 163.52 47.94 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 123.578 0.751 . . . . 0.0 109.72 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.07 155.85 5.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.358 3.372 . . . . 0.0 113.696 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -137.52 145.49 43.03 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.17 152.48 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 125.045 1.338 . . . . 0.0 108.618 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -68.2 162.17 25.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.034 0.534 . . . . 0.0 111.166 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.912 1.244 . . . . 0.0 110.51 172.411 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.236 0.364 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -142.04 155.21 45.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.854 1.661 . . . . 0.0 108.164 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -137.47 148.82 46.36 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.453 1.101 . . . . 0.0 108.475 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.32 135.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -90.62 116.31 28.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 167.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.86 11.87 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -88.05 -174.81 4.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.057 1.299 . . . . 0.0 109.668 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m -58.4 152.83 41.66 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 122.67 0.388 . . . . 0.0 110.512 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.39 -17.17 58.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.727 2.285 . . . . 0.0 113.379 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -57.01 -39.2 74.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.112 0.869 . . . . 0.0 110.87 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -69.88 -35.04 74.34 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.349 0.522 . . . . 0.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -60.24 -26.71 66.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.676 1.19 . . . . 0.0 111.311 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -71.23 -46.1 61.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.683 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.9 -52.15 64.21 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.667 0.667 . . . . 0.0 109.315 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.82 157.36 8.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.655 1.582 . . . . 0.0 108.01 165.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -144.77 153.35 41.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.444 1.098 . . . . 0.0 108.634 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.68 123.31 4.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.75 68.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 0.0 111.754 -172.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.81 6.24 83.32 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.281 -1.289 . . . . 0.0 113.852 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.9 164.7 13.75 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.44 1.62 . . . . 0.0 111.16 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.7 139.02 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 126.282 1.833 . . . . 0.0 107.269 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.82 114.22 17.58 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.222 0.464 . . . . 0.0 109.779 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -141.67 89.25 9.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.44 155.64 20.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.438 2.758 . . . . 0.0 114.729 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.75 -36.17 24.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.722 2.009 . . . . 0.0 112.383 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.16 -17.53 62.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.873 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -128.12 -16.99 4.42 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.773 0.829 . . . . 0.0 112.309 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -50.0 -32.12 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.021 1.328 . . . . 0.0 112.41 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -55.33 -26.09 38.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.091 1.356 . . . . 0.0 112.969 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -116.81 -43.03 2.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.671 0.669 . . . . 0.0 109.544 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -69.57 -9.11 52.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.8 tp -53.47 -36.96 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.935 1.243 . . . . 0.0 110.408 169.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.59 96.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.351 0.978 . . . . 0.0 111.543 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -33.91 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.881 0.472 . . . . 0.0 111.042 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.89 73.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.395 0.543 . . . . 0.0 111.114 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.93 113.86 4.96 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.607 1.563 . . . . 0.0 106.995 -171.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.78 -23.87 43.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.096 2.531 . . . . 0.0 115.275 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -146.2 118.51 8.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 108.861 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.02 -12.16 7.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.824 1.249 . . . . 0.0 114.033 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.52 -20.51 59.94 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.847 0.749 . . . . 0.0 112.229 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.39 155.22 40.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.03 0.832 . . . . 0.0 108.87 168.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.41 131.16 44.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.133 0.879 . . . . 0.0 109.445 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.8 t -129.16 129.89 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.81 84.38 2.27 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 m -67.49 147.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.1 167.33 22.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.66 178.38 8.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -56.05 -35.79 67.31 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.88 5.3 6.6 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.57 -25.89 5.49 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.254 1.407 . . . . 0.0 114.891 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -64.24 -49.14 73.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.268 1.534 . . . . 0.0 110.799 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.22 -31.68 67.87 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.79 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -68.81 -31.31 70.22 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.906 1.23 . . . . 0.0 111.065 169.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.42 -50.14 64.55 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 167.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.74 -42.52 99.71 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-N 117.813 0.807 . . . . 0.0 111.745 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.66 82.91 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.849 0.75 . . . . 0.0 109.812 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -66.81 -39.46 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.232 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.48 -44.45 97.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.755 1.161 . . . . 0.0 110.827 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.71 -53.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.91 -27.39 65.73 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.047 -0.408 . . . . 0.0 110.652 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -64.44 -43.1 95.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.762 0.71 . . . . 0.0 110.624 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.71 -32.83 74.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.343 0.519 . . . . 0.0 110.258 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.9 mtp -74.3 4.15 6.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 113.114 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.56 47.15 6.49 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.972 1.26 . . . . 0.0 111.891 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.2 166.4 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.304 1.042 . . . . 0.0 113.465 173.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 p -138.47 -34.95 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.813 0.845 . . . . 0.0 111.014 167.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -138.37 32.9 2.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.178 0.899 . . . . 0.0 112.008 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -92.52 139.44 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.66 147.0 31.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.774 1.23 . . . . 0.0 108.938 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -87.83 114.58 24.58 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -51.43 65.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.779 0.432 . . . . 0.0 110.301 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.43 -164.46 27.68 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.91 170.68 40.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.9 tp -55.36 -31.07 61.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 0.0 112.7 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.66 -24.83 65.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.271 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.55 -48.45 32.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.209 0.913 . . . . 0.0 111.628 -170.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.527 ' H ' HD12 ' A' ' 78' ' ' ILE . 2.4 mp -61.34 115.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.27 0.628 . . . . 0.0 109.682 -169.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.38 56.48 2.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.453 1.501 . . . . 0.0 110.358 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.3 mtp -135.63 155.3 78.34 Favored Pre-proline 0 C--O 1.239 0.53 0 C-N-CA 125.3 1.44 . . . . 0.0 109.3 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.8 152.02 14.19 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.945 3.097 . . . . 0.0 112.662 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -135.94 143.29 44.83 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 m -141.16 155.51 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.991 1.316 . . . . 0.0 108.38 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.77 159.71 29.68 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.264 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.572 -1.127 . . . . 0.0 110.616 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.646 0.26 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -133.46 114.2 13.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.389 1.476 . . . . 0.0 107.837 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.4 141.97 48.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.5 mm -137.12 122.07 24.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.4 122.14 28.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 m -110.38 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.21 -168.43 1.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.864 -1.148 . . . . 0.0 109.701 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.52 152.37 96.29 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.078 0.551 . . . . 0.0 110.09 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.48 -21.72 14.72 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.577 2.851 . . . . 0.0 114.475 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.34 -28.99 69.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.104 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -74.73 -47.27 32.18 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 120.098 1.317 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.06 -42.96 77.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.983 0.913 . . . . 0.0 111.275 -171.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -59.0 -51.79 68.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.388 1.075 . . . . 0.0 110.904 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.71 -41.03 60.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.38 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -167.39 140.11 3.37 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.412 1.006 . . . . 0.0 109.473 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -133.86 154.45 51.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.308 1.043 . . . . 0.0 108.622 171.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.5 130.95 19.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.6 119.48 6.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.24 59.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.208 0.909 . . . . 0.0 112.695 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.62 159.94 32.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.474 1.137 . . . . 0.0 110.75 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.9 pt -136.43 141.33 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.204 1.802 . . . . 0.0 106.5 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.54 110.22 14.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -132.72 78.42 66.69 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.532 1.933 . . . . 0.0 106.131 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.91 151.35 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.818 3.012 . . . . 0.0 114.04 -170.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.1 tp -49.22 -39.58 30.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 112.468 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.91 -11.46 56.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -130.04 -15.97 3.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.351 1.06 . . . . 0.0 111.914 -172.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -51.7 -33.89 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.295 1.438 . . . . 0.0 112.101 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -53.03 -38.69 62.6 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.286 1.034 . . . . 0.0 111.908 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.52 -45.33 4.47 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.37 -21.41 66.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.582 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -57.38 -31.66 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.805 1.184 . . . . 0.0 110.988 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -22.6 63.71 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -113.46 -28.92 7.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 110.685 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.27 -41.56 94.11 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.764 0.711 . . . . 0.0 111.294 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 t -142.96 83.6 11.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.617 1.567 . . . . 0.0 107.037 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.01 -31.46 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.018 1.812 . . . . 0.0 112.482 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -80.88 94.59 6.51 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -68.03 -0.31 4.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.31 -8.47 20.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.257 0.935 . . . . 0.0 111.674 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.83 149.49 49.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.206 0.912 . . . . 0.0 109.439 170.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -65.48 141.3 58.54 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.03 -0.419 . . . . 0.0 109.918 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.47 133.74 64.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -126.26 88.99 2.93 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.04 141.68 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.57 164.24 34.08 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.343 1.057 . . . . 0.0 109.088 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -153.39 172.21 17.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.604 1.562 . . . . 0.0 107.474 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -54.16 -18.7 4.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.16 8.52 2.95 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -171.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 -43.76 1.92 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.241 1.401 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -54.05 -53.83 47.71 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.229 1.012 . . . . 0.0 112.525 -170.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -65.46 -35.86 82.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -67.52 -34.56 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.584 -0.698 . . . . 0.0 112.321 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.21 -45.6 73.32 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -65.39 -49.53 68.95 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.236 0.518 . . . . 0.0 110.359 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.67 72.04 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 122.776 0.431 . . . . 0.0 110.648 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.49 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.42 -36.59 71.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.541 -0.725 . . . . 0.0 110.977 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.62 -46.65 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.552 1.069 . . . . 0.0 109.12 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.59 -36.86 85.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.239 0.616 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 m -66.91 -37.86 85.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.537 0.335 . . . . 0.0 110.549 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.48 -36.03 81.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -69.91 0.19 6.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.757 1.223 . . . . 0.0 112.647 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.95 80.83 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.197 -0.939 . . . . 0.0 112.985 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -64.11 155.39 31.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.832 1.316 . . . . 0.0 108.907 171.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 p -131.19 164.07 26.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.984 1.314 . . . . 0.0 108.427 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.2 m80 52.65 34.44 15.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.49 144.09 10.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.99 155.62 37.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 108.292 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.31 117.47 29.17 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 168.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.3 90.89 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.411 0.444 . . . . 0.0 111.6 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.58 -26.48 2.4 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.7 1.143 . . . . 0.0 111.921 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.02 176.73 22.58 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 173.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.0 -33.66 70.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.137 0.575 . . . . 0.0 110.147 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.9 -38.51 88.62 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 110.962 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.95 -47.15 26.26 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.611 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 82.8 mt -62.54 126.36 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -171.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.01 22.48 15.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.789 1.235 . . . . 0.0 112.087 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -73.65 158.67 85.96 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 124.22 1.008 . . . . 0.0 109.126 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.8 155.55 10.6 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.587 2.858 . . . . 0.0 111.846 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -138.07 149.41 45.96 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.74 154.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.349 1.459 . . . . 0.0 108.575 -171.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.14 151.56 45.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 172.603 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -134.36 156.32 48.71 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.259 1.824 . . . . 0.0 107.704 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -121.61 137.46 54.73 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.28 125.94 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.79 108.77 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.295 22.7 m -101.88 22.63 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.137 0.426 . . . . 0.0 111.89 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.05 -177.06 3.16 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.704 -0.622 . . . . 0.0 110.464 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.08 152.84 95.62 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.221 0.608 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.81 -17.33 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.851 3.034 . . . . 0.0 115.042 171.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.08 -38.18 72.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.136 0.88 . . . . 0.0 111.461 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.93 -45.2 51.95 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.251 0.932 . . . . 0.0 109.991 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -52.85 -39.67 62.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.569 1.148 . . . . 0.0 111.699 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -54.8 -54.53 40.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.779 1.232 . . . . 0.0 111.385 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.19 -49.0 48.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.117 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.82 152.44 15.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.927 0.785 . . . . 0.0 110.635 167.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -134.19 158.32 43.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.593 1.157 . . . . 0.0 108.672 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.43 130.58 20.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 120.13 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.458 1.103 . . . . 0.0 110.101 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.63 -2.55 67.35 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.529 -1.15 . . . . 0.0 114.04 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.73 134.34 52.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.586 1.693 . . . . 0.0 109.787 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.4 130.64 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.07 113.84 12.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.567 1.076 . . . . 0.0 109.019 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.0 mt -140.79 81.62 16.44 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.59 151.97 17.58 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.661 2.907 . . . . 0.0 113.47 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.7 tp -47.75 -37.18 12.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.245 1.818 . . . . 0.0 113.216 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.86 -14.61 63.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -125.35 -19.79 4.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.836 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -50.11 -35.06 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.027 1.331 . . . . 0.0 112.465 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.69 -30.01 62.98 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.966 0.907 . . . . 0.0 112.327 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.81 -45.78 3.31 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.654 0.661 . . . . 0.0 110.102 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -63.87 -20.58 65.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.61 -34.13 34.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 0.0 111.477 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.35 97.12 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -34.71 55.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 111.137 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.39 70.84 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.429 0.559 . . . . 0.0 112.197 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.79 80.07 32.05 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.344 1.458 . . . . 0.0 107.238 -171.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.76 -1.58 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.191 2.594 . . . . 0.0 113.979 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -130.28 105.81 8.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.33 -15.0 55.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.85 -20.78 62.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.58 0.627 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.58 154.22 39.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.252 0.621 . . . . 0.0 111.619 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -76.95 135.49 38.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.625 -0.672 . . . . 0.0 109.567 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.09 90.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -72.17 131.54 42.92 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.41 143.14 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.67 163.11 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.076 0.951 . . . . 0.0 109.085 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 m -144.54 -179.19 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.416 1.886 . . . . 0.0 107.735 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -64.19 -37.73 88.51 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.455 -0.778 . . . . 0.0 112.245 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.97 -20.06 8.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.059 0.944 . . . . 0.0 113.249 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.63 -23.72 16.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.267 0.937 . . . . 0.0 113.922 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -68.88 -41.05 78.86 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.099 1.449 . . . . 0.0 111.469 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.31 -33.37 75.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.664 0.665 . . . . 0.0 111.418 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -71.62 -31.1 66.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.749 1.159 . . . . 0.0 110.694 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.19 -47.99 77.64 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -61.75 -46.12 90.98 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.967 -0.726 . . . . 0.0 110.547 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.58 -34.97 73.39 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.026 -0.421 . . . . 0.0 111.064 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -63.0 -42.42 99.84 Favored 'General case' 0 C--N 1.335 -0.064 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.69 -44.54 93.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.72 0.691 . . . . 0.0 110.544 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.42 -51.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.3 mt -71.2 -28.05 63.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.927 -0.483 . . . . 0.0 111.587 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 m -64.88 -43.31 93.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.512 0.596 . . . . 0.0 110.134 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.97 -34.49 78.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.687 0.676 . . . . 0.0 110.813 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.74 -6.03 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.867 0.867 . . . . 0.0 112.798 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.91 58.62 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.909 170.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -72.34 122.7 21.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.124 1.462 . . . . 0.0 108.403 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -74.59 -29.95 61.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.79 1.236 . . . . 0.0 113.833 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -136.26 44.11 2.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.422 0.689 . . . . 0.0 111.123 -168.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.56 147.93 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -145.79 123.72 12.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -74.75 106.59 6.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.45 -28.27 67.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.05 0.94 . . . . 0.0 111.694 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.47 -161.68 21.53 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.265 0.936 . . . . 0.0 110.97 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.85 159.54 33.07 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.4 tp -58.01 -26.52 62.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.032 1.333 . . . . 0.0 111.875 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -69.04 -10.51 57.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.473 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.61 -33.25 3.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.877 1.271 . . . . 0.0 112.437 -170.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.16 135.8 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.504 1.502 . . . . 0.0 107.39 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.08 23.91 11.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.539 1.136 . . . . 0.0 112.16 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 75.6 mmm -68.61 160.15 78.2 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 108.765 168.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.14 155.25 62.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.659 1.573 . . . . 0.0 109.124 167.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -138.68 144.62 39.68 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.87 150.57 16.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.206 1.402 . . . . 0.0 108.66 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -65.91 161.56 20.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.837 0.455 . . . . 0.0 110.88 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -141.33 159.42 42.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.181 1.792 . . . . 0.0 107.655 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -129.71 145.65 51.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.72 1.208 . . . . 0.0 108.148 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.9 mt -146.48 135.45 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -90.17 124.8 35.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.7 m -115.78 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.959 0.504 . . . . 0.0 112.229 -174.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.28 -170.56 1.77 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 m -66.68 157.36 83.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.197 0.599 . . . . 0.0 110.329 171.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -53.32 -16.75 7.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.224 3.282 . . . . 0.0 115.436 172.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.95 -41.65 46.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 111.915 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -75.44 -45.14 40.51 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.619 0.645 . . . . 0.0 109.925 174.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -54.3 -38.61 66.13 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.009 0.924 . . . . 0.0 112.289 -174.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.13 -50.68 72.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.649 1.18 . . . . 0.0 110.956 177.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -83.95 -38.5 20.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.748 -170.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.87 139.36 2.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.65 1.18 . . . . 0.0 109.359 169.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -134.79 145.7 48.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.142 1.377 . . . . 0.0 107.909 172.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.9 t -58.81 133.94 23.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.73 142.56 39.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.264 -0.273 . . . . 0.0 110.286 -178.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.13 -18.09 29.45 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.108 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.51 163.51 20.93 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.173 1.486 . . . . 0.0 110.788 172.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -145.69 138.08 20.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.652 2.381 . . . . 0.0 105.124 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -76.77 114.68 15.8 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -176.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -141.13 85.41 12.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.37 157.31 11.89 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.87 3.047 . . . . 0.0 114.506 -170.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 tp -46.8 -41.1 14.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.782 2.033 . . . . 0.0 113.215 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.53 -10.74 60.03 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -123.7 -21.46 5.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.042 1.337 . . . . 0.0 111.303 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.37 -33.19 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.396 1.478 . . . . 0.0 112.669 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.54 -43.84 72.32 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.799 1.24 . . . . 0.0 111.142 -170.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -93.78 -45.59 7.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.671 0.669 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -17.85 65.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -52.94 -36.49 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.133 0.878 . . . . 0.0 111.248 171.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.62 96.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.982 0.81 . . . . 0.0 110.954 -175.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -35.06 66.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.232 0.613 . . . . 0.0 111.11 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.5 78.61 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.406 0.548 . . . . 0.0 111.618 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.0 t -142.09 87.98 9.45 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.385 1.474 . . . . 0.0 107.306 -171.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.88 21.77 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.953 3.102 . . . . 0.0 114.107 -172.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -144.08 104.67 4.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 107.605 173.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.88 -10.79 52.17 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -82.42 -13.62 56.5 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.976 0.807 . . . . 0.0 111.838 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.45 154.24 40.97 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.007 0.822 . . . . 0.0 111.453 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -71.97 136.95 46.96 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.67 135.81 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -115.97 128.65 55.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.44 145.29 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.26 159.75 44.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.568 1.547 . . . . 0.0 107.754 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.5 m -157.24 167.48 30.21 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.157 1.783 . . . . 0.0 108.851 -177.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -46.55 -30.2 2.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -176.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.42 7.97 5.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.568 1.076 . . . . 0.0 113.525 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.8 -40.95 1.88 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.045 1.307 . . . . 0.0 112.385 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -52.66 -47.96 66.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.595 1.158 . . . . 0.0 111.569 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -65.0 -37.86 89.06 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.059 0.391 . . . . 0.0 110.132 -173.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -30.98 69.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.016 172.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.64 -44.32 95.71 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 169.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -61.05 -49.49 77.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.803 0.802 . . . . 0.0 109.982 175.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.19 -40.41 77.34 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.86 0.3 . . . . 0.0 110.617 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.15 -37.92 87.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.71 -34.82 67.38 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.53 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.61 -47.37 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.889 1.222 . . . . 0.0 108.323 171.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 mt -70.49 -29.91 66.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.741 -0.6 . . . . 0.0 111.507 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.2 m -65.54 -38.04 88.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.227 0.467 . . . . 0.0 110.407 172.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.48 -36.05 81.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.821 0.737 . . . . 0.0 110.255 174.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mmm -68.93 -5.79 23.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.109 0.964 . . . . 0.0 112.579 170.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 12.0 64.48 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.425 1.012 . . . . 0.0 113.529 172.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.61 127.85 34.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.129 1.464 . . . . 0.0 107.731 175.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -89.42 -22.0 22.75 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -169.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.59 33.48 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.1 0.96 . . . . 0.0 111.551 -169.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.57 136.92 22.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 167.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.09 144.13 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.78 110.58 18.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -29.61 70.55 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.92 -162.08 28.84 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.239 1.399 . . . . 0.0 109.754 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.63 158.91 31.39 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 170.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -55.33 -35.62 65.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.358 1.063 . . . . 0.0 110.89 175.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.97 0.96 11.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.259 1.023 . . . . 0.0 112.735 176.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -130.9 -28.39 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.433 -169.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.71 134.99 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 120.936 1.698 . . . . 0.0 107.554 168.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.22 53.02 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.714 1.605 . . . . 0.0 108.831 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.0 mtp -133.88 158.38 75.58 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.188 1.795 . . . . 0.0 107.627 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.54 149.16 40.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.022 2.481 . . . . 0.0 113.354 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -127.85 159.17 35.71 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.202 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 100.0 t -134.82 167.83 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 127.708 2.403 . . . . 0.0 105.271 -175.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -128.71 161.61 29.3 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.798 -1.189 . . . . 0.0 109.871 -170.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 174.71 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.4 158.37 43.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.1 m80 -132.53 150.17 52.2 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.135 166.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.498 ' CH2' ' CE ' ' A' ' 80' ' ' MET . 23.6 m95 -123.98 142.65 50.97 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.065 -1.879 . . . . 0.0 109.252 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 mm -140.0 123.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -79.86 121.7 25.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 163.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -112.28 21.35 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.937 0.79 . . . . 0.0 112.324 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HD2' ' H ' ' A' ' 49' ' ' ASN . 7.4 ttt180 -106.3 -175.47 2.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.687 -1.258 . . . . 0.0 110.105 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 m -60.11 151.71 65.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.358 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.76 -17.14 28.12 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.221 2.614 . . . . 0.0 113.964 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -54.08 -39.87 66.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.607 1.163 . . . . 0.0 113.528 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.45 -41.74 69.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.866 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -57.54 -37.41 73.02 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.192 0.997 . . . . 0.0 111.814 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -59.96 -39.08 84.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.975 0.91 . . . . 0.0 112.319 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -87.9 -44.69 10.87 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 117.816 -1.087 . . . . 0.0 111.293 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -162.86 150.11 13.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 167.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -139.98 152.77 46.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 67.5 t -54.17 128.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.578 169.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.32 113.29 2.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -13.29 25.39 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.34 164.05 27.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 117.491 0.646 . . . . 0.0 110.346 171.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.58 138.25 54.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 127.084 2.154 . . . . 0.0 106.95 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.12 115.66 16.06 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 123.935 0.772 . . . . 0.0 109.592 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.41 82.78 15.96 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 126.102 1.761 . . . . 0.0 106.511 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.39 153.49 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.502 2.802 . . . . 0.0 113.791 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -49.42 -36.92 23.61 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.166 1.386 . . . . 0.0 112.457 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -67.02 -15.35 63.67 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 32' ' ' ARG . 23.9 mt-10 -130.81 -13.61 3.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 O-C-N 124.586 1.179 . . . . 0.0 110.867 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.62 -34.15 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.342 1.057 . . . . 0.0 111.328 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -56.85 -31.36 64.7 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -105.24 -35.96 7.39 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.015 0.912 . . . . 0.0 110.482 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.479 ' HD2' ' HB3' ' A' ' 28' ' ' GLU . 5.8 mtp180 -81.2 -17.26 50.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.03 -34.39 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.56 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.48 -32.02 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.897 0.771 . . . . 0.0 111.726 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.64 -28.62 21.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.305 0.642 . . . . 0.0 111.438 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.45 -40.05 44.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.447 0.567 . . . . 0.0 111.613 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 t -142.67 82.58 12.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.41 -25.41 70.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.354 2.036 . . . . 0.0 113.84 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -101.4 100.68 11.18 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -69.34 -6.87 32.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -176.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -18.42 58.98 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 170.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -66.76 150.75 48.67 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -72.08 131.73 43.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.93 124.42 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HD2' ' NE1' ' A' ' 4' ' ' TRP . 88.5 mttt -110.34 121.04 44.33 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.04 147.02 12.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.47 163.89 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 107.975 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.706 ' HG ' ' HB2' ' A' ' 53' ' ' GLN . 19.8 p -154.39 -176.34 5.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 61.9 t30 -60.14 -30.68 69.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.11 1.0 7.19 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.211 -0.931 . . . . 0.0 113.101 -168.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.1 -26.57 3.79 Favored Glycine 0 C--O 1.225 -0.466 0 CA-C-O 122.611 1.117 . . . . 0.0 113.339 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.321 2.3 tpt85 -69.96 -48.16 59.43 Favored 'General case' 0 N--CA 1.426 -1.641 0 O-C-N 120.449 -1.618 . . . . 0.0 112.117 -176.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.706 ' HB2' ' HG ' ' A' ' 48' ' ' CYS . 38.6 mt-30 -71.9 -29.73 64.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.227 -173.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -35.51 79.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.252 0.478 . . . . 0.0 111.796 167.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.86 -47.28 72.79 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -63.74 -46.01 87.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.864 0.832 . . . . 0.0 110.608 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.192 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -61.42 -41.44 97.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.86 -42.04 90.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.108 0.867 . . . . 0.0 111.255 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.3 -48.78 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 42.9 mt -64.7 -47.97 76.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.5 m -52.93 -36.26 59.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 121.761 2.073 . . . . 0.0 112.258 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -66.61 -37.93 85.92 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 41.9 mmm -68.0 -6.59 23.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.015 1.326 . . . . 0.0 113.529 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.31 28.91 13.36 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.706 -1.246 . . . . 0.0 113.866 167.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.517 ' CG ' ' CG2' ' A' ' 69' ' ' VAL 0.333 49.4 m-85 -68.2 151.5 46.87 Favored 'General case' 0 CA--C 1.469 -2.169 0 C-N-CA 123.686 0.794 . . . . 0.0 110.057 173.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.57 -24.44 11.77 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.711 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -138.77 47.35 1.94 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.911 1.339 . . . . 0.0 111.571 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.517 ' CG2' ' CG ' ' A' ' 66' ' ' TYR . 2.1 t -90.32 148.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -147.05 134.5 20.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.629 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -78.14 110.6 13.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 163.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.53 -31.65 72.82 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.76 -147.51 19.26 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -100.52 165.56 19.26 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 40.3 tp -50.06 -32.81 16.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.971 1.367 . . . . 0.0 112.864 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.272 59.9 mttt -69.22 -28.45 66.36 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -86.32 -40.38 15.53 Favored 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 126.178 2.174 . . . . 0.0 107.58 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -60.92 126.28 18.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.179 . . . . 0.0 108.806 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.85 34.24 3.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.231 1.012 . . . . 0.0 110.264 -174.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.498 ' CE ' ' CH2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -91.24 161.47 34.85 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 123.459 0.704 . . . . 0.0 109.553 170.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -51.22 150.91 13.52 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.535 2.157 . . . . 0.0 111.519 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 17.2 mttp -133.84 153.32 51.81 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 157.6 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.71 162.7 19.56 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.443 173.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.346 0 O-C-N 127.502 3.001 . . . . 0.0 111.29 170.133 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.37 147.77 38.57 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.417 1.487 . . . . 0.0 107.38 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -135.28 110.98 9.26 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 107.959 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -75.95 133.02 40.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.3 mm -132.86 122.53 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -78.51 129.39 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.93 31.34 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.691 0.678 . . . . 0.0 111.991 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 5.7 ttt180 -120.02 -173.42 2.55 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.424 -0.797 . . . . 0.0 109.788 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.423 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 2.9 m -65.21 157.46 77.05 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.458 0.703 . . . . 0.0 110.01 173.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.62 -14.43 39.83 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.918 2.412 . . . . 0.0 113.649 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -47.37 -47.87 25.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.957 1.303 . . . . 0.0 111.087 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -70.61 -42.0 71.53 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 118.529 0.604 . . . . 0.0 109.957 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -57.05 -38.56 73.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.952 0.901 . . . . 0.0 111.18 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.7 -45.03 88.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.772 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -73.54 -47.26 42.16 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.542 1.065 . . . . 0.0 110.771 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.83 149.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 109.729 166.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -138.6 151.24 47.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.081 1.752 . . . . 0.0 107.991 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.96 131.55 16.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 119.18 3.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.567 1.147 . . . . 0.0 110.346 -171.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.05 76.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.626 -1.097 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.9 55.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.372 1.586 . . . . 0.0 109.424 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 mt -78.83 129.17 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -78.36 118.59 20.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.164 0.893 . . . . 0.0 109.498 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.9 mt -141.16 84.57 12.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.23 151.03 9.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.94 3.093 . . . . 0.0 113.895 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.2 tp -46.74 -42.65 17.14 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.539 1.536 . . . . 0.0 112.575 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -66.82 -12.55 59.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.745 0.818 . . . . 0.0 112.992 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.39 -9.15 4.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.739 1.216 . . . . 0.0 112.389 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 p -49.37 -42.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.735 1.152 . . . . 0.0 112.238 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -57.92 -34.95 70.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.969 0.908 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -92.77 7.57 43.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.062 0.945 . . . . 0.0 111.585 -168.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -140.94 -27.84 0.7 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.274 -0.891 . . . . 0.0 112.116 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.36 -34.81 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.687 1.131 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.39 23.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.482 1.113 . . . . 0.0 113.676 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -121.42 -27.94 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.902 1.281 . . . . 0.0 111.156 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.98 -38.54 76.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.807 0.731 . . . . 0.0 111.04 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -140.26 75.78 27.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.63 -32.88 18.21 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.34 2.026 . . . . 0.0 112.37 -172.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -79.03 97.71 6.2 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.14 -10.31 39.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -78.68 -18.99 53.52 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.686 1.13 . . . . 0.0 111.563 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.38 147.06 54.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.056 0.843 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -70.98 137.79 49.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.1 t -127.87 141.17 47.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -130.33 128.45 41.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.29 154.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.149 0.979 . . . . 0.0 108.925 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -155.92 161.76 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.593 1.957 . . . . 0.0 107.077 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.2 171.49 20.1 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.376 0.67 . . . . 0.0 109.638 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -48.32 -30.62 5.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.361 1.864 . . . . 0.0 114.545 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.75 2.05 8.17 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.52 -31.81 0.85 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.687 1.613 . . . . 0.0 113.918 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -63.57 -52.37 61.31 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.783 1.291 . . . . 0.0 111.507 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.94 -35.56 80.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.05 0.841 . . . . 0.0 110.892 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.9 p -72.04 -33.15 67.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.53 -0.732 . . . . 0.0 111.651 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.62 77.46 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -64.66 -49.2 71.92 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 117.516 0.658 . . . . 0.0 110.04 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.14 -36.63 70.94 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.443 0.297 . . . . 0.0 110.873 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.06 -42.12 97.13 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.44 -34.72 72.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.877 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -58.66 -50.45 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.323 0.965 . . . . 0.0 108.927 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.28 -34.44 78.36 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.753 -0.592 . . . . 0.0 110.825 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -63.16 -40.6 98.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.562 0.345 . . . . 0.0 110.687 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.99 -35.57 80.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.55 0.74 . . . . 0.0 110.677 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.05 -6.46 28.26 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.969 0.908 . . . . 0.0 112.415 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.631 -1.094 . . . . 0.0 113.159 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -65.93 119.26 11.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.381 1.591 . . . . 0.0 107.081 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 p -81.54 -19.86 41.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.01 76.81 1.67 Allowed 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.313 1.045 . . . . 0.0 108.441 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.76 141.99 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.25 140.87 35.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -91.74 102.99 15.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.74 76.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.743 -171.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.12 -168.3 27.1 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.53 153.63 51.78 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.8 tp -45.25 -45.09 11.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.861 1.664 . . . . 0.0 113.289 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -67.15 -25.36 66.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.13 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.56 -34.53 46.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.716 0.689 . . . . 0.0 111.574 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.77 123.93 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.06 22.9 12.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.12 0.968 . . . . 0.0 112.324 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.7 mmm -73.63 153.21 89.56 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.81 157.37 12.93 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.276 2.651 . . . . 0.0 110.948 167.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -136.43 158.0 45.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.128 0.571 . . . . 0.0 110.055 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.27 164.55 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.213 2.205 . . . . 0.0 105.186 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -147.56 172.18 14.4 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.805 -1.184 . . . . 0.0 110.648 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -173.579 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -133.87 155.66 49.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 107.909 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -140.61 163.99 31.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.574 1.55 . . . . 0.0 107.427 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -128.26 136.18 50.68 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -131.04 127.76 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -94.53 121.38 36.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 168.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.46 13.97 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -93.93 179.49 5.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.7 1.136 . . . . 0.0 110.366 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -51.9 148.09 11.17 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.76 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.56 -27.15 24.35 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.332 2.688 . . . . 0.0 113.533 171.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.73 -39.55 65.37 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.667 0.787 . . . . 0.0 111.391 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -69.83 -41.64 74.67 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.122 0.874 . . . . 0.0 110.501 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -58.1 -39.62 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.096 1.359 . . . . 0.0 110.486 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.88 -10.66 60.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.006 . . . . 0.0 113.696 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -81.69 -71.29 0.49 Allowed 'General case' 0 C--N 1.341 0.202 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 168.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.68 158.29 28.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.63 1.572 . . . . 0.0 107.702 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -143.44 152.75 41.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.527 1.131 . . . . 0.0 108.41 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.74 131.5 14.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.36 120.4 5.99 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.06 90.38 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.511 -1.161 . . . . 0.0 113.884 173.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.38 142.21 57.94 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.227 1.513 . . . . 0.0 110.005 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -87.9 127.33 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -77.18 115.33 16.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.56 81.56 23.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.133 1.773 . . . . 0.0 106.561 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.16 148.87 23.27 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.255 2.636 . . . . 0.0 112.625 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.88 -29.72 42.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.782 1.233 . . . . 0.0 112.722 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -60.08 -20.36 57.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.696 0.798 . . . . 0.0 113.049 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -128.41 -17.44 4.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.534 1.134 . . . . 0.0 112.096 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.87 -36.44 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.341 . . . . 0.0 112.765 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.65 -30.46 68.75 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.468 0.707 . . . . 0.0 112.073 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.92 -47.78 4.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.368 0.667 . . . . 0.0 109.514 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -63.89 -18.76 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.112 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -52.58 -40.55 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.43 1.014 . . . . 0.0 111.04 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.79 90.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.828 0.74 . . . . 0.0 110.917 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -71.72 -37.02 70.68 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.487 0.715 . . . . 0.0 111.063 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.87 62.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.217 0.462 . . . . 0.0 111.738 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.24 98.19 6.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 108.128 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.18 -9.76 7.01 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.088 3.192 . . . . 0.0 116.253 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -134.83 111.29 9.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.834 1.197 . . . . 0.0 110.155 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.0 -12.37 60.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.701 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -86.54 -4.17 59.13 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.151 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.74 151.03 47.9 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.362 -0.836 . . . . 0.0 108.9 168.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 m -79.62 70.21 6.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.73 0.776 . . . . 0.0 109.758 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 t -74.01 97.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -79.58 141.26 36.75 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.99 126.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -171.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.06 169.67 17.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.23 1.412 . . . . 0.0 109.307 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 p -150.11 178.45 8.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.78 -23.36 67.33 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.01 -6.81 11.97 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.63 30.13 77.08 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.661 1.119 . . . . 0.0 114.627 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -137.26 -45.8 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.012 0.906 . . . . 0.0 110.235 170.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.98 -22.38 65.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.726 0.239 . . . . 0.0 110.614 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 p -64.36 -42.21 96.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.05 -1.031 . . . . 0.0 110.95 168.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.77 -43.27 96.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.14 -40.07 96.51 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.147 1.474 . . . . 0.0 111.315 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.53 76.06 Favored 'General case' 0 C--O 1.227 -0.087 0 O-C-N 121.376 -0.828 . . . . 0.0 110.685 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.03 -39.65 83.06 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.488 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.97 -44.02 97.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.37 0.987 . . . . 0.0 109.714 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.41 -50.38 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.921 0.889 . . . . 0.0 109.688 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.05 -18.65 62.55 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.441 -0.787 . . . . 0.0 111.502 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -68.22 -36.73 79.96 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.54 -0.725 . . . . 0.0 110.126 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.12 -36.49 83.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.299 0.954 . . . . 0.0 110.052 171.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.1 mmm -73.23 -1.87 19.49 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.064 0.945 . . . . 0.0 112.796 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.08 46.05 17.78 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 119.849 1.204 . . . . 0.0 111.659 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -46.24 158.41 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.501 1.121 . . . . 0.0 113.299 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.83 -26.67 1.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.893 -1.051 . . . . 0.0 112.217 173.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -147.92 23.86 1.08 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.585 1.539 . . . . 0.0 113.845 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 144.58 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.2 128.33 16.64 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.856 0.862 . . . . 0.0 109.002 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.63 108.17 10.63 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 168.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.73 73.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.0 0.52 . . . . 0.0 110.957 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.54 -139.36 7.23 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.22 166.34 15.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.5 tp -51.03 -40.16 57.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -168.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.91 -27.61 66.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.642 0.377 . . . . 0.0 111.677 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -86.71 -36.28 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.884 0.874 . . . . 0.0 111.658 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.95 119.66 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.46 22.87 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.05 0.94 . . . . 0.0 112.468 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mmm -81.3 158.35 69.41 Favored Pre-proline 0 C--O 1.24 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 109.462 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.65 154.92 11.19 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.441 2.761 . . . . 0.0 111.754 168.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -134.41 154.34 51.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 t -130.54 141.04 47.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.59 161.0 24.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.09 0.556 . . . . 0.0 110.281 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.032 169.355 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -161.4 156.96 24.47 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.204 1.401 . . . . 0.0 107.896 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -82.8 158.07 22.94 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.22 141.66 49.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.621 1.168 . . . . 0.0 107.998 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -139.84 136.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.89 122.24 36.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.64 20.21 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 15.8 ttt85 -109.56 -162.84 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.238 -0.914 . . . . 0.0 108.766 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.557 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 11.1 m -77.98 156.13 79.83 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.343 0.657 . . . . 0.0 109.588 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.41 -23.77 19.75 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.364 2.709 . . . . 0.0 114.029 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -26.08 64.2 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.688 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -86.2 -51.34 6.34 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 119.95 1.25 . . . . 0.0 109.142 167.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -53.25 -37.81 62.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.871 1.269 . . . . 0.0 112.992 -170.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -66.59 -45.59 78.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 0.0 111.52 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.38 -30.36 60.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.953 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.74 153.37 2.21 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.616 1.566 . . . . 0.0 109.667 166.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -146.02 146.51 31.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 t -60.15 132.67 25.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.4 149.43 16.83 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.577 0.751 . . . . 0.0 111.529 -172.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.93 -14.87 46.43 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.462 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.82 171.39 7.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.889 1.345 . . . . 0.0 111.797 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.8 mt -135.4 134.22 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -73.92 115.65 13.63 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.162 0.892 . . . . 0.0 109.031 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 mt -141.29 87.55 10.52 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.22 149.83 11.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.009 3.139 . . . . 0.0 114.027 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.49 -36.37 14.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.883 1.673 . . . . 0.0 113.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -63.88 -20.45 65.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -129.29 -11.3 4.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.93 0.892 . . . . 0.0 111.865 -169.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -50.26 -34.65 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 111.51 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.69 -33.83 56.74 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 112.609 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.54 -36.72 4.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.485 0.584 . . . . 0.0 111.211 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -69.26 -15.67 63.41 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.597 -0.689 . . . . 0.0 112.317 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.67 -35.35 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.056 169.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.08 99.43 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.385 0.993 . . . . 0.0 111.184 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -35.94 59.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.405 0.682 . . . . 0.0 111.158 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.74 75.02 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -140.66 82.47 15.78 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.994 1.718 . . . . 0.0 107.062 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.46 3.71 4.53 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.381 2.72 . . . . 0.0 114.256 -173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.06 103.88 5.99 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.801 1.24 . . . . 0.0 107.863 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -15.78 52.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.98 -25.15 63.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.468 0.577 . . . . 0.0 111.876 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -63.66 154.7 32.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.63 0.65 . . . . 0.0 111.773 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -73.2 142.67 47.34 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.22 140.59 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -120.67 139.93 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.19 144.6 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -143.57 160.59 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.46 1.104 . . . . 0.0 109.109 170.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -130.01 -139.34 0.22 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 125.034 1.334 . . . . 0.0 107.423 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -80.53 -45.15 17.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.789 1.631 . . . . 0.0 111.89 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.87 -26.44 3.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -169.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.35 2.41 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.073 0.851 . . . . 0.0 113.933 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -66.08 -44.21 85.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.984 1.392 . . . . 0.0 112.517 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.2 -33.03 71.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.868 0.758 . . . . 0.0 110.648 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -33.39 74.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.251 -0.906 . . . . 0.0 110.648 170.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.96 -49.18 68.34 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -60.47 -46.91 88.37 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.529 0.664 . . . . 0.0 110.655 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.51 75.25 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.474 0.579 . . . . 0.0 110.791 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -65.4 -42.79 92.22 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -42.34 98.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.876 0.762 . . . . 0.0 111.111 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.84 -51.21 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.88 -24.56 59.74 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.733 -0.604 . . . . 0.0 111.858 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 m -67.38 -38.95 85.52 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.321 0.51 . . . . 0.0 110.248 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -67.26 -37.21 83.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.831 0.741 . . . . 0.0 110.256 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mmm -67.39 -12.98 61.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.688 0.795 . . . . 0.0 112.289 170.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.89 14.6 66.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.349 -1.25 . . . . 0.0 113.955 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -64.26 122.87 17.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.522 1.661 . . . . 0.0 107.716 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -68.19 -30.88 70.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -165.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.27 42.9 2.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.271 0.942 . . . . 0.0 112.213 -166.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.83 146.67 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -142.65 137.76 30.18 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.144 1.378 . . . . 0.0 108.356 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -78.5 114.37 17.35 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.38 63.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.637 0.775 . . . . 0.0 112.031 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.58 -145.7 17.71 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.93 168.99 16.02 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.98 -25.48 67.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.142 0.977 . . . . 0.0 112.234 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -78.25 -6.02 53.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.353 172.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.58 -35.09 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.311 1.044 . . . . 0.0 112.471 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.61 146.19 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 120.264 1.393 . . . . 0.0 108.615 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.97 67.14 1.34 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.471 1.508 . . . . 0.0 108.427 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.2 ptm -140.23 166.1 25.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.9 1.28 . . . . 0.0 108.543 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 147.1 33.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.231 2.621 . . . . 0.0 113.561 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.87 160.06 24.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.5 1.12 . . . . 0.0 109.029 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.56 155.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -134.86 155.86 49.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.124 0.97 . . . . 0.0 109.089 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 174.642 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -140.52 145.4 36.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.475 1.11 . . . . 0.0 108.213 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -134.72 98.67 4.11 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.626 1.571 . . . . 0.0 107.149 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -72.64 147.08 46.12 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mm -140.34 124.69 18.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -79.79 114.35 18.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.4 m -106.42 18.55 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.49 -171.93 2.22 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 120.946 -1.096 . . . . 0.0 109.288 173.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.74 154.9 64.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.02 -11.11 25.7 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.059 2.506 . . . . 0.0 114.1 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -54.27 -37.26 64.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.575 1.55 . . . . 0.0 112.275 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.38 -41.85 75.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.141 0.882 . . . . 0.0 110.296 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -58.75 -31.44 68.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.945 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -64.66 -14.63 59.07 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -132.08 -36.47 1.17 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.536 1.062 . . . . 0.0 112.709 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.91 139.74 6.4 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.865 1.211 . . . . 0.0 108.256 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -141.71 154.7 45.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 170.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.39 128.8 14.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -29.68 65.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.046 0.539 . . . . 0.0 112.235 -169.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.94 22.77 36.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.241 -1.311 . . . . 0.0 113.12 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.57 163.69 17.62 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.173 1.487 . . . . 0.0 112.319 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 pt -137.36 144.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 127.053 2.141 . . . . 0.0 107.33 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.3 117.23 20.1 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.113 0.565 . . . . 0.0 109.805 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.0 mt -141.21 83.45 13.7 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.222 1.809 . . . . 0.0 106.268 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.32 152.83 24.3 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.769 2.979 . . . . 0.0 114.555 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -47.38 -36.57 9.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.651 1.981 . . . . 0.0 113.016 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -64.14 -20.06 65.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.29 -11.75 4.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.852 0.861 . . . . 0.0 112.105 -169.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -51.4 -33.75 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.763 1.225 . . . . 0.0 112.058 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -54.43 -35.75 63.28 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.577 1.151 . . . . 0.0 111.974 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.96 -42.17 5.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -66.96 -14.31 62.71 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 tp -52.18 -38.62 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.467 1.031 . . . . 0.0 111.204 170.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.76 98.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.131 0.878 . . . . 0.0 111.041 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.14 -35.63 69.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.531 0.732 . . . . 0.0 111.201 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.46 -46.27 67.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 0.0 111.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 t -143.66 101.32 5.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -171.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.17 -22.92 34.1 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.57 2.847 . . . . 0.0 115.53 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -144.43 116.63 8.44 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.305 1.042 . . . . 0.0 108.849 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -66.74 -4.56 9.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 113.088 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.62 -23.58 62.58 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.146 0.579 . . . . 0.0 111.087 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.13 150.0 45.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.07 130.17 41.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.685 -0.634 . . . . 0.0 109.416 -173.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -125.74 134.49 66.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.34 86.65 2.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.87 144.44 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -152.18 163.63 38.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.559 1.544 . . . . 0.0 108.379 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.71 170.46 21.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.466 1.106 . . . . 0.0 109.147 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -54.79 -14.98 1.6 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 -3.4 4.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.51 -30.26 0.59 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.447 1.499 . . . . 0.0 114.137 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -64.97 -49.71 69.22 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.438 1.095 . . . . 0.0 111.525 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.67 -31.35 71.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.399 0.545 . . . . 0.0 110.638 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -71.57 -30.89 66.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.173 -0.954 . . . . 0.0 111.289 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.2 -48.97 70.81 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 167.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -61.36 -44.42 97.19 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.974 -0.721 . . . . 0.0 111.166 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.06 75.46 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 118.372 0.533 . . . . 0.0 110.572 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.39 -40.38 85.66 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -64.12 -41.39 97.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.361 0.982 . . . . 0.0 110.842 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.11 -53.01 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -69.78 -23.19 63.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.927 -0.483 . . . . 0.0 111.829 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.411 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 34.9 m -63.12 -44.28 96.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.558 0.617 . . . . 0.0 110.128 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -67.22 -28.92 68.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.313 0.506 . . . . 0.0 110.884 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mmm -76.7 6.59 5.74 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.142 0.977 . . . . 0.0 112.73 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 42.51 8.55 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 119.677 1.126 . . . . 0.0 112.525 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.2 OUTLIER -53.3 161.85 0.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 175.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.33 -40.72 0.65 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 110.622 168.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -135.23 33.36 3.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.818 1.19 . . . . 0.0 112.537 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.4 t -82.42 140.67 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -147.16 143.6 28.36 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.075 0.95 . . . . 0.0 108.875 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -79.35 107.46 12.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.21 -29.29 70.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.059 0.544 . . . . 0.0 111.958 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.95 -162.12 25.21 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.05 30.83 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -58.19 -34.06 69.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 110.565 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.13 -14.66 63.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.92 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -110.7 -39.26 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.114 0.966 . . . . 0.0 111.33 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 mt -64.42 139.79 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.721 1.146 . . . . 0.0 109.498 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.06 27.39 7.18 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.022 1.329 . . . . 0.0 111.508 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.0 162.51 45.44 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.05 144.26 46.92 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.285 1.99 . . . . 0.0 110.547 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.14 153.09 51.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.609 0.764 . . . . 0.0 109.261 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.77 160.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.458 1.903 . . . . 0.0 106.725 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.47 157.05 23.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 173.508 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -142.93 153.03 42.67 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 108.814 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -141.12 153.37 45.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.091 1.757 . . . . 0.0 106.906 169.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -123.08 150.44 43.15 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 mm -140.04 123.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -80.87 111.18 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -103.3 20.69 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.451 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 11.6 ttt-85 -106.94 -175.48 2.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.194 -0.942 . . . . 0.0 109.61 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 4.4 m -69.14 156.86 90.72 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.185 0.594 . . . . 0.0 109.868 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.53 -14.2 4.62 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.107 3.205 . . . . 0.0 115.759 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -48.65 -38.02 19.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.099 1.36 . . . . 0.0 112.058 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.43 -48.52 12.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.227 0.467 . . . . 0.0 110.305 173.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -55.81 -38.99 70.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.129 0.971 . . . . 0.0 112.02 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -65.4 -7.8 15.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.259 1.424 . . . . 0.0 113.637 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -130.23 -29.68 2.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.657 1.117 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -167.04 143.15 4.35 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.062 1.301 . . . . 0.0 108.797 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -143.75 153.36 42.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.337 1.055 . . . . 0.0 108.217 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.44 131.58 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -33.64 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.373 0.669 . . . . 0.0 111.54 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.37 12.94 67.81 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.048 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.03 166.05 13.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.128 1.464 . . . . 0.0 112.169 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.45 142.16 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.022 2.129 . . . . 0.0 107.373 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -80.0 114.79 19.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.877 0.471 . . . . 0.0 110.231 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 mt -139.04 80.4 24.01 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.811 1.644 . . . . 0.0 107.034 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.62 153.86 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.669 2.912 . . . . 0.0 113.912 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 tp -46.61 -38.96 10.37 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 113.114 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -69.23 -13.14 62.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -126.98 -18.84 4.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.164 0.986 . . . . 0.0 111.989 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.55 -34.48 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.018 1.327 . . . . 0.0 112.813 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -57.11 -29.88 63.9 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.356 1.062 . . . . 0.0 112.476 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.18 -41.29 3.33 Favored 'General case' 0 C--N 1.334 -0.065 0 C-N-CA 123.374 0.67 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.12 -16.85 63.94 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.3 -35.16 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.662 1.119 . . . . 0.0 110.85 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.24 -7.15 28.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.931 0.893 . . . . 0.0 113.145 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 p -120.91 15.79 11.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.732 1.613 . . . . 0.0 110.512 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.74 -51.08 0.79 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.266 1.026 . . . . 0.0 110.733 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.21 67.51 21.34 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.726 1.21 . . . . 0.0 108.142 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.98 -28.92 75.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.331 2.021 . . . . 0.0 112.211 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.65 81.09 3.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -52.47 -26.4 12.78 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.934 1.294 . . . . 0.0 113.092 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -66.64 -24.33 66.28 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.172 0.989 . . . . 0.0 112.743 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.43 150.61 44.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.29 0.95 . . . . 0.0 109.8 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.35 137.78 54.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.546 -0.721 . . . . 0.0 110.221 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.7 131.57 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -125.34 90.94 3.32 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.7 144.46 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.08 162.22 38.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.706 1.202 . . . . 0.0 109.115 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.6 p -153.35 172.45 17.03 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.214 1.006 . . . . 0.0 109.603 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -51.28 -25.96 6.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.621 1.568 . . . . 0.0 115.232 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.77 -0.68 6.05 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 -36.64 0.96 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.594 1.569 . . . . 0.0 113.811 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -63.35 -44.3 95.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.902 1.351 . . . . 0.0 111.425 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -72.94 -29.07 62.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.098 0.408 . . . . 0.0 110.412 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -69.93 -32.41 70.67 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.945 -1.097 . . . . 0.0 109.961 168.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.38 -47.96 66.62 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.48 -41.8 98.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.261 1.03 . . . . 0.0 111.095 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.48 76.31 Favored 'General case' 0 CA--C 1.526 0.035 0 CA-C-N 118.802 0.728 . . . . 0.0 110.491 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.63 -41.43 79.47 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.95 -44.34 94.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.47 1.032 . . . . 0.0 110.53 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.5 -52.12 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.97 0.908 . . . . 0.0 109.431 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.09 -26.75 65.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.989 -0.444 . . . . 0.0 110.954 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 m -61.38 -39.39 90.5 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.551 -0.718 . . . . 0.0 110.627 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.91 -41.8 77.69 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.263 0.483 . . . . 0.0 110.424 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -74.41 -16.2 60.89 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.54 46.07 0.19 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.01 168.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.05 157.48 3.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.639 1.219 . . . . 0.0 112.752 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.9 -44.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 109.491 168.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.99 35.47 2.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.394 1.078 . . . . 0.0 111.359 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.76 135.68 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -140.22 146.86 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.385 1.074 . . . . 0.0 108.963 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -80.15 113.9 18.67 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.6 -31.34 71.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.469 0.708 . . . . 0.0 111.685 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.88 -165.39 24.27 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.9 160.41 31.1 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.3 tp -49.6 -34.08 16.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.014 1.725 . . . . 0.0 111.944 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -66.68 -9.8 39.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 112.53 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.88 -27.39 3.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.223 1.409 . . . . 0.0 112.751 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.03 89.88 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.572 1.533 . . . . 0.0 107.037 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.57 27.39 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.358 1.463 . . . . 0.0 113.15 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -73.13 156.37 89.48 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 123.51 0.724 . . . . 0.0 109.226 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.24 155.24 12.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.458 2.772 . . . . 0.0 111.643 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -132.87 154.64 50.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.036 0.534 . . . . 0.0 110.518 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -133.02 173.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.298 2.239 . . . . 0.0 105.652 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -125.41 146.04 49.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.986 -1.071 . . . . 0.0 109.217 -172.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 172.701 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.19 146.69 32.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.542 1.137 . . . . 0.0 108.797 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -140.38 169.92 16.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.534 1.134 . . . . 0.0 108.264 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -131.11 138.39 49.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -169.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.1 mm -137.84 129.75 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.71 120.61 26.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.97 19.42 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 118.199 0.454 . . . . 0.0 111.617 -176.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -98.77 -177.62 3.71 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.347 -0.846 . . . . 0.0 109.601 176.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.43 154.46 54.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.16 -19.67 12.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.568 2.846 . . . . 0.0 114.899 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -47.45 -44.83 25.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -73.0 -45.86 55.46 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.747 0.703 . . . . 0.0 110.719 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -55.29 -37.15 66.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.41 1.484 . . . . 0.0 111.37 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -67.64 -16.31 64.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.73 1.212 . . . . 0.0 113.119 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -92.51 -59.74 2.0 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -159.95 158.85 31.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.363 1.465 . . . . 0.0 107.755 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -140.19 154.36 46.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.38 141.31 13.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.49 121.56 4.61 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.385 1.074 . . . . 0.0 110.132 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.26 2.91 68.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.536 -1.147 . . . . 0.0 114.14 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 154.51 35.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.505 1.652 . . . . 0.0 110.964 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.02 127.93 73.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.39 114.36 9.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.754 0.706 . . . . 0.0 109.501 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -140.54 79.7 19.79 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.325 1.85 . . . . 0.0 106.508 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.54 151.24 24.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.951 3.1 . . . . 0.0 114.731 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -47.92 -38.92 17.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.881 2.072 . . . . 0.0 112.863 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -64.4 -20.45 66.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -129.71 -3.49 4.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.047 0.939 . . . . 0.0 112.045 -169.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 p -49.97 -40.98 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.476 1.111 . . . . 0.0 111.691 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -56.93 -38.01 72.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.802 0.841 . . . . 0.0 112.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -90.31 -3.76 57.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.591 0.757 . . . . 0.0 111.399 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -132.12 -26.54 1.91 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -59.56 -35.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.855 0.752 . . . . 0.0 110.739 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.12 96.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.559 0.618 . . . . 0.0 111.26 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -36.14 65.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.157 0.583 . . . . 0.0 111.143 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.19 -42.27 72.61 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.476 0.58 . . . . 0.0 111.705 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.28 82.36 13.16 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.37 1.468 . . . . 0.0 108.247 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.44 -37.78 93.19 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.014 2.476 . . . . 0.0 113.133 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -79.2 96.02 5.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -69.51 -3.28 13.98 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -7.12 25.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.732 1.213 . . . . 0.0 111.108 174.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.11 150.56 49.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.668 1.122 . . . . 0.0 109.327 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -73.88 131.81 41.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -130.48 96.31 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -74.62 134.36 42.07 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.01 146.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -146.25 163.16 36.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.003 1.321 . . . . 0.0 108.162 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 m -159.99 -178.59 7.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.801 1.641 . . . . 0.0 109.695 -176.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -63.03 132.35 51.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 166.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.85 0.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.162 2.185 . . . . 0.0 116.413 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.03 -8.0 40.39 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.836 1.208 . . . . 0.0 114.252 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -63.06 -56.89 13.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.545 1.672 . . . . 0.0 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.74 -29.49 70.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.948 -170.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -76.19 -33.23 59.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.204 -0.935 . . . . 0.0 111.28 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.37 -47.4 75.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.32 -46.53 88.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.643 0.777 . . . . 0.0 110.533 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.3 73.96 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 121.719 -0.613 . . . . 0.0 111.058 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -64.39 -44.75 90.35 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.24 -33.07 72.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.105 0.866 . . . . 0.0 111.215 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.32 -49.9 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.204 0.911 . . . . 0.0 108.938 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.88 -31.29 70.98 Favored 'General case' 0 C--O 1.231 0.123 0 O-C-N 121.54 -0.725 . . . . 0.0 111.378 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.94 -41.04 99.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.38 -35.91 80.28 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.78 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.86 -7.09 25.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.192 0.997 . . . . 0.0 112.318 171.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.51 12.42 59.64 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.155 -0.966 . . . . 0.0 113.328 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -68.35 148.07 51.23 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.068 1.434 . . . . 0.0 108.106 168.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.5 t -128.0 -10.29 5.4 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -128.51 34.27 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.31 1.044 . . . . 0.0 110.109 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.1 143.06 13.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -146.94 128.74 15.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -76.75 104.56 7.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.21 66.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.589 0.755 . . . . 0.0 111.872 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.3 -166.54 24.96 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.983 0.801 . . . . 0.0 111.227 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.76 48.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.2 tp -44.94 -49.7 10.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 -25.35 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.305 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.74 -28.35 30.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.007 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.56 120.33 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.611 1.096 . . . . 0.0 108.884 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.5 55.54 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.563 1.545 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.0 mtp -134.53 156.14 79.04 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 124.792 1.237 . . . . 0.0 108.673 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.81 157.3 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.073 2.515 . . . . 0.0 111.434 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -134.69 128.97 34.05 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.09 139.58 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.65 155.78 28.82 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.993 -0.442 . . . . 0.0 110.805 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 168.504 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -160.02 161.21 33.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.171 1.388 . . . . 0.0 107.729 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -84.32 158.39 21.19 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -133.97 122.13 22.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -123.57 126.46 73.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.04 117.19 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.275 21.5 m -114.6 52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 12.9 ttt180 -141.44 -169.92 2.97 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.508 -1.37 . . . . 0.0 110.144 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.442 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 12.0 m -58.62 153.95 37.88 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.34 -22.15 15.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.157 2.572 . . . . 0.0 114.124 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.69 -25.49 64.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.101 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -78.37 -49.86 12.78 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 120.22 1.373 . . . . 0.0 109.43 169.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.55 -40.71 75.6 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.469 1.107 . . . . 0.0 111.691 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.14 -4.76 11.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.027 1.331 . . . . 0.0 113.599 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -126.27 -34.6 2.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.941 1.246 . . . . 0.0 111.912 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -163.79 145.77 9.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.852 1.206 . . . . 0.0 109.243 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -146.75 154.87 41.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.78 1.232 . . . . 0.0 107.944 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.92 131.24 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.95 -36.5 49.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -166.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.18 2.11 83.3 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.601 0.637 . . . . 0.0 113.672 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' CB ' ' HH ' ' A' ' 47' ' ' TYR . . . -72.3 157.72 37.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.255 1.026 . . . . 0.0 113.636 -169.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.3 pt -131.52 134.44 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.14 120.87 25.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.802 0.441 . . . . 0.0 109.981 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -143.72 94.46 6.0 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.69 151.24 11.01 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.053 3.168 . . . . 0.0 114.86 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.52 -50.06 33.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.962 1.305 . . . . 0.0 112.272 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -71.75 -5.65 35.58 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -124.1 -18.95 5.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.608 1.163 . . . . 0.0 111.96 -167.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.34 -31.93 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.813 1.645 . . . . 0.0 112.452 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -52.73 -40.48 63.1 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.5 1.12 . . . . 0.0 111.802 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.26 -45.97 8.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.898 0.317 . . . . 0.0 110.543 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -73.05 -20.35 61.0 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.624 -0.672 . . . . 0.0 112.207 -168.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.54 -33.6 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.391 0.996 . . . . 0.0 110.642 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.04 -17.01 61.77 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 p -116.81 -29.31 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 110.984 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.06 72.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.68 0.673 . . . . 0.0 111.271 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.52 74.34 28.44 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.894 1.677 . . . . 0.0 106.507 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.19 -29.41 39.35 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.09 1.86 . . . . 0.0 112.435 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -79.68 95.14 5.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.436 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -62.47 -10.62 12.29 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -81.99 -19.94 39.51 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.839 1.199 . . . . 0.0 111.795 173.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.49 146.21 54.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.877 0.762 . . . . 0.0 110.635 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -70.68 145.98 50.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.139 0.976 . . . . 0.0 110.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.06 141.88 40.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -117.03 144.01 45.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.787 1.235 . . . . 0.0 107.928 171.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.75 144.34 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.367 1.067 . . . . 0.0 108.762 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.473 ' HH ' ' CB ' ' A' ' 21' ' ' ALA . 5.0 p90 -157.58 149.11 21.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.406 1.483 . . . . 0.0 109.19 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 t -149.01 174.64 12.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.989 1.716 . . . . 0.0 108.427 -168.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.13 -25.07 60.96 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.604 0.761 . . . . 0.0 112.92 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.65 140.81 41.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.596 1.159 . . . . 0.0 108.836 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.97 -28.87 72.74 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.213 0.911 . . . . 0.0 113.054 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -55.55 -46.11 77.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.483 1.141 . . . . 0.0 110.035 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -71.86 -36.89 70.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.633 0.651 . . . . 0.0 110.095 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -56.9 -44.63 82.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.268 0.485 . . . . 0.0 110.038 169.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.99 -43.04 98.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.95 1.262 . . . . 0.0 111.859 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -62.08 -43.01 99.76 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 118.445 1.123 . . . . 0.0 110.509 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.36 76.79 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-N 119.008 0.822 . . . . 0.0 110.651 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -64.07 -45.83 87.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.03 -39.45 94.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.269 0.486 . . . . 0.0 111.014 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.61 -48.04 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.975 0.807 . . . . 0.0 109.621 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.02 -29.04 66.0 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.7 m -67.11 -38.52 85.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.04 0.536 . . . . 0.0 110.61 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.1 -37.74 88.46 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.147 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.23 -3.82 18.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.841 0.856 . . . . 0.0 112.708 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.29 22.91 76.97 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.217 172.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 10.9 m-85 -65.36 124.09 21.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.175 1.487 . . . . 0.0 107.728 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -27.3 67.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.311 0.644 . . . . 0.0 112.364 -169.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -139.27 107.64 5.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.7 t -141.99 144.15 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.92 125.74 25.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -71.16 109.14 5.04 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.98 -25.09 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.862 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.04 -166.61 23.63 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.21 157.55 40.95 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 168.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.44 -41.96 86.28 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.767 -0.843 . . . . 0.0 110.462 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.3 -29.78 69.46 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.281 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.36 -39.91 31.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.15 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.0 137.79 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.579 0.627 . . . . 0.0 109.631 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.2 23.73 14.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.419 1.088 . . . . 0.0 112.296 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -72.84 154.4 91.09 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.79 152.35 17.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.715 2.943 . . . . 0.0 112.137 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -140.17 152.92 46.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.688 0.795 . . . . 0.0 109.448 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.3 158.17 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.337 1.855 . . . . 0.0 107.242 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.69 154.14 38.57 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.668 -0.645 . . . . 0.0 110.251 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 171.134 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -140.77 148.75 41.14 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.526 1.131 . . . . 0.0 108.382 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -137.3 156.66 47.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.257 1.823 . . . . 0.0 106.773 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -128.94 139.21 52.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.4 mm -130.93 121.18 49.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -81.3 110.42 16.74 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 166.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 m -99.11 21.46 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -111.26 -172.25 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.004 -1.06 . . . . 0.0 110.381 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.75 152.59 95.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.105 0.562 . . . . 0.0 110.181 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.72 -19.63 11.05 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.625 2.883 . . . . 0.0 114.836 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.43 -28.82 67.29 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.286 -0.864 . . . . 0.0 112.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -77.41 -46.43 22.72 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.841 1.2 . . . . 0.0 109.39 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -56.43 -40.82 75.38 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.858 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -62.4 -46.99 86.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.1 0.96 . . . . 0.0 111.381 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.51 -48.23 17.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.58 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.02 142.51 7.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.125 0.875 . . . . 0.0 110.185 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -135.38 155.32 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.917 1.287 . . . . 0.0 108.198 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.68 130.18 20.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.39 114.74 3.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.58 -12.97 18.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.888 1.232 . . . . 0.0 111.942 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 164.0 24.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.307 1.054 . . . . 0.0 111.751 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.6 pt -138.84 140.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 126.53 1.932 . . . . 0.0 106.921 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.09 114.18 18.8 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.62 83.77 16.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.49 153.55 13.57 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.034 3.156 . . . . 0.0 113.378 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.9 tp -50.41 -35.6 29.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.213 1.405 . . . . 0.0 112.555 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -66.47 -15.43 63.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.672 0.789 . . . . 0.0 113.021 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -129.01 -18.44 3.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.279 1.031 . . . . 0.0 112.111 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.52 -34.05 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.014 1.326 . . . . 0.0 111.969 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.63 -11.69 46.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.125 0.97 . . . . 0.0 113.384 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -122.06 -53.42 1.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.093 0.957 . . . . 0.0 108.481 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.51 -23.19 67.29 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -56.01 -36.35 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.453 1.024 . . . . 0.0 110.884 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.68 51.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.775 0.83 . . . . 0.0 112.802 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -119.95 12.31 11.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.866 1.666 . . . . 0.0 110.813 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.08 -38.14 1.44 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.618 1.167 . . . . 0.0 111.433 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.94 71.99 48.25 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.54 -29.36 52.82 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.506 2.137 . . . . 0.0 112.607 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -78.58 96.78 5.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.65 -11.01 21.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -76.86 -17.49 58.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.258 0.935 . . . . 0.0 111.879 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.1 157.79 36.92 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.773 0.715 . . . . 0.0 111.826 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -73.79 133.67 43.29 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.76 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.78 96.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -79.01 132.28 36.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.12 135.27 64.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 123.735 0.814 . . . . 0.0 109.57 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.91 162.22 39.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.851 1.66 . . . . 0.0 108.736 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -154.64 165.81 35.36 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.399 1.48 . . . . 0.0 107.594 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -54.57 -31.98 57.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 113.009 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.87 -15.89 43.09 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.67 35.08 61.5 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.977 1.262 . . . . 0.0 112.752 -170.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -144.15 -53.87 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.666 1.186 . . . . 0.0 109.919 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.76 -27.89 68.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.27 0.628 . . . . 0.0 110.461 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -66.33 -40.06 89.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.955 1.302 . . . . 0.0 112.519 170.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.68 96.13 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -64.02 -47.12 81.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.971 0.885 . . . . 0.0 110.399 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.94 72.68 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 122.203 -0.311 . . . . 0.0 110.986 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -62.81 -45.45 92.59 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -64.05 -40.18 95.73 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.852 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.32 -53.18 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 118.947 0.794 . . . . 0.0 109.235 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.3 mt -69.31 -29.14 66.93 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.961 -0.462 . . . . 0.0 110.93 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -65.52 -40.57 93.13 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.241 0.473 . . . . 0.0 110.697 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.07 -36.67 84.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.884 0.766 . . . . 0.0 110.094 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -71.94 -3.25 21.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.04 0.936 . . . . 0.0 112.712 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 16.92 72.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.56 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -67.12 127.41 32.5 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 p -86.5 -21.83 26.75 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -131.49 35.99 3.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.763 0.825 . . . . 0.0 111.197 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.44 146.3 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.15 125.68 15.8 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -75.13 97.99 3.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.09 72.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.033 0.533 . . . . 0.0 110.679 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 -115.07 0.94 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.09 172.69 25.14 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.22 -34.46 77.69 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.002 0.521 . . . . 0.0 111.297 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.35 -36.03 80.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.823 0.449 . . . . 0.0 110.537 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.48 -41.98 31.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.509 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.91 142.91 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.859 0.754 . . . . 0.0 109.686 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.89 24.53 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.828 1.251 . . . . 0.0 111.923 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.39 165.37 49.19 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.495 1.118 . . . . 0.0 108.85 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -52.49 149.29 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.844 2.363 . . . . 0.0 111.359 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.97 148.94 45.7 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.55 149.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.42 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.1 165.02 22.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.661 0.384 . . . . 0.0 110.94 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.785 1.183 . . . . 0.0 110.625 173.355 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -139.21 158.91 43.33 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.826 0.85 . . . . 0.0 110.036 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -140.33 161.75 36.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.849 2.06 . . . . 0.0 106.98 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -119.15 143.34 47.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -138.62 131.68 39.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.46 125.09 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.03 14.32 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -91.9 -169.18 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.397 1.453 . . . . 0.0 109.695 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -57.91 150.4 49.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.089 0.555 . . . . 0.0 109.637 167.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.47 -19.22 67.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.306 2.004 . . . . 0.0 112.624 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.08 -24.89 67.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.919 -1.113 . . . . 0.0 112.145 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -68.61 -41.18 79.92 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.517 1.053 . . . . 0.0 109.913 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -59.85 -37.34 79.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.736 1.615 . . . . 0.0 110.269 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.01 -43.49 81.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.515 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -66.39 -58.2 5.79 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -174.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -167.02 151.27 6.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.959 1.704 . . . . 0.0 107.114 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -138.53 153.61 48.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.61 126.92 12.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 96.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.51 -18.71 4.1 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.82 1.2 . . . . 0.0 111.63 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.42 162.8 25.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.146 0.973 . . . . 0.0 110.202 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -135.66 147.16 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.787 1.635 . . . . 0.0 106.831 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -80.87 116.55 20.91 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -136.92 81.52 33.36 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.48 150.45 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.5 2.8 . . . . 0.0 114.078 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -47.49 -41.54 20.99 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.671 1.989 . . . . 0.0 111.933 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.97 -15.77 57.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -129.55 -13.36 4.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.471 1.108 . . . . 0.0 112.053 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.15 -35.04 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.966 1.306 . . . . 0.0 111.735 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -56.6 -34.5 67.26 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.744 0.818 . . . . 0.0 112.234 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.4 -47.09 4.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -65.57 -22.2 66.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.673 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.66 -32.79 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.658 1.117 . . . . 0.0 111.267 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.74 60.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 112.899 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -111.39 -28.72 8.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.661 1.184 . . . . 0.0 111.01 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.55 -43.78 68.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.817 0.735 . . . . 0.0 111.546 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.94 77.11 18.89 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.036 1.334 . . . . 0.0 107.403 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.44 -36.03 93.26 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.102 2.535 . . . . 0.0 114.368 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -77.55 98.66 5.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.212 0.605 . . . . 0.0 109.484 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.15 -6.65 18.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -85.45 -14.74 45.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.184 0.902 . . . . 0.0 111.929 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.913 0.885 . . . . 0.0 110.427 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -77.98 96.44 5.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.968 0.907 . . . . 0.0 110.17 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.51 93.28 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -73.36 129.74 38.65 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -115.18 143.31 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -142.13 168.12 20.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.216 1.006 . . . . 0.0 108.355 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.3 p -153.19 178.3 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -60.31 -25.43 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.76 5.76 4.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -29.67 2.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.987 1.279 . . . . 0.0 114.532 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.5 -51.95 67.28 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.535 1.168 . . . . 0.0 111.481 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -69.01 -33.83 74.29 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.889 -171.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -68.28 -34.93 77.06 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.156 0.889 . . . . 0.0 110.974 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.3 -50.92 57.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -62.93 -46.28 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.388 0.594 . . . . 0.0 110.864 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.51 -34.38 70.88 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 110.581 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.5 94.32 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.52 -43.24 77.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.287 0.494 . . . . 0.0 110.301 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -56.93 -49.16 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.474 0.71 . . . . 0.0 109.302 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.34 -30.67 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.709 0.804 . . . . 0.0 111.313 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 m -69.81 -37.51 76.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.682 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.72 -36.66 84.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.98 0.809 . . . . 0.0 110.162 174.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mmm -69.48 -3.78 15.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.34 1.056 . . . . 0.0 112.702 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.54 78.99 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.531 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -64.54 123.56 19.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.909 1.354 . . . . 0.0 107.599 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -29.78 69.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.157 0.583 . . . . 0.0 112.362 -169.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.01 111.81 7.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -146.7 149.57 15.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.76 128.39 9.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -80.19 113.38 18.32 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.3 69.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.95 -26.23 7.6 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.368 0.985 . . . . 0.0 112.335 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.96 167.79 16.04 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.89 1.233 . . . . 0.0 110.324 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.9 tp -54.77 -33.15 60.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.129 0.972 . . . . 0.0 112.313 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.12 -29.04 69.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.599 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.79 -40.83 54.43 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.48 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -53.27 117.24 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 123.441 0.697 . . . . 0.0 111.359 -168.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 50.67 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.353 1.461 . . . . 0.0 109.72 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.1 mmm -133.42 154.48 80.92 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.477 1.511 . . . . 0.0 108.143 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.72 145.94 29.15 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.684 2.256 . . . . 0.0 110.677 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.08 147.56 33.95 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.66 154.6 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.984 0.914 . . . . 0.0 108.835 -167.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -63.46 150.19 44.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.85 0.46 . . . . 0.0 110.08 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 173.861 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -138.67 158.0 45.06 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 109.528 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -148.41 126.71 12.23 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -76.14 143.67 41.04 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -140.36 128.95 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.97 124.95 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.05 16.35 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.525 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 35.0 ttt85 -89.46 -176.17 4.95 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.757 -1.214 . . . . 0.0 108.636 169.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 10.9 m -63.9 154.34 81.64 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 121.813 -0.554 . . . . 0.0 109.51 170.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.3 -12.99 35.59 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.314 2.676 . . . . 0.0 114.25 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.05 -37.83 69.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.824 0.849 . . . . 0.0 111.573 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.67 -43.29 84.91 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.854 0.752 . . . . 0.0 110.128 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -57.74 -30.5 65.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.955 1.302 . . . . 0.0 111.269 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -65.87 -50.79 63.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.305 0.642 . . . . 0.0 110.856 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.97 -49.88 40.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.868 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.85 150.81 13.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.824 0.738 . . . . 0.0 110.49 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -139.07 156.03 47.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.947 1.299 . . . . 0.0 108.289 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.75 130.85 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.69 105.97 0.73 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.67 -13.48 9.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.045 1.307 . . . . 0.0 112.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.08 155.05 41.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.342 1.071 . . . . 0.0 110.191 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mm -120.09 135.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.98 116.15 16.39 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.54 81.06 17.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.611 . . . . 0.0 106.77 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.4 151.4 23.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.778 2.985 . . . . 0.0 114.31 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.8 tp -48.6 -41.66 31.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.29 1.836 . . . . 0.0 113.001 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.75 -12.0 61.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -126.15 -15.28 5.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.938 1.295 . . . . 0.0 112.051 -169.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.06 -39.79 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.769 1.627 . . . . 0.0 113.252 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -55.26 -40.93 71.52 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.575 0.75 . . . . 0.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -91.07 -2.4 57.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.219 0.607 . . . . 0.0 111.272 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.32 -15.32 1.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.79 -40.37 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.052 1.296 . . . . 0.0 111.262 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.22 -32.55 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.405 0.548 . . . . 0.0 112.13 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -10.3 58.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.909 0.883 . . . . 0.0 113.175 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 -30.4 4.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.356 0.98 . . . . 0.0 111.992 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.42 79.69 41.37 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.571 1.149 . . . . 0.0 107.994 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.98 -37.75 91.73 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.415 2.077 . . . . 0.0 112.131 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -77.51 96.76 4.81 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.134 0.974 . . . . 0.0 109.841 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.37 8.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -107.8 -6.99 16.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.671 1.188 . . . . 0.0 111.769 170.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.39 145.34 52.95 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 m -80.14 97.36 6.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 109.676 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -72.03 104.7 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -83.16 84.65 7.4 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 m -69.34 140.17 19.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -145.12 164.04 32.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.178 0.991 . . . . 0.0 108.936 171.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.02 171.25 18.66 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.281 1.432 . . . . 0.0 107.717 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -49.94 -33.22 16.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.02 -6.73 10.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.12 -31.44 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.792 1.178 . . . . 0.0 113.949 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.78 -56.48 21.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.852 1.326 . . . . 0.0 111.303 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.03 -32.4 74.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.674 0.39 . . . . 0.0 110.824 -169.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 p -71.66 -35.53 70.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.339 0.972 . . . . 0.0 111.405 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.27 -48.52 59.27 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.94 -48.4 76.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.671 0.788 . . . . 0.0 110.576 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.95 69.2 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.891 -0.506 . . . . 0.0 111.814 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -60.83 -45.0 96.18 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.92 -41.59 91.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.142 0.428 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.88 -50.53 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.6 mt -70.31 -29.01 65.64 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.554 -0.717 . . . . 0.0 111.395 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.386 0.539 . . . . 0.0 109.953 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.95 -35.78 78.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.282 0.633 . . . . 0.0 110.968 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.5 mmm -64.98 -15.48 62.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.851 0.86 . . . . 0.0 112.118 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.37 14.43 55.74 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.074 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -66.25 121.67 15.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.235 1.517 . . . . 0.0 107.37 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.5 p -75.08 -23.81 58.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.497 0.319 . . . . 0.0 111.522 -171.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -134.98 104.81 6.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.819 1.248 . . . . 0.0 107.67 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -142.16 143.33 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.39 127.17 17.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.14 111.98 9.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 166.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.55 66.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.29 -26.84 10.69 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 125.026 1.298 . . . . 0.0 110.765 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.3 174.68 13.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 124.524 1.059 . . . . 0.0 111.481 168.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 tp -60.45 -30.33 69.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 110.067 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -61.55 -18.82 60.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.748 1.619 . . . . 0.0 113.271 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -118.12 -36.93 3.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.027 0.83 . . . . 0.0 112.021 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 82.4 mt -57.52 141.2 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.029 0.831 . . . . 0.0 109.538 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.88 24.5 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.011 1.324 . . . . 0.0 111.959 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.2 mmm -69.52 164.16 52.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.506 1.123 . . . . 0.0 108.596 167.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.77 147.78 30.71 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.612 2.208 . . . . 0.0 110.904 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -134.78 142.86 46.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.27 149.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.131 1.372 . . . . 0.0 108.486 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -69.08 162.19 27.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.769 0.428 . . . . 0.0 111.093 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 124.883 1.23 . . . . 0.0 110.611 172.725 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.204 0.526 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.22 162.22 36.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.012 1.725 . . . . 0.0 108.785 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -82.69 100.66 10.36 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -73.01 145.45 46.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.9 mt -147.16 139.26 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -96.93 124.97 41.05 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.45 12.74 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.77 -174.34 4.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.172 1.351 . . . . 0.0 108.159 167.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 1.6 m -57.29 156.04 16.38 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.656 0.782 . . . . 0.0 110.358 167.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.48 -14.35 43.83 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.081 2.521 . . . . 0.0 113.511 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -46.15 -49.44 16.79 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 110.82 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -69.75 -37.81 76.59 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.308 -0.245 . . . . 0.0 110.383 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -58.46 -31.22 67.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.119 1.368 . . . . 0.0 111.314 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -67.12 -39.67 86.7 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.23 0.468 . . . . 0.0 110.73 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -68.73 -54.21 17.46 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.27 152.53 4.99 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.015 1.726 . . . . 0.0 106.907 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.65 147.98 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 108.952 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.6 t -54.09 125.77 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -56.34 -24.11 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -166.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.59 -8.07 41.05 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.885 0.755 . . . . 0.0 112.764 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.81 170.3 15.61 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.223 1.011 . . . . 0.0 111.094 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.6 pt -142.95 138.92 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.661 2.384 . . . . 0.0 105.213 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.38 116.43 18.79 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.3 mt -140.67 86.98 11.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.95 153.47 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.638 2.892 . . . . 0.0 113.9 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.7 tp -51.21 -35.81 38.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.065 1.746 . . . . 0.0 112.943 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.22 -16.49 63.59 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.501 0.721 . . . . 0.0 112.775 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.76 -22.26 3.59 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.553 1.141 . . . . 0.0 111.911 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -47.42 -37.19 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.641 1.576 . . . . 0.0 112.377 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.75 -33.12 60.79 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.416 1.086 . . . . 0.0 112.301 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.52 -45.24 4.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.0 0.52 . . . . 0.0 109.951 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.91 -19.64 65.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.311 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -54.97 -34.99 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.104 0.866 . . . . 0.0 111.133 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.16 96.64 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.19 0.904 . . . . 0.0 111.273 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -37.04 45.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.463 0.705 . . . . 0.0 111.133 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.7 72.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.369 0.531 . . . . 0.0 112.057 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -139.55 79.42 24.53 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.771 1.628 . . . . 0.0 107.179 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.91 10.68 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.766 2.978 . . . . 0.0 114.502 -171.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -138.21 107.88 6.24 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.272 1.429 . . . . 0.0 107.163 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -63.25 -15.08 55.99 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.64 -15.51 58.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.73 0.695 . . . . 0.0 111.957 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -67.94 150.19 48.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.027 0.83 . . . . 0.0 110.672 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -70.24 141.87 52.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.969 0.907 . . . . 0.0 109.674 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.85 145.33 31.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -130.72 135.33 47.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.92 137.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -136.68 168.57 19.27 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 p -152.55 -175.89 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 170.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -59.18 -29.55 67.54 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.65 10.33 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -168.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.52 -29.36 2.29 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.795 1.188 . . . . 0.0 114.304 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -62.34 -50.85 69.99 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.374 1.087 . . . . 0.0 111.418 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -69.49 -31.97 70.57 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.537 0.608 . . . . 0.0 110.569 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -36.22 82.45 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 119.381 0.991 . . . . 0.0 110.734 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.24 -52.0 50.33 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -62.4 -46.24 89.48 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.486 -0.42 . . . . 0.0 111.176 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.32 74.84 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 118.222 0.465 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -63.05 -43.45 98.62 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.98 -44.78 91.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.662 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.56 -52.51 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.976 0.807 . . . . 0.0 109.072 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.15 -28.4 64.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.987 -0.446 . . . . 0.0 111.221 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.0 m -65.23 -42.16 93.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.353 0.524 . . . . 0.0 110.397 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.12 -33.92 76.49 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.879 0.763 . . . . 0.0 110.91 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -69.46 -8.75 49.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.845 0.858 . . . . 0.0 112.303 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.97 60.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.972 -0.904 . . . . 0.0 113.467 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.98 120.81 19.12 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -84.6 -17.22 39.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -167.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -133.24 38.77 3.3 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.873 0.869 . . . . 0.0 111.037 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -80.6 145.81 8.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -140.91 137.91 33.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.715 0.806 . . . . 0.0 109.139 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -72.32 106.73 4.59 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.89 79.18 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.39 -148.22 19.83 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.73 167.26 13.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.35 -34.17 66.36 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.533 1.133 . . . . 0.0 112.552 -170.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.36 -11.44 57.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.114 0.966 . . . . 0.0 113.168 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -117.1 -34.87 4.24 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.796 1.238 . . . . 0.0 111.982 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.4 127.14 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.23 24.31 8.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.484 1.113 . . . . 0.0 111.869 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.1 165.36 48.56 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 167.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.31 149.9 21.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.484 2.122 . . . . 0.0 111.688 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -131.91 158.47 41.31 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.878 0.871 . . . . 0.0 109.118 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -128.72 169.05 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -131.68 167.77 18.89 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.949 -1.094 . . . . 0.0 109.685 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 173.562 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.83 153.75 43.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.685 1.594 . . . . 0.0 106.797 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.55 152.27 43.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.442 1.497 . . . . 0.0 107.806 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -130.04 136.13 49.03 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.591 1.156 . . . . 0.0 108.78 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.96 131.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.21 117.05 23.27 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.84 23.12 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 5.6 ttt180 -111.24 -175.5 2.72 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.8 -1.188 . . . . 0.0 110.74 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 2.7 m -60.64 150.41 75.4 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.875 0.87 . . . . 0.0 109.971 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -53.81 -23.98 29.09 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.573 2.849 . . . . 0.0 115.118 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.92 -26.35 68.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 117.428 -1.272 . . . . 0.0 113.283 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.01 -50.82 45.39 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 120.818 1.645 . . . . 0.0 109.5 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -55.91 -37.28 68.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.164 1.386 . . . . 0.0 111.373 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -61.77 -11.05 10.48 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.379 1.471 . . . . 0.0 113.985 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.16 -38.76 1.77 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.513 1.506 . . . . 0.0 112.153 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -156.48 145.32 20.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.042 1.292 . . . . 0.0 110.754 168.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -142.06 154.77 45.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 107.49 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.21 132.61 20.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -55.88 120.45 7.4 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.27 -13.51 61.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.298 0.951 . . . . 0.0 112.984 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.02 161.17 30.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.474 1.137 . . . . 0.0 111.067 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.58 137.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.9 1.68 . . . . 0.0 107.338 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.27 117.15 19.25 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -143.2 87.93 8.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -54.12 155.6 15.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.1 3.2 . . . . 0.0 114.382 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 tp -48.49 -41.93 31.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.2 1.8 . . . . 0.0 112.979 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.18 -8.38 54.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.5 -17.1 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.104 1.362 . . . . 0.0 111.829 -169.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.29 -30.42 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.314 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.6 -47.66 73.12 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.732 1.213 . . . . 0.0 111.623 -169.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -88.95 -41.82 12.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.93 0.332 . . . . 0.0 110.241 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -70.28 -15.36 62.89 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.59 -33.22 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.071 0.85 . . . . 0.0 110.851 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.11 -40.69 98.35 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.42 1.009 . . . . 0.0 111.043 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.28 -36.73 66.37 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.26 0.624 . . . . 0.0 111.168 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.43 72.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.478 0.581 . . . . 0.0 111.968 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.08 83.66 11.0 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.719 1.607 . . . . 0.0 107.425 -171.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.6 -38.12 96.17 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.875 2.383 . . . . 0.0 113.845 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -85.37 99.96 11.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.224 0.609 . . . . 0.0 109.677 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 48.6 pttt -62.81 -15.32 53.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -82.86 -11.9 57.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.024 0.829 . . . . 0.0 111.912 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.07 155.48 40.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.878 0.763 . . . . 0.0 111.191 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 140.01 54.25 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.38 140.5 43.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -123.75 147.46 28.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -150.07 164.72 34.82 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.894 1.677 . . . . 0.0 107.231 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.479 ' HG ' ' HB2' ' A' ' 53' ' ' GLN . 48.8 t -161.09 157.19 25.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.572 0.349 . . . . 0.0 110.167 -172.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.93 -23.62 19.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.13 0.972 . . . . 0.0 112.72 168.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.06 105.12 7.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 170.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.99 -23.77 57.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.622 1.106 . . . . 0.0 114.215 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -57.6 -36.9 72.36 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.433 1.116 . . . . 0.0 111.778 171.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.479 ' HB2' ' HG ' ' A' ' 48' ' ' CYS . 38.2 mt-30 -71.53 -37.67 71.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.567 0.747 . . . . 0.0 110.685 -177.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p -68.24 -26.99 65.97 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 110.824 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.36 -46.24 93.25 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -61.02 -48.7 80.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.865 0.833 . . . . 0.0 110.242 175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.14 77.13 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.819 0.282 . . . . 0.0 110.706 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.77 -39.57 92.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.42 -35.32 73.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.174 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.05 -47.99 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.749 1.159 . . . . 0.0 108.786 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.68 -33.82 76.49 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.668 -0.645 . . . . 0.0 110.861 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 m -65.56 -39.21 91.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.828 0.451 . . . . 0.0 110.656 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.12 -36.22 82.56 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.504 0.721 . . . . 0.0 110.241 175.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mmm -69.17 -3.92 15.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.189 0.995 . . . . 0.0 112.595 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.4 14.75 65.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.359 170.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.426 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 20.9 m-85 -70.0 129.14 38.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.936 1.368 . . . . 0.0 107.552 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -91.59 -18.74 23.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -167.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.88 40.47 3.36 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.323 1.049 . . . . 0.0 110.387 -169.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.78 149.45 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -143.93 142.06 30.56 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -86.33 106.8 17.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.75 66.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.872 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.53 -165.64 14.47 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.968 0.794 . . . . 0.0 112.238 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.48 151.7 52.33 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.92 30.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.255 1.822 . . . . 0.0 113.134 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -64.14 -33.19 75.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.607 0.763 . . . . 0.0 111.825 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.41 -30.03 64.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.371 0.532 . . . . 0.0 111.705 -172.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.76 91.28 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 26.43 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.851 1.261 . . . . 0.0 113.507 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.8 mtp -77.64 158.89 77.91 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.42 153.97 12.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.582 2.855 . . . . 0.0 111.703 167.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -138.97 153.9 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 108.864 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.7 p -151.84 156.69 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -68.16 152.17 45.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.796 0.839 . . . . 0.0 109.134 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.074 174.725 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.086 0.47 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.21 164.16 37.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.851 1.66 . . . . 0.0 108.075 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -77.17 151.67 35.17 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -126.23 135.32 51.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -136.68 125.63 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.67 120.99 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.3 21.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.7 -173.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.943 -1.098 . . . . 0.0 110.216 173.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.84 152.06 77.46 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.03 -13.4 35.03 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.626 2.217 . . . . 0.0 113.371 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -55.22 -39.09 69.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.284 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -66.29 -47.85 72.31 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 120.405 1.457 . . . . 0.0 109.909 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -56.46 -37.31 70.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.948 1.299 . . . . 0.0 111.293 -172.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -58.87 -52.99 63.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.2 1.8 . . . . 0.0 110.949 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -72.32 -49.1 37.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.265 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.05 151.46 14.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.331 0.968 . . . . 0.0 111.029 167.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -139.03 153.06 48.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 170.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.44 128.4 15.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.92 106.85 1.32 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -17.69 7.49 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.933 1.254 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.18 164.75 25.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.777 0.788 . . . . 0.0 110.71 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 pt -139.88 139.0 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.263 1.825 . . . . 0.0 106.939 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -77.38 115.8 17.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.872 0.469 . . . . 0.0 109.941 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -141.2 84.09 13.13 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.11 150.73 18.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.999 3.133 . . . . 0.0 113.806 -171.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.82 -41.01 22.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.159 1.784 . . . . 0.0 112.58 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.06 -14.68 61.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.432 0.693 . . . . 0.0 112.832 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.15 -7.82 3.84 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.328 1.051 . . . . 0.0 112.369 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.8 -38.62 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.098 1.317 . . . . 0.0 110.695 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.2 -26.36 64.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.694 1.197 . . . . 0.0 112.669 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -105.48 -2.24 23.92 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.378 1.071 . . . . 0.0 111.385 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -131.48 -23.58 2.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -168.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tp -57.94 -33.94 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.355 0.979 . . . . 0.0 110.576 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -16.62 52.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 113.357 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -114.96 -28.63 6.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.657 1.183 . . . . 0.0 111.028 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.03 -38.67 72.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.733 0.697 . . . . 0.0 111.459 173.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -140.37 72.83 31.4 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.094 1.758 . . . . 0.0 107.289 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.0 -37.96 93.86 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.812 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.94 88.88 5.88 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.288 0.635 . . . . 0.0 109.84 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -65.37 -4.95 6.23 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.84 -18.69 58.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.408 1.003 . . . . 0.0 111.486 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.96 152.29 41.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.154 -0.966 . . . . 0.0 110.327 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -71.51 149.57 45.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.0 146.81 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -129.22 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.89 148.6 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -174.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -150.83 166.72 29.65 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.775 1.63 . . . . 0.0 107.379 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.0 p -161.34 172.55 16.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.563 0.745 . . . . 0.0 109.623 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.96 -52.52 62.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.7 1.2 . . . . 0.0 112.192 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.28 -35.52 61.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.337 0.255 . . . . 0.0 111.389 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.43 8.91 55.89 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.034 -0.87 . . . . 0.0 113.498 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -124.08 -23.68 4.53 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.117 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.46 -33.59 71.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.762 1.619 . . . . 0.0 110.031 169.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 p -65.99 -37.88 87.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.703 0.801 . . . . 0.0 111.587 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.41 -47.88 73.2 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 169.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -61.91 -50.97 70.03 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.872 0.869 . . . . 0.0 109.992 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.07 79.27 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.05 0.54 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -61.45 -39.76 92.01 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -35.09 69.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.068 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.19 -49.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.604 1.093 . . . . 0.0 108.648 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -66.16 -34.71 78.66 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.907 -0.495 . . . . 0.0 110.5 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -64.3 -41.56 96.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 110.746 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.12 -37.13 86.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.322 0.649 . . . . 0.0 110.195 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mtp -71.39 -3.05 18.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 112.792 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.89 16.01 68.81 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.458 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.2 124.97 22.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.217 1.509 . . . . 0.0 107.177 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.7 p -68.81 -29.05 67.31 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -166.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -150.09 106.87 3.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -173.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.22 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.19 145.94 32.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.472 0.709 . . . . 0.0 109.123 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -90.4 114.27 26.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.87 69.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.669 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.48 -158.27 14.56 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.615 1.102 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.09 162.32 35.91 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.737 0.684 . . . . 0.0 111.72 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -30.22 64.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.347 1.059 . . . . 0.0 112.869 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.66 -27.76 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.475 -0.766 . . . . 0.0 111.939 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.03 -44.73 62.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.841 0.746 . . . . 0.0 112.971 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.53 HD13 ' H ' ' A' ' 78' ' ' ILE . 3.1 mp -55.85 119.59 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.346 0.658 . . . . 0.0 110.276 -169.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.56 52.75 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.294 1.438 . . . . 0.0 110.669 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -136.69 154.74 76.75 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.295 1.438 . . . . 0.0 109.169 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.89 155.7 10.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.644 2.896 . . . . 0.0 112.096 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -138.97 146.1 40.55 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.16 152.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.908 1.283 . . . . 0.0 108.566 -169.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.37 161.73 26.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.05 0.54 . . . . 0.0 110.149 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 124.596 1.094 . . . . 0.0 110.887 170.595 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.91 146.97 31.28 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.214 1.006 . . . . 0.0 109.242 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -140.28 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.011 1.324 . . . . 0.0 107.701 168.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -134.43 137.91 44.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.3 133.19 58.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.28 134.21 38.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.84 33.67 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.442 1.019 . . . . 0.0 113.569 -168.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -125.15 -179.21 4.48 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.659 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.07 160.97 80.81 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.559 1.144 . . . . 0.0 111.005 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.7 -16.78 11.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.273 3.315 . . . . 0.0 116.108 175.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -50.89 -37.86 46.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.756 1.223 . . . . 0.0 112.296 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.25 -45.16 15.39 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -56.69 -37.09 70.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.919 1.288 . . . . 0.0 111.424 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -67.81 -5.36 16.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.056 1.343 . . . . 0.0 114.095 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -131.76 -33.82 1.37 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.782 1.174 . . . . 0.0 112.147 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.24 139.96 8.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.731 1.151 . . . . 0.0 108.819 166.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -142.6 148.81 38.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 166.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.57 132.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 -35.48 80.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.874 0.47 . . . . 0.0 111.124 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 -4.16 90.47 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.3 -0.722 . . . . 0.0 113.06 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.01 166.86 23.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.515 1.157 . . . . 0.0 111.075 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.6 pt -135.75 131.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -82.89 115.43 21.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.2 81.09 38.92 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.977 1.711 . . . . 0.0 106.726 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 152.81 7.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 113.706 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.23 -44.58 8.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.953 1.701 . . . . 0.0 112.359 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -67.15 -15.69 63.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -176.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -122.0 -18.86 6.83 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.405 1.082 . . . . 0.0 111.893 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.46 -32.39 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.61 1.164 . . . . 0.0 111.457 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -64.76 -8.68 15.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.14 -48.91 1.33 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.255 0.934 . . . . 0.0 109.83 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.64 -23.53 67.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.12 -32.58 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.868 0.758 . . . . 0.0 111.32 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.53 96.67 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.253 0.933 . . . . 0.0 110.655 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.67 -35.89 67.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.4 -44.58 64.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.526 0.603 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.77 85.25 9.31 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 108.018 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.63 -29.57 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.135 1.89 . . . . 0.0 112.25 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -79.68 96.63 6.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -68.84 -7.23 32.49 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.08 -6.06 39.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.664 0.786 . . . . 0.0 110.673 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.23 151.67 47.11 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -72.4 129.74 39.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.65 95.38 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -77.26 133.82 38.74 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.84 143.61 36.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.76 0.824 . . . . 0.0 108.958 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.42 159.51 44.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 109.036 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.5 p -155.52 169.6 23.91 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.728 1.611 . . . . 0.0 107.918 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -48.24 -26.2 1.86 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.24 -1.0 8.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.99 -46.75 1.52 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.413 1.482 . . . . 0.0 112.557 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 tpt85 -59.55 -45.95 90.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.234 1.017 . . . . 0.0 112.46 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -70.43 -31.82 69.15 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.239 0.472 . . . . 0.0 110.005 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -33.68 75.85 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.97 -1.081 . . . . 0.0 110.775 168.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -46.62 85.62 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -62.46 -43.53 98.6 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.571 1.186 . . . . 0.0 110.648 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 -39.61 80.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.271 0.487 . . . . 0.0 109.734 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -66.8 -38.81 87.23 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.853 -0.53 . . . . 0.0 109.867 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.06 -45.04 95.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 110.073 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.8 mt -57.99 -50.39 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.783 0.833 . . . . 0.0 109.084 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.1 -31.56 72.11 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.826 -0.546 . . . . 0.0 111.058 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -64.4 -40.63 96.17 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.492 0.587 . . . . 0.0 110.358 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.36 -36.95 85.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.751 0.705 . . . . 0.0 110.477 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -71.26 -5.1 29.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.077 0.951 . . . . 0.0 112.834 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.65 56.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.215 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -68.89 146.01 53.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.208 1.504 . . . . 0.0 107.708 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 p -125.06 -1.19 7.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 31.58 1.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.911 0.862 . . . . 0.0 111.007 175.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.11 146.99 7.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.803 0.841 . . . . 0.0 108.975 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.12 141.85 19.98 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -84.04 110.61 18.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -30.98 72.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.316 0.247 . . . . 0.0 111.483 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.15 -163.19 29.13 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.294 1.426 . . . . 0.0 109.982 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.12 159.26 32.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 169.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.5 tp -55.69 -33.03 63.8 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.86 1.264 . . . . 0.0 112.295 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -68.48 -28.68 67.24 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.112 0.565 . . . . 0.0 111.527 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.61 -39.44 22.18 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.043 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.17 134.13 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.96 26.4 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.775 1.23 . . . . 0.0 111.531 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -66.94 159.55 75.32 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 143.19 43.71 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.915 2.41 . . . . 0.0 111.707 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.14 155.76 47.6 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.96 0.904 . . . . 0.0 109.674 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.97 160.44 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.257 1.823 . . . . 0.0 108.026 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -73.4 150.03 42.03 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 169.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.104 -1.386 . . . . 0.0 110.306 172.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -140.09 148.58 41.94 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 108.561 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -131.0 95.4 3.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.213 1.805 . . . . 0.0 106.313 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -77.95 136.94 38.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.99 122.53 52.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -81.45 113.68 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.5 20.7 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -110.27 -169.12 1.41 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.256 -0.902 . . . . 0.0 109.714 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.62 149.49 61.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.46 -14.44 44.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.305 2.003 . . . . 0.0 112.899 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -55.22 -38.39 68.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.753 0.821 . . . . 0.0 111.372 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -69.28 -46.27 67.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.553 1.07 . . . . 0.0 109.826 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -58.65 -34.38 71.14 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 111.473 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -62.63 -39.78 94.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.507 1.123 . . . . 0.0 110.677 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -67.95 -49.67 60.43 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.385 0.993 . . . . 0.0 108.704 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.81 152.58 4.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.334 1.853 . . . . 0.0 107.548 167.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -136.95 152.38 50.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.704 1.201 . . . . 0.0 108.577 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.77 126.51 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -55.92 121.71 9.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.112 0.565 . . . . 0.0 109.682 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.67 70.64 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.222 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.25 163.14 13.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.79 1.295 . . . . 0.0 111.549 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.2 138.99 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.276 1.43 . . . . 0.0 108.394 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.82 114.86 18.11 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.037 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.72 80.94 20.45 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.639 1.575 . . . . 0.0 107.095 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.81 154.34 12.91 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.725 2.95 . . . . 0.0 113.819 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.4 tp -47.46 -36.19 9.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 113.039 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.77 -17.94 65.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.809 0.844 . . . . 0.0 113.116 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -127.75 -17.43 4.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.983 0.913 . . . . 0.0 112.174 -169.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.41 -33.03 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.119 1.368 . . . . 0.0 112.686 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.05 -25.0 65.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 112.877 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.21 -41.34 2.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.667 0.667 . . . . 0.0 110.392 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -63.53 -17.47 62.82 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.02 -37.24 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.24 0.927 . . . . 0.0 111.22 171.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.7 90.26 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.972 0.805 . . . . 0.0 111.528 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -79.41 -38.25 35.27 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.082 0.553 . . . . 0.0 110.352 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.71 78.98 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.961 0.504 . . . . 0.0 112.211 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 83.28 21.58 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.81 1.244 . . . . 0.0 107.962 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.86 -21.18 32.05 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.63 2.887 . . . . 0.0 115.129 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -131.63 95.57 3.76 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.549 1.14 . . . . 0.0 108.674 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -65.82 -5.52 9.22 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.496 1.119 . . . . 0.0 113.251 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -71.13 -21.43 62.2 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.113 0.87 . . . . 0.0 111.09 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 147.73 52.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -62.91 127.43 31.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.233 0.47 . . . . 0.0 109.765 -172.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.06 134.99 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.14 103.28 6.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.43 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.33 158.55 43.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.531 1.533 . . . . 0.0 108.562 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.5 p -144.22 -175.52 4.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.105 1.362 . . . . 0.0 107.667 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -56.76 -32.13 65.3 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.8 7.36 4.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -167.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.13 2.28 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.74 1.162 . . . . 0.0 113.416 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -59.51 -48.13 82.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.372 1.086 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.78 -24.91 58.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.052 0.842 . . . . 0.0 111.514 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -33.1 67.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 120.973 -1.08 . . . . 0.0 110.16 168.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -47.09 84.15 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.25 -45.17 95.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.166 0.983 . . . . 0.0 110.459 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.09 74.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.103 0.411 . . . . 0.0 110.797 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.84 -44.28 77.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.198 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.66 -39.5 88.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.274 1.397 . . . . 0.0 110.58 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.73 -51.18 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.866 0.866 . . . . 0.0 109.557 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.89 -34.2 76.19 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.894 -0.504 . . . . 0.0 111.147 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.7 m -66.09 -35.88 81.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.636 0.775 . . . . 0.0 110.0 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.85 -47.69 65.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.759 0.424 . . . . 0.0 110.152 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -68.65 -35.94 77.91 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.713 -0.661 . . . . 0.0 112.174 -170.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.88 45.18 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 CA-C-O 119.021 -0.877 . . . . 0.0 114.177 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -55.48 159.48 2.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.661 1.23 . . . . 0.0 112.742 175.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.5 p -137.95 -37.01 0.6 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.893 0.877 . . . . 0.0 110.942 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -142.67 34.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.364 0.983 . . . . 0.0 111.523 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.82 141.02 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.34 144.85 38.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.601 1.561 . . . . 0.0 107.316 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -87.06 105.64 17.3 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.13 75.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.444 0.298 . . . . 0.0 111.275 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.87 -136.27 5.78 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.14 170.76 20.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 169.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.93 -39.92 91.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.728 0.811 . . . . 0.0 109.915 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -67.95 -3.69 10.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.919 1.287 . . . . 0.0 113.669 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.37 -37.33 2.03 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.289 0.949 . . . . 0.0 112.245 -169.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 mt -58.96 144.3 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.602 1.092 . . . . 0.0 110.519 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 75.42 1.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.751 1.62 . . . . 0.0 107.775 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.2 mtp -140.21 162.86 47.65 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 126.68 1.992 . . . . 0.0 107.669 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.03 143.48 40.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.965 2.444 . . . . 0.0 111.653 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -138.52 147.44 43.13 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.05 154.29 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.253 1.421 . . . . 0.0 108.408 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.6 155.92 39.53 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.006 -0.434 . . . . 0.0 110.576 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.2 145.92 36.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.623 1.169 . . . . 0.0 108.233 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -135.26 107.61 7.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -73.57 149.1 42.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mm -138.12 131.59 41.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.87 94.49 8.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.85 35.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -166.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.37 -179.78 6.88 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.465 -1.397 . . . . 0.0 108.635 -172.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -53.4 146.72 22.17 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.406 0.548 . . . . 0.0 111.999 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -10.1 14.04 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 114.465 -172.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.69 -42.6 71.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 110.939 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -35.76 69.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.941 -0.474 . . . . 0.0 111.462 178.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -58.02 -28.73 64.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.904 1.281 . . . . 0.0 110.953 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.69 -46.67 81.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.061 0.544 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.21 -45.0 43.24 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.152 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.15 152.06 12.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.074 0.852 . . . . 0.0 110.934 167.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -146.78 160.53 42.14 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.131 1.373 . . . . 0.0 108.94 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -55.65 125.82 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.052 1.341 . . . . 0.0 108.66 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -29.54 69.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 111.818 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.06 17.27 57.42 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.167 -1.352 . . . . 0.0 113.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.28 170.58 10.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.216 1.508 . . . . 0.0 112.018 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.0 pt -142.47 142.8 26.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 127.207 2.203 . . . . 0.0 107.023 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.21 116.1 19.27 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.162 0.585 . . . . 0.0 109.919 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -137.73 73.3 47.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.26 150.61 14.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.652 2.902 . . . . 0.0 113.733 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 tp -45.84 -36.16 5.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.973 1.709 . . . . 0.0 112.916 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -63.34 -18.45 63.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.018 0.927 . . . . 0.0 113.03 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -127.49 -24.17 3.37 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.293 1.037 . . . . 0.0 111.13 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -44.66 -35.63 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.407 1.883 . . . . 0.0 113.431 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -53.84 -36.48 62.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.273 0.942 . . . . 0.0 112.47 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.45 -39.14 4.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.412 0.551 . . . . 0.0 109.729 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -67.74 -16.41 64.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.686 0.795 . . . . 0.0 112.352 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.12 -32.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.478 1.035 . . . . 0.0 111.024 169.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.02 98.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.103 . . . . 0.0 110.765 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.25 -35.75 74.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.4 0.68 . . . . 0.0 111.247 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -45.3 66.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.096 0.558 . . . . 0.0 111.968 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.25 88.12 8.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.47 1.508 . . . . 0.0 107.761 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.55 -40.87 70.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.917 2.412 . . . . 0.0 113.18 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -81.22 99.08 8.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 28.5 mtmm -66.2 -8.09 22.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.62 -7.39 22.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.136 0.88 . . . . 0.0 111.597 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.92 151.17 48.09 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.941 0.791 . . . . 0.0 109.718 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 131.49 46.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.464 0.575 . . . . 0.0 109.84 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.87 129.39 75.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -126.61 86.32 2.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.04 154.72 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.54 158.5 41.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 108.08 168.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 p -133.52 -139.56 0.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.409 0.684 . . . . 0.0 110.241 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -74.32 -37.94 63.46 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.141 -0.974 . . . . 0.0 111.229 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.83 -39.31 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.52 -26.08 0.14 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.77 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.27 -62.75 1.55 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.177 1.488 . . . . 0.0 111.813 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.08 -32.64 73.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.977 0.353 . . . . 0.0 111.17 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -76.19 -33.85 59.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.582 -0.699 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.97 -46.52 93.57 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -60.4 -50.35 73.94 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.664 0.786 . . . . 0.0 109.784 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.75 78.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.68 -38.7 87.35 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.84 -39.31 87.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.313 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.48 -46.29 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.34 0.973 . . . . 0.0 109.356 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.74 -36.86 85.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.85 0.75 . . . . 0.0 110.462 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -64.44 -42.36 96.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.067 0.547 . . . . 0.0 110.305 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.63 -33.91 76.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.758 0.708 . . . . 0.0 111.126 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.3 mmm -71.28 -3.18 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.74 18.68 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.373 -0.829 . . . . 0.0 112.975 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 23.0 m-85 -66.95 157.2 33.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.719 1.259 . . . . 0.0 109.23 169.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 p -135.17 164.78 26.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.269 1.428 . . . . 0.0 108.242 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 51.99 35.34 15.78 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.4 1.08 . . . . 0.0 111.932 -169.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.18 143.54 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.48 154.04 41.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.005 1.322 . . . . 0.0 107.49 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -109.51 116.0 30.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.75 61.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.533 0.733 . . . . 0.0 111.96 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.51 -92.27 0.58 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.2 175.22 28.52 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 tp -47.95 -35.67 11.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 113.672 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -65.27 -27.62 68.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.263 0.625 . . . . 0.0 112.146 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.42 -45.65 37.57 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.831 0.741 . . . . 0.0 111.726 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.546 ' H ' HD12 ' A' ' 78' ' ' ILE . 4.9 mp -58.78 115.46 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.978 0.911 . . . . 0.0 110.162 -170.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.19 53.57 2.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 110.399 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.0 ptm -137.54 163.52 47.94 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 123.578 0.751 . . . . 0.0 109.72 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.07 155.85 5.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.358 3.372 . . . . 0.0 113.696 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -137.52 145.49 43.03 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.17 152.48 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 125.045 1.338 . . . . 0.0 108.618 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -68.2 162.17 25.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.034 0.534 . . . . 0.0 111.166 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.912 1.244 . . . . 0.0 110.51 172.411 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.24 149.25 41.11 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.812 1.245 . . . . 0.0 107.888 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -142.04 155.21 45.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.854 1.661 . . . . 0.0 108.164 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -137.47 148.82 46.36 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.453 1.101 . . . . 0.0 108.475 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.32 135.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -90.62 116.31 28.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 167.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.86 11.87 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -88.05 -174.81 4.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.057 1.299 . . . . 0.0 109.668 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m -58.4 152.83 41.66 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 122.67 0.388 . . . . 0.0 110.512 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.39 -17.17 58.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.727 2.285 . . . . 0.0 113.379 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -57.01 -39.2 74.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.112 0.869 . . . . 0.0 110.87 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -69.88 -35.04 74.34 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.349 0.522 . . . . 0.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -60.24 -26.71 66.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.676 1.19 . . . . 0.0 111.311 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -71.23 -46.1 61.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.683 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.9 -52.15 64.21 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.667 0.667 . . . . 0.0 109.315 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.82 157.36 8.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.655 1.582 . . . . 0.0 108.01 165.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -144.77 153.35 41.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.444 1.098 . . . . 0.0 108.634 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.68 123.31 4.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.75 68.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 0.0 111.754 -172.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.81 6.24 83.32 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.281 -1.289 . . . . 0.0 113.852 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.9 164.7 13.75 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.44 1.62 . . . . 0.0 111.16 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.7 139.02 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 126.282 1.833 . . . . 0.0 107.269 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.82 114.22 17.58 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.222 0.464 . . . . 0.0 109.779 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -141.67 89.25 9.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.44 155.64 20.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.438 2.758 . . . . 0.0 114.729 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.75 -36.17 24.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.722 2.009 . . . . 0.0 112.383 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.16 -17.53 62.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.873 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -128.12 -16.99 4.42 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.773 0.829 . . . . 0.0 112.309 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -50.0 -32.12 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.021 1.328 . . . . 0.0 112.41 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -55.33 -26.09 38.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.091 1.356 . . . . 0.0 112.969 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -116.81 -43.03 2.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.671 0.669 . . . . 0.0 109.544 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -69.57 -9.11 52.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.8 tp -53.47 -36.96 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.935 1.243 . . . . 0.0 110.408 169.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.59 96.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.351 0.978 . . . . 0.0 111.543 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -33.91 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.881 0.472 . . . . 0.0 111.042 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.89 73.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.395 0.543 . . . . 0.0 111.114 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.93 113.86 4.96 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.607 1.563 . . . . 0.0 106.995 -171.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.78 -23.87 43.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.096 2.531 . . . . 0.0 115.275 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -146.2 118.51 8.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 108.861 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.02 -12.16 7.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.824 1.249 . . . . 0.0 114.033 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.52 -20.51 59.94 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.847 0.749 . . . . 0.0 112.229 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.39 155.22 40.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.03 0.832 . . . . 0.0 108.87 168.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.41 131.16 44.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.133 0.879 . . . . 0.0 109.445 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.8 t -129.16 129.89 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.81 84.38 2.27 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 m -67.49 147.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.1 167.33 22.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.66 178.38 8.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -56.05 -35.79 67.31 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.88 5.3 6.6 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.57 -25.89 5.49 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.254 1.407 . . . . 0.0 114.891 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -64.24 -49.14 73.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.268 1.534 . . . . 0.0 110.799 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.22 -31.68 67.87 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.79 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -68.81 -31.31 70.22 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.906 1.23 . . . . 0.0 111.065 169.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.42 -50.14 64.55 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 167.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.74 -42.52 99.71 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-N 117.813 0.807 . . . . 0.0 111.745 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.66 82.91 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.849 0.75 . . . . 0.0 109.812 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -66.81 -39.46 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.232 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.48 -44.45 97.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.755 1.161 . . . . 0.0 110.827 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.71 -53.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.91 -27.39 65.73 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.047 -0.408 . . . . 0.0 110.652 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -64.44 -43.1 95.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.762 0.71 . . . . 0.0 110.624 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.71 -32.83 74.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.343 0.519 . . . . 0.0 110.258 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.9 mtp -74.3 4.15 6.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 113.114 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.56 47.15 6.49 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.972 1.26 . . . . 0.0 111.891 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.2 166.4 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.304 1.042 . . . . 0.0 113.465 173.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 p -138.47 -34.95 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.813 0.845 . . . . 0.0 111.014 167.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -138.37 32.9 2.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.178 0.899 . . . . 0.0 112.008 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -92.52 139.44 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.66 147.0 31.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.774 1.23 . . . . 0.0 108.938 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -87.83 114.58 24.58 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -51.43 65.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.779 0.432 . . . . 0.0 110.301 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.43 -164.46 27.68 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.91 170.68 40.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.9 tp -55.36 -31.07 61.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 0.0 112.7 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.66 -24.83 65.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.271 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.55 -48.45 32.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.209 0.913 . . . . 0.0 111.628 -170.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.527 ' H ' HD12 ' A' ' 78' ' ' ILE . 2.4 mp -61.34 115.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.27 0.628 . . . . 0.0 109.682 -169.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.38 56.48 2.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.453 1.501 . . . . 0.0 110.358 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.3 mtp -135.63 155.3 78.34 Favored Pre-proline 0 C--O 1.239 0.53 0 C-N-CA 125.3 1.44 . . . . 0.0 109.3 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.8 152.02 14.19 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.945 3.097 . . . . 0.0 112.662 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -135.94 143.29 44.83 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 m -141.16 155.51 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.991 1.316 . . . . 0.0 108.38 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.77 159.71 29.68 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.264 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.572 -1.127 . . . . 0.0 110.616 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.39 161.65 38.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 169.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -133.46 114.2 13.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.389 1.476 . . . . 0.0 107.837 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.4 141.97 48.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.5 mm -137.12 122.07 24.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.4 122.14 28.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 m -110.38 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.21 -168.43 1.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.864 -1.148 . . . . 0.0 109.701 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.52 152.37 96.29 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.078 0.551 . . . . 0.0 110.09 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.48 -21.72 14.72 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.577 2.851 . . . . 0.0 114.475 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.34 -28.99 69.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.104 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -74.73 -47.27 32.18 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 120.098 1.317 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.06 -42.96 77.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.983 0.913 . . . . 0.0 111.275 -171.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -59.0 -51.79 68.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.388 1.075 . . . . 0.0 110.904 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.71 -41.03 60.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.38 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -167.39 140.11 3.37 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.412 1.006 . . . . 0.0 109.473 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -133.86 154.45 51.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.308 1.043 . . . . 0.0 108.622 171.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.5 130.95 19.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.6 119.48 6.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.24 59.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.208 0.909 . . . . 0.0 112.695 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.62 159.94 32.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.474 1.137 . . . . 0.0 110.75 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.9 pt -136.43 141.33 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.204 1.802 . . . . 0.0 106.5 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.54 110.22 14.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -132.72 78.42 66.69 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.532 1.933 . . . . 0.0 106.131 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.91 151.35 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.818 3.012 . . . . 0.0 114.04 -170.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.1 tp -49.22 -39.58 30.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 112.468 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.91 -11.46 56.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -130.04 -15.97 3.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.351 1.06 . . . . 0.0 111.914 -172.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -51.7 -33.89 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.295 1.438 . . . . 0.0 112.101 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -53.03 -38.69 62.6 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.286 1.034 . . . . 0.0 111.908 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.52 -45.33 4.47 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.37 -21.41 66.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.582 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -57.38 -31.66 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.805 1.184 . . . . 0.0 110.988 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -22.6 63.71 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -113.46 -28.92 7.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 110.685 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.27 -41.56 94.11 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.764 0.711 . . . . 0.0 111.294 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 t -142.96 83.6 11.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.617 1.567 . . . . 0.0 107.037 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.01 -31.46 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.018 1.812 . . . . 0.0 112.482 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -80.88 94.59 6.51 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -68.03 -0.31 4.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.31 -8.47 20.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.257 0.935 . . . . 0.0 111.674 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.83 149.49 49.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.206 0.912 . . . . 0.0 109.439 170.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -65.48 141.3 58.54 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.03 -0.419 . . . . 0.0 109.918 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.47 133.74 64.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -126.26 88.99 2.93 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.04 141.68 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.57 164.24 34.08 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.343 1.057 . . . . 0.0 109.088 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -153.39 172.21 17.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.604 1.562 . . . . 0.0 107.474 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -54.16 -18.7 4.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.16 8.52 2.95 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -171.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 -43.76 1.92 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.241 1.401 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -54.05 -53.83 47.71 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.229 1.012 . . . . 0.0 112.525 -170.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -65.46 -35.86 82.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -67.52 -34.56 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.584 -0.698 . . . . 0.0 112.321 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.21 -45.6 73.32 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -65.39 -49.53 68.95 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.236 0.518 . . . . 0.0 110.359 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.67 72.04 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 122.776 0.431 . . . . 0.0 110.648 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.49 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.42 -36.59 71.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.541 -0.725 . . . . 0.0 110.977 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.62 -46.65 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.552 1.069 . . . . 0.0 109.12 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.59 -36.86 85.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.239 0.616 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 m -66.91 -37.86 85.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.537 0.335 . . . . 0.0 110.549 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.48 -36.03 81.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -69.91 0.19 6.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.757 1.223 . . . . 0.0 112.647 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.95 80.83 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.197 -0.939 . . . . 0.0 112.985 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -64.11 155.39 31.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.832 1.316 . . . . 0.0 108.907 171.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 p -131.19 164.07 26.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.984 1.314 . . . . 0.0 108.427 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.2 m80 52.65 34.44 15.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.49 144.09 10.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.99 155.62 37.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 108.292 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.31 117.47 29.17 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 168.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.3 90.89 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.411 0.444 . . . . 0.0 111.6 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.58 -26.48 2.4 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.7 1.143 . . . . 0.0 111.921 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.02 176.73 22.58 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 173.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.0 -33.66 70.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.137 0.575 . . . . 0.0 110.147 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.9 -38.51 88.62 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 110.962 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.95 -47.15 26.26 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.611 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 82.8 mt -62.54 126.36 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -171.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.01 22.48 15.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.789 1.235 . . . . 0.0 112.087 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -73.65 158.67 85.96 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 124.22 1.008 . . . . 0.0 109.126 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.8 155.55 10.6 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.587 2.858 . . . . 0.0 111.846 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -138.07 149.41 45.96 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.74 154.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.349 1.459 . . . . 0.0 108.575 -171.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.14 151.56 45.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 172.603 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.75 153.28 47.14 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.228 1.011 . . . . 0.0 109.013 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -134.36 156.32 48.71 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.259 1.824 . . . . 0.0 107.704 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -121.61 137.46 54.73 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.28 125.94 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.79 108.77 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.295 22.7 m -101.88 22.63 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.137 0.426 . . . . 0.0 111.89 -174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.05 -177.06 3.16 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.704 -0.622 . . . . 0.0 110.464 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.08 152.84 95.62 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.221 0.608 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.81 -17.33 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.851 3.034 . . . . 0.0 115.042 171.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.08 -38.18 72.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.136 0.88 . . . . 0.0 111.461 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.93 -45.2 51.95 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.251 0.932 . . . . 0.0 109.991 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -52.85 -39.67 62.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.569 1.148 . . . . 0.0 111.699 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -54.8 -54.53 40.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.779 1.232 . . . . 0.0 111.385 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.19 -49.0 48.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.117 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.82 152.44 15.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.927 0.785 . . . . 0.0 110.635 167.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -134.19 158.32 43.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.593 1.157 . . . . 0.0 108.672 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.43 130.58 20.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 120.13 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.458 1.103 . . . . 0.0 110.101 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.63 -2.55 67.35 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.529 -1.15 . . . . 0.0 114.04 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.73 134.34 52.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.586 1.693 . . . . 0.0 109.787 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.4 130.64 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.07 113.84 12.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.567 1.076 . . . . 0.0 109.019 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.0 mt -140.79 81.62 16.44 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.59 151.97 17.58 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.661 2.907 . . . . 0.0 113.47 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.7 tp -47.75 -37.18 12.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.245 1.818 . . . . 0.0 113.216 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.86 -14.61 63.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -125.35 -19.79 4.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.836 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -50.11 -35.06 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.027 1.331 . . . . 0.0 112.465 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.69 -30.01 62.98 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.966 0.907 . . . . 0.0 112.327 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.81 -45.78 3.31 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.654 0.661 . . . . 0.0 110.102 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -63.87 -20.58 65.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.61 -34.13 34.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 0.0 111.477 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.35 97.12 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -34.71 55.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 111.137 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.39 70.84 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.429 0.559 . . . . 0.0 112.197 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.79 80.07 32.05 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.344 1.458 . . . . 0.0 107.238 -171.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.76 -1.58 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.191 2.594 . . . . 0.0 113.979 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -130.28 105.81 8.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.33 -15.0 55.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.85 -20.78 62.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.58 0.627 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.58 154.22 39.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.252 0.621 . . . . 0.0 111.619 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -76.95 135.49 38.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.625 -0.672 . . . . 0.0 109.567 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.09 90.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -72.17 131.54 42.92 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.41 143.14 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.67 163.11 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.076 0.951 . . . . 0.0 109.085 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 1.7 m -144.54 -179.19 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.416 1.886 . . . . 0.0 107.735 176.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -64.19 -37.73 88.51 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.455 -0.778 . . . . 0.0 112.245 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.97 -20.06 8.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.059 0.944 . . . . 0.0 113.249 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.63 -23.72 16.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.267 0.937 . . . . 0.0 113.922 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -68.88 -41.05 78.86 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.099 1.449 . . . . 0.0 111.469 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.31 -33.37 75.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.664 0.665 . . . . 0.0 111.418 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -71.62 -31.1 66.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.749 1.159 . . . . 0.0 110.694 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.19 -47.99 77.64 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -61.75 -46.12 90.98 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.967 -0.726 . . . . 0.0 110.547 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.58 -34.97 73.39 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.026 -0.421 . . . . 0.0 111.064 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -63.0 -42.42 99.84 Favored 'General case' 0 C--N 1.335 -0.064 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.69 -44.54 93.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.72 0.691 . . . . 0.0 110.544 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.42 -51.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.3 mt -71.2 -28.05 63.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.927 -0.483 . . . . 0.0 111.587 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 m -64.88 -43.31 93.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.512 0.596 . . . . 0.0 110.134 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.97 -34.49 78.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.687 0.676 . . . . 0.0 110.813 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.74 -6.03 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.867 0.867 . . . . 0.0 112.798 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.91 58.62 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.909 170.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -72.34 122.7 21.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.124 1.462 . . . . 0.0 108.403 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -74.59 -29.95 61.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.79 1.236 . . . . 0.0 113.833 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -136.26 44.11 2.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.422 0.689 . . . . 0.0 111.123 -168.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.56 147.93 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -145.79 123.72 12.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -74.75 106.59 6.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.45 -28.27 67.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.05 0.94 . . . . 0.0 111.694 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.47 -161.68 21.53 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.265 0.936 . . . . 0.0 110.97 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.85 159.54 33.07 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.4 tp -58.01 -26.52 62.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.032 1.333 . . . . 0.0 111.875 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -69.04 -10.51 57.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.473 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.61 -33.25 3.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.877 1.271 . . . . 0.0 112.437 -170.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.16 135.8 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.504 1.502 . . . . 0.0 107.39 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.08 23.91 11.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.539 1.136 . . . . 0.0 112.16 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 75.6 mmm -68.61 160.15 78.2 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 108.765 168.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.14 155.25 62.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.659 1.573 . . . . 0.0 109.124 167.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -138.68 144.62 39.68 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.87 150.57 16.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.206 1.402 . . . . 0.0 108.66 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -65.91 161.56 20.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.837 0.455 . . . . 0.0 110.88 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.58 152.68 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.183 1.393 . . . . 0.0 107.629 173.501 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -141.33 159.42 42.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.181 1.792 . . . . 0.0 107.655 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -129.71 145.65 51.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.72 1.208 . . . . 0.0 108.148 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.9 mt -146.48 135.45 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -90.17 124.8 35.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 22.7 m -115.78 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.959 0.504 . . . . 0.0 112.229 -174.15 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.28 -170.56 1.77 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 m -66.68 157.36 83.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.197 0.599 . . . . 0.0 110.329 171.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -53.32 -16.75 7.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.224 3.282 . . . . 0.0 115.436 172.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.95 -41.65 46.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 111.915 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -75.44 -45.14 40.51 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.619 0.645 . . . . 0.0 109.925 174.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -54.3 -38.61 66.13 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.009 0.924 . . . . 0.0 112.289 -174.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.13 -50.68 72.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.649 1.18 . . . . 0.0 110.956 177.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -83.95 -38.5 20.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.748 -170.413 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.87 139.36 2.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.65 1.18 . . . . 0.0 109.359 169.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -134.79 145.7 48.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.142 1.377 . . . . 0.0 107.909 172.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.9 t -58.81 133.94 23.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.73 142.56 39.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.264 -0.273 . . . . 0.0 110.286 -178.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.13 -18.09 29.45 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.108 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.51 163.51 20.93 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.173 1.486 . . . . 0.0 110.788 172.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -145.69 138.08 20.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.652 2.381 . . . . 0.0 105.124 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -76.77 114.68 15.8 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -176.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -141.13 85.41 12.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.37 157.31 11.89 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.87 3.047 . . . . 0.0 114.506 -170.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 tp -46.8 -41.1 14.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.782 2.033 . . . . 0.0 113.215 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.53 -10.74 60.03 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -123.7 -21.46 5.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.042 1.337 . . . . 0.0 111.303 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.37 -33.19 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.396 1.478 . . . . 0.0 112.669 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.54 -43.84 72.32 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.799 1.24 . . . . 0.0 111.142 -170.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -93.78 -45.59 7.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.671 0.669 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -17.85 65.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -52.94 -36.49 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.133 0.878 . . . . 0.0 111.248 171.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.62 96.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.982 0.81 . . . . 0.0 110.954 -175.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -35.06 66.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.232 0.613 . . . . 0.0 111.11 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.5 78.61 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.406 0.548 . . . . 0.0 111.618 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.0 t -142.09 87.98 9.45 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.385 1.474 . . . . 0.0 107.306 -171.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.88 21.77 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.953 3.102 . . . . 0.0 114.107 -172.728 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -144.08 104.67 4.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 107.605 173.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.88 -10.79 52.17 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -82.42 -13.62 56.5 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.976 0.807 . . . . 0.0 111.838 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.45 154.24 40.97 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.007 0.822 . . . . 0.0 111.453 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -71.97 136.95 46.96 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.67 135.81 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -115.97 128.65 55.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.44 145.29 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.26 159.75 44.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.568 1.547 . . . . 0.0 107.754 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 5.5 m -157.24 167.48 30.21 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.157 1.783 . . . . 0.0 108.851 -177.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -46.55 -30.2 2.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -176.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.42 7.97 5.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.568 1.076 . . . . 0.0 113.525 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.8 -40.95 1.88 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.045 1.307 . . . . 0.0 112.385 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -52.66 -47.96 66.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.595 1.158 . . . . 0.0 111.569 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -65.0 -37.86 89.06 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.059 0.391 . . . . 0.0 110.132 -173.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -30.98 69.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.016 172.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.64 -44.32 95.71 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 169.334 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -61.05 -49.49 77.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.803 0.802 . . . . 0.0 109.982 175.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.19 -40.41 77.34 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.86 0.3 . . . . 0.0 110.617 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.15 -37.92 87.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.71 -34.82 67.38 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.53 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.61 -47.37 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.889 1.222 . . . . 0.0 108.323 171.392 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 mt -70.49 -29.91 66.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.741 -0.6 . . . . 0.0 111.507 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.2 m -65.54 -38.04 88.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.227 0.467 . . . . 0.0 110.407 172.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.48 -36.05 81.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.821 0.737 . . . . 0.0 110.255 174.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mmm -68.93 -5.79 23.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.109 0.964 . . . . 0.0 112.579 170.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 12.0 64.48 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.425 1.012 . . . . 0.0 113.529 172.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.61 127.85 34.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.129 1.464 . . . . 0.0 107.731 175.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -89.42 -22.0 22.75 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -169.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.59 33.48 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.1 0.96 . . . . 0.0 111.551 -169.068 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.57 136.92 22.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 167.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.09 144.13 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.78 110.58 18.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -29.61 70.55 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.92 -162.08 28.84 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.239 1.399 . . . . 0.0 109.754 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.63 158.91 31.39 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 170.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -55.33 -35.62 65.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.358 1.063 . . . . 0.0 110.89 175.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.97 0.96 11.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.259 1.023 . . . . 0.0 112.735 176.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -130.9 -28.39 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.433 -169.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.71 134.99 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 120.936 1.698 . . . . 0.0 107.554 168.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.22 53.02 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.714 1.605 . . . . 0.0 108.831 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.0 mtp -133.88 158.38 75.58 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.188 1.795 . . . . 0.0 107.627 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.54 149.16 40.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.022 2.481 . . . . 0.0 113.354 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -127.85 159.17 35.71 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.202 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 100.0 t -134.82 167.83 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 127.708 2.403 . . . . 0.0 105.271 -175.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -128.71 161.61 29.3 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.798 -1.189 . . . . 0.0 109.871 -170.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 174.71 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.1 m80 -132.53 150.17 52.2 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.135 166.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.588 ' HZ3' ' HE2' ' A' ' 80' ' ' MET . 23.6 m95 -123.98 142.65 50.97 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.065 -1.879 . . . . 0.0 109.252 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 mm -140.0 123.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -79.86 121.7 25.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 163.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -112.28 21.35 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.937 0.79 . . . . 0.0 112.324 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.552 ' HD2' ' H ' ' A' ' 49' ' ' ASN . 7.4 ttt180 -106.3 -175.47 2.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.687 -1.258 . . . . 0.0 110.105 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 m -60.11 151.71 65.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.358 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.76 -17.14 28.12 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.221 2.614 . . . . 0.0 113.964 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -54.08 -39.87 66.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.607 1.163 . . . . 0.0 113.528 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.45 -41.74 69.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.866 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -57.54 -37.41 73.02 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.192 0.997 . . . . 0.0 111.814 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -59.96 -39.08 84.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.975 0.91 . . . . 0.0 112.319 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -87.9 -44.69 10.87 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 117.816 -1.087 . . . . 0.0 111.293 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -162.86 150.11 13.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 167.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -139.98 152.77 46.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.492 HG11 ' HE3' ' A' ' 4' ' ' TRP . 67.5 t -54.17 128.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.578 169.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.32 113.29 2.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -13.29 25.39 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.34 164.05 27.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 117.491 0.646 . . . . 0.0 110.346 171.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.58 138.25 54.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 127.084 2.154 . . . . 0.0 106.95 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.12 115.66 16.06 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 123.935 0.772 . . . . 0.0 109.592 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.41 82.78 15.96 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 126.102 1.761 . . . . 0.0 106.511 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.39 153.49 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.502 2.802 . . . . 0.0 113.791 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -49.42 -36.92 23.61 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.166 1.386 . . . . 0.0 112.457 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -67.02 -15.35 63.67 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.673 ' HB3' ' HD2' ' A' ' 32' ' ' ARG . 23.9 mt-10 -130.81 -13.61 3.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 O-C-N 124.586 1.179 . . . . 0.0 110.867 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.62 -34.15 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.342 1.057 . . . . 0.0 111.328 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -56.85 -31.36 64.7 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -105.24 -35.96 7.39 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.015 0.912 . . . . 0.0 110.482 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.673 ' HD2' ' HB3' ' A' ' 28' ' ' GLU . 5.8 mtp180 -81.2 -17.26 50.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.03 -34.39 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.56 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.48 -32.02 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.897 0.771 . . . . 0.0 111.726 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.64 -28.62 21.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.305 0.642 . . . . 0.0 111.438 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.45 -40.05 44.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.447 0.567 . . . . 0.0 111.613 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 t -142.67 82.58 12.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.41 -25.41 70.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.354 2.036 . . . . 0.0 113.84 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -101.4 100.68 11.18 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -69.34 -6.87 32.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -176.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -18.42 58.98 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 170.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -66.76 150.75 48.67 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -72.08 131.73 43.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.93 124.42 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HD2' ' HE1' ' A' ' 4' ' ' TRP . 88.5 mttt -110.34 121.04 44.33 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.04 147.02 12.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.47 163.89 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 107.975 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.8 p -154.39 -176.34 5.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.552 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 61.9 t30 -60.14 -30.68 69.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.11 1.0 7.19 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.211 -0.931 . . . . 0.0 113.101 -168.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.1 -26.57 3.79 Favored Glycine 0 C--O 1.225 -0.466 0 CA-C-O 122.611 1.117 . . . . 0.0 113.339 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.321 2.3 tpt85 -69.96 -48.16 59.43 Favored 'General case' 0 N--CA 1.426 -1.641 0 O-C-N 120.449 -1.618 . . . . 0.0 112.117 -176.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.9 -29.73 64.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.227 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -35.51 79.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.252 0.478 . . . . 0.0 111.796 167.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.86 -47.28 72.79 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -63.74 -46.01 87.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.864 0.832 . . . . 0.0 110.608 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.192 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -61.42 -41.44 97.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.86 -42.04 90.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.108 0.867 . . . . 0.0 111.255 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.3 -48.78 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 42.9 mt -64.7 -47.97 76.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.5 m -52.93 -36.26 59.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 121.761 2.073 . . . . 0.0 112.258 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -66.61 -37.93 85.92 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 41.9 mmm -68.0 -6.59 23.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.015 1.326 . . . . 0.0 113.529 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.31 28.91 13.36 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.706 -1.246 . . . . 0.0 113.866 167.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.668 ' HB3' HG23 ' A' ' 69' ' ' VAL 0.333 49.4 m-85 -68.2 151.5 46.87 Favored 'General case' 0 CA--C 1.469 -2.169 0 C-N-CA 123.686 0.794 . . . . 0.0 110.057 173.393 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.57 -24.44 11.77 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.711 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -138.77 47.35 1.94 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.911 1.339 . . . . 0.0 111.571 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 66' ' ' TYR . 2.1 t -90.32 148.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -147.05 134.5 20.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.629 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -78.14 110.6 13.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 163.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.53 -31.65 72.82 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.76 -147.51 19.26 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -100.52 165.56 19.26 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' HE2' ' A' ' 82' ' ' LYS . 40.3 tp -50.06 -32.81 16.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.971 1.367 . . . . 0.0 112.864 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.272 59.9 mttt -69.22 -28.45 66.36 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -86.32 -40.38 15.53 Favored 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 126.178 2.174 . . . . 0.0 107.58 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 80' ' ' MET . 2.2 mp -60.92 126.28 18.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.179 . . . . 0.0 108.806 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.85 34.24 3.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.231 1.012 . . . . 0.0 110.264 -174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.588 ' HE2' ' HZ3' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -91.24 161.47 34.85 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 123.459 0.704 . . . . 0.0 109.553 170.558 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -51.22 150.91 13.52 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.535 2.157 . . . . 0.0 111.519 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HE2' HD12 ' A' ' 75' ' ' LEU . 17.2 mttp -133.84 153.32 51.81 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 157.6 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -84.71 162.7 19.56 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.443 173.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.346 0 O-C-N 127.502 3.001 . . . . 0.0 111.29 170.133 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -135.28 110.98 9.26 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 107.959 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -75.95 133.02 40.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.3 mm -132.86 122.53 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -78.51 129.39 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.93 31.34 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.691 0.678 . . . . 0.0 111.991 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -120.02 -173.42 2.55 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.424 -0.797 . . . . 0.0 109.788 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.21 157.46 77.05 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.458 0.703 . . . . 0.0 110.01 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.62 -14.43 39.83 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.918 2.412 . . . . 0.0 113.649 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -47.37 -47.87 25.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.957 1.303 . . . . 0.0 111.087 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -70.61 -42.0 71.53 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 118.529 0.604 . . . . 0.0 109.957 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -57.05 -38.56 73.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.952 0.901 . . . . 0.0 111.18 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.7 -45.03 88.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.772 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -73.54 -47.26 42.16 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.542 1.065 . . . . 0.0 110.771 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.83 149.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 109.729 166.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -138.6 151.24 47.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.081 1.752 . . . . 0.0 107.991 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.96 131.55 16.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 119.18 3.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.567 1.147 . . . . 0.0 110.346 -171.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.05 76.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.626 -1.097 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.9 55.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.372 1.586 . . . . 0.0 109.424 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 mt -78.83 129.17 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -78.36 118.59 20.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.164 0.893 . . . . 0.0 109.498 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.9 mt -141.16 84.57 12.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.23 151.03 9.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.94 3.093 . . . . 0.0 113.895 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.2 tp -46.74 -42.65 17.14 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.539 1.536 . . . . 0.0 112.575 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -66.82 -12.55 59.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.745 0.818 . . . . 0.0 112.992 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.39 -9.15 4.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.739 1.216 . . . . 0.0 112.389 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 p -49.37 -42.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.735 1.152 . . . . 0.0 112.238 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -57.92 -34.95 70.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.969 0.908 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -92.77 7.57 43.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.062 0.945 . . . . 0.0 111.585 -168.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -140.94 -27.84 0.7 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.274 -0.891 . . . . 0.0 112.116 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.36 -34.81 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.687 1.131 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.39 23.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.482 1.113 . . . . 0.0 113.676 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -121.42 -27.94 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.902 1.281 . . . . 0.0 111.156 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.98 -38.54 76.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.807 0.731 . . . . 0.0 111.04 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -140.26 75.78 27.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.63 -32.88 18.21 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.34 2.026 . . . . 0.0 112.37 -172.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -79.03 97.71 6.2 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.14 -10.31 39.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -78.68 -18.99 53.52 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.686 1.13 . . . . 0.0 111.563 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.38 147.06 54.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.056 0.843 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -70.98 137.79 49.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.1 t -127.87 141.17 47.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -130.33 128.45 41.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.29 154.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.149 0.979 . . . . 0.0 108.925 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -155.92 161.76 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.593 1.957 . . . . 0.0 107.077 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.2 171.49 20.1 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.376 0.67 . . . . 0.0 109.638 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -48.32 -30.62 5.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.361 1.864 . . . . 0.0 114.545 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.75 2.05 8.17 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.52 -31.81 0.85 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.687 1.613 . . . . 0.0 113.918 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -63.57 -52.37 61.31 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.783 1.291 . . . . 0.0 111.507 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.94 -35.56 80.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.05 0.841 . . . . 0.0 110.892 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.9 p -72.04 -33.15 67.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.53 -0.732 . . . . 0.0 111.651 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.62 77.46 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -64.66 -49.2 71.92 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 117.516 0.658 . . . . 0.0 110.04 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.14 -36.63 70.94 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.443 0.297 . . . . 0.0 110.873 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.06 -42.12 97.13 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.44 -34.72 72.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.877 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -58.66 -50.45 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.323 0.965 . . . . 0.0 108.927 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.28 -34.44 78.36 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.753 -0.592 . . . . 0.0 110.825 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -63.16 -40.6 98.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.562 0.345 . . . . 0.0 110.687 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.99 -35.57 80.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.55 0.74 . . . . 0.0 110.677 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.05 -6.46 28.26 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.969 0.908 . . . . 0.0 112.415 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.631 -1.094 . . . . 0.0 113.159 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -65.93 119.26 11.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.381 1.591 . . . . 0.0 107.081 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 p -81.54 -19.86 41.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.01 76.81 1.67 Allowed 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.313 1.045 . . . . 0.0 108.441 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.76 141.99 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.25 140.87 35.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -91.74 102.99 15.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.74 76.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.743 -171.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.12 -168.3 27.1 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.53 153.63 51.78 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.8 tp -45.25 -45.09 11.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.861 1.664 . . . . 0.0 113.289 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -67.15 -25.36 66.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.13 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.56 -34.53 46.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.716 0.689 . . . . 0.0 111.574 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.77 123.93 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.06 22.9 12.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.12 0.968 . . . . 0.0 112.324 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.7 mmm -73.63 153.21 89.56 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.81 157.37 12.93 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.276 2.651 . . . . 0.0 110.948 167.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -136.43 158.0 45.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.128 0.571 . . . . 0.0 110.055 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.27 164.55 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.213 2.205 . . . . 0.0 105.186 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -147.56 172.18 14.4 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.805 -1.184 . . . . 0.0 110.648 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -173.579 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.236 0.387 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -140.61 163.99 31.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.574 1.55 . . . . 0.0 107.427 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -128.26 136.18 50.68 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -131.04 127.76 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -94.53 121.38 36.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 168.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.46 13.97 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -93.93 179.49 5.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.7 1.136 . . . . 0.0 110.366 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -51.9 148.09 11.17 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.76 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.56 -27.15 24.35 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.332 2.688 . . . . 0.0 113.533 171.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.73 -39.55 65.37 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.667 0.787 . . . . 0.0 111.391 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -69.83 -41.64 74.67 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.122 0.874 . . . . 0.0 110.501 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -58.1 -39.62 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.096 1.359 . . . . 0.0 110.486 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.88 -10.66 60.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.006 . . . . 0.0 113.696 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -81.69 -71.29 0.49 Allowed 'General case' 0 C--N 1.341 0.202 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 168.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.68 158.29 28.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.63 1.572 . . . . 0.0 107.702 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -143.44 152.75 41.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.527 1.131 . . . . 0.0 108.41 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.74 131.5 14.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.36 120.4 5.99 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.06 90.38 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.511 -1.161 . . . . 0.0 113.884 173.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.38 142.21 57.94 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.227 1.513 . . . . 0.0 110.005 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -87.9 127.33 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -77.18 115.33 16.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.56 81.56 23.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.133 1.773 . . . . 0.0 106.561 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.16 148.87 23.27 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.255 2.636 . . . . 0.0 112.625 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.88 -29.72 42.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.782 1.233 . . . . 0.0 112.722 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -60.08 -20.36 57.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.696 0.798 . . . . 0.0 113.049 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -128.41 -17.44 4.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.534 1.134 . . . . 0.0 112.096 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.87 -36.44 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.341 . . . . 0.0 112.765 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.65 -30.46 68.75 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.468 0.707 . . . . 0.0 112.073 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.92 -47.78 4.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.368 0.667 . . . . 0.0 109.514 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -63.89 -18.76 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.112 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -52.58 -40.55 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.43 1.014 . . . . 0.0 111.04 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.79 90.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.828 0.74 . . . . 0.0 110.917 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -71.72 -37.02 70.68 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.487 0.715 . . . . 0.0 111.063 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.87 62.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.217 0.462 . . . . 0.0 111.738 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.24 98.19 6.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 108.128 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.18 -9.76 7.01 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.088 3.192 . . . . 0.0 116.253 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -134.83 111.29 9.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.834 1.197 . . . . 0.0 110.155 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.0 -12.37 60.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.701 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -86.54 -4.17 59.13 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.151 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.74 151.03 47.9 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.362 -0.836 . . . . 0.0 108.9 168.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 m -79.62 70.21 6.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.73 0.776 . . . . 0.0 109.758 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 t -74.01 97.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -79.58 141.26 36.75 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.99 126.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -171.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.06 169.67 17.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.23 1.412 . . . . 0.0 109.307 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 p -150.11 178.45 8.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.78 -23.36 67.33 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.01 -6.81 11.97 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.63 30.13 77.08 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.661 1.119 . . . . 0.0 114.627 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -137.26 -45.8 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.012 0.906 . . . . 0.0 110.235 170.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.98 -22.38 65.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.726 0.239 . . . . 0.0 110.614 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 p -64.36 -42.21 96.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.05 -1.031 . . . . 0.0 110.95 168.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.77 -43.27 96.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.14 -40.07 96.51 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.147 1.474 . . . . 0.0 111.315 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.53 76.06 Favored 'General case' 0 C--O 1.227 -0.087 0 O-C-N 121.376 -0.828 . . . . 0.0 110.685 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.03 -39.65 83.06 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.488 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.97 -44.02 97.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.37 0.987 . . . . 0.0 109.714 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.41 -50.38 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.921 0.889 . . . . 0.0 109.688 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.05 -18.65 62.55 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.441 -0.787 . . . . 0.0 111.502 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -68.22 -36.73 79.96 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.54 -0.725 . . . . 0.0 110.126 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.12 -36.49 83.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.299 0.954 . . . . 0.0 110.052 171.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.1 mmm -73.23 -1.87 19.49 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.064 0.945 . . . . 0.0 112.796 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.08 46.05 17.78 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 119.849 1.204 . . . . 0.0 111.659 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -46.24 158.41 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.501 1.121 . . . . 0.0 113.299 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.83 -26.67 1.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.893 -1.051 . . . . 0.0 112.217 173.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -147.92 23.86 1.08 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.585 1.539 . . . . 0.0 113.845 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 144.58 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.2 128.33 16.64 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.856 0.862 . . . . 0.0 109.002 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.63 108.17 10.63 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 168.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.73 73.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.0 0.52 . . . . 0.0 110.957 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.54 -139.36 7.23 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.22 166.34 15.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.5 tp -51.03 -40.16 57.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -168.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.91 -27.61 66.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.642 0.377 . . . . 0.0 111.677 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -86.71 -36.28 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.884 0.874 . . . . 0.0 111.658 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.95 119.66 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.46 22.87 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.05 0.94 . . . . 0.0 112.468 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mmm -81.3 158.35 69.41 Favored Pre-proline 0 C--O 1.24 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 109.462 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.65 154.92 11.19 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.441 2.761 . . . . 0.0 111.754 168.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -134.41 154.34 51.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 t -130.54 141.04 47.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.59 161.0 24.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.09 0.556 . . . . 0.0 110.281 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.032 169.355 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.373 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -82.8 158.07 22.94 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.22 141.66 49.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.621 1.168 . . . . 0.0 107.998 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -139.84 136.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.89 122.24 36.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.64 20.21 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.598 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 15.8 ttt85 -109.56 -162.84 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.238 -0.914 . . . . 0.0 108.766 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 11.1 m -77.98 156.13 79.83 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.343 0.657 . . . . 0.0 109.588 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.41 -23.77 19.75 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.364 2.709 . . . . 0.0 114.029 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -26.08 64.2 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.688 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -86.2 -51.34 6.34 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 119.95 1.25 . . . . 0.0 109.142 167.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -53.25 -37.81 62.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.871 1.269 . . . . 0.0 112.992 -170.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -66.59 -45.59 78.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 0.0 111.52 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.38 -30.36 60.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.953 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.74 153.37 2.21 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.616 1.566 . . . . 0.0 109.667 166.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -146.02 146.51 31.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 t -60.15 132.67 25.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.4 149.43 16.83 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.577 0.751 . . . . 0.0 111.529 -172.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.93 -14.87 46.43 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.462 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.82 171.39 7.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.889 1.345 . . . . 0.0 111.797 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.8 mt -135.4 134.22 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -73.92 115.65 13.63 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.162 0.892 . . . . 0.0 109.031 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 mt -141.29 87.55 10.52 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.22 149.83 11.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.009 3.139 . . . . 0.0 114.027 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.49 -36.37 14.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.883 1.673 . . . . 0.0 113.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -63.88 -20.45 65.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -129.29 -11.3 4.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.93 0.892 . . . . 0.0 111.865 -169.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -50.26 -34.65 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 111.51 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.69 -33.83 56.74 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 112.609 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.54 -36.72 4.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.485 0.584 . . . . 0.0 111.211 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -69.26 -15.67 63.41 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.597 -0.689 . . . . 0.0 112.317 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.67 -35.35 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.056 169.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.08 99.43 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.385 0.993 . . . . 0.0 111.184 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -35.94 59.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.405 0.682 . . . . 0.0 111.158 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.74 75.02 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -140.66 82.47 15.78 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.994 1.718 . . . . 0.0 107.062 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.46 3.71 4.53 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.381 2.72 . . . . 0.0 114.256 -173.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.06 103.88 5.99 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.801 1.24 . . . . 0.0 107.863 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -15.78 52.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.98 -25.15 63.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.468 0.577 . . . . 0.0 111.876 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -63.66 154.7 32.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.63 0.65 . . . . 0.0 111.773 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -73.2 142.67 47.34 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.22 140.59 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -120.67 139.93 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.19 144.6 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -143.57 160.59 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.46 1.104 . . . . 0.0 109.109 170.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -130.01 -139.34 0.22 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 125.034 1.334 . . . . 0.0 107.423 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -80.53 -45.15 17.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.789 1.631 . . . . 0.0 111.89 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.87 -26.44 3.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -169.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.35 2.41 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.073 0.851 . . . . 0.0 113.933 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -66.08 -44.21 85.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.984 1.392 . . . . 0.0 112.517 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.2 -33.03 71.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.868 0.758 . . . . 0.0 110.648 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -33.39 74.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.251 -0.906 . . . . 0.0 110.648 170.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.96 -49.18 68.34 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -60.47 -46.91 88.37 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.529 0.664 . . . . 0.0 110.655 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.51 75.25 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.474 0.579 . . . . 0.0 110.791 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -65.4 -42.79 92.22 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -42.34 98.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.876 0.762 . . . . 0.0 111.111 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.84 -51.21 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.88 -24.56 59.74 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.733 -0.604 . . . . 0.0 111.858 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 m -67.38 -38.95 85.52 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.321 0.51 . . . . 0.0 110.248 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -67.26 -37.21 83.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.831 0.741 . . . . 0.0 110.256 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mmm -67.39 -12.98 61.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.688 0.795 . . . . 0.0 112.289 170.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.89 14.6 66.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.349 -1.25 . . . . 0.0 113.955 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -64.26 122.87 17.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.522 1.661 . . . . 0.0 107.716 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -68.19 -30.88 70.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -165.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.27 42.9 2.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.271 0.942 . . . . 0.0 112.213 -166.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.83 146.67 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -142.65 137.76 30.18 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.144 1.378 . . . . 0.0 108.356 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -78.5 114.37 17.35 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.38 63.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.637 0.775 . . . . 0.0 112.031 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.58 -145.7 17.71 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.93 168.99 16.02 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.98 -25.48 67.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.142 0.977 . . . . 0.0 112.234 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -78.25 -6.02 53.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.353 172.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.58 -35.09 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.311 1.044 . . . . 0.0 112.471 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.61 146.19 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 120.264 1.393 . . . . 0.0 108.615 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.97 67.14 1.34 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.471 1.508 . . . . 0.0 108.427 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.2 ptm -140.23 166.1 25.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.9 1.28 . . . . 0.0 108.543 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 147.1 33.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.231 2.621 . . . . 0.0 113.561 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.87 160.06 24.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.5 1.12 . . . . 0.0 109.029 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.56 155.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -134.86 155.86 49.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.124 0.97 . . . . 0.0 109.089 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 174.642 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -134.72 98.67 4.11 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.626 1.571 . . . . 0.0 107.149 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -72.64 147.08 46.12 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mm -140.34 124.69 18.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -79.79 114.35 18.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.4 m -106.42 18.55 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.49 -171.93 2.22 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 120.946 -1.096 . . . . 0.0 109.288 173.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.74 154.9 64.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.02 -11.11 25.7 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.059 2.506 . . . . 0.0 114.1 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -54.27 -37.26 64.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.575 1.55 . . . . 0.0 112.275 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.38 -41.85 75.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.141 0.882 . . . . 0.0 110.296 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -58.75 -31.44 68.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.945 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -64.66 -14.63 59.07 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -132.08 -36.47 1.17 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.536 1.062 . . . . 0.0 112.709 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.91 139.74 6.4 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.865 1.211 . . . . 0.0 108.256 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -141.71 154.7 45.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 170.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.39 128.8 14.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -29.68 65.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.046 0.539 . . . . 0.0 112.235 -169.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.94 22.77 36.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.241 -1.311 . . . . 0.0 113.12 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.57 163.69 17.62 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.173 1.487 . . . . 0.0 112.319 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 pt -137.36 144.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 127.053 2.141 . . . . 0.0 107.33 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.3 117.23 20.1 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.113 0.565 . . . . 0.0 109.805 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.0 mt -141.21 83.45 13.7 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.222 1.809 . . . . 0.0 106.268 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.32 152.83 24.3 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.769 2.979 . . . . 0.0 114.555 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -47.38 -36.57 9.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.651 1.981 . . . . 0.0 113.016 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -64.14 -20.06 65.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.29 -11.75 4.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.852 0.861 . . . . 0.0 112.105 -169.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -51.4 -33.75 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.763 1.225 . . . . 0.0 112.058 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -54.43 -35.75 63.28 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.577 1.151 . . . . 0.0 111.974 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.96 -42.17 5.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -66.96 -14.31 62.71 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 tp -52.18 -38.62 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.467 1.031 . . . . 0.0 111.204 170.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.76 98.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.131 0.878 . . . . 0.0 111.041 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.14 -35.63 69.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.531 0.732 . . . . 0.0 111.201 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.46 -46.27 67.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 0.0 111.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 t -143.66 101.32 5.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -171.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.17 -22.92 34.1 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.57 2.847 . . . . 0.0 115.53 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -144.43 116.63 8.44 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.305 1.042 . . . . 0.0 108.849 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -66.74 -4.56 9.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 113.088 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.62 -23.58 62.58 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.146 0.579 . . . . 0.0 111.087 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.13 150.0 45.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.07 130.17 41.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.685 -0.634 . . . . 0.0 109.416 -173.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -125.74 134.49 66.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.34 86.65 2.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.87 144.44 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -152.18 163.63 38.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.559 1.544 . . . . 0.0 108.379 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.71 170.46 21.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.466 1.106 . . . . 0.0 109.147 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -54.79 -14.98 1.6 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 -3.4 4.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.51 -30.26 0.59 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.447 1.499 . . . . 0.0 114.137 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -64.97 -49.71 69.22 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.438 1.095 . . . . 0.0 111.525 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.67 -31.35 71.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.399 0.545 . . . . 0.0 110.638 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -71.57 -30.89 66.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.173 -0.954 . . . . 0.0 111.289 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.2 -48.97 70.81 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 167.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -61.36 -44.42 97.19 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.974 -0.721 . . . . 0.0 111.166 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.06 75.46 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 118.372 0.533 . . . . 0.0 110.572 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.39 -40.38 85.66 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -64.12 -41.39 97.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.361 0.982 . . . . 0.0 110.842 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.11 -53.01 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -69.78 -23.19 63.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.927 -0.483 . . . . 0.0 111.829 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 34.9 m -63.12 -44.28 96.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.558 0.617 . . . . 0.0 110.128 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -67.22 -28.92 68.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.313 0.506 . . . . 0.0 110.884 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mmm -76.7 6.59 5.74 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.142 0.977 . . . . 0.0 112.73 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 42.51 8.55 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 119.677 1.126 . . . . 0.0 112.525 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.2 OUTLIER -53.3 161.85 0.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 175.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.33 -40.72 0.65 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 110.622 168.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -135.23 33.36 3.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.818 1.19 . . . . 0.0 112.537 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.4 t -82.42 140.67 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -147.16 143.6 28.36 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.075 0.95 . . . . 0.0 108.875 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -79.35 107.46 12.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.21 -29.29 70.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.059 0.544 . . . . 0.0 111.958 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.95 -162.12 25.21 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.05 30.83 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -58.19 -34.06 69.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 110.565 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.13 -14.66 63.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.92 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -110.7 -39.26 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.114 0.966 . . . . 0.0 111.33 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 mt -64.42 139.79 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.721 1.146 . . . . 0.0 109.498 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.06 27.39 7.18 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.022 1.329 . . . . 0.0 111.508 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.0 162.51 45.44 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.05 144.26 46.92 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.285 1.99 . . . . 0.0 110.547 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.14 153.09 51.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.609 0.764 . . . . 0.0 109.261 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.77 160.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.458 1.903 . . . . 0.0 106.725 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.47 157.05 23.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 173.508 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -141.12 153.37 45.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.091 1.757 . . . . 0.0 106.906 169.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -123.08 150.44 43.15 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 mm -140.04 123.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -80.87 111.18 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -103.3 20.69 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 11.6 ttt-85 -106.94 -175.48 2.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.194 -0.942 . . . . 0.0 109.61 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 4.4 m -69.14 156.86 90.72 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.185 0.594 . . . . 0.0 109.868 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.53 -14.2 4.62 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.107 3.205 . . . . 0.0 115.759 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -48.65 -38.02 19.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.099 1.36 . . . . 0.0 112.058 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.43 -48.52 12.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.227 0.467 . . . . 0.0 110.305 173.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -55.81 -38.99 70.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.129 0.971 . . . . 0.0 112.02 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -65.4 -7.8 15.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.259 1.424 . . . . 0.0 113.637 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -130.23 -29.68 2.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.657 1.117 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -167.04 143.15 4.35 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.062 1.301 . . . . 0.0 108.797 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -143.75 153.36 42.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.337 1.055 . . . . 0.0 108.217 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.44 131.58 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -33.64 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.373 0.669 . . . . 0.0 111.54 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.37 12.94 67.81 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.048 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.03 166.05 13.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.128 1.464 . . . . 0.0 112.169 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.45 142.16 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.022 2.129 . . . . 0.0 107.373 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -80.0 114.79 19.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.877 0.471 . . . . 0.0 110.231 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 mt -139.04 80.4 24.01 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.811 1.644 . . . . 0.0 107.034 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.62 153.86 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.669 2.912 . . . . 0.0 113.912 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 tp -46.61 -38.96 10.37 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 113.114 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -69.23 -13.14 62.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -126.98 -18.84 4.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.164 0.986 . . . . 0.0 111.989 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.55 -34.48 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.018 1.327 . . . . 0.0 112.813 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -57.11 -29.88 63.9 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.356 1.062 . . . . 0.0 112.476 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.18 -41.29 3.33 Favored 'General case' 0 C--N 1.334 -0.065 0 C-N-CA 123.374 0.67 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.12 -16.85 63.94 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.3 -35.16 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.662 1.119 . . . . 0.0 110.85 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.24 -7.15 28.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.931 0.893 . . . . 0.0 113.145 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 p -120.91 15.79 11.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.732 1.613 . . . . 0.0 110.512 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.74 -51.08 0.79 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.266 1.026 . . . . 0.0 110.733 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.21 67.51 21.34 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.726 1.21 . . . . 0.0 108.142 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.98 -28.92 75.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.331 2.021 . . . . 0.0 112.211 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.65 81.09 3.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -52.47 -26.4 12.78 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.934 1.294 . . . . 0.0 113.092 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -66.64 -24.33 66.28 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.172 0.989 . . . . 0.0 112.743 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.43 150.61 44.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.29 0.95 . . . . 0.0 109.8 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.35 137.78 54.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.546 -0.721 . . . . 0.0 110.221 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.7 131.57 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -125.34 90.94 3.32 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.7 144.46 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.08 162.22 38.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.706 1.202 . . . . 0.0 109.115 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.6 p -153.35 172.45 17.03 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.214 1.006 . . . . 0.0 109.603 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -51.28 -25.96 6.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.621 1.568 . . . . 0.0 115.232 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.77 -0.68 6.05 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 -36.64 0.96 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.594 1.569 . . . . 0.0 113.811 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -63.35 -44.3 95.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.902 1.351 . . . . 0.0 111.425 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -72.94 -29.07 62.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.098 0.408 . . . . 0.0 110.412 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -69.93 -32.41 70.67 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.945 -1.097 . . . . 0.0 109.961 168.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.38 -47.96 66.62 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.48 -41.8 98.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.261 1.03 . . . . 0.0 111.095 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.48 76.31 Favored 'General case' 0 CA--C 1.526 0.035 0 CA-C-N 118.802 0.728 . . . . 0.0 110.491 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.63 -41.43 79.47 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.95 -44.34 94.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.47 1.032 . . . . 0.0 110.53 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.5 -52.12 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.97 0.908 . . . . 0.0 109.431 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.09 -26.75 65.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.989 -0.444 . . . . 0.0 110.954 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 m -61.38 -39.39 90.5 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.551 -0.718 . . . . 0.0 110.627 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.91 -41.8 77.69 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.263 0.483 . . . . 0.0 110.424 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -74.41 -16.2 60.89 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.54 46.07 0.19 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.01 168.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.05 157.48 3.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.639 1.219 . . . . 0.0 112.752 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.9 -44.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 109.491 168.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.99 35.47 2.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.394 1.078 . . . . 0.0 111.359 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.76 135.68 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -140.22 146.86 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.385 1.074 . . . . 0.0 108.963 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -80.15 113.9 18.67 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.6 -31.34 71.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.469 0.708 . . . . 0.0 111.685 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.88 -165.39 24.27 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.9 160.41 31.1 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.3 tp -49.6 -34.08 16.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.014 1.725 . . . . 0.0 111.944 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -66.68 -9.8 39.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 112.53 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.88 -27.39 3.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.223 1.409 . . . . 0.0 112.751 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.03 89.88 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.572 1.533 . . . . 0.0 107.037 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.57 27.39 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.358 1.463 . . . . 0.0 113.15 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -73.13 156.37 89.48 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 123.51 0.724 . . . . 0.0 109.226 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.24 155.24 12.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.458 2.772 . . . . 0.0 111.643 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -132.87 154.64 50.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.036 0.534 . . . . 0.0 110.518 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -133.02 173.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.298 2.239 . . . . 0.0 105.652 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -125.41 146.04 49.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.986 -1.071 . . . . 0.0 109.217 -172.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 172.701 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 C--O 1.236 0.343 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -140.38 169.92 16.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.534 1.134 . . . . 0.0 108.264 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -131.11 138.39 49.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -169.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.1 mm -137.84 129.75 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.71 120.61 26.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.415 HG23 ' SG ' ' A' ' 48' ' ' CYS . 29.2 m -111.97 19.42 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 118.199 0.454 . . . . 0.0 111.617 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -98.77 -177.62 3.71 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.347 -0.846 . . . . 0.0 109.601 176.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.43 154.46 54.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.16 -19.67 12.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.568 2.846 . . . . 0.0 114.899 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -47.45 -44.83 25.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -73.0 -45.86 55.46 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.747 0.703 . . . . 0.0 110.719 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -55.29 -37.15 66.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.41 1.484 . . . . 0.0 111.37 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -67.64 -16.31 64.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.73 1.212 . . . . 0.0 113.119 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -92.51 -59.74 2.0 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -159.95 158.85 31.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.363 1.465 . . . . 0.0 107.755 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -140.19 154.36 46.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.38 141.31 13.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.49 121.56 4.61 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.385 1.074 . . . . 0.0 110.132 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.26 2.91 68.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.536 -1.147 . . . . 0.0 114.14 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 154.51 35.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.505 1.652 . . . . 0.0 110.964 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.02 127.93 73.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.39 114.36 9.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.754 0.706 . . . . 0.0 109.501 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -140.54 79.7 19.79 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.325 1.85 . . . . 0.0 106.508 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.54 151.24 24.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.951 3.1 . . . . 0.0 114.731 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -47.92 -38.92 17.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.881 2.072 . . . . 0.0 112.863 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -64.4 -20.45 66.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -129.71 -3.49 4.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.047 0.939 . . . . 0.0 112.045 -169.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 p -49.97 -40.98 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.476 1.111 . . . . 0.0 111.691 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -56.93 -38.01 72.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.802 0.841 . . . . 0.0 112.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -90.31 -3.76 57.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.591 0.757 . . . . 0.0 111.399 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -132.12 -26.54 1.91 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -59.56 -35.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.855 0.752 . . . . 0.0 110.739 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.12 96.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.559 0.618 . . . . 0.0 111.26 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -36.14 65.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.157 0.583 . . . . 0.0 111.143 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.19 -42.27 72.61 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.476 0.58 . . . . 0.0 111.705 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.28 82.36 13.16 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.37 1.468 . . . . 0.0 108.247 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.44 -37.78 93.19 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.014 2.476 . . . . 0.0 113.133 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -79.2 96.02 5.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -69.51 -3.28 13.98 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -7.12 25.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.732 1.213 . . . . 0.0 111.108 174.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.11 150.56 49.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.668 1.122 . . . . 0.0 109.327 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -73.88 131.81 41.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -130.48 96.31 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -74.62 134.36 42.07 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.01 146.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -146.25 163.16 36.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.003 1.321 . . . . 0.0 108.162 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' A' ' 7' ' ' VAL . 1.7 m -159.99 -178.59 7.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.801 1.641 . . . . 0.0 109.695 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -63.03 132.35 51.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 166.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.85 0.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.162 2.185 . . . . 0.0 116.413 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.03 -8.0 40.39 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.836 1.208 . . . . 0.0 114.252 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -63.06 -56.89 13.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.545 1.672 . . . . 0.0 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.74 -29.49 70.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.948 -170.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -76.19 -33.23 59.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.204 -0.935 . . . . 0.0 111.28 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.37 -47.4 75.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.32 -46.53 88.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.643 0.777 . . . . 0.0 110.533 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.3 73.96 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 121.719 -0.613 . . . . 0.0 111.058 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HE2' HG23 ' A' ' 69' ' ' VAL . 12.3 tmtt? -64.39 -44.75 90.35 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.24 -33.07 72.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.105 0.866 . . . . 0.0 111.215 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.32 -49.9 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.204 0.911 . . . . 0.0 108.938 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.88 -31.29 70.98 Favored 'General case' 0 C--O 1.231 0.123 0 O-C-N 121.54 -0.725 . . . . 0.0 111.378 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.94 -41.04 99.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.38 -35.91 80.28 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.78 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.86 -7.09 25.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.192 0.997 . . . . 0.0 112.318 171.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.51 12.42 59.64 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.155 -0.966 . . . . 0.0 113.328 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -68.35 148.07 51.23 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.068 1.434 . . . . 0.0 108.106 168.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.5 t -128.0 -10.29 5.4 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -128.51 34.27 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.31 1.044 . . . . 0.0 110.109 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG23 ' HE2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -79.1 143.06 13.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -146.94 128.74 15.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -76.75 104.56 7.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.21 66.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.589 0.755 . . . . 0.0 111.872 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.3 -166.54 24.96 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.983 0.801 . . . . 0.0 111.227 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.76 48.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.2 tp -44.94 -49.7 10.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 -25.35 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.305 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.74 -28.35 30.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.007 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.56 120.33 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.611 1.096 . . . . 0.0 108.884 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.5 55.54 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.563 1.545 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.0 mtp -134.53 156.14 79.04 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 124.792 1.237 . . . . 0.0 108.673 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.81 157.3 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.073 2.515 . . . . 0.0 111.434 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -134.69 128.97 34.05 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.09 139.58 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.65 155.78 28.82 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.993 -0.442 . . . . 0.0 110.805 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 168.504 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -84.32 158.39 21.19 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -133.97 122.13 22.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -123.57 126.46 73.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.04 117.19 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.275 21.5 m -114.6 52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 12.9 ttt180 -141.44 -169.92 2.97 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.508 -1.37 . . . . 0.0 110.144 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 12.0 m -58.62 153.95 37.88 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.34 -22.15 15.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.157 2.572 . . . . 0.0 114.124 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.69 -25.49 64.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.101 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -78.37 -49.86 12.78 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 120.22 1.373 . . . . 0.0 109.43 169.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.55 -40.71 75.6 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.469 1.107 . . . . 0.0 111.691 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.14 -4.76 11.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.027 1.331 . . . . 0.0 113.599 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -126.27 -34.6 2.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.941 1.246 . . . . 0.0 111.912 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -163.79 145.77 9.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.852 1.206 . . . . 0.0 109.243 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -146.75 154.87 41.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.78 1.232 . . . . 0.0 107.944 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.92 131.24 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.95 -36.5 49.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -166.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.18 2.11 83.3 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.601 0.637 . . . . 0.0 113.672 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.3 157.72 37.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.255 1.026 . . . . 0.0 113.636 -169.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.3 pt -131.52 134.44 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.14 120.87 25.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.802 0.441 . . . . 0.0 109.981 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -143.72 94.46 6.0 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.69 151.24 11.01 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.053 3.168 . . . . 0.0 114.86 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.52 -50.06 33.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.962 1.305 . . . . 0.0 112.272 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -71.75 -5.65 35.58 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -124.1 -18.95 5.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.608 1.163 . . . . 0.0 111.96 -167.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.34 -31.93 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.813 1.645 . . . . 0.0 112.452 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -52.73 -40.48 63.1 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.5 1.12 . . . . 0.0 111.802 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.26 -45.97 8.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.898 0.317 . . . . 0.0 110.543 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -73.05 -20.35 61.0 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.624 -0.672 . . . . 0.0 112.207 -168.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.54 -33.6 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.391 0.996 . . . . 0.0 110.642 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.04 -17.01 61.77 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 p -116.81 -29.31 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 110.984 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.06 72.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.68 0.673 . . . . 0.0 111.271 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.52 74.34 28.44 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.894 1.677 . . . . 0.0 106.507 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.19 -29.41 39.35 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.09 1.86 . . . . 0.0 112.435 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -79.68 95.14 5.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.435 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -62.47 -10.62 12.29 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -81.99 -19.94 39.51 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.839 1.199 . . . . 0.0 111.795 173.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.49 146.21 54.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.877 0.762 . . . . 0.0 110.635 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -70.68 145.98 50.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.139 0.976 . . . . 0.0 110.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.06 141.88 40.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -117.03 144.01 45.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.787 1.235 . . . . 0.0 107.928 171.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.75 144.34 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.367 1.067 . . . . 0.0 108.762 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -157.58 149.11 21.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.406 1.483 . . . . 0.0 109.19 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 t -149.01 174.64 12.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.989 1.716 . . . . 0.0 108.427 -168.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.13 -25.07 60.96 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.604 0.761 . . . . 0.0 112.92 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.65 140.81 41.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.596 1.159 . . . . 0.0 108.836 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.97 -28.87 72.74 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.213 0.911 . . . . 0.0 113.054 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -55.55 -46.11 77.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.483 1.141 . . . . 0.0 110.035 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -71.86 -36.89 70.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.633 0.651 . . . . 0.0 110.095 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -56.9 -44.63 82.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.268 0.485 . . . . 0.0 110.038 169.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.99 -43.04 98.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.95 1.262 . . . . 0.0 111.859 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -62.08 -43.01 99.76 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 118.445 1.123 . . . . 0.0 110.509 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.36 76.79 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-N 119.008 0.822 . . . . 0.0 110.651 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -64.07 -45.83 87.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.03 -39.45 94.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.269 0.486 . . . . 0.0 111.014 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.61 -48.04 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.975 0.807 . . . . 0.0 109.621 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.02 -29.04 66.0 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.7 m -67.11 -38.52 85.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.04 0.536 . . . . 0.0 110.61 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.1 -37.74 88.46 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.147 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.23 -3.82 18.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.841 0.856 . . . . 0.0 112.708 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.29 22.91 76.97 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.217 172.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 10.9 m-85 -65.36 124.09 21.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.175 1.487 . . . . 0.0 107.728 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -27.3 67.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.311 0.644 . . . . 0.0 112.364 -169.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -139.27 107.64 5.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.7 t -141.99 144.15 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.92 125.74 25.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -71.16 109.14 5.04 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.98 -25.09 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.862 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.04 -166.61 23.63 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.21 157.55 40.95 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 168.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.44 -41.96 86.28 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.767 -0.843 . . . . 0.0 110.462 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.3 -29.78 69.46 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.281 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.36 -39.91 31.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.15 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.0 137.79 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.579 0.627 . . . . 0.0 109.631 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.2 23.73 14.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.419 1.088 . . . . 0.0 112.296 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -72.84 154.4 91.09 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.79 152.35 17.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.715 2.943 . . . . 0.0 112.137 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -140.17 152.92 46.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.688 0.795 . . . . 0.0 109.448 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.3 158.17 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.337 1.855 . . . . 0.0 107.242 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.69 154.14 38.57 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.668 -0.645 . . . . 0.0 110.251 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 171.134 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.236 0.353 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -137.3 156.66 47.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.257 1.823 . . . . 0.0 106.773 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -128.94 139.21 52.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.4 mm -130.93 121.18 49.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -81.3 110.42 16.74 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 166.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 m -99.11 21.46 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -111.26 -172.25 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.004 -1.06 . . . . 0.0 110.381 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.75 152.59 95.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.105 0.562 . . . . 0.0 110.181 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.72 -19.63 11.05 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.625 2.883 . . . . 0.0 114.836 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.43 -28.82 67.29 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.286 -0.864 . . . . 0.0 112.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -77.41 -46.43 22.72 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.841 1.2 . . . . 0.0 109.39 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -56.43 -40.82 75.38 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.858 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -62.4 -46.99 86.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.1 0.96 . . . . 0.0 111.381 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.51 -48.23 17.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.58 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.02 142.51 7.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.125 0.875 . . . . 0.0 110.185 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -135.38 155.32 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.917 1.287 . . . . 0.0 108.198 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.68 130.18 20.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.39 114.74 3.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.58 -12.97 18.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.888 1.232 . . . . 0.0 111.942 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 164.0 24.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.307 1.054 . . . . 0.0 111.751 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.6 pt -138.84 140.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 126.53 1.932 . . . . 0.0 106.921 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.09 114.18 18.8 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.62 83.77 16.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.49 153.55 13.57 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.034 3.156 . . . . 0.0 113.378 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.9 tp -50.41 -35.6 29.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.213 1.405 . . . . 0.0 112.555 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -66.47 -15.43 63.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.672 0.789 . . . . 0.0 113.021 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -129.01 -18.44 3.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.279 1.031 . . . . 0.0 112.111 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.52 -34.05 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.014 1.326 . . . . 0.0 111.969 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.63 -11.69 46.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.125 0.97 . . . . 0.0 113.384 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -122.06 -53.42 1.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.093 0.957 . . . . 0.0 108.481 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.51 -23.19 67.29 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -56.01 -36.35 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.453 1.024 . . . . 0.0 110.884 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.68 51.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.775 0.83 . . . . 0.0 112.802 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -119.95 12.31 11.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.866 1.666 . . . . 0.0 110.813 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.08 -38.14 1.44 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.618 1.167 . . . . 0.0 111.433 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.94 71.99 48.25 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.54 -29.36 52.82 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.506 2.137 . . . . 0.0 112.607 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -78.58 96.78 5.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.65 -11.01 21.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -76.86 -17.49 58.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.258 0.935 . . . . 0.0 111.879 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.1 157.79 36.92 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.773 0.715 . . . . 0.0 111.826 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -73.79 133.67 43.29 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.76 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.78 96.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -79.01 132.28 36.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.12 135.27 64.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 123.735 0.814 . . . . 0.0 109.57 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.91 162.22 39.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.851 1.66 . . . . 0.0 108.736 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -154.64 165.81 35.36 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.399 1.48 . . . . 0.0 107.594 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -54.57 -31.98 57.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 113.009 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.87 -15.89 43.09 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.67 35.08 61.5 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.977 1.262 . . . . 0.0 112.752 -170.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -144.15 -53.87 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.666 1.186 . . . . 0.0 109.919 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.76 -27.89 68.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.27 0.628 . . . . 0.0 110.461 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -66.33 -40.06 89.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.955 1.302 . . . . 0.0 112.519 170.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.68 96.13 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -64.02 -47.12 81.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.971 0.885 . . . . 0.0 110.399 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.94 72.68 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 122.203 -0.311 . . . . 0.0 110.986 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -62.81 -45.45 92.59 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -64.05 -40.18 95.73 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.852 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.32 -53.18 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 118.947 0.794 . . . . 0.0 109.235 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.3 mt -69.31 -29.14 66.93 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.961 -0.462 . . . . 0.0 110.93 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -65.52 -40.57 93.13 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.241 0.473 . . . . 0.0 110.697 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.07 -36.67 84.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.884 0.766 . . . . 0.0 110.094 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -71.94 -3.25 21.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.04 0.936 . . . . 0.0 112.712 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 16.92 72.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.56 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -67.12 127.41 32.5 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 p -86.5 -21.83 26.75 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -131.49 35.99 3.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.763 0.825 . . . . 0.0 111.197 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.44 146.3 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.15 125.68 15.8 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -75.13 97.99 3.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.09 72.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.033 0.533 . . . . 0.0 110.679 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 -115.07 0.94 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.09 172.69 25.14 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.22 -34.46 77.69 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.002 0.521 . . . . 0.0 111.297 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.35 -36.03 80.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.823 0.449 . . . . 0.0 110.537 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.48 -41.98 31.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.509 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.91 142.91 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.859 0.754 . . . . 0.0 109.686 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.89 24.53 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.828 1.251 . . . . 0.0 111.923 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.39 165.37 49.19 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.495 1.118 . . . . 0.0 108.85 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -52.49 149.29 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.844 2.363 . . . . 0.0 111.359 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.97 148.94 45.7 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.55 149.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.42 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.1 165.02 22.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.661 0.384 . . . . 0.0 110.94 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.785 1.183 . . . . 0.0 110.625 173.355 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.237 0.404 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -140.33 161.75 36.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.849 2.06 . . . . 0.0 106.98 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -119.15 143.34 47.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -138.62 131.68 39.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.46 125.09 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.03 14.32 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -91.9 -169.18 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.397 1.453 . . . . 0.0 109.695 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -57.91 150.4 49.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.089 0.555 . . . . 0.0 109.637 167.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.47 -19.22 67.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.306 2.004 . . . . 0.0 112.624 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.08 -24.89 67.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.919 -1.113 . . . . 0.0 112.145 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -68.61 -41.18 79.92 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.517 1.053 . . . . 0.0 109.913 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -59.85 -37.34 79.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.736 1.615 . . . . 0.0 110.269 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.01 -43.49 81.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.515 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -66.39 -58.2 5.79 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -174.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -167.02 151.27 6.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.959 1.704 . . . . 0.0 107.114 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -138.53 153.61 48.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.61 126.92 12.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 96.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.51 -18.71 4.1 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.82 1.2 . . . . 0.0 111.63 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.42 162.8 25.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.146 0.973 . . . . 0.0 110.202 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -135.66 147.16 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.787 1.635 . . . . 0.0 106.831 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -80.87 116.55 20.91 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -136.92 81.52 33.36 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.48 150.45 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.5 2.8 . . . . 0.0 114.078 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -47.49 -41.54 20.99 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.671 1.989 . . . . 0.0 111.933 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.97 -15.77 57.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -129.55 -13.36 4.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.471 1.108 . . . . 0.0 112.053 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.15 -35.04 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.966 1.306 . . . . 0.0 111.735 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -56.6 -34.5 67.26 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.744 0.818 . . . . 0.0 112.234 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.4 -47.09 4.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -65.57 -22.2 66.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.673 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.66 -32.79 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.658 1.117 . . . . 0.0 111.267 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.74 60.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 112.899 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -111.39 -28.72 8.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.661 1.184 . . . . 0.0 111.01 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.55 -43.78 68.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.817 0.735 . . . . 0.0 111.546 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.94 77.11 18.89 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.036 1.334 . . . . 0.0 107.403 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.44 -36.03 93.26 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.102 2.535 . . . . 0.0 114.368 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -77.55 98.66 5.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.212 0.605 . . . . 0.0 109.484 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.15 -6.65 18.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -85.45 -14.74 45.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.184 0.902 . . . . 0.0 111.929 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.913 0.885 . . . . 0.0 110.427 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -77.98 96.44 5.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.968 0.907 . . . . 0.0 110.17 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.51 93.28 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -73.36 129.74 38.65 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -115.18 143.31 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -142.13 168.12 20.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.216 1.006 . . . . 0.0 108.355 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.3 p -153.19 178.3 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -60.31 -25.43 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.76 5.76 4.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -29.67 2.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.987 1.279 . . . . 0.0 114.532 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.5 -51.95 67.28 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.535 1.168 . . . . 0.0 111.481 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -69.01 -33.83 74.29 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.889 -171.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -68.28 -34.93 77.06 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.156 0.889 . . . . 0.0 110.974 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.3 -50.92 57.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -62.93 -46.28 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.388 0.594 . . . . 0.0 110.864 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.51 -34.38 70.88 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 110.581 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.5 94.32 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.52 -43.24 77.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.287 0.494 . . . . 0.0 110.301 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -56.93 -49.16 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.474 0.71 . . . . 0.0 109.302 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.34 -30.67 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.709 0.804 . . . . 0.0 111.313 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 m -69.81 -37.51 76.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.682 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.72 -36.66 84.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.98 0.809 . . . . 0.0 110.162 174.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mmm -69.48 -3.78 15.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.34 1.056 . . . . 0.0 112.702 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.54 78.99 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.531 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -64.54 123.56 19.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.909 1.354 . . . . 0.0 107.599 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -29.78 69.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.157 0.583 . . . . 0.0 112.362 -169.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.01 111.81 7.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -146.7 149.57 15.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.76 128.39 9.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -80.19 113.38 18.32 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.3 69.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.95 -26.23 7.6 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.368 0.985 . . . . 0.0 112.335 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.96 167.79 16.04 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.89 1.233 . . . . 0.0 110.324 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.9 tp -54.77 -33.15 60.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.129 0.972 . . . . 0.0 112.313 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.12 -29.04 69.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.599 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.79 -40.83 54.43 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.48 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -53.27 117.24 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 123.441 0.697 . . . . 0.0 111.359 -168.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 50.67 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.353 1.461 . . . . 0.0 109.72 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.1 mmm -133.42 154.48 80.92 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.477 1.511 . . . . 0.0 108.143 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.72 145.94 29.15 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.684 2.256 . . . . 0.0 110.677 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.08 147.56 33.95 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.66 154.6 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.984 0.914 . . . . 0.0 108.835 -167.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -63.46 150.19 44.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.85 0.46 . . . . 0.0 110.08 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 173.861 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -148.41 126.71 12.23 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -76.14 143.67 41.04 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -140.36 128.95 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.97 124.95 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.05 16.35 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -89.46 -176.17 4.95 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.757 -1.214 . . . . 0.0 108.636 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 m -63.9 154.34 81.64 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 121.813 -0.554 . . . . 0.0 109.51 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.3 -12.99 35.59 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.314 2.676 . . . . 0.0 114.25 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.05 -37.83 69.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.824 0.849 . . . . 0.0 111.573 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.67 -43.29 84.91 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.854 0.752 . . . . 0.0 110.128 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -57.74 -30.5 65.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.955 1.302 . . . . 0.0 111.269 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -65.87 -50.79 63.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.305 0.642 . . . . 0.0 110.856 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.97 -49.88 40.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.868 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.85 150.81 13.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.824 0.738 . . . . 0.0 110.49 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -139.07 156.03 47.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.947 1.299 . . . . 0.0 108.289 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.75 130.85 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.69 105.97 0.73 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.67 -13.48 9.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.045 1.307 . . . . 0.0 112.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.08 155.05 41.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.342 1.071 . . . . 0.0 110.191 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mm -120.09 135.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.98 116.15 16.39 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.54 81.06 17.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.611 . . . . 0.0 106.77 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.4 151.4 23.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.778 2.985 . . . . 0.0 114.31 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.8 tp -48.6 -41.66 31.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.29 1.836 . . . . 0.0 113.001 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.75 -12.0 61.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -126.15 -15.28 5.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.938 1.295 . . . . 0.0 112.051 -169.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.06 -39.79 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.769 1.627 . . . . 0.0 113.252 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -55.26 -40.93 71.52 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.575 0.75 . . . . 0.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -91.07 -2.4 57.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.219 0.607 . . . . 0.0 111.272 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.32 -15.32 1.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.79 -40.37 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.052 1.296 . . . . 0.0 111.262 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.22 -32.55 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.405 0.548 . . . . 0.0 112.13 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -10.3 58.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.909 0.883 . . . . 0.0 113.175 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 -30.4 4.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.356 0.98 . . . . 0.0 111.992 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.42 79.69 41.37 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.571 1.149 . . . . 0.0 107.994 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.98 -37.75 91.73 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.415 2.077 . . . . 0.0 112.131 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -77.51 96.76 4.81 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.134 0.974 . . . . 0.0 109.841 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.37 8.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -107.8 -6.99 16.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.671 1.188 . . . . 0.0 111.769 170.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.39 145.34 52.95 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 m -80.14 97.36 6.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 109.676 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -72.03 104.7 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -83.16 84.65 7.4 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 m -69.34 140.17 19.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -145.12 164.04 32.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.178 0.991 . . . . 0.0 108.936 171.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.02 171.25 18.66 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.281 1.432 . . . . 0.0 107.717 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -49.94 -33.22 16.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.02 -6.73 10.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.12 -31.44 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.792 1.178 . . . . 0.0 113.949 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.78 -56.48 21.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.852 1.326 . . . . 0.0 111.303 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.03 -32.4 74.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.674 0.39 . . . . 0.0 110.824 -169.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 p -71.66 -35.53 70.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.339 0.972 . . . . 0.0 111.405 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.27 -48.52 59.27 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.94 -48.4 76.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.671 0.788 . . . . 0.0 110.576 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.95 69.2 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.891 -0.506 . . . . 0.0 111.814 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -60.83 -45.0 96.18 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.92 -41.59 91.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.142 0.428 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.88 -50.53 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.6 mt -70.31 -29.01 65.64 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.554 -0.717 . . . . 0.0 111.395 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.386 0.539 . . . . 0.0 109.953 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.95 -35.78 78.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.282 0.633 . . . . 0.0 110.968 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.5 mmm -64.98 -15.48 62.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.851 0.86 . . . . 0.0 112.118 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.37 14.43 55.74 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.074 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -66.25 121.67 15.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.235 1.517 . . . . 0.0 107.37 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.5 p -75.08 -23.81 58.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.497 0.319 . . . . 0.0 111.522 -171.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -134.98 104.81 6.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.819 1.248 . . . . 0.0 107.67 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -142.16 143.33 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.39 127.17 17.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.14 111.98 9.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 166.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.55 66.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.29 -26.84 10.69 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 125.026 1.298 . . . . 0.0 110.765 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.3 174.68 13.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 124.524 1.059 . . . . 0.0 111.481 168.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 tp -60.45 -30.33 69.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 110.067 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -61.55 -18.82 60.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.748 1.619 . . . . 0.0 113.271 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -118.12 -36.93 3.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.027 0.83 . . . . 0.0 112.021 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 80' ' ' MET . 82.4 mt -57.52 141.2 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.029 0.831 . . . . 0.0 109.538 174.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.88 24.5 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.011 1.324 . . . . 0.0 111.959 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.419 ' H ' HG22 ' A' ' 78' ' ' ILE . 93.2 mmm -69.52 164.16 52.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.506 1.123 . . . . 0.0 108.596 167.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.77 147.78 30.71 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.612 2.208 . . . . 0.0 110.904 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -134.78 142.86 46.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.27 149.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.131 1.372 . . . . 0.0 108.486 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -69.08 162.19 27.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.769 0.428 . . . . 0.0 111.093 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 124.883 1.23 . . . . 0.0 110.611 172.725 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.314 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -82.69 100.66 10.36 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -73.01 145.45 46.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.9 mt -147.16 139.26 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -96.93 124.97 41.05 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.45 12.74 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.77 -174.34 4.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.172 1.351 . . . . 0.0 108.159 167.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 9' ' ' VAL . 1.6 m -57.29 156.04 16.38 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.656 0.782 . . . . 0.0 110.358 167.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.48 -14.35 43.83 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.081 2.521 . . . . 0.0 113.511 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -46.15 -49.44 16.79 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 110.82 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -69.75 -37.81 76.59 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.308 -0.245 . . . . 0.0 110.383 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -58.46 -31.22 67.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.119 1.368 . . . . 0.0 111.314 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -67.12 -39.67 86.7 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.23 0.468 . . . . 0.0 110.73 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -68.73 -54.21 17.46 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.27 152.53 4.99 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.015 1.726 . . . . 0.0 106.907 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.65 147.98 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 108.952 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.6 t -54.09 125.77 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -56.34 -24.11 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -166.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.59 -8.07 41.05 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.885 0.755 . . . . 0.0 112.764 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.81 170.3 15.61 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.223 1.011 . . . . 0.0 111.094 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.6 pt -142.95 138.92 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.661 2.384 . . . . 0.0 105.213 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.38 116.43 18.79 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.3 mt -140.67 86.98 11.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.95 153.47 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.638 2.892 . . . . 0.0 113.9 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.7 tp -51.21 -35.81 38.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.065 1.746 . . . . 0.0 112.943 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.22 -16.49 63.59 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.501 0.721 . . . . 0.0 112.775 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.76 -22.26 3.59 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.553 1.141 . . . . 0.0 111.911 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -47.42 -37.19 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.641 1.576 . . . . 0.0 112.377 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.75 -33.12 60.79 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.416 1.086 . . . . 0.0 112.301 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.52 -45.24 4.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.0 0.52 . . . . 0.0 109.951 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.91 -19.64 65.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.311 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -54.97 -34.99 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.104 0.866 . . . . 0.0 111.133 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.16 96.64 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.19 0.904 . . . . 0.0 111.273 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -37.04 45.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.463 0.705 . . . . 0.0 111.133 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.7 72.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.369 0.531 . . . . 0.0 112.057 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -139.55 79.42 24.53 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.771 1.628 . . . . 0.0 107.179 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.91 10.68 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.766 2.978 . . . . 0.0 114.502 -171.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -138.21 107.88 6.24 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.272 1.429 . . . . 0.0 107.163 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -63.25 -15.08 55.99 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.64 -15.51 58.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.73 0.695 . . . . 0.0 111.957 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -67.94 150.19 48.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.027 0.83 . . . . 0.0 110.672 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -70.24 141.87 52.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.969 0.907 . . . . 0.0 109.674 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.85 145.33 31.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -130.72 135.33 47.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.92 137.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -136.68 168.57 19.27 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 p -152.55 -175.89 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 170.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -59.18 -29.55 67.54 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.65 10.33 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -168.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.52 -29.36 2.29 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.795 1.188 . . . . 0.0 114.304 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -62.34 -50.85 69.99 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.374 1.087 . . . . 0.0 111.418 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -69.49 -31.97 70.57 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.537 0.608 . . . . 0.0 110.569 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -36.22 82.45 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 119.381 0.991 . . . . 0.0 110.734 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.24 -52.0 50.33 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -62.4 -46.24 89.48 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.486 -0.42 . . . . 0.0 111.176 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.32 74.84 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 118.222 0.465 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -63.05 -43.45 98.62 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.98 -44.78 91.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.662 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.56 -52.51 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.976 0.807 . . . . 0.0 109.072 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.15 -28.4 64.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.987 -0.446 . . . . 0.0 111.221 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.0 m -65.23 -42.16 93.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.353 0.524 . . . . 0.0 110.397 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.12 -33.92 76.49 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.879 0.763 . . . . 0.0 110.91 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -69.46 -8.75 49.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.845 0.858 . . . . 0.0 112.303 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.97 60.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.972 -0.904 . . . . 0.0 113.467 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.98 120.81 19.12 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -84.6 -17.22 39.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -167.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -133.24 38.77 3.3 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.873 0.869 . . . . 0.0 111.037 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -80.6 145.81 8.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -140.91 137.91 33.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.715 0.806 . . . . 0.0 109.139 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -72.32 106.73 4.59 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.89 79.18 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.39 -148.22 19.83 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.73 167.26 13.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.35 -34.17 66.36 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.533 1.133 . . . . 0.0 112.552 -170.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.36 -11.44 57.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.114 0.966 . . . . 0.0 113.168 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -117.1 -34.87 4.24 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.796 1.238 . . . . 0.0 111.982 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.4 127.14 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.23 24.31 8.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.484 1.113 . . . . 0.0 111.869 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.1 165.36 48.56 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 167.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.31 149.9 21.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.484 2.122 . . . . 0.0 111.688 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -131.91 158.47 41.31 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.878 0.871 . . . . 0.0 109.118 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -128.72 169.05 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -131.68 167.77 18.89 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.949 -1.094 . . . . 0.0 109.685 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 173.562 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.55 152.27 43.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.442 1.497 . . . . 0.0 107.806 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -130.04 136.13 49.03 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.591 1.156 . . . . 0.0 108.78 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.96 131.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.21 117.05 23.27 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.84 23.12 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 5.6 ttt180 -111.24 -175.5 2.72 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.8 -1.188 . . . . 0.0 110.74 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 2.7 m -60.64 150.41 75.4 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.875 0.87 . . . . 0.0 109.971 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -53.81 -23.98 29.09 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.573 2.849 . . . . 0.0 115.118 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.92 -26.35 68.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 117.428 -1.272 . . . . 0.0 113.283 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.01 -50.82 45.39 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 120.818 1.645 . . . . 0.0 109.5 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -55.91 -37.28 68.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.164 1.386 . . . . 0.0 111.373 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -61.77 -11.05 10.48 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.379 1.471 . . . . 0.0 113.985 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.16 -38.76 1.77 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.513 1.506 . . . . 0.0 112.153 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -156.48 145.32 20.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.042 1.292 . . . . 0.0 110.754 168.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -142.06 154.77 45.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 107.49 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.21 132.61 20.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -55.88 120.45 7.4 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.27 -13.51 61.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.298 0.951 . . . . 0.0 112.984 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.02 161.17 30.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.474 1.137 . . . . 0.0 111.067 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.58 137.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.9 1.68 . . . . 0.0 107.338 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.27 117.15 19.25 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -143.2 87.93 8.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -54.12 155.6 15.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.1 3.2 . . . . 0.0 114.382 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 tp -48.49 -41.93 31.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.2 1.8 . . . . 0.0 112.979 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.18 -8.38 54.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.5 -17.1 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.104 1.362 . . . . 0.0 111.829 -169.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.29 -30.42 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.314 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.6 -47.66 73.12 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.732 1.213 . . . . 0.0 111.623 -169.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -88.95 -41.82 12.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.93 0.332 . . . . 0.0 110.241 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -70.28 -15.36 62.89 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.59 -33.22 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.071 0.85 . . . . 0.0 110.851 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.11 -40.69 98.35 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.42 1.009 . . . . 0.0 111.043 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.28 -36.73 66.37 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.26 0.624 . . . . 0.0 111.168 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.43 72.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.478 0.581 . . . . 0.0 111.968 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.08 83.66 11.0 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.719 1.607 . . . . 0.0 107.425 -171.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.6 -38.12 96.17 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.875 2.383 . . . . 0.0 113.845 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -85.37 99.96 11.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.224 0.609 . . . . 0.0 109.677 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 48.6 pttt -62.81 -15.32 53.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -82.86 -11.9 57.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.024 0.829 . . . . 0.0 111.912 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.07 155.48 40.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.878 0.763 . . . . 0.0 111.191 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 140.01 54.25 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.38 140.5 43.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -123.75 147.46 28.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -150.07 164.72 34.82 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.894 1.677 . . . . 0.0 107.231 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -161.09 157.19 25.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.572 0.349 . . . . 0.0 110.167 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.93 -23.62 19.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.13 0.972 . . . . 0.0 112.72 168.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.06 105.12 7.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 170.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.99 -23.77 57.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.622 1.106 . . . . 0.0 114.215 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -57.6 -36.9 72.36 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.433 1.116 . . . . 0.0 111.778 171.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.53 -37.67 71.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.567 0.747 . . . . 0.0 110.685 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p -68.24 -26.99 65.97 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 110.824 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.36 -46.24 93.25 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -61.02 -48.7 80.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.865 0.833 . . . . 0.0 110.242 175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.14 77.13 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.819 0.282 . . . . 0.0 110.706 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.77 -39.57 92.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.42 -35.32 73.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.174 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.05 -47.99 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.749 1.159 . . . . 0.0 108.786 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.68 -33.82 76.49 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.668 -0.645 . . . . 0.0 110.861 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 m -65.56 -39.21 91.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.828 0.451 . . . . 0.0 110.656 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.12 -36.22 82.56 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.504 0.721 . . . . 0.0 110.241 175.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mmm -69.17 -3.92 15.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.189 0.995 . . . . 0.0 112.595 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.4 14.75 65.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.359 170.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 20.9 m-85 -70.0 129.14 38.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.936 1.368 . . . . 0.0 107.552 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -91.59 -18.74 23.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -167.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.88 40.47 3.36 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.323 1.049 . . . . 0.0 110.387 -169.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.78 149.45 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -143.93 142.06 30.56 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -86.33 106.8 17.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.75 66.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.872 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.53 -165.64 14.47 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.968 0.794 . . . . 0.0 112.238 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.48 151.7 52.33 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.92 30.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.255 1.822 . . . . 0.0 113.134 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -64.14 -33.19 75.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.607 0.763 . . . . 0.0 111.825 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.41 -30.03 64.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.371 0.532 . . . . 0.0 111.705 -172.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.76 91.28 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 26.43 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.851 1.261 . . . . 0.0 113.507 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.8 mtp -77.64 158.89 77.91 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.42 153.97 12.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.582 2.855 . . . . 0.0 111.703 167.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -138.97 153.9 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 108.864 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.7 p -151.84 156.69 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -68.16 152.17 45.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.796 0.839 . . . . 0.0 109.134 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.074 174.725 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.39 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -77.17 151.67 35.17 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -126.23 135.32 51.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -136.68 125.63 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.67 120.99 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.3 21.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.7 -173.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.943 -1.098 . . . . 0.0 110.216 173.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.84 152.06 77.46 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.03 -13.4 35.03 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.626 2.217 . . . . 0.0 113.371 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -55.22 -39.09 69.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.284 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -66.29 -47.85 72.31 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 120.405 1.457 . . . . 0.0 109.909 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -56.46 -37.31 70.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.948 1.299 . . . . 0.0 111.293 -172.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -58.87 -52.99 63.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.2 1.8 . . . . 0.0 110.949 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -72.32 -49.1 37.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.265 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.05 151.46 14.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.331 0.968 . . . . 0.0 111.029 167.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -139.03 153.06 48.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 170.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.44 128.4 15.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.92 106.85 1.32 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -17.69 7.49 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.933 1.254 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.18 164.75 25.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.777 0.788 . . . . 0.0 110.71 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 pt -139.88 139.0 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.263 1.825 . . . . 0.0 106.939 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -77.38 115.8 17.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.872 0.469 . . . . 0.0 109.941 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -141.2 84.09 13.13 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.11 150.73 18.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.999 3.133 . . . . 0.0 113.806 -171.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.82 -41.01 22.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.159 1.784 . . . . 0.0 112.58 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.06 -14.68 61.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.432 0.693 . . . . 0.0 112.832 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.15 -7.82 3.84 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.328 1.051 . . . . 0.0 112.369 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.8 -38.62 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.098 1.317 . . . . 0.0 110.695 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.2 -26.36 64.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.694 1.197 . . . . 0.0 112.669 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -105.48 -2.24 23.92 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.378 1.071 . . . . 0.0 111.385 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -131.48 -23.58 2.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -168.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tp -57.94 -33.94 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.355 0.979 . . . . 0.0 110.576 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -16.62 52.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 113.357 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -114.96 -28.63 6.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.657 1.183 . . . . 0.0 111.028 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.03 -38.67 72.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.733 0.697 . . . . 0.0 111.459 173.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -140.37 72.83 31.4 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.094 1.758 . . . . 0.0 107.289 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.0 -37.96 93.86 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.812 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.94 88.88 5.88 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.288 0.635 . . . . 0.0 109.84 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -65.37 -4.95 6.23 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.84 -18.69 58.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.408 1.003 . . . . 0.0 111.486 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.96 152.29 41.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.154 -0.966 . . . . 0.0 110.327 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -71.51 149.57 45.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.0 146.81 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -129.22 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.89 148.6 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -174.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -150.83 166.72 29.65 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.775 1.63 . . . . 0.0 107.379 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.0 p -161.34 172.55 16.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.563 0.745 . . . . 0.0 109.623 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.96 -52.52 62.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.7 1.2 . . . . 0.0 112.192 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.28 -35.52 61.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.337 0.255 . . . . 0.0 111.389 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.43 8.91 55.89 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.034 -0.87 . . . . 0.0 113.498 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -124.08 -23.68 4.53 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.117 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.46 -33.59 71.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.762 1.619 . . . . 0.0 110.031 169.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 p -65.99 -37.88 87.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.703 0.801 . . . . 0.0 111.587 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.41 -47.88 73.2 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 169.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -61.91 -50.97 70.03 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.872 0.869 . . . . 0.0 109.992 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.07 79.27 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.05 0.54 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -61.45 -39.76 92.01 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -35.09 69.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.068 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.19 -49.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.604 1.093 . . . . 0.0 108.648 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -66.16 -34.71 78.66 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.907 -0.495 . . . . 0.0 110.5 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -64.3 -41.56 96.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 110.746 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.12 -37.13 86.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.322 0.649 . . . . 0.0 110.195 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mtp -71.39 -3.05 18.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 112.792 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.89 16.01 68.81 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.458 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.2 124.97 22.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.217 1.509 . . . . 0.0 107.177 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.7 p -68.81 -29.05 67.31 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -166.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -150.09 106.87 3.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -173.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.22 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.19 145.94 32.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.472 0.709 . . . . 0.0 109.123 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -90.4 114.27 26.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.87 69.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.669 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.48 -158.27 14.56 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.615 1.102 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.09 162.32 35.91 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.737 0.684 . . . . 0.0 111.72 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -30.22 64.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.347 1.059 . . . . 0.0 112.869 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.66 -27.76 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.475 -0.766 . . . . 0.0 111.939 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.03 -44.73 62.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.841 0.746 . . . . 0.0 112.971 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.1 mp -55.85 119.59 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.346 0.658 . . . . 0.0 110.276 -169.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.56 52.75 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.294 1.438 . . . . 0.0 110.669 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -136.69 154.74 76.75 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.295 1.438 . . . . 0.0 109.169 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.89 155.7 10.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.644 2.896 . . . . 0.0 112.096 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -138.97 146.1 40.55 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.16 152.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.908 1.283 . . . . 0.0 108.566 -169.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.37 161.73 26.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.05 0.54 . . . . 0.0 110.149 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 124.596 1.094 . . . . 0.0 110.887 170.595 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--O 1.235 0.32 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -140.28 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.011 1.324 . . . . 0.0 107.701 168.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -134.43 137.91 44.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.3 133.19 58.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.28 134.21 38.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.84 33.67 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.442 1.019 . . . . 0.0 113.569 -168.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -125.15 -179.21 4.48 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.659 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.07 160.97 80.81 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.559 1.144 . . . . 0.0 111.005 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.7 -16.78 11.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.273 3.315 . . . . 0.0 116.108 175.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -50.89 -37.86 46.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.756 1.223 . . . . 0.0 112.296 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.25 -45.16 15.39 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -56.69 -37.09 70.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.919 1.288 . . . . 0.0 111.424 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -67.81 -5.36 16.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.056 1.343 . . . . 0.0 114.095 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -131.76 -33.82 1.37 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.782 1.174 . . . . 0.0 112.147 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.24 139.96 8.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.731 1.151 . . . . 0.0 108.819 166.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -142.6 148.81 38.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 166.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.57 132.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 -35.48 80.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.874 0.47 . . . . 0.0 111.124 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 -4.16 90.47 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.3 -0.722 . . . . 0.0 113.06 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.01 166.86 23.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.515 1.157 . . . . 0.0 111.075 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.6 pt -135.75 131.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -82.89 115.43 21.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.2 81.09 38.92 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.977 1.711 . . . . 0.0 106.726 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 152.81 7.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 113.706 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.23 -44.58 8.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.953 1.701 . . . . 0.0 112.359 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -67.15 -15.69 63.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -176.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -122.0 -18.86 6.83 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.405 1.082 . . . . 0.0 111.893 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.46 -32.39 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.61 1.164 . . . . 0.0 111.457 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -64.76 -8.68 15.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.14 -48.91 1.33 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.255 0.934 . . . . 0.0 109.83 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.64 -23.53 67.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.12 -32.58 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.868 0.758 . . . . 0.0 111.32 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.53 96.67 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.253 0.933 . . . . 0.0 110.655 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.67 -35.89 67.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.4 -44.58 64.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.526 0.603 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.77 85.25 9.31 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 108.018 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.63 -29.57 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.135 1.89 . . . . 0.0 112.25 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -79.68 96.63 6.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -68.84 -7.23 32.49 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.08 -6.06 39.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.664 0.786 . . . . 0.0 110.673 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.23 151.67 47.11 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -72.4 129.74 39.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.65 95.38 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -77.26 133.82 38.74 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.84 143.61 36.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.76 0.824 . . . . 0.0 108.958 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.42 159.51 44.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 109.036 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.5 p -155.52 169.6 23.91 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.728 1.611 . . . . 0.0 107.918 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -48.24 -26.2 1.86 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.24 -1.0 8.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.99 -46.75 1.52 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.413 1.482 . . . . 0.0 112.557 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 tpt85 -59.55 -45.95 90.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.234 1.017 . . . . 0.0 112.46 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -70.43 -31.82 69.15 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.239 0.472 . . . . 0.0 110.005 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -33.68 75.85 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.97 -1.081 . . . . 0.0 110.775 168.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -46.62 85.62 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -62.46 -43.53 98.6 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.571 1.186 . . . . 0.0 110.648 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 -39.61 80.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.271 0.487 . . . . 0.0 109.734 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -66.8 -38.81 87.23 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.853 -0.53 . . . . 0.0 109.867 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.06 -45.04 95.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 110.073 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.8 mt -57.99 -50.39 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.783 0.833 . . . . 0.0 109.084 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.1 -31.56 72.11 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.826 -0.546 . . . . 0.0 111.058 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -64.4 -40.63 96.17 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.492 0.587 . . . . 0.0 110.358 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.36 -36.95 85.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.751 0.705 . . . . 0.0 110.477 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -71.26 -5.1 29.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.077 0.951 . . . . 0.0 112.834 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.65 56.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.215 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -68.89 146.01 53.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.208 1.504 . . . . 0.0 107.708 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 p -125.06 -1.19 7.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 31.58 1.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.911 0.862 . . . . 0.0 111.007 175.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.11 146.99 7.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.803 0.841 . . . . 0.0 108.975 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.12 141.85 19.98 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -84.04 110.61 18.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -30.98 72.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.316 0.247 . . . . 0.0 111.483 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.15 -163.19 29.13 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.294 1.426 . . . . 0.0 109.982 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.12 159.26 32.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 169.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.5 tp -55.69 -33.03 63.8 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.86 1.264 . . . . 0.0 112.295 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -68.48 -28.68 67.24 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.112 0.565 . . . . 0.0 111.527 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.61 -39.44 22.18 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.043 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.17 134.13 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.96 26.4 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.775 1.23 . . . . 0.0 111.531 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -66.94 159.55 75.32 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 143.19 43.71 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.915 2.41 . . . . 0.0 111.707 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.14 155.76 47.6 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.96 0.904 . . . . 0.0 109.674 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.97 160.44 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.257 1.823 . . . . 0.0 108.026 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -73.4 150.03 42.03 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 169.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.104 -1.386 . . . . 0.0 110.306 172.777 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.235 0.32 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -131.0 95.4 3.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.213 1.805 . . . . 0.0 106.313 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -77.95 136.94 38.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.99 122.53 52.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -81.45 113.68 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.5 20.7 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -110.27 -169.12 1.41 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.256 -0.902 . . . . 0.0 109.714 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.62 149.49 61.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.46 -14.44 44.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.305 2.003 . . . . 0.0 112.899 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -55.22 -38.39 68.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.753 0.821 . . . . 0.0 111.372 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -69.28 -46.27 67.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.553 1.07 . . . . 0.0 109.826 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -58.65 -34.38 71.14 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 111.473 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -62.63 -39.78 94.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.507 1.123 . . . . 0.0 110.677 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -67.95 -49.67 60.43 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.385 0.993 . . . . 0.0 108.704 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.81 152.58 4.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.334 1.853 . . . . 0.0 107.548 167.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -136.95 152.38 50.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.704 1.201 . . . . 0.0 108.577 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.77 126.51 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -55.92 121.71 9.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.112 0.565 . . . . 0.0 109.682 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.67 70.64 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.222 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.25 163.14 13.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.79 1.295 . . . . 0.0 111.549 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.2 138.99 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.276 1.43 . . . . 0.0 108.394 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.82 114.86 18.11 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.037 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.72 80.94 20.45 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.639 1.575 . . . . 0.0 107.095 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.81 154.34 12.91 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.725 2.95 . . . . 0.0 113.819 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.4 tp -47.46 -36.19 9.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 113.039 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.77 -17.94 65.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.809 0.844 . . . . 0.0 113.116 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -127.75 -17.43 4.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.983 0.913 . . . . 0.0 112.174 -169.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.41 -33.03 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.119 1.368 . . . . 0.0 112.686 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.05 -25.0 65.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 112.877 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.21 -41.34 2.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.667 0.667 . . . . 0.0 110.392 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -63.53 -17.47 62.82 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.02 -37.24 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.24 0.927 . . . . 0.0 111.22 171.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.7 90.26 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.972 0.805 . . . . 0.0 111.528 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -79.41 -38.25 35.27 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.082 0.553 . . . . 0.0 110.352 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.71 78.98 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.961 0.504 . . . . 0.0 112.211 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 83.28 21.58 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.81 1.244 . . . . 0.0 107.962 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.86 -21.18 32.05 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.63 2.887 . . . . 0.0 115.129 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -131.63 95.57 3.76 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.549 1.14 . . . . 0.0 108.674 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -65.82 -5.52 9.22 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.496 1.119 . . . . 0.0 113.251 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -71.13 -21.43 62.2 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.113 0.87 . . . . 0.0 111.09 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 147.73 52.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -62.91 127.43 31.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.233 0.47 . . . . 0.0 109.765 -172.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.06 134.99 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.14 103.28 6.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.43 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.33 158.55 43.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.531 1.533 . . . . 0.0 108.562 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.5 p -144.22 -175.52 4.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.105 1.362 . . . . 0.0 107.667 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -56.76 -32.13 65.3 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.8 7.36 4.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -167.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.13 2.28 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.74 1.162 . . . . 0.0 113.416 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -59.51 -48.13 82.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.372 1.086 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.78 -24.91 58.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.052 0.842 . . . . 0.0 111.514 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -33.1 67.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 120.973 -1.08 . . . . 0.0 110.16 168.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -47.09 84.15 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.25 -45.17 95.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.166 0.983 . . . . 0.0 110.459 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.09 74.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.103 0.411 . . . . 0.0 110.797 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.84 -44.28 77.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.198 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.66 -39.5 88.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.274 1.397 . . . . 0.0 110.58 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.73 -51.18 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.866 0.866 . . . . 0.0 109.557 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.89 -34.2 76.19 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.894 -0.504 . . . . 0.0 111.147 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 19.7 m -66.09 -35.88 81.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.636 0.775 . . . . 0.0 110.0 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.85 -47.69 65.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.759 0.424 . . . . 0.0 110.152 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -68.65 -35.94 77.91 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.713 -0.661 . . . . 0.0 112.174 -170.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.88 45.18 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 CA-C-O 119.021 -0.877 . . . . 0.0 114.177 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.3 OUTLIER -55.48 159.48 2.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.661 1.23 . . . . 0.0 112.742 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.5 p -137.95 -37.01 0.6 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.893 0.877 . . . . 0.0 110.942 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -142.67 34.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.364 0.983 . . . . 0.0 111.523 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.82 141.02 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.34 144.85 38.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.601 1.561 . . . . 0.0 107.316 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -87.06 105.64 17.3 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.13 75.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.444 0.298 . . . . 0.0 111.275 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.87 -136.27 5.78 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.14 170.76 20.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 169.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.93 -39.92 91.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.728 0.811 . . . . 0.0 109.915 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -67.95 -3.69 10.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.919 1.287 . . . . 0.0 113.669 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.37 -37.33 2.03 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.289 0.949 . . . . 0.0 112.245 -169.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 mt -58.96 144.3 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.602 1.092 . . . . 0.0 110.519 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 75.42 1.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.751 1.62 . . . . 0.0 107.775 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.2 mtp -140.21 162.86 47.65 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 126.68 1.992 . . . . 0.0 107.669 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.03 143.48 40.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.965 2.444 . . . . 0.0 111.653 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -138.52 147.44 43.13 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.05 154.29 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.253 1.421 . . . . 0.0 108.408 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.6 155.92 39.53 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.006 -0.434 . . . . 0.0 110.576 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.235 0.342 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -135.26 107.61 7.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -73.57 149.1 42.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mm -138.12 131.59 41.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.87 94.49 8.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.85 35.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -166.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.37 -179.78 6.88 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.465 -1.397 . . . . 0.0 108.635 -172.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -53.4 146.72 22.17 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.406 0.548 . . . . 0.0 111.999 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -10.1 14.04 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 114.465 -172.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.69 -42.6 71.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 110.939 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -35.76 69.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.941 -0.474 . . . . 0.0 111.462 178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -58.02 -28.73 64.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.904 1.281 . . . . 0.0 110.953 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.69 -46.67 81.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.061 0.544 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.21 -45.0 43.24 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.152 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.15 152.06 12.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.074 0.852 . . . . 0.0 110.934 167.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -146.78 160.53 42.14 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.131 1.373 . . . . 0.0 108.94 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -55.65 125.82 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.052 1.341 . . . . 0.0 108.66 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -29.54 69.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 111.818 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.06 17.27 57.42 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.167 -1.352 . . . . 0.0 113.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.28 170.58 10.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.216 1.508 . . . . 0.0 112.018 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.0 pt -142.47 142.8 26.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 127.207 2.203 . . . . 0.0 107.023 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.21 116.1 19.27 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.162 0.585 . . . . 0.0 109.919 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -137.73 73.3 47.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.26 150.61 14.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.652 2.902 . . . . 0.0 113.733 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 tp -45.84 -36.16 5.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.973 1.709 . . . . 0.0 112.916 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -63.34 -18.45 63.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.018 0.927 . . . . 0.0 113.03 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -127.49 -24.17 3.37 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.293 1.037 . . . . 0.0 111.13 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -44.66 -35.63 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.407 1.883 . . . . 0.0 113.431 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -53.84 -36.48 62.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.273 0.942 . . . . 0.0 112.47 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.45 -39.14 4.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.412 0.551 . . . . 0.0 109.729 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -67.74 -16.41 64.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.686 0.795 . . . . 0.0 112.352 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.12 -32.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.478 1.035 . . . . 0.0 111.024 169.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.02 98.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.103 . . . . 0.0 110.765 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.25 -35.75 74.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.4 0.68 . . . . 0.0 111.247 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -45.3 66.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.096 0.558 . . . . 0.0 111.968 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.25 88.12 8.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.47 1.508 . . . . 0.0 107.761 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.55 -40.87 70.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.917 2.412 . . . . 0.0 113.18 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -81.22 99.08 8.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 28.5 mtmm -66.2 -8.09 22.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.62 -7.39 22.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.136 0.88 . . . . 0.0 111.597 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.92 151.17 48.09 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.941 0.791 . . . . 0.0 109.718 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 131.49 46.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.464 0.575 . . . . 0.0 109.84 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.87 129.39 75.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -126.61 86.32 2.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.04 154.72 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.54 158.5 41.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 108.08 168.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 p -133.52 -139.56 0.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.409 0.684 . . . . 0.0 110.241 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -74.32 -37.94 63.46 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.141 -0.974 . . . . 0.0 111.229 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.83 -39.31 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.52 -26.08 0.14 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.77 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.27 -62.75 1.55 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.177 1.488 . . . . 0.0 111.813 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.08 -32.64 73.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.977 0.353 . . . . 0.0 111.17 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -76.19 -33.85 59.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.582 -0.699 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.97 -46.52 93.57 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -60.4 -50.35 73.94 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.664 0.786 . . . . 0.0 109.784 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.75 78.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.68 -38.7 87.35 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.84 -39.31 87.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.313 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.48 -46.29 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.34 0.973 . . . . 0.0 109.356 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.74 -36.86 85.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.85 0.75 . . . . 0.0 110.462 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -64.44 -42.36 96.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.067 0.547 . . . . 0.0 110.305 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.63 -33.91 76.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.758 0.708 . . . . 0.0 111.126 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.3 mmm -71.28 -3.18 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.74 18.68 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.373 -0.829 . . . . 0.0 112.975 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 23.0 m-85 -66.95 157.2 33.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.719 1.259 . . . . 0.0 109.23 169.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 p -135.17 164.78 26.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.269 1.428 . . . . 0.0 108.242 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 51.99 35.34 15.78 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.4 1.08 . . . . 0.0 111.932 -169.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.18 143.54 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.48 154.04 41.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.005 1.322 . . . . 0.0 107.49 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -109.51 116.0 30.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.75 61.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.533 0.733 . . . . 0.0 111.96 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.51 -92.27 0.58 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.2 175.22 28.52 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 tp -47.95 -35.67 11.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 113.672 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -65.27 -27.62 68.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.263 0.625 . . . . 0.0 112.146 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.42 -45.65 37.57 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.831 0.741 . . . . 0.0 111.726 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 78' ' ' ILE . 4.9 mp -58.78 115.46 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.978 0.911 . . . . 0.0 110.162 -170.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.19 53.57 2.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 110.399 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.0 ptm -137.54 163.52 47.94 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 123.578 0.751 . . . . 0.0 109.72 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.07 155.85 5.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.358 3.372 . . . . 0.0 113.696 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -137.52 145.49 43.03 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.17 152.48 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 125.045 1.338 . . . . 0.0 108.618 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -68.2 162.17 25.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.034 0.534 . . . . 0.0 111.166 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.912 1.244 . . . . 0.0 110.51 172.411 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.236 0.364 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -142.04 155.21 45.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.854 1.661 . . . . 0.0 108.164 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -137.47 148.82 46.36 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.453 1.101 . . . . 0.0 108.475 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.32 135.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -90.62 116.31 28.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 167.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.86 11.87 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -88.05 -174.81 4.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.057 1.299 . . . . 0.0 109.668 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m -58.4 152.83 41.66 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 122.67 0.388 . . . . 0.0 110.512 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.39 -17.17 58.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.727 2.285 . . . . 0.0 113.379 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -57.01 -39.2 74.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.112 0.869 . . . . 0.0 110.87 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -69.88 -35.04 74.34 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.349 0.522 . . . . 0.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -60.24 -26.71 66.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.676 1.19 . . . . 0.0 111.311 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -71.23 -46.1 61.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.683 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.9 -52.15 64.21 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.667 0.667 . . . . 0.0 109.315 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.82 157.36 8.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.655 1.582 . . . . 0.0 108.01 165.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -144.77 153.35 41.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.444 1.098 . . . . 0.0 108.634 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.68 123.31 4.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.75 68.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 0.0 111.754 -172.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.81 6.24 83.32 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.281 -1.289 . . . . 0.0 113.852 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.9 164.7 13.75 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.44 1.62 . . . . 0.0 111.16 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.7 139.02 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 126.282 1.833 . . . . 0.0 107.269 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.82 114.22 17.58 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.222 0.464 . . . . 0.0 109.779 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -141.67 89.25 9.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.44 155.64 20.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.438 2.758 . . . . 0.0 114.729 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.75 -36.17 24.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.722 2.009 . . . . 0.0 112.383 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.16 -17.53 62.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.873 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -128.12 -16.99 4.42 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.773 0.829 . . . . 0.0 112.309 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -50.0 -32.12 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.021 1.328 . . . . 0.0 112.41 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -55.33 -26.09 38.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.091 1.356 . . . . 0.0 112.969 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -116.81 -43.03 2.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.671 0.669 . . . . 0.0 109.544 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -69.57 -9.11 52.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.8 tp -53.47 -36.96 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.935 1.243 . . . . 0.0 110.408 169.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.59 96.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.351 0.978 . . . . 0.0 111.543 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -33.91 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.881 0.472 . . . . 0.0 111.042 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.89 73.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.395 0.543 . . . . 0.0 111.114 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.93 113.86 4.96 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.607 1.563 . . . . 0.0 106.995 -171.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.78 -23.87 43.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.096 2.531 . . . . 0.0 115.275 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -146.2 118.51 8.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 108.861 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.02 -12.16 7.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.824 1.249 . . . . 0.0 114.033 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.52 -20.51 59.94 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.847 0.749 . . . . 0.0 112.229 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.39 155.22 40.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.03 0.832 . . . . 0.0 108.87 168.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.41 131.16 44.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.133 0.879 . . . . 0.0 109.445 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.8 t -129.16 129.89 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.81 84.38 2.27 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 m -67.49 147.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.1 167.33 22.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.66 178.38 8.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -56.05 -35.79 67.31 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.88 5.3 6.6 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.57 -25.89 5.49 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.254 1.407 . . . . 0.0 114.891 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -64.24 -49.14 73.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.268 1.534 . . . . 0.0 110.799 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.22 -31.68 67.87 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.79 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -68.81 -31.31 70.22 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.906 1.23 . . . . 0.0 111.065 169.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.42 -50.14 64.55 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 167.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.74 -42.52 99.71 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-N 117.813 0.807 . . . . 0.0 111.745 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.66 82.91 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.849 0.75 . . . . 0.0 109.812 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -66.81 -39.46 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.232 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.48 -44.45 97.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.755 1.161 . . . . 0.0 110.827 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.71 -53.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.91 -27.39 65.73 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.047 -0.408 . . . . 0.0 110.652 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -64.44 -43.1 95.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.762 0.71 . . . . 0.0 110.624 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.71 -32.83 74.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.343 0.519 . . . . 0.0 110.258 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.9 mtp -74.3 4.15 6.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 113.114 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.56 47.15 6.49 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.972 1.26 . . . . 0.0 111.891 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.2 166.4 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.304 1.042 . . . . 0.0 113.465 173.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 p -138.47 -34.95 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.813 0.845 . . . . 0.0 111.014 167.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -138.37 32.9 2.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.178 0.899 . . . . 0.0 112.008 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -92.52 139.44 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.66 147.0 31.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.774 1.23 . . . . 0.0 108.938 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -87.83 114.58 24.58 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -51.43 65.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.779 0.432 . . . . 0.0 110.301 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.43 -164.46 27.68 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.91 170.68 40.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.9 tp -55.36 -31.07 61.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 0.0 112.7 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.66 -24.83 65.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.271 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.55 -48.45 32.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.209 0.913 . . . . 0.0 111.628 -170.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 78' ' ' ILE . 2.4 mp -61.34 115.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.27 0.628 . . . . 0.0 109.682 -169.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.38 56.48 2.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.453 1.501 . . . . 0.0 110.358 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.3 mtp -135.63 155.3 78.34 Favored Pre-proline 0 C--O 1.239 0.53 0 C-N-CA 125.3 1.44 . . . . 0.0 109.3 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.8 152.02 14.19 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.945 3.097 . . . . 0.0 112.662 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -135.94 143.29 44.83 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 m -141.16 155.51 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.991 1.316 . . . . 0.0 108.38 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.77 159.71 29.68 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.264 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.572 -1.127 . . . . 0.0 110.616 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.646 0.26 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -133.46 114.2 13.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.389 1.476 . . . . 0.0 107.837 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.4 141.97 48.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.5 mm -137.12 122.07 24.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.4 122.14 28.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 m -110.38 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.21 -168.43 1.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.864 -1.148 . . . . 0.0 109.701 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.52 152.37 96.29 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.078 0.551 . . . . 0.0 110.09 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.48 -21.72 14.72 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.577 2.851 . . . . 0.0 114.475 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.34 -28.99 69.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.104 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -74.73 -47.27 32.18 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 120.098 1.317 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.06 -42.96 77.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.983 0.913 . . . . 0.0 111.275 -171.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -59.0 -51.79 68.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.388 1.075 . . . . 0.0 110.904 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.71 -41.03 60.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.38 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -167.39 140.11 3.37 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.412 1.006 . . . . 0.0 109.473 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -133.86 154.45 51.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.308 1.043 . . . . 0.0 108.622 171.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.5 130.95 19.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.6 119.48 6.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.24 59.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.208 0.909 . . . . 0.0 112.695 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.62 159.94 32.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.474 1.137 . . . . 0.0 110.75 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.9 pt -136.43 141.33 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.204 1.802 . . . . 0.0 106.5 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.54 110.22 14.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -132.72 78.42 66.69 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.532 1.933 . . . . 0.0 106.131 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.91 151.35 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.818 3.012 . . . . 0.0 114.04 -170.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.1 tp -49.22 -39.58 30.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 112.468 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.91 -11.46 56.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -130.04 -15.97 3.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.351 1.06 . . . . 0.0 111.914 -172.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -51.7 -33.89 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.295 1.438 . . . . 0.0 112.101 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -53.03 -38.69 62.6 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.286 1.034 . . . . 0.0 111.908 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.52 -45.33 4.47 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.37 -21.41 66.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.582 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -57.38 -31.66 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.805 1.184 . . . . 0.0 110.988 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -22.6 63.71 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -113.46 -28.92 7.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 110.685 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.27 -41.56 94.11 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.764 0.711 . . . . 0.0 111.294 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 t -142.96 83.6 11.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.617 1.567 . . . . 0.0 107.037 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.01 -31.46 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.018 1.812 . . . . 0.0 112.482 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -80.88 94.59 6.51 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -68.03 -0.31 4.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.31 -8.47 20.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.257 0.935 . . . . 0.0 111.674 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.83 149.49 49.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.206 0.912 . . . . 0.0 109.439 170.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -65.48 141.3 58.54 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.03 -0.419 . . . . 0.0 109.918 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.47 133.74 64.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -126.26 88.99 2.93 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.04 141.68 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.57 164.24 34.08 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.343 1.057 . . . . 0.0 109.088 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -153.39 172.21 17.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.604 1.562 . . . . 0.0 107.474 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -54.16 -18.7 4.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.16 8.52 2.95 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -171.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 -43.76 1.92 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.241 1.401 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -54.05 -53.83 47.71 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.229 1.012 . . . . 0.0 112.525 -170.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -65.46 -35.86 82.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -67.52 -34.56 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.584 -0.698 . . . . 0.0 112.321 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.21 -45.6 73.32 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -65.39 -49.53 68.95 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.236 0.518 . . . . 0.0 110.359 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.67 72.04 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 122.776 0.431 . . . . 0.0 110.648 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.49 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.42 -36.59 71.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.541 -0.725 . . . . 0.0 110.977 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.62 -46.65 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.552 1.069 . . . . 0.0 109.12 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.59 -36.86 85.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.239 0.616 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 m -66.91 -37.86 85.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.537 0.335 . . . . 0.0 110.549 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.48 -36.03 81.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -69.91 0.19 6.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.757 1.223 . . . . 0.0 112.647 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.95 80.83 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.197 -0.939 . . . . 0.0 112.985 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -64.11 155.39 31.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.832 1.316 . . . . 0.0 108.907 171.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 p -131.19 164.07 26.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.984 1.314 . . . . 0.0 108.427 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.2 m80 52.65 34.44 15.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.49 144.09 10.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.99 155.62 37.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 108.292 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.31 117.47 29.17 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 168.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.3 90.89 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.411 0.444 . . . . 0.0 111.6 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.58 -26.48 2.4 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.7 1.143 . . . . 0.0 111.921 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.02 176.73 22.58 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 173.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.0 -33.66 70.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.137 0.575 . . . . 0.0 110.147 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.9 -38.51 88.62 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 110.962 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.95 -47.15 26.26 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.611 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 82.8 mt -62.54 126.36 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -171.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.01 22.48 15.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.789 1.235 . . . . 0.0 112.087 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -73.65 158.67 85.96 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 124.22 1.008 . . . . 0.0 109.126 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.8 155.55 10.6 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.587 2.858 . . . . 0.0 111.846 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -138.07 149.41 45.96 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.74 154.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.349 1.459 . . . . 0.0 108.575 -171.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.14 151.56 45.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 172.603 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -134.36 156.32 48.71 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.259 1.824 . . . . 0.0 107.704 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -121.61 137.46 54.73 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.28 125.94 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.79 108.77 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 48' ' ' CYS 0.295 22.7 m -101.88 22.63 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.137 0.426 . . . . 0.0 111.89 -174.848 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.05 -177.06 3.16 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.704 -0.622 . . . . 0.0 110.464 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.08 152.84 95.62 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.221 0.608 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.81 -17.33 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.851 3.034 . . . . 0.0 115.042 171.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.08 -38.18 72.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.136 0.88 . . . . 0.0 111.461 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.93 -45.2 51.95 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.251 0.932 . . . . 0.0 109.991 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -52.85 -39.67 62.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.569 1.148 . . . . 0.0 111.699 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -54.8 -54.53 40.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.779 1.232 . . . . 0.0 111.385 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.19 -49.0 48.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.117 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.82 152.44 15.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.927 0.785 . . . . 0.0 110.635 167.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -134.19 158.32 43.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.593 1.157 . . . . 0.0 108.672 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.43 130.58 20.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 120.13 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.458 1.103 . . . . 0.0 110.101 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.63 -2.55 67.35 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.529 -1.15 . . . . 0.0 114.04 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.73 134.34 52.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.586 1.693 . . . . 0.0 109.787 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.4 130.64 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.07 113.84 12.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.567 1.076 . . . . 0.0 109.019 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.0 mt -140.79 81.62 16.44 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.59 151.97 17.58 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.661 2.907 . . . . 0.0 113.47 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.7 tp -47.75 -37.18 12.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.245 1.818 . . . . 0.0 113.216 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.86 -14.61 63.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -125.35 -19.79 4.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.836 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -50.11 -35.06 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.027 1.331 . . . . 0.0 112.465 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.69 -30.01 62.98 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.966 0.907 . . . . 0.0 112.327 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.81 -45.78 3.31 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.654 0.661 . . . . 0.0 110.102 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -63.87 -20.58 65.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.61 -34.13 34.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 0.0 111.477 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.35 97.12 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -34.71 55.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 111.137 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.39 70.84 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.429 0.559 . . . . 0.0 112.197 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.79 80.07 32.05 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.344 1.458 . . . . 0.0 107.238 -171.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.76 -1.58 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.191 2.594 . . . . 0.0 113.979 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -130.28 105.81 8.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.33 -15.0 55.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.85 -20.78 62.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.58 0.627 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.58 154.22 39.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.252 0.621 . . . . 0.0 111.619 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -76.95 135.49 38.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.625 -0.672 . . . . 0.0 109.567 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.09 90.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -72.17 131.54 42.92 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.41 143.14 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.67 163.11 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.076 0.951 . . . . 0.0 109.085 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 7' ' ' VAL . 1.7 m -144.54 -179.19 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.416 1.886 . . . . 0.0 107.735 176.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -64.19 -37.73 88.51 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.455 -0.778 . . . . 0.0 112.245 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.97 -20.06 8.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.059 0.944 . . . . 0.0 113.249 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.63 -23.72 16.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.267 0.937 . . . . 0.0 113.922 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -68.88 -41.05 78.86 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.099 1.449 . . . . 0.0 111.469 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.31 -33.37 75.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.664 0.665 . . . . 0.0 111.418 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -71.62 -31.1 66.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.749 1.159 . . . . 0.0 110.694 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.19 -47.99 77.64 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -61.75 -46.12 90.98 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.967 -0.726 . . . . 0.0 110.547 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.58 -34.97 73.39 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.026 -0.421 . . . . 0.0 111.064 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -63.0 -42.42 99.84 Favored 'General case' 0 C--N 1.335 -0.064 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.69 -44.54 93.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.72 0.691 . . . . 0.0 110.544 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.42 -51.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.3 mt -71.2 -28.05 63.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.927 -0.483 . . . . 0.0 111.587 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 m -64.88 -43.31 93.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.512 0.596 . . . . 0.0 110.134 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.97 -34.49 78.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.687 0.676 . . . . 0.0 110.813 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.74 -6.03 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.867 0.867 . . . . 0.0 112.798 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.91 58.62 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.909 170.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -72.34 122.7 21.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.124 1.462 . . . . 0.0 108.403 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -74.59 -29.95 61.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.79 1.236 . . . . 0.0 113.833 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -136.26 44.11 2.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.422 0.689 . . . . 0.0 111.123 -168.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.56 147.93 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -145.79 123.72 12.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -74.75 106.59 6.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.45 -28.27 67.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.05 0.94 . . . . 0.0 111.694 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.47 -161.68 21.53 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.265 0.936 . . . . 0.0 110.97 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.85 159.54 33.07 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.4 tp -58.01 -26.52 62.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.032 1.333 . . . . 0.0 111.875 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -69.04 -10.51 57.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.473 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.61 -33.25 3.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.877 1.271 . . . . 0.0 112.437 -170.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.16 135.8 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.504 1.502 . . . . 0.0 107.39 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.08 23.91 11.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.539 1.136 . . . . 0.0 112.16 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 75.6 mmm -68.61 160.15 78.2 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 108.765 168.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.14 155.25 62.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.659 1.573 . . . . 0.0 109.124 167.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -138.68 144.62 39.68 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.87 150.57 16.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.206 1.402 . . . . 0.0 108.66 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -65.91 161.56 20.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.837 0.455 . . . . 0.0 110.88 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -141.33 159.42 42.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.181 1.792 . . . . 0.0 107.655 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -129.71 145.65 51.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.72 1.208 . . . . 0.0 108.148 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.9 mt -146.48 135.45 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -90.17 124.8 35.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG23 ' SG ' ' A' ' 48' ' ' CYS . 22.7 m -115.78 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.959 0.504 . . . . 0.0 112.229 -174.15 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.28 -170.56 1.77 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 m -66.68 157.36 83.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.197 0.599 . . . . 0.0 110.329 171.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -53.32 -16.75 7.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.224 3.282 . . . . 0.0 115.436 172.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.95 -41.65 46.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 111.915 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -75.44 -45.14 40.51 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.619 0.645 . . . . 0.0 109.925 174.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -54.3 -38.61 66.13 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.009 0.924 . . . . 0.0 112.289 -174.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.13 -50.68 72.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.649 1.18 . . . . 0.0 110.956 177.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -83.95 -38.5 20.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.748 -170.413 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.87 139.36 2.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.65 1.18 . . . . 0.0 109.359 169.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -134.79 145.7 48.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.142 1.377 . . . . 0.0 107.909 172.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.9 t -58.81 133.94 23.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.73 142.56 39.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.264 -0.273 . . . . 0.0 110.286 -178.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.13 -18.09 29.45 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.108 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.51 163.51 20.93 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.173 1.486 . . . . 0.0 110.788 172.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -145.69 138.08 20.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.652 2.381 . . . . 0.0 105.124 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -76.77 114.68 15.8 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -176.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -141.13 85.41 12.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.37 157.31 11.89 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.87 3.047 . . . . 0.0 114.506 -170.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 tp -46.8 -41.1 14.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.782 2.033 . . . . 0.0 113.215 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.53 -10.74 60.03 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -123.7 -21.46 5.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.042 1.337 . . . . 0.0 111.303 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.37 -33.19 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.396 1.478 . . . . 0.0 112.669 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.54 -43.84 72.32 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.799 1.24 . . . . 0.0 111.142 -170.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -93.78 -45.59 7.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.671 0.669 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -17.85 65.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -52.94 -36.49 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.133 0.878 . . . . 0.0 111.248 171.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.62 96.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.982 0.81 . . . . 0.0 110.954 -175.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -35.06 66.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.232 0.613 . . . . 0.0 111.11 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.5 78.61 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.406 0.548 . . . . 0.0 111.618 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.0 t -142.09 87.98 9.45 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.385 1.474 . . . . 0.0 107.306 -171.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.88 21.77 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.953 3.102 . . . . 0.0 114.107 -172.728 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -144.08 104.67 4.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 107.605 173.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.88 -10.79 52.17 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -82.42 -13.62 56.5 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.976 0.807 . . . . 0.0 111.838 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.45 154.24 40.97 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.007 0.822 . . . . 0.0 111.453 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -71.97 136.95 46.96 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.67 135.81 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -115.97 128.65 55.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.44 145.29 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.26 159.75 44.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.568 1.547 . . . . 0.0 107.754 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' HG23 ' A' ' 7' ' ' VAL . 5.5 m -157.24 167.48 30.21 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.157 1.783 . . . . 0.0 108.851 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -46.55 -30.2 2.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -176.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.42 7.97 5.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.568 1.076 . . . . 0.0 113.525 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.8 -40.95 1.88 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.045 1.307 . . . . 0.0 112.385 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -52.66 -47.96 66.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.595 1.158 . . . . 0.0 111.569 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -65.0 -37.86 89.06 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.059 0.391 . . . . 0.0 110.132 -173.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -30.98 69.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.016 172.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.64 -44.32 95.71 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 169.334 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -61.05 -49.49 77.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.803 0.802 . . . . 0.0 109.982 175.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.19 -40.41 77.34 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.86 0.3 . . . . 0.0 110.617 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.15 -37.92 87.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.71 -34.82 67.38 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.53 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.61 -47.37 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.889 1.222 . . . . 0.0 108.323 171.392 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 mt -70.49 -29.91 66.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.741 -0.6 . . . . 0.0 111.507 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.2 m -65.54 -38.04 88.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.227 0.467 . . . . 0.0 110.407 172.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.48 -36.05 81.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.821 0.737 . . . . 0.0 110.255 174.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mmm -68.93 -5.79 23.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.109 0.964 . . . . 0.0 112.579 170.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 12.0 64.48 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.425 1.012 . . . . 0.0 113.529 172.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.61 127.85 34.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.129 1.464 . . . . 0.0 107.731 175.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -89.42 -22.0 22.75 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -169.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.59 33.48 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.1 0.96 . . . . 0.0 111.551 -169.068 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.57 136.92 22.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 167.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.09 144.13 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.78 110.58 18.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -29.61 70.55 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.92 -162.08 28.84 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.239 1.399 . . . . 0.0 109.754 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.63 158.91 31.39 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 170.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -55.33 -35.62 65.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.358 1.063 . . . . 0.0 110.89 175.648 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.97 0.96 11.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.259 1.023 . . . . 0.0 112.735 176.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -130.9 -28.39 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.433 -169.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.71 134.99 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 120.936 1.698 . . . . 0.0 107.554 168.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.22 53.02 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.714 1.605 . . . . 0.0 108.831 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.0 mtp -133.88 158.38 75.58 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.188 1.795 . . . . 0.0 107.627 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.54 149.16 40.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.022 2.481 . . . . 0.0 113.354 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -127.85 159.17 35.71 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.202 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 100.0 t -134.82 167.83 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 127.708 2.403 . . . . 0.0 105.271 -175.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -128.71 161.61 29.3 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.798 -1.189 . . . . 0.0 109.871 -170.03 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 174.71 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.4 158.37 43.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.1 m80 -132.53 150.17 52.2 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.135 166.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.588 ' HZ3' ' HE2' ' A' ' 80' ' ' MET . 23.6 m95 -123.98 142.65 50.97 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.065 -1.879 . . . . 0.0 109.252 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 mm -140.0 123.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -79.86 121.7 25.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 163.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -112.28 21.35 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.937 0.79 . . . . 0.0 112.324 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.552 ' HD2' ' H ' ' A' ' 49' ' ' ASN . 7.4 ttt180 -106.3 -175.47 2.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.687 -1.258 . . . . 0.0 110.105 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 m -60.11 151.71 65.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.358 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.76 -17.14 28.12 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.221 2.614 . . . . 0.0 113.964 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -54.08 -39.87 66.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.607 1.163 . . . . 0.0 113.528 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.45 -41.74 69.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.866 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -57.54 -37.41 73.02 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.192 0.997 . . . . 0.0 111.814 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -59.96 -39.08 84.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.975 0.91 . . . . 0.0 112.319 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -87.9 -44.69 10.87 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 117.816 -1.087 . . . . 0.0 111.293 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -162.86 150.11 13.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 167.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -139.98 152.77 46.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.492 HG11 ' HE3' ' A' ' 4' ' ' TRP . 67.5 t -54.17 128.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.578 169.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.32 113.29 2.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -13.29 25.39 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.34 164.05 27.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 117.491 0.646 . . . . 0.0 110.346 171.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.58 138.25 54.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 127.084 2.154 . . . . 0.0 106.95 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.12 115.66 16.06 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 123.935 0.772 . . . . 0.0 109.592 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.41 82.78 15.96 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 126.102 1.761 . . . . 0.0 106.511 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.39 153.49 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.502 2.802 . . . . 0.0 113.791 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -49.42 -36.92 23.61 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.166 1.386 . . . . 0.0 112.457 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -67.02 -15.35 63.67 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.673 ' HB3' ' HD2' ' A' ' 32' ' ' ARG . 23.9 mt-10 -130.81 -13.61 3.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 O-C-N 124.586 1.179 . . . . 0.0 110.867 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.62 -34.15 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.342 1.057 . . . . 0.0 111.328 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -56.85 -31.36 64.7 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -105.24 -35.96 7.39 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.015 0.912 . . . . 0.0 110.482 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.673 ' HD2' ' HB3' ' A' ' 28' ' ' GLU . 5.8 mtp180 -81.2 -17.26 50.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.03 -34.39 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.56 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.48 -32.02 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.897 0.771 . . . . 0.0 111.726 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.64 -28.62 21.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.305 0.642 . . . . 0.0 111.438 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.45 -40.05 44.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.447 0.567 . . . . 0.0 111.613 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 t -142.67 82.58 12.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.41 -25.41 70.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.354 2.036 . . . . 0.0 113.84 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -101.4 100.68 11.18 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -69.34 -6.87 32.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -176.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -18.42 58.98 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 170.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -66.76 150.75 48.67 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -72.08 131.73 43.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.93 124.42 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HD2' ' HE1' ' A' ' 4' ' ' TRP . 88.5 mttt -110.34 121.04 44.33 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.04 147.02 12.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.47 163.89 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 107.975 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.8 p -154.39 -176.34 5.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.552 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 61.9 t30 -60.14 -30.68 69.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.11 1.0 7.19 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.211 -0.931 . . . . 0.0 113.101 -168.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.1 -26.57 3.79 Favored Glycine 0 C--O 1.225 -0.466 0 CA-C-O 122.611 1.117 . . . . 0.0 113.339 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.321 2.3 tpt85 -69.96 -48.16 59.43 Favored 'General case' 0 N--CA 1.426 -1.641 0 O-C-N 120.449 -1.618 . . . . 0.0 112.117 -176.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.9 -29.73 64.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.227 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -35.51 79.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.252 0.478 . . . . 0.0 111.796 167.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.86 -47.28 72.79 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -63.74 -46.01 87.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.864 0.832 . . . . 0.0 110.608 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.192 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -61.42 -41.44 97.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.86 -42.04 90.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.108 0.867 . . . . 0.0 111.255 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.3 -48.78 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 42.9 mt -64.7 -47.97 76.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.5 m -52.93 -36.26 59.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 121.761 2.073 . . . . 0.0 112.258 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -66.61 -37.93 85.92 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 41.9 mmm -68.0 -6.59 23.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.015 1.326 . . . . 0.0 113.529 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.31 28.91 13.36 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.706 -1.246 . . . . 0.0 113.866 167.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.668 ' HB3' HG23 ' A' ' 69' ' ' VAL 0.333 49.4 m-85 -68.2 151.5 46.87 Favored 'General case' 0 CA--C 1.469 -2.169 0 C-N-CA 123.686 0.794 . . . . 0.0 110.057 173.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.57 -24.44 11.77 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.711 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -138.77 47.35 1.94 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.911 1.339 . . . . 0.0 111.571 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 66' ' ' TYR . 2.1 t -90.32 148.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -147.05 134.5 20.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.629 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -78.14 110.6 13.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 163.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.53 -31.65 72.82 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.76 -147.51 19.26 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -100.52 165.56 19.26 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' HE2' ' A' ' 82' ' ' LYS . 40.3 tp -50.06 -32.81 16.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.971 1.367 . . . . 0.0 112.864 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.272 59.9 mttt -69.22 -28.45 66.36 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -86.32 -40.38 15.53 Favored 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 126.178 2.174 . . . . 0.0 107.58 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 80' ' ' MET . 2.2 mp -60.92 126.28 18.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.179 . . . . 0.0 108.806 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.85 34.24 3.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.231 1.012 . . . . 0.0 110.264 -174.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.588 ' HE2' ' HZ3' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -91.24 161.47 34.85 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 123.459 0.704 . . . . 0.0 109.553 170.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -51.22 150.91 13.52 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.535 2.157 . . . . 0.0 111.519 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HE2' HD12 ' A' ' 75' ' ' LEU . 17.2 mttp -133.84 153.32 51.81 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 157.6 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -84.71 162.7 19.56 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.443 173.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.346 0 O-C-N 127.502 3.001 . . . . 0.0 111.29 170.133 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.37 147.77 38.57 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.417 1.487 . . . . 0.0 107.38 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -135.28 110.98 9.26 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 107.959 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -75.95 133.02 40.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.3 mm -132.86 122.53 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -78.51 129.39 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.93 31.34 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.691 0.678 . . . . 0.0 111.991 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -120.02 -173.42 2.55 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.424 -0.797 . . . . 0.0 109.788 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.21 157.46 77.05 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.458 0.703 . . . . 0.0 110.01 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.62 -14.43 39.83 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.918 2.412 . . . . 0.0 113.649 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -47.37 -47.87 25.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.957 1.303 . . . . 0.0 111.087 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -70.61 -42.0 71.53 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 118.529 0.604 . . . . 0.0 109.957 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -57.05 -38.56 73.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.952 0.901 . . . . 0.0 111.18 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.7 -45.03 88.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.772 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -73.54 -47.26 42.16 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.542 1.065 . . . . 0.0 110.771 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.83 149.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 109.729 166.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -138.6 151.24 47.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.081 1.752 . . . . 0.0 107.991 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.96 131.55 16.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 119.18 3.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.567 1.147 . . . . 0.0 110.346 -171.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.05 76.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.626 -1.097 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.9 55.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.372 1.586 . . . . 0.0 109.424 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 mt -78.83 129.17 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -78.36 118.59 20.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.164 0.893 . . . . 0.0 109.498 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.9 mt -141.16 84.57 12.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.23 151.03 9.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.94 3.093 . . . . 0.0 113.895 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.2 tp -46.74 -42.65 17.14 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.539 1.536 . . . . 0.0 112.575 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -66.82 -12.55 59.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.745 0.818 . . . . 0.0 112.992 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.39 -9.15 4.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.739 1.216 . . . . 0.0 112.389 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 p -49.37 -42.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.735 1.152 . . . . 0.0 112.238 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -57.92 -34.95 70.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.969 0.908 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -92.77 7.57 43.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.062 0.945 . . . . 0.0 111.585 -168.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -140.94 -27.84 0.7 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.274 -0.891 . . . . 0.0 112.116 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.36 -34.81 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.687 1.131 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.39 23.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.482 1.113 . . . . 0.0 113.676 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -121.42 -27.94 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.902 1.281 . . . . 0.0 111.156 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.98 -38.54 76.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.807 0.731 . . . . 0.0 111.04 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -140.26 75.78 27.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.63 -32.88 18.21 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.34 2.026 . . . . 0.0 112.37 -172.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -79.03 97.71 6.2 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.14 -10.31 39.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -78.68 -18.99 53.52 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.686 1.13 . . . . 0.0 111.563 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.38 147.06 54.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.056 0.843 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -70.98 137.79 49.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.1 t -127.87 141.17 47.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -130.33 128.45 41.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.29 154.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.149 0.979 . . . . 0.0 108.925 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -155.92 161.76 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.593 1.957 . . . . 0.0 107.077 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.2 171.49 20.1 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.376 0.67 . . . . 0.0 109.638 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -48.32 -30.62 5.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.361 1.864 . . . . 0.0 114.545 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.75 2.05 8.17 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.52 -31.81 0.85 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.687 1.613 . . . . 0.0 113.918 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -63.57 -52.37 61.31 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.783 1.291 . . . . 0.0 111.507 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.94 -35.56 80.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.05 0.841 . . . . 0.0 110.892 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.9 p -72.04 -33.15 67.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.53 -0.732 . . . . 0.0 111.651 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.62 77.46 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -64.66 -49.2 71.92 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 117.516 0.658 . . . . 0.0 110.04 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.14 -36.63 70.94 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.443 0.297 . . . . 0.0 110.873 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.06 -42.12 97.13 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.44 -34.72 72.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.877 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -58.66 -50.45 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.323 0.965 . . . . 0.0 108.927 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.28 -34.44 78.36 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.753 -0.592 . . . . 0.0 110.825 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -63.16 -40.6 98.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.562 0.345 . . . . 0.0 110.687 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.99 -35.57 80.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.55 0.74 . . . . 0.0 110.677 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.05 -6.46 28.26 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.969 0.908 . . . . 0.0 112.415 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.631 -1.094 . . . . 0.0 113.159 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -65.93 119.26 11.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.381 1.591 . . . . 0.0 107.081 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 p -81.54 -19.86 41.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.01 76.81 1.67 Allowed 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.313 1.045 . . . . 0.0 108.441 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.76 141.99 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.25 140.87 35.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -91.74 102.99 15.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.74 76.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.743 -171.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.12 -168.3 27.1 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.53 153.63 51.78 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.8 tp -45.25 -45.09 11.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.861 1.664 . . . . 0.0 113.289 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -67.15 -25.36 66.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.13 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.56 -34.53 46.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.716 0.689 . . . . 0.0 111.574 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.77 123.93 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.06 22.9 12.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.12 0.968 . . . . 0.0 112.324 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.7 mmm -73.63 153.21 89.56 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.81 157.37 12.93 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.276 2.651 . . . . 0.0 110.948 167.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -136.43 158.0 45.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.128 0.571 . . . . 0.0 110.055 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.27 164.55 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.213 2.205 . . . . 0.0 105.186 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -147.56 172.18 14.4 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.805 -1.184 . . . . 0.0 110.648 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -173.579 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -133.87 155.66 49.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 107.909 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -140.61 163.99 31.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.574 1.55 . . . . 0.0 107.427 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -128.26 136.18 50.68 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -131.04 127.76 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -94.53 121.38 36.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 168.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.46 13.97 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -93.93 179.49 5.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.7 1.136 . . . . 0.0 110.366 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -51.9 148.09 11.17 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.76 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.56 -27.15 24.35 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.332 2.688 . . . . 0.0 113.533 171.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.73 -39.55 65.37 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.667 0.787 . . . . 0.0 111.391 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -69.83 -41.64 74.67 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.122 0.874 . . . . 0.0 110.501 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -58.1 -39.62 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.096 1.359 . . . . 0.0 110.486 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.88 -10.66 60.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.006 . . . . 0.0 113.696 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -81.69 -71.29 0.49 Allowed 'General case' 0 C--N 1.341 0.202 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 168.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.68 158.29 28.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.63 1.572 . . . . 0.0 107.702 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -143.44 152.75 41.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.527 1.131 . . . . 0.0 108.41 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.74 131.5 14.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.36 120.4 5.99 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.06 90.38 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.511 -1.161 . . . . 0.0 113.884 173.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.38 142.21 57.94 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.227 1.513 . . . . 0.0 110.005 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -87.9 127.33 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -77.18 115.33 16.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.56 81.56 23.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.133 1.773 . . . . 0.0 106.561 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.16 148.87 23.27 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.255 2.636 . . . . 0.0 112.625 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.88 -29.72 42.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.782 1.233 . . . . 0.0 112.722 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -60.08 -20.36 57.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.696 0.798 . . . . 0.0 113.049 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -128.41 -17.44 4.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.534 1.134 . . . . 0.0 112.096 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.87 -36.44 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.341 . . . . 0.0 112.765 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.65 -30.46 68.75 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.468 0.707 . . . . 0.0 112.073 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.92 -47.78 4.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.368 0.667 . . . . 0.0 109.514 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -63.89 -18.76 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.112 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -52.58 -40.55 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.43 1.014 . . . . 0.0 111.04 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.79 90.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.828 0.74 . . . . 0.0 110.917 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -71.72 -37.02 70.68 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.487 0.715 . . . . 0.0 111.063 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.87 62.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.217 0.462 . . . . 0.0 111.738 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.24 98.19 6.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 108.128 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.18 -9.76 7.01 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.088 3.192 . . . . 0.0 116.253 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -134.83 111.29 9.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.834 1.197 . . . . 0.0 110.155 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.0 -12.37 60.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.701 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -86.54 -4.17 59.13 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.151 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.74 151.03 47.9 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.362 -0.836 . . . . 0.0 108.9 168.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 m -79.62 70.21 6.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.73 0.776 . . . . 0.0 109.758 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 t -74.01 97.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -79.58 141.26 36.75 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.99 126.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -171.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.06 169.67 17.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.23 1.412 . . . . 0.0 109.307 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 p -150.11 178.45 8.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.78 -23.36 67.33 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.01 -6.81 11.97 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.63 30.13 77.08 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.661 1.119 . . . . 0.0 114.627 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -137.26 -45.8 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.012 0.906 . . . . 0.0 110.235 170.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.98 -22.38 65.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.726 0.239 . . . . 0.0 110.614 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 p -64.36 -42.21 96.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.05 -1.031 . . . . 0.0 110.95 168.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.77 -43.27 96.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.14 -40.07 96.51 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.147 1.474 . . . . 0.0 111.315 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.53 76.06 Favored 'General case' 0 C--O 1.227 -0.087 0 O-C-N 121.376 -0.828 . . . . 0.0 110.685 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.03 -39.65 83.06 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.488 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.97 -44.02 97.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.37 0.987 . . . . 0.0 109.714 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.41 -50.38 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.921 0.889 . . . . 0.0 109.688 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.05 -18.65 62.55 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.441 -0.787 . . . . 0.0 111.502 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -68.22 -36.73 79.96 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.54 -0.725 . . . . 0.0 110.126 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.12 -36.49 83.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.299 0.954 . . . . 0.0 110.052 171.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.1 mmm -73.23 -1.87 19.49 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.064 0.945 . . . . 0.0 112.796 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.08 46.05 17.78 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 119.849 1.204 . . . . 0.0 111.659 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -46.24 158.41 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.501 1.121 . . . . 0.0 113.299 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.83 -26.67 1.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.893 -1.051 . . . . 0.0 112.217 173.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -147.92 23.86 1.08 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.585 1.539 . . . . 0.0 113.845 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 144.58 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.2 128.33 16.64 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.856 0.862 . . . . 0.0 109.002 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.63 108.17 10.63 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 168.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.73 73.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.0 0.52 . . . . 0.0 110.957 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.54 -139.36 7.23 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.22 166.34 15.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.5 tp -51.03 -40.16 57.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -168.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.91 -27.61 66.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.642 0.377 . . . . 0.0 111.677 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -86.71 -36.28 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.884 0.874 . . . . 0.0 111.658 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.95 119.66 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.46 22.87 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.05 0.94 . . . . 0.0 112.468 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mmm -81.3 158.35 69.41 Favored Pre-proline 0 C--O 1.24 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 109.462 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.65 154.92 11.19 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.441 2.761 . . . . 0.0 111.754 168.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -134.41 154.34 51.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 t -130.54 141.04 47.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.59 161.0 24.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.09 0.556 . . . . 0.0 110.281 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.032 169.355 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -161.4 156.96 24.47 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.204 1.401 . . . . 0.0 107.896 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -82.8 158.07 22.94 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.22 141.66 49.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.621 1.168 . . . . 0.0 107.998 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -139.84 136.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.89 122.24 36.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.64 20.21 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.598 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 15.8 ttt85 -109.56 -162.84 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.238 -0.914 . . . . 0.0 108.766 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 11.1 m -77.98 156.13 79.83 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.343 0.657 . . . . 0.0 109.588 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.41 -23.77 19.75 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.364 2.709 . . . . 0.0 114.029 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -26.08 64.2 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.688 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -86.2 -51.34 6.34 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 119.95 1.25 . . . . 0.0 109.142 167.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -53.25 -37.81 62.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.871 1.269 . . . . 0.0 112.992 -170.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -66.59 -45.59 78.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 0.0 111.52 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.38 -30.36 60.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.953 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.74 153.37 2.21 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.616 1.566 . . . . 0.0 109.667 166.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -146.02 146.51 31.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 t -60.15 132.67 25.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.4 149.43 16.83 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.577 0.751 . . . . 0.0 111.529 -172.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.93 -14.87 46.43 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.462 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.82 171.39 7.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.889 1.345 . . . . 0.0 111.797 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.8 mt -135.4 134.22 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -73.92 115.65 13.63 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.162 0.892 . . . . 0.0 109.031 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 mt -141.29 87.55 10.52 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.22 149.83 11.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.009 3.139 . . . . 0.0 114.027 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.49 -36.37 14.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.883 1.673 . . . . 0.0 113.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -63.88 -20.45 65.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -129.29 -11.3 4.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.93 0.892 . . . . 0.0 111.865 -169.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -50.26 -34.65 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 111.51 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.69 -33.83 56.74 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 112.609 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.54 -36.72 4.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.485 0.584 . . . . 0.0 111.211 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -69.26 -15.67 63.41 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.597 -0.689 . . . . 0.0 112.317 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.67 -35.35 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.056 169.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.08 99.43 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.385 0.993 . . . . 0.0 111.184 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -35.94 59.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.405 0.682 . . . . 0.0 111.158 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.74 75.02 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -140.66 82.47 15.78 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.994 1.718 . . . . 0.0 107.062 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.46 3.71 4.53 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.381 2.72 . . . . 0.0 114.256 -173.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.06 103.88 5.99 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.801 1.24 . . . . 0.0 107.863 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -15.78 52.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.98 -25.15 63.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.468 0.577 . . . . 0.0 111.876 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -63.66 154.7 32.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.63 0.65 . . . . 0.0 111.773 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -73.2 142.67 47.34 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.22 140.59 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -120.67 139.93 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.19 144.6 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -143.57 160.59 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.46 1.104 . . . . 0.0 109.109 170.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -130.01 -139.34 0.22 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 125.034 1.334 . . . . 0.0 107.423 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -80.53 -45.15 17.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.789 1.631 . . . . 0.0 111.89 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.87 -26.44 3.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -169.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.35 2.41 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.073 0.851 . . . . 0.0 113.933 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -66.08 -44.21 85.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.984 1.392 . . . . 0.0 112.517 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.2 -33.03 71.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.868 0.758 . . . . 0.0 110.648 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -33.39 74.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.251 -0.906 . . . . 0.0 110.648 170.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.96 -49.18 68.34 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -60.47 -46.91 88.37 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.529 0.664 . . . . 0.0 110.655 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.51 75.25 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.474 0.579 . . . . 0.0 110.791 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -65.4 -42.79 92.22 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -42.34 98.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.876 0.762 . . . . 0.0 111.111 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.84 -51.21 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.88 -24.56 59.74 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.733 -0.604 . . . . 0.0 111.858 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 m -67.38 -38.95 85.52 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.321 0.51 . . . . 0.0 110.248 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -67.26 -37.21 83.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.831 0.741 . . . . 0.0 110.256 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mmm -67.39 -12.98 61.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.688 0.795 . . . . 0.0 112.289 170.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.89 14.6 66.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.349 -1.25 . . . . 0.0 113.955 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -64.26 122.87 17.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.522 1.661 . . . . 0.0 107.716 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -68.19 -30.88 70.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -165.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.27 42.9 2.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.271 0.942 . . . . 0.0 112.213 -166.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.83 146.67 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -142.65 137.76 30.18 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.144 1.378 . . . . 0.0 108.356 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -78.5 114.37 17.35 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.38 63.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.637 0.775 . . . . 0.0 112.031 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.58 -145.7 17.71 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.93 168.99 16.02 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.98 -25.48 67.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.142 0.977 . . . . 0.0 112.234 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -78.25 -6.02 53.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.353 172.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.58 -35.09 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.311 1.044 . . . . 0.0 112.471 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.61 146.19 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 120.264 1.393 . . . . 0.0 108.615 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.97 67.14 1.34 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.471 1.508 . . . . 0.0 108.427 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.2 ptm -140.23 166.1 25.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.9 1.28 . . . . 0.0 108.543 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 147.1 33.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.231 2.621 . . . . 0.0 113.561 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.87 160.06 24.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.5 1.12 . . . . 0.0 109.029 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.56 155.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -134.86 155.86 49.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.124 0.97 . . . . 0.0 109.089 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 174.642 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -140.52 145.4 36.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.475 1.11 . . . . 0.0 108.213 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -134.72 98.67 4.11 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.626 1.571 . . . . 0.0 107.149 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -72.64 147.08 46.12 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mm -140.34 124.69 18.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -79.79 114.35 18.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.4 m -106.42 18.55 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.49 -171.93 2.22 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 120.946 -1.096 . . . . 0.0 109.288 173.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.74 154.9 64.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.02 -11.11 25.7 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.059 2.506 . . . . 0.0 114.1 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -54.27 -37.26 64.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.575 1.55 . . . . 0.0 112.275 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.38 -41.85 75.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.141 0.882 . . . . 0.0 110.296 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -58.75 -31.44 68.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.945 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -64.66 -14.63 59.07 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -132.08 -36.47 1.17 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.536 1.062 . . . . 0.0 112.709 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.91 139.74 6.4 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.865 1.211 . . . . 0.0 108.256 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -141.71 154.7 45.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 170.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.39 128.8 14.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -29.68 65.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.046 0.539 . . . . 0.0 112.235 -169.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.94 22.77 36.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.241 -1.311 . . . . 0.0 113.12 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.57 163.69 17.62 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.173 1.487 . . . . 0.0 112.319 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 pt -137.36 144.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 127.053 2.141 . . . . 0.0 107.33 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.3 117.23 20.1 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.113 0.565 . . . . 0.0 109.805 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.0 mt -141.21 83.45 13.7 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.222 1.809 . . . . 0.0 106.268 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.32 152.83 24.3 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.769 2.979 . . . . 0.0 114.555 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -47.38 -36.57 9.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.651 1.981 . . . . 0.0 113.016 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -64.14 -20.06 65.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.29 -11.75 4.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.852 0.861 . . . . 0.0 112.105 -169.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -51.4 -33.75 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.763 1.225 . . . . 0.0 112.058 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -54.43 -35.75 63.28 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.577 1.151 . . . . 0.0 111.974 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.96 -42.17 5.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -66.96 -14.31 62.71 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 tp -52.18 -38.62 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.467 1.031 . . . . 0.0 111.204 170.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.76 98.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.131 0.878 . . . . 0.0 111.041 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.14 -35.63 69.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.531 0.732 . . . . 0.0 111.201 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.46 -46.27 67.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 0.0 111.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 t -143.66 101.32 5.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -171.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.17 -22.92 34.1 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.57 2.847 . . . . 0.0 115.53 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -144.43 116.63 8.44 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.305 1.042 . . . . 0.0 108.849 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -66.74 -4.56 9.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 113.088 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.62 -23.58 62.58 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.146 0.579 . . . . 0.0 111.087 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.13 150.0 45.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.07 130.17 41.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.685 -0.634 . . . . 0.0 109.416 -173.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -125.74 134.49 66.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.34 86.65 2.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.87 144.44 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -152.18 163.63 38.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.559 1.544 . . . . 0.0 108.379 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.71 170.46 21.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.466 1.106 . . . . 0.0 109.147 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -54.79 -14.98 1.6 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 -3.4 4.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.51 -30.26 0.59 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.447 1.499 . . . . 0.0 114.137 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -64.97 -49.71 69.22 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.438 1.095 . . . . 0.0 111.525 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.67 -31.35 71.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.399 0.545 . . . . 0.0 110.638 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -71.57 -30.89 66.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.173 -0.954 . . . . 0.0 111.289 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.2 -48.97 70.81 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 167.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -61.36 -44.42 97.19 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.974 -0.721 . . . . 0.0 111.166 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.06 75.46 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 118.372 0.533 . . . . 0.0 110.572 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.39 -40.38 85.66 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -64.12 -41.39 97.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.361 0.982 . . . . 0.0 110.842 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.11 -53.01 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -69.78 -23.19 63.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.927 -0.483 . . . . 0.0 111.829 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 34.9 m -63.12 -44.28 96.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.558 0.617 . . . . 0.0 110.128 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -67.22 -28.92 68.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.313 0.506 . . . . 0.0 110.884 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mmm -76.7 6.59 5.74 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.142 0.977 . . . . 0.0 112.73 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 42.51 8.55 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 119.677 1.126 . . . . 0.0 112.525 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.2 OUTLIER -53.3 161.85 0.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 175.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.33 -40.72 0.65 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 110.622 168.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -135.23 33.36 3.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.818 1.19 . . . . 0.0 112.537 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.4 t -82.42 140.67 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -147.16 143.6 28.36 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.075 0.95 . . . . 0.0 108.875 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -79.35 107.46 12.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.21 -29.29 70.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.059 0.544 . . . . 0.0 111.958 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.95 -162.12 25.21 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.05 30.83 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -58.19 -34.06 69.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 110.565 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.13 -14.66 63.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.92 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -110.7 -39.26 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.114 0.966 . . . . 0.0 111.33 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 mt -64.42 139.79 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.721 1.146 . . . . 0.0 109.498 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.06 27.39 7.18 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.022 1.329 . . . . 0.0 111.508 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.0 162.51 45.44 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.05 144.26 46.92 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.285 1.99 . . . . 0.0 110.547 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.14 153.09 51.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.609 0.764 . . . . 0.0 109.261 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.77 160.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.458 1.903 . . . . 0.0 106.725 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.47 157.05 23.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 173.508 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -142.93 153.03 42.67 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 108.814 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -141.12 153.37 45.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.091 1.757 . . . . 0.0 106.906 169.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -123.08 150.44 43.15 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 mm -140.04 123.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -80.87 111.18 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -103.3 20.69 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 11.6 ttt-85 -106.94 -175.48 2.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.194 -0.942 . . . . 0.0 109.61 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 4.4 m -69.14 156.86 90.72 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.185 0.594 . . . . 0.0 109.868 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.53 -14.2 4.62 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.107 3.205 . . . . 0.0 115.759 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -48.65 -38.02 19.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.099 1.36 . . . . 0.0 112.058 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.43 -48.52 12.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.227 0.467 . . . . 0.0 110.305 173.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -55.81 -38.99 70.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.129 0.971 . . . . 0.0 112.02 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -65.4 -7.8 15.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.259 1.424 . . . . 0.0 113.637 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -130.23 -29.68 2.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.657 1.117 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -167.04 143.15 4.35 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.062 1.301 . . . . 0.0 108.797 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -143.75 153.36 42.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.337 1.055 . . . . 0.0 108.217 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.44 131.58 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -33.64 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.373 0.669 . . . . 0.0 111.54 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.37 12.94 67.81 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.048 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.03 166.05 13.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.128 1.464 . . . . 0.0 112.169 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.45 142.16 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.022 2.129 . . . . 0.0 107.373 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -80.0 114.79 19.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.877 0.471 . . . . 0.0 110.231 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 mt -139.04 80.4 24.01 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.811 1.644 . . . . 0.0 107.034 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.62 153.86 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.669 2.912 . . . . 0.0 113.912 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 tp -46.61 -38.96 10.37 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 113.114 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -69.23 -13.14 62.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -126.98 -18.84 4.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.164 0.986 . . . . 0.0 111.989 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.55 -34.48 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.018 1.327 . . . . 0.0 112.813 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -57.11 -29.88 63.9 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.356 1.062 . . . . 0.0 112.476 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.18 -41.29 3.33 Favored 'General case' 0 C--N 1.334 -0.065 0 C-N-CA 123.374 0.67 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.12 -16.85 63.94 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.3 -35.16 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.662 1.119 . . . . 0.0 110.85 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.24 -7.15 28.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.931 0.893 . . . . 0.0 113.145 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 p -120.91 15.79 11.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.732 1.613 . . . . 0.0 110.512 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.74 -51.08 0.79 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.266 1.026 . . . . 0.0 110.733 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.21 67.51 21.34 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.726 1.21 . . . . 0.0 108.142 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.98 -28.92 75.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.331 2.021 . . . . 0.0 112.211 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.65 81.09 3.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -52.47 -26.4 12.78 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.934 1.294 . . . . 0.0 113.092 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -66.64 -24.33 66.28 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.172 0.989 . . . . 0.0 112.743 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.43 150.61 44.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.29 0.95 . . . . 0.0 109.8 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.35 137.78 54.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.546 -0.721 . . . . 0.0 110.221 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.7 131.57 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -125.34 90.94 3.32 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.7 144.46 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.08 162.22 38.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.706 1.202 . . . . 0.0 109.115 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.6 p -153.35 172.45 17.03 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.214 1.006 . . . . 0.0 109.603 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -51.28 -25.96 6.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.621 1.568 . . . . 0.0 115.232 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.77 -0.68 6.05 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 -36.64 0.96 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.594 1.569 . . . . 0.0 113.811 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -63.35 -44.3 95.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.902 1.351 . . . . 0.0 111.425 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -72.94 -29.07 62.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.098 0.408 . . . . 0.0 110.412 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -69.93 -32.41 70.67 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.945 -1.097 . . . . 0.0 109.961 168.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.38 -47.96 66.62 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.48 -41.8 98.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.261 1.03 . . . . 0.0 111.095 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.48 76.31 Favored 'General case' 0 CA--C 1.526 0.035 0 CA-C-N 118.802 0.728 . . . . 0.0 110.491 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.63 -41.43 79.47 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.95 -44.34 94.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.47 1.032 . . . . 0.0 110.53 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.5 -52.12 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.97 0.908 . . . . 0.0 109.431 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.09 -26.75 65.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.989 -0.444 . . . . 0.0 110.954 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 m -61.38 -39.39 90.5 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.551 -0.718 . . . . 0.0 110.627 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.91 -41.8 77.69 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.263 0.483 . . . . 0.0 110.424 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -74.41 -16.2 60.89 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.54 46.07 0.19 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.01 168.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.05 157.48 3.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.639 1.219 . . . . 0.0 112.752 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.9 -44.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 109.491 168.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.99 35.47 2.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.394 1.078 . . . . 0.0 111.359 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.76 135.68 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -140.22 146.86 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.385 1.074 . . . . 0.0 108.963 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -80.15 113.9 18.67 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.6 -31.34 71.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.469 0.708 . . . . 0.0 111.685 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.88 -165.39 24.27 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.9 160.41 31.1 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.3 tp -49.6 -34.08 16.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.014 1.725 . . . . 0.0 111.944 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -66.68 -9.8 39.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 112.53 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.88 -27.39 3.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.223 1.409 . . . . 0.0 112.751 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.03 89.88 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.572 1.533 . . . . 0.0 107.037 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.57 27.39 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.358 1.463 . . . . 0.0 113.15 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -73.13 156.37 89.48 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 123.51 0.724 . . . . 0.0 109.226 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.24 155.24 12.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.458 2.772 . . . . 0.0 111.643 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -132.87 154.64 50.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.036 0.534 . . . . 0.0 110.518 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -133.02 173.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.298 2.239 . . . . 0.0 105.652 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -125.41 146.04 49.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.986 -1.071 . . . . 0.0 109.217 -172.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 172.701 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.19 146.69 32.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.542 1.137 . . . . 0.0 108.797 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -140.38 169.92 16.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.534 1.134 . . . . 0.0 108.264 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -131.11 138.39 49.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -169.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.1 mm -137.84 129.75 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.71 120.61 26.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.415 HG23 ' SG ' ' A' ' 48' ' ' CYS . 29.2 m -111.97 19.42 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 118.199 0.454 . . . . 0.0 111.617 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -98.77 -177.62 3.71 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.347 -0.846 . . . . 0.0 109.601 176.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.43 154.46 54.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.16 -19.67 12.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.568 2.846 . . . . 0.0 114.899 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -47.45 -44.83 25.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -73.0 -45.86 55.46 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.747 0.703 . . . . 0.0 110.719 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -55.29 -37.15 66.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.41 1.484 . . . . 0.0 111.37 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -67.64 -16.31 64.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.73 1.212 . . . . 0.0 113.119 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -92.51 -59.74 2.0 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -159.95 158.85 31.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.363 1.465 . . . . 0.0 107.755 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -140.19 154.36 46.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.38 141.31 13.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.49 121.56 4.61 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.385 1.074 . . . . 0.0 110.132 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.26 2.91 68.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.536 -1.147 . . . . 0.0 114.14 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 154.51 35.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.505 1.652 . . . . 0.0 110.964 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.02 127.93 73.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.39 114.36 9.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.754 0.706 . . . . 0.0 109.501 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -140.54 79.7 19.79 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.325 1.85 . . . . 0.0 106.508 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.54 151.24 24.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.951 3.1 . . . . 0.0 114.731 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -47.92 -38.92 17.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.881 2.072 . . . . 0.0 112.863 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -64.4 -20.45 66.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -129.71 -3.49 4.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.047 0.939 . . . . 0.0 112.045 -169.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 p -49.97 -40.98 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.476 1.111 . . . . 0.0 111.691 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -56.93 -38.01 72.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.802 0.841 . . . . 0.0 112.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -90.31 -3.76 57.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.591 0.757 . . . . 0.0 111.399 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -132.12 -26.54 1.91 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -59.56 -35.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.855 0.752 . . . . 0.0 110.739 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.12 96.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.559 0.618 . . . . 0.0 111.26 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -36.14 65.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.157 0.583 . . . . 0.0 111.143 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.19 -42.27 72.61 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.476 0.58 . . . . 0.0 111.705 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.28 82.36 13.16 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.37 1.468 . . . . 0.0 108.247 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.44 -37.78 93.19 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.014 2.476 . . . . 0.0 113.133 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -79.2 96.02 5.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -69.51 -3.28 13.98 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -7.12 25.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.732 1.213 . . . . 0.0 111.108 174.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.11 150.56 49.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.668 1.122 . . . . 0.0 109.327 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -73.88 131.81 41.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -130.48 96.31 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -74.62 134.36 42.07 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.01 146.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -146.25 163.16 36.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.003 1.321 . . . . 0.0 108.162 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' A' ' 7' ' ' VAL . 1.7 m -159.99 -178.59 7.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.801 1.641 . . . . 0.0 109.695 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -63.03 132.35 51.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 166.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.85 0.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.162 2.185 . . . . 0.0 116.413 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.03 -8.0 40.39 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.836 1.208 . . . . 0.0 114.252 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -63.06 -56.89 13.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.545 1.672 . . . . 0.0 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.74 -29.49 70.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.948 -170.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -76.19 -33.23 59.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.204 -0.935 . . . . 0.0 111.28 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.37 -47.4 75.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.32 -46.53 88.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.643 0.777 . . . . 0.0 110.533 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.3 73.96 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 121.719 -0.613 . . . . 0.0 111.058 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HE2' HG23 ' A' ' 69' ' ' VAL . 12.3 tmtt? -64.39 -44.75 90.35 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.24 -33.07 72.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.105 0.866 . . . . 0.0 111.215 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.32 -49.9 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.204 0.911 . . . . 0.0 108.938 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.88 -31.29 70.98 Favored 'General case' 0 C--O 1.231 0.123 0 O-C-N 121.54 -0.725 . . . . 0.0 111.378 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.94 -41.04 99.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.38 -35.91 80.28 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.78 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.86 -7.09 25.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.192 0.997 . . . . 0.0 112.318 171.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.51 12.42 59.64 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.155 -0.966 . . . . 0.0 113.328 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -68.35 148.07 51.23 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.068 1.434 . . . . 0.0 108.106 168.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.5 t -128.0 -10.29 5.4 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -128.51 34.27 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.31 1.044 . . . . 0.0 110.109 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG23 ' HE2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -79.1 143.06 13.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -146.94 128.74 15.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -76.75 104.56 7.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.21 66.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.589 0.755 . . . . 0.0 111.872 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.3 -166.54 24.96 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.983 0.801 . . . . 0.0 111.227 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.76 48.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.2 tp -44.94 -49.7 10.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 -25.35 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.305 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.74 -28.35 30.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.007 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.56 120.33 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.611 1.096 . . . . 0.0 108.884 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.5 55.54 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.563 1.545 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.0 mtp -134.53 156.14 79.04 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 124.792 1.237 . . . . 0.0 108.673 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.81 157.3 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.073 2.515 . . . . 0.0 111.434 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -134.69 128.97 34.05 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.09 139.58 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.65 155.78 28.82 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.993 -0.442 . . . . 0.0 110.805 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 168.504 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -160.02 161.21 33.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.171 1.388 . . . . 0.0 107.729 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -84.32 158.39 21.19 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -133.97 122.13 22.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -123.57 126.46 73.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.04 117.19 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.275 21.5 m -114.6 52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 12.9 ttt180 -141.44 -169.92 2.97 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.508 -1.37 . . . . 0.0 110.144 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 12.0 m -58.62 153.95 37.88 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.34 -22.15 15.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.157 2.572 . . . . 0.0 114.124 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.69 -25.49 64.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.101 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -78.37 -49.86 12.78 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 120.22 1.373 . . . . 0.0 109.43 169.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.55 -40.71 75.6 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.469 1.107 . . . . 0.0 111.691 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.14 -4.76 11.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.027 1.331 . . . . 0.0 113.599 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -126.27 -34.6 2.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.941 1.246 . . . . 0.0 111.912 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -163.79 145.77 9.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.852 1.206 . . . . 0.0 109.243 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -146.75 154.87 41.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.78 1.232 . . . . 0.0 107.944 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.92 131.24 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.95 -36.5 49.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -166.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.18 2.11 83.3 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.601 0.637 . . . . 0.0 113.672 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.3 157.72 37.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.255 1.026 . . . . 0.0 113.636 -169.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.3 pt -131.52 134.44 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.14 120.87 25.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.802 0.441 . . . . 0.0 109.981 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -143.72 94.46 6.0 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.69 151.24 11.01 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.053 3.168 . . . . 0.0 114.86 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.52 -50.06 33.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.962 1.305 . . . . 0.0 112.272 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -71.75 -5.65 35.58 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -124.1 -18.95 5.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.608 1.163 . . . . 0.0 111.96 -167.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.34 -31.93 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.813 1.645 . . . . 0.0 112.452 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -52.73 -40.48 63.1 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.5 1.12 . . . . 0.0 111.802 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.26 -45.97 8.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.898 0.317 . . . . 0.0 110.543 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -73.05 -20.35 61.0 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.624 -0.672 . . . . 0.0 112.207 -168.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.54 -33.6 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.391 0.996 . . . . 0.0 110.642 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.04 -17.01 61.77 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 p -116.81 -29.31 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 110.984 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.06 72.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.68 0.673 . . . . 0.0 111.271 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.52 74.34 28.44 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.894 1.677 . . . . 0.0 106.507 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.19 -29.41 39.35 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.09 1.86 . . . . 0.0 112.435 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -79.68 95.14 5.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.435 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -62.47 -10.62 12.29 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -81.99 -19.94 39.51 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.839 1.199 . . . . 0.0 111.795 173.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.49 146.21 54.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.877 0.762 . . . . 0.0 110.635 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -70.68 145.98 50.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.139 0.976 . . . . 0.0 110.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.06 141.88 40.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -117.03 144.01 45.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.787 1.235 . . . . 0.0 107.928 171.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.75 144.34 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.367 1.067 . . . . 0.0 108.762 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -157.58 149.11 21.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.406 1.483 . . . . 0.0 109.19 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 t -149.01 174.64 12.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.989 1.716 . . . . 0.0 108.427 -168.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.13 -25.07 60.96 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.604 0.761 . . . . 0.0 112.92 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.65 140.81 41.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.596 1.159 . . . . 0.0 108.836 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.97 -28.87 72.74 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.213 0.911 . . . . 0.0 113.054 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -55.55 -46.11 77.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.483 1.141 . . . . 0.0 110.035 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -71.86 -36.89 70.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.633 0.651 . . . . 0.0 110.095 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -56.9 -44.63 82.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.268 0.485 . . . . 0.0 110.038 169.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.99 -43.04 98.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.95 1.262 . . . . 0.0 111.859 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -62.08 -43.01 99.76 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 118.445 1.123 . . . . 0.0 110.509 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.36 76.79 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-N 119.008 0.822 . . . . 0.0 110.651 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -64.07 -45.83 87.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.03 -39.45 94.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.269 0.486 . . . . 0.0 111.014 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.61 -48.04 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.975 0.807 . . . . 0.0 109.621 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.02 -29.04 66.0 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.7 m -67.11 -38.52 85.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.04 0.536 . . . . 0.0 110.61 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.1 -37.74 88.46 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.147 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.23 -3.82 18.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.841 0.856 . . . . 0.0 112.708 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.29 22.91 76.97 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.217 172.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 10.9 m-85 -65.36 124.09 21.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.175 1.487 . . . . 0.0 107.728 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -27.3 67.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.311 0.644 . . . . 0.0 112.364 -169.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -139.27 107.64 5.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.7 t -141.99 144.15 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.92 125.74 25.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -71.16 109.14 5.04 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.98 -25.09 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.862 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.04 -166.61 23.63 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.21 157.55 40.95 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 168.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.44 -41.96 86.28 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.767 -0.843 . . . . 0.0 110.462 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.3 -29.78 69.46 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.281 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.36 -39.91 31.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.15 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.0 137.79 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.579 0.627 . . . . 0.0 109.631 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.2 23.73 14.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.419 1.088 . . . . 0.0 112.296 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -72.84 154.4 91.09 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.79 152.35 17.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.715 2.943 . . . . 0.0 112.137 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -140.17 152.92 46.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.688 0.795 . . . . 0.0 109.448 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.3 158.17 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.337 1.855 . . . . 0.0 107.242 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.69 154.14 38.57 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.668 -0.645 . . . . 0.0 110.251 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 171.134 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -140.77 148.75 41.14 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.526 1.131 . . . . 0.0 108.382 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -137.3 156.66 47.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.257 1.823 . . . . 0.0 106.773 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -128.94 139.21 52.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.4 mm -130.93 121.18 49.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -81.3 110.42 16.74 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 166.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 m -99.11 21.46 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -111.26 -172.25 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.004 -1.06 . . . . 0.0 110.381 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.75 152.59 95.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.105 0.562 . . . . 0.0 110.181 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.72 -19.63 11.05 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.625 2.883 . . . . 0.0 114.836 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.43 -28.82 67.29 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.286 -0.864 . . . . 0.0 112.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -77.41 -46.43 22.72 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.841 1.2 . . . . 0.0 109.39 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -56.43 -40.82 75.38 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.858 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -62.4 -46.99 86.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.1 0.96 . . . . 0.0 111.381 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.51 -48.23 17.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.58 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.02 142.51 7.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.125 0.875 . . . . 0.0 110.185 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -135.38 155.32 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.917 1.287 . . . . 0.0 108.198 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.68 130.18 20.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.39 114.74 3.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.58 -12.97 18.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.888 1.232 . . . . 0.0 111.942 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 164.0 24.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.307 1.054 . . . . 0.0 111.751 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.6 pt -138.84 140.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 126.53 1.932 . . . . 0.0 106.921 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.09 114.18 18.8 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.62 83.77 16.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.49 153.55 13.57 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.034 3.156 . . . . 0.0 113.378 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.9 tp -50.41 -35.6 29.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.213 1.405 . . . . 0.0 112.555 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -66.47 -15.43 63.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.672 0.789 . . . . 0.0 113.021 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -129.01 -18.44 3.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.279 1.031 . . . . 0.0 112.111 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.52 -34.05 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.014 1.326 . . . . 0.0 111.969 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.63 -11.69 46.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.125 0.97 . . . . 0.0 113.384 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -122.06 -53.42 1.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.093 0.957 . . . . 0.0 108.481 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.51 -23.19 67.29 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -56.01 -36.35 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.453 1.024 . . . . 0.0 110.884 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.68 51.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.775 0.83 . . . . 0.0 112.802 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -119.95 12.31 11.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.866 1.666 . . . . 0.0 110.813 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.08 -38.14 1.44 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.618 1.167 . . . . 0.0 111.433 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.94 71.99 48.25 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.54 -29.36 52.82 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.506 2.137 . . . . 0.0 112.607 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -78.58 96.78 5.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.65 -11.01 21.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -76.86 -17.49 58.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.258 0.935 . . . . 0.0 111.879 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.1 157.79 36.92 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.773 0.715 . . . . 0.0 111.826 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -73.79 133.67 43.29 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.76 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.78 96.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -79.01 132.28 36.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.12 135.27 64.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 123.735 0.814 . . . . 0.0 109.57 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.91 162.22 39.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.851 1.66 . . . . 0.0 108.736 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -154.64 165.81 35.36 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.399 1.48 . . . . 0.0 107.594 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -54.57 -31.98 57.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 113.009 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.87 -15.89 43.09 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.67 35.08 61.5 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.977 1.262 . . . . 0.0 112.752 -170.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -144.15 -53.87 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.666 1.186 . . . . 0.0 109.919 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.76 -27.89 68.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.27 0.628 . . . . 0.0 110.461 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -66.33 -40.06 89.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.955 1.302 . . . . 0.0 112.519 170.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.68 96.13 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -64.02 -47.12 81.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.971 0.885 . . . . 0.0 110.399 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.94 72.68 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 122.203 -0.311 . . . . 0.0 110.986 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -62.81 -45.45 92.59 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -64.05 -40.18 95.73 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.852 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.32 -53.18 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 118.947 0.794 . . . . 0.0 109.235 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.3 mt -69.31 -29.14 66.93 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.961 -0.462 . . . . 0.0 110.93 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -65.52 -40.57 93.13 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.241 0.473 . . . . 0.0 110.697 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.07 -36.67 84.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.884 0.766 . . . . 0.0 110.094 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -71.94 -3.25 21.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.04 0.936 . . . . 0.0 112.712 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 16.92 72.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.56 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -67.12 127.41 32.5 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 p -86.5 -21.83 26.75 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -131.49 35.99 3.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.763 0.825 . . . . 0.0 111.197 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.44 146.3 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.15 125.68 15.8 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -75.13 97.99 3.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.09 72.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.033 0.533 . . . . 0.0 110.679 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 -115.07 0.94 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.09 172.69 25.14 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.22 -34.46 77.69 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.002 0.521 . . . . 0.0 111.297 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.35 -36.03 80.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.823 0.449 . . . . 0.0 110.537 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.48 -41.98 31.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.509 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.91 142.91 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.859 0.754 . . . . 0.0 109.686 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.89 24.53 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.828 1.251 . . . . 0.0 111.923 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.39 165.37 49.19 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.495 1.118 . . . . 0.0 108.85 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -52.49 149.29 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.844 2.363 . . . . 0.0 111.359 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.97 148.94 45.7 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.55 149.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.42 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.1 165.02 22.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.661 0.384 . . . . 0.0 110.94 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.785 1.183 . . . . 0.0 110.625 173.355 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -139.21 158.91 43.33 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.826 0.85 . . . . 0.0 110.036 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -140.33 161.75 36.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.849 2.06 . . . . 0.0 106.98 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -119.15 143.34 47.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -138.62 131.68 39.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.46 125.09 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.03 14.32 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -91.9 -169.18 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.397 1.453 . . . . 0.0 109.695 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -57.91 150.4 49.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.089 0.555 . . . . 0.0 109.637 167.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.47 -19.22 67.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.306 2.004 . . . . 0.0 112.624 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.08 -24.89 67.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.919 -1.113 . . . . 0.0 112.145 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -68.61 -41.18 79.92 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.517 1.053 . . . . 0.0 109.913 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -59.85 -37.34 79.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.736 1.615 . . . . 0.0 110.269 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.01 -43.49 81.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.515 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -66.39 -58.2 5.79 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -174.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -167.02 151.27 6.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.959 1.704 . . . . 0.0 107.114 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -138.53 153.61 48.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.61 126.92 12.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 96.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.51 -18.71 4.1 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.82 1.2 . . . . 0.0 111.63 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.42 162.8 25.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.146 0.973 . . . . 0.0 110.202 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -135.66 147.16 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.787 1.635 . . . . 0.0 106.831 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -80.87 116.55 20.91 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -136.92 81.52 33.36 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.48 150.45 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.5 2.8 . . . . 0.0 114.078 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -47.49 -41.54 20.99 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.671 1.989 . . . . 0.0 111.933 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.97 -15.77 57.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -129.55 -13.36 4.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.471 1.108 . . . . 0.0 112.053 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.15 -35.04 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.966 1.306 . . . . 0.0 111.735 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -56.6 -34.5 67.26 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.744 0.818 . . . . 0.0 112.234 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.4 -47.09 4.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -65.57 -22.2 66.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.673 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.66 -32.79 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.658 1.117 . . . . 0.0 111.267 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.74 60.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 112.899 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -111.39 -28.72 8.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.661 1.184 . . . . 0.0 111.01 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.55 -43.78 68.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.817 0.735 . . . . 0.0 111.546 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.94 77.11 18.89 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.036 1.334 . . . . 0.0 107.403 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.44 -36.03 93.26 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.102 2.535 . . . . 0.0 114.368 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -77.55 98.66 5.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.212 0.605 . . . . 0.0 109.484 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.15 -6.65 18.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -85.45 -14.74 45.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.184 0.902 . . . . 0.0 111.929 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.913 0.885 . . . . 0.0 110.427 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -77.98 96.44 5.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.968 0.907 . . . . 0.0 110.17 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.51 93.28 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -73.36 129.74 38.65 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -115.18 143.31 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -142.13 168.12 20.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.216 1.006 . . . . 0.0 108.355 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.3 p -153.19 178.3 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -60.31 -25.43 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.76 5.76 4.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -29.67 2.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.987 1.279 . . . . 0.0 114.532 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.5 -51.95 67.28 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.535 1.168 . . . . 0.0 111.481 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -69.01 -33.83 74.29 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.889 -171.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -68.28 -34.93 77.06 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.156 0.889 . . . . 0.0 110.974 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.3 -50.92 57.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -62.93 -46.28 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.388 0.594 . . . . 0.0 110.864 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.51 -34.38 70.88 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 110.581 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.5 94.32 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.52 -43.24 77.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.287 0.494 . . . . 0.0 110.301 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -56.93 -49.16 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.474 0.71 . . . . 0.0 109.302 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.34 -30.67 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.709 0.804 . . . . 0.0 111.313 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 m -69.81 -37.51 76.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.682 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.72 -36.66 84.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.98 0.809 . . . . 0.0 110.162 174.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mmm -69.48 -3.78 15.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.34 1.056 . . . . 0.0 112.702 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.54 78.99 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.531 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -64.54 123.56 19.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.909 1.354 . . . . 0.0 107.599 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -29.78 69.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.157 0.583 . . . . 0.0 112.362 -169.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.01 111.81 7.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -146.7 149.57 15.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.76 128.39 9.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -80.19 113.38 18.32 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.3 69.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.95 -26.23 7.6 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.368 0.985 . . . . 0.0 112.335 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.96 167.79 16.04 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.89 1.233 . . . . 0.0 110.324 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.9 tp -54.77 -33.15 60.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.129 0.972 . . . . 0.0 112.313 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.12 -29.04 69.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.599 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.79 -40.83 54.43 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.48 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -53.27 117.24 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 123.441 0.697 . . . . 0.0 111.359 -168.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 50.67 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.353 1.461 . . . . 0.0 109.72 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.1 mmm -133.42 154.48 80.92 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.477 1.511 . . . . 0.0 108.143 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.72 145.94 29.15 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.684 2.256 . . . . 0.0 110.677 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.08 147.56 33.95 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.66 154.6 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.984 0.914 . . . . 0.0 108.835 -167.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -63.46 150.19 44.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.85 0.46 . . . . 0.0 110.08 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 173.861 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -138.67 158.0 45.06 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 109.528 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -148.41 126.71 12.23 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -76.14 143.67 41.04 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -140.36 128.95 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.97 124.95 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.05 16.35 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -89.46 -176.17 4.95 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.757 -1.214 . . . . 0.0 108.636 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 m -63.9 154.34 81.64 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 121.813 -0.554 . . . . 0.0 109.51 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.3 -12.99 35.59 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.314 2.676 . . . . 0.0 114.25 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.05 -37.83 69.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.824 0.849 . . . . 0.0 111.573 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.67 -43.29 84.91 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.854 0.752 . . . . 0.0 110.128 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -57.74 -30.5 65.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.955 1.302 . . . . 0.0 111.269 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -65.87 -50.79 63.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.305 0.642 . . . . 0.0 110.856 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.97 -49.88 40.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.868 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.85 150.81 13.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.824 0.738 . . . . 0.0 110.49 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -139.07 156.03 47.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.947 1.299 . . . . 0.0 108.289 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.75 130.85 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.69 105.97 0.73 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.67 -13.48 9.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.045 1.307 . . . . 0.0 112.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.08 155.05 41.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.342 1.071 . . . . 0.0 110.191 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mm -120.09 135.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.98 116.15 16.39 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.54 81.06 17.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.611 . . . . 0.0 106.77 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.4 151.4 23.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.778 2.985 . . . . 0.0 114.31 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.8 tp -48.6 -41.66 31.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.29 1.836 . . . . 0.0 113.001 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.75 -12.0 61.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -126.15 -15.28 5.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.938 1.295 . . . . 0.0 112.051 -169.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.06 -39.79 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.769 1.627 . . . . 0.0 113.252 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -55.26 -40.93 71.52 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.575 0.75 . . . . 0.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -91.07 -2.4 57.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.219 0.607 . . . . 0.0 111.272 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.32 -15.32 1.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.79 -40.37 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.052 1.296 . . . . 0.0 111.262 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.22 -32.55 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.405 0.548 . . . . 0.0 112.13 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -10.3 58.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.909 0.883 . . . . 0.0 113.175 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 -30.4 4.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.356 0.98 . . . . 0.0 111.992 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.42 79.69 41.37 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.571 1.149 . . . . 0.0 107.994 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.98 -37.75 91.73 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.415 2.077 . . . . 0.0 112.131 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -77.51 96.76 4.81 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.134 0.974 . . . . 0.0 109.841 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.37 8.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -107.8 -6.99 16.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.671 1.188 . . . . 0.0 111.769 170.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.39 145.34 52.95 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 m -80.14 97.36 6.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 109.676 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -72.03 104.7 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -83.16 84.65 7.4 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 m -69.34 140.17 19.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -145.12 164.04 32.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.178 0.991 . . . . 0.0 108.936 171.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.02 171.25 18.66 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.281 1.432 . . . . 0.0 107.717 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -49.94 -33.22 16.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.02 -6.73 10.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.12 -31.44 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.792 1.178 . . . . 0.0 113.949 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.78 -56.48 21.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.852 1.326 . . . . 0.0 111.303 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.03 -32.4 74.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.674 0.39 . . . . 0.0 110.824 -169.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 p -71.66 -35.53 70.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.339 0.972 . . . . 0.0 111.405 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.27 -48.52 59.27 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.94 -48.4 76.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.671 0.788 . . . . 0.0 110.576 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.95 69.2 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.891 -0.506 . . . . 0.0 111.814 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -60.83 -45.0 96.18 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.92 -41.59 91.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.142 0.428 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.88 -50.53 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.6 mt -70.31 -29.01 65.64 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.554 -0.717 . . . . 0.0 111.395 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.386 0.539 . . . . 0.0 109.953 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.95 -35.78 78.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.282 0.633 . . . . 0.0 110.968 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.5 mmm -64.98 -15.48 62.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.851 0.86 . . . . 0.0 112.118 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.37 14.43 55.74 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.074 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -66.25 121.67 15.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.235 1.517 . . . . 0.0 107.37 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.5 p -75.08 -23.81 58.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.497 0.319 . . . . 0.0 111.522 -171.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -134.98 104.81 6.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.819 1.248 . . . . 0.0 107.67 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -142.16 143.33 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.39 127.17 17.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.14 111.98 9.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 166.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.55 66.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.29 -26.84 10.69 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 125.026 1.298 . . . . 0.0 110.765 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.3 174.68 13.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 124.524 1.059 . . . . 0.0 111.481 168.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 tp -60.45 -30.33 69.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 110.067 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -61.55 -18.82 60.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.748 1.619 . . . . 0.0 113.271 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -118.12 -36.93 3.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.027 0.83 . . . . 0.0 112.021 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 80' ' ' MET . 82.4 mt -57.52 141.2 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.029 0.831 . . . . 0.0 109.538 174.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.88 24.5 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.011 1.324 . . . . 0.0 111.959 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.419 ' H ' HG22 ' A' ' 78' ' ' ILE . 93.2 mmm -69.52 164.16 52.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.506 1.123 . . . . 0.0 108.596 167.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.77 147.78 30.71 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.612 2.208 . . . . 0.0 110.904 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -134.78 142.86 46.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.27 149.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.131 1.372 . . . . 0.0 108.486 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -69.08 162.19 27.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.769 0.428 . . . . 0.0 111.093 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 124.883 1.23 . . . . 0.0 110.611 172.725 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.204 0.526 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.22 162.22 36.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.012 1.725 . . . . 0.0 108.785 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -82.69 100.66 10.36 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -73.01 145.45 46.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.9 mt -147.16 139.26 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -96.93 124.97 41.05 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.45 12.74 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.77 -174.34 4.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.172 1.351 . . . . 0.0 108.159 167.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 9' ' ' VAL . 1.6 m -57.29 156.04 16.38 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.656 0.782 . . . . 0.0 110.358 167.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.48 -14.35 43.83 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.081 2.521 . . . . 0.0 113.511 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -46.15 -49.44 16.79 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 110.82 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -69.75 -37.81 76.59 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.308 -0.245 . . . . 0.0 110.383 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -58.46 -31.22 67.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.119 1.368 . . . . 0.0 111.314 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -67.12 -39.67 86.7 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.23 0.468 . . . . 0.0 110.73 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -68.73 -54.21 17.46 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.27 152.53 4.99 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.015 1.726 . . . . 0.0 106.907 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.65 147.98 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 108.952 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.6 t -54.09 125.77 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -56.34 -24.11 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -166.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.59 -8.07 41.05 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.885 0.755 . . . . 0.0 112.764 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.81 170.3 15.61 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.223 1.011 . . . . 0.0 111.094 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.6 pt -142.95 138.92 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.661 2.384 . . . . 0.0 105.213 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.38 116.43 18.79 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.3 mt -140.67 86.98 11.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.95 153.47 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.638 2.892 . . . . 0.0 113.9 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.7 tp -51.21 -35.81 38.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.065 1.746 . . . . 0.0 112.943 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.22 -16.49 63.59 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.501 0.721 . . . . 0.0 112.775 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.76 -22.26 3.59 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.553 1.141 . . . . 0.0 111.911 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -47.42 -37.19 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.641 1.576 . . . . 0.0 112.377 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.75 -33.12 60.79 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.416 1.086 . . . . 0.0 112.301 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.52 -45.24 4.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.0 0.52 . . . . 0.0 109.951 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.91 -19.64 65.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.311 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -54.97 -34.99 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.104 0.866 . . . . 0.0 111.133 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.16 96.64 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.19 0.904 . . . . 0.0 111.273 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -37.04 45.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.463 0.705 . . . . 0.0 111.133 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.7 72.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.369 0.531 . . . . 0.0 112.057 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -139.55 79.42 24.53 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.771 1.628 . . . . 0.0 107.179 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.91 10.68 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.766 2.978 . . . . 0.0 114.502 -171.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -138.21 107.88 6.24 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.272 1.429 . . . . 0.0 107.163 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -63.25 -15.08 55.99 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.64 -15.51 58.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.73 0.695 . . . . 0.0 111.957 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -67.94 150.19 48.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.027 0.83 . . . . 0.0 110.672 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -70.24 141.87 52.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.969 0.907 . . . . 0.0 109.674 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.85 145.33 31.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -130.72 135.33 47.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.92 137.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -136.68 168.57 19.27 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 p -152.55 -175.89 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 170.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -59.18 -29.55 67.54 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.65 10.33 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -168.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.52 -29.36 2.29 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.795 1.188 . . . . 0.0 114.304 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -62.34 -50.85 69.99 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.374 1.087 . . . . 0.0 111.418 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -69.49 -31.97 70.57 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.537 0.608 . . . . 0.0 110.569 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -36.22 82.45 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 119.381 0.991 . . . . 0.0 110.734 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.24 -52.0 50.33 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -62.4 -46.24 89.48 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.486 -0.42 . . . . 0.0 111.176 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.32 74.84 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 118.222 0.465 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -63.05 -43.45 98.62 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.98 -44.78 91.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.662 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.56 -52.51 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.976 0.807 . . . . 0.0 109.072 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.15 -28.4 64.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.987 -0.446 . . . . 0.0 111.221 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.0 m -65.23 -42.16 93.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.353 0.524 . . . . 0.0 110.397 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.12 -33.92 76.49 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.879 0.763 . . . . 0.0 110.91 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -69.46 -8.75 49.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.845 0.858 . . . . 0.0 112.303 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.97 60.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.972 -0.904 . . . . 0.0 113.467 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.98 120.81 19.12 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -84.6 -17.22 39.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -167.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -133.24 38.77 3.3 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.873 0.869 . . . . 0.0 111.037 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -80.6 145.81 8.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -140.91 137.91 33.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.715 0.806 . . . . 0.0 109.139 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -72.32 106.73 4.59 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.89 79.18 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.39 -148.22 19.83 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.73 167.26 13.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.35 -34.17 66.36 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.533 1.133 . . . . 0.0 112.552 -170.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.36 -11.44 57.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.114 0.966 . . . . 0.0 113.168 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -117.1 -34.87 4.24 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.796 1.238 . . . . 0.0 111.982 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.4 127.14 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.23 24.31 8.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.484 1.113 . . . . 0.0 111.869 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.1 165.36 48.56 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 167.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.31 149.9 21.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.484 2.122 . . . . 0.0 111.688 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -131.91 158.47 41.31 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.878 0.871 . . . . 0.0 109.118 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -128.72 169.05 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -131.68 167.77 18.89 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.949 -1.094 . . . . 0.0 109.685 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 173.562 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.83 153.75 43.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.685 1.594 . . . . 0.0 106.797 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.55 152.27 43.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.442 1.497 . . . . 0.0 107.806 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -130.04 136.13 49.03 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.591 1.156 . . . . 0.0 108.78 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.96 131.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.21 117.05 23.27 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.84 23.12 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 5.6 ttt180 -111.24 -175.5 2.72 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.8 -1.188 . . . . 0.0 110.74 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 2.7 m -60.64 150.41 75.4 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.875 0.87 . . . . 0.0 109.971 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -53.81 -23.98 29.09 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.573 2.849 . . . . 0.0 115.118 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.92 -26.35 68.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 117.428 -1.272 . . . . 0.0 113.283 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.01 -50.82 45.39 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 120.818 1.645 . . . . 0.0 109.5 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -55.91 -37.28 68.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.164 1.386 . . . . 0.0 111.373 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -61.77 -11.05 10.48 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.379 1.471 . . . . 0.0 113.985 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.16 -38.76 1.77 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.513 1.506 . . . . 0.0 112.153 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -156.48 145.32 20.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.042 1.292 . . . . 0.0 110.754 168.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -142.06 154.77 45.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 107.49 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.21 132.61 20.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -55.88 120.45 7.4 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.27 -13.51 61.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.298 0.951 . . . . 0.0 112.984 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.02 161.17 30.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.474 1.137 . . . . 0.0 111.067 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.58 137.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.9 1.68 . . . . 0.0 107.338 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.27 117.15 19.25 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -143.2 87.93 8.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -54.12 155.6 15.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.1 3.2 . . . . 0.0 114.382 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 tp -48.49 -41.93 31.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.2 1.8 . . . . 0.0 112.979 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.18 -8.38 54.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.5 -17.1 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.104 1.362 . . . . 0.0 111.829 -169.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.29 -30.42 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.314 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.6 -47.66 73.12 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.732 1.213 . . . . 0.0 111.623 -169.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -88.95 -41.82 12.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.93 0.332 . . . . 0.0 110.241 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -70.28 -15.36 62.89 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.59 -33.22 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.071 0.85 . . . . 0.0 110.851 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.11 -40.69 98.35 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.42 1.009 . . . . 0.0 111.043 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.28 -36.73 66.37 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.26 0.624 . . . . 0.0 111.168 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.43 72.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.478 0.581 . . . . 0.0 111.968 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.08 83.66 11.0 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.719 1.607 . . . . 0.0 107.425 -171.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.6 -38.12 96.17 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.875 2.383 . . . . 0.0 113.845 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -85.37 99.96 11.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.224 0.609 . . . . 0.0 109.677 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 48.6 pttt -62.81 -15.32 53.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -82.86 -11.9 57.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.024 0.829 . . . . 0.0 111.912 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.07 155.48 40.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.878 0.763 . . . . 0.0 111.191 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 140.01 54.25 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.38 140.5 43.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -123.75 147.46 28.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -150.07 164.72 34.82 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.894 1.677 . . . . 0.0 107.231 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -161.09 157.19 25.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.572 0.349 . . . . 0.0 110.167 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.93 -23.62 19.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.13 0.972 . . . . 0.0 112.72 168.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.06 105.12 7.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 170.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.99 -23.77 57.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.622 1.106 . . . . 0.0 114.215 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -57.6 -36.9 72.36 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.433 1.116 . . . . 0.0 111.778 171.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.53 -37.67 71.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.567 0.747 . . . . 0.0 110.685 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p -68.24 -26.99 65.97 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 110.824 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.36 -46.24 93.25 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -61.02 -48.7 80.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.865 0.833 . . . . 0.0 110.242 175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.14 77.13 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.819 0.282 . . . . 0.0 110.706 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.77 -39.57 92.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.42 -35.32 73.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.174 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.05 -47.99 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.749 1.159 . . . . 0.0 108.786 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.68 -33.82 76.49 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.668 -0.645 . . . . 0.0 110.861 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 m -65.56 -39.21 91.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.828 0.451 . . . . 0.0 110.656 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.12 -36.22 82.56 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.504 0.721 . . . . 0.0 110.241 175.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mmm -69.17 -3.92 15.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.189 0.995 . . . . 0.0 112.595 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.4 14.75 65.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.359 170.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 20.9 m-85 -70.0 129.14 38.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.936 1.368 . . . . 0.0 107.552 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -91.59 -18.74 23.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -167.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.88 40.47 3.36 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.323 1.049 . . . . 0.0 110.387 -169.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.78 149.45 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -143.93 142.06 30.56 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -86.33 106.8 17.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.75 66.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.872 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.53 -165.64 14.47 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.968 0.794 . . . . 0.0 112.238 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.48 151.7 52.33 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.92 30.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.255 1.822 . . . . 0.0 113.134 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -64.14 -33.19 75.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.607 0.763 . . . . 0.0 111.825 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.41 -30.03 64.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.371 0.532 . . . . 0.0 111.705 -172.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.76 91.28 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 26.43 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.851 1.261 . . . . 0.0 113.507 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.8 mtp -77.64 158.89 77.91 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.42 153.97 12.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.582 2.855 . . . . 0.0 111.703 167.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -138.97 153.9 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 108.864 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.7 p -151.84 156.69 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -68.16 152.17 45.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.796 0.839 . . . . 0.0 109.134 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.074 174.725 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.086 0.47 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.21 164.16 37.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.851 1.66 . . . . 0.0 108.075 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -77.17 151.67 35.17 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -126.23 135.32 51.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -136.68 125.63 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.67 120.99 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.3 21.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.7 -173.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.943 -1.098 . . . . 0.0 110.216 173.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.84 152.06 77.46 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.03 -13.4 35.03 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.626 2.217 . . . . 0.0 113.371 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -55.22 -39.09 69.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.284 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -66.29 -47.85 72.31 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 120.405 1.457 . . . . 0.0 109.909 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -56.46 -37.31 70.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.948 1.299 . . . . 0.0 111.293 -172.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -58.87 -52.99 63.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.2 1.8 . . . . 0.0 110.949 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -72.32 -49.1 37.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.265 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.05 151.46 14.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.331 0.968 . . . . 0.0 111.029 167.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -139.03 153.06 48.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 170.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.44 128.4 15.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.92 106.85 1.32 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -17.69 7.49 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.933 1.254 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.18 164.75 25.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.777 0.788 . . . . 0.0 110.71 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 pt -139.88 139.0 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.263 1.825 . . . . 0.0 106.939 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -77.38 115.8 17.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.872 0.469 . . . . 0.0 109.941 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -141.2 84.09 13.13 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.11 150.73 18.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.999 3.133 . . . . 0.0 113.806 -171.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.82 -41.01 22.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.159 1.784 . . . . 0.0 112.58 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.06 -14.68 61.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.432 0.693 . . . . 0.0 112.832 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.15 -7.82 3.84 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.328 1.051 . . . . 0.0 112.369 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.8 -38.62 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.098 1.317 . . . . 0.0 110.695 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.2 -26.36 64.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.694 1.197 . . . . 0.0 112.669 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -105.48 -2.24 23.92 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.378 1.071 . . . . 0.0 111.385 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -131.48 -23.58 2.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -168.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tp -57.94 -33.94 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.355 0.979 . . . . 0.0 110.576 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -16.62 52.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 113.357 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -114.96 -28.63 6.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.657 1.183 . . . . 0.0 111.028 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.03 -38.67 72.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.733 0.697 . . . . 0.0 111.459 173.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -140.37 72.83 31.4 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.094 1.758 . . . . 0.0 107.289 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.0 -37.96 93.86 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.812 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.94 88.88 5.88 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.288 0.635 . . . . 0.0 109.84 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -65.37 -4.95 6.23 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.84 -18.69 58.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.408 1.003 . . . . 0.0 111.486 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.96 152.29 41.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.154 -0.966 . . . . 0.0 110.327 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -71.51 149.57 45.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.0 146.81 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -129.22 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.89 148.6 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -174.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -150.83 166.72 29.65 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.775 1.63 . . . . 0.0 107.379 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.0 p -161.34 172.55 16.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.563 0.745 . . . . 0.0 109.623 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.96 -52.52 62.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.7 1.2 . . . . 0.0 112.192 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.28 -35.52 61.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.337 0.255 . . . . 0.0 111.389 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.43 8.91 55.89 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.034 -0.87 . . . . 0.0 113.498 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -124.08 -23.68 4.53 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.117 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.46 -33.59 71.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.762 1.619 . . . . 0.0 110.031 169.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 p -65.99 -37.88 87.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.703 0.801 . . . . 0.0 111.587 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.41 -47.88 73.2 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 169.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -61.91 -50.97 70.03 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.872 0.869 . . . . 0.0 109.992 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.07 79.27 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.05 0.54 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -61.45 -39.76 92.01 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -35.09 69.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.068 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.19 -49.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.604 1.093 . . . . 0.0 108.648 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -66.16 -34.71 78.66 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.907 -0.495 . . . . 0.0 110.5 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -64.3 -41.56 96.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 110.746 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.12 -37.13 86.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.322 0.649 . . . . 0.0 110.195 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mtp -71.39 -3.05 18.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 112.792 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.89 16.01 68.81 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.458 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.2 124.97 22.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.217 1.509 . . . . 0.0 107.177 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.7 p -68.81 -29.05 67.31 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -166.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -150.09 106.87 3.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -173.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.22 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.19 145.94 32.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.472 0.709 . . . . 0.0 109.123 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -90.4 114.27 26.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.87 69.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.669 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.48 -158.27 14.56 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.615 1.102 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.09 162.32 35.91 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.737 0.684 . . . . 0.0 111.72 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -30.22 64.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.347 1.059 . . . . 0.0 112.869 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.66 -27.76 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.475 -0.766 . . . . 0.0 111.939 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.03 -44.73 62.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.841 0.746 . . . . 0.0 112.971 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.1 mp -55.85 119.59 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.346 0.658 . . . . 0.0 110.276 -169.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.56 52.75 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.294 1.438 . . . . 0.0 110.669 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -136.69 154.74 76.75 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.295 1.438 . . . . 0.0 109.169 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.89 155.7 10.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.644 2.896 . . . . 0.0 112.096 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -138.97 146.1 40.55 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.16 152.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.908 1.283 . . . . 0.0 108.566 -169.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.37 161.73 26.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.05 0.54 . . . . 0.0 110.149 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 124.596 1.094 . . . . 0.0 110.887 170.595 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.91 146.97 31.28 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.214 1.006 . . . . 0.0 109.242 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -140.28 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.011 1.324 . . . . 0.0 107.701 168.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -134.43 137.91 44.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.3 133.19 58.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.28 134.21 38.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.84 33.67 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.442 1.019 . . . . 0.0 113.569 -168.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -125.15 -179.21 4.48 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.659 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.07 160.97 80.81 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.559 1.144 . . . . 0.0 111.005 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.7 -16.78 11.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.273 3.315 . . . . 0.0 116.108 175.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -50.89 -37.86 46.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.756 1.223 . . . . 0.0 112.296 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.25 -45.16 15.39 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -56.69 -37.09 70.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.919 1.288 . . . . 0.0 111.424 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -67.81 -5.36 16.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.056 1.343 . . . . 0.0 114.095 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -131.76 -33.82 1.37 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.782 1.174 . . . . 0.0 112.147 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.24 139.96 8.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.731 1.151 . . . . 0.0 108.819 166.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -142.6 148.81 38.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 166.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.57 132.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 -35.48 80.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.874 0.47 . . . . 0.0 111.124 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 -4.16 90.47 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.3 -0.722 . . . . 0.0 113.06 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.01 166.86 23.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.515 1.157 . . . . 0.0 111.075 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.6 pt -135.75 131.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -82.89 115.43 21.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.2 81.09 38.92 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.977 1.711 . . . . 0.0 106.726 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 152.81 7.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 113.706 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.23 -44.58 8.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.953 1.701 . . . . 0.0 112.359 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -67.15 -15.69 63.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -176.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -122.0 -18.86 6.83 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.405 1.082 . . . . 0.0 111.893 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.46 -32.39 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.61 1.164 . . . . 0.0 111.457 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -64.76 -8.68 15.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.14 -48.91 1.33 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.255 0.934 . . . . 0.0 109.83 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.64 -23.53 67.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.12 -32.58 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.868 0.758 . . . . 0.0 111.32 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.53 96.67 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.253 0.933 . . . . 0.0 110.655 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.67 -35.89 67.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.4 -44.58 64.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.526 0.603 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.77 85.25 9.31 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 108.018 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.63 -29.57 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.135 1.89 . . . . 0.0 112.25 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -79.68 96.63 6.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -68.84 -7.23 32.49 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.08 -6.06 39.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.664 0.786 . . . . 0.0 110.673 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.23 151.67 47.11 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -72.4 129.74 39.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.65 95.38 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -77.26 133.82 38.74 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.84 143.61 36.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.76 0.824 . . . . 0.0 108.958 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.42 159.51 44.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 109.036 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.5 p -155.52 169.6 23.91 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.728 1.611 . . . . 0.0 107.918 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -48.24 -26.2 1.86 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.24 -1.0 8.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.99 -46.75 1.52 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.413 1.482 . . . . 0.0 112.557 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 tpt85 -59.55 -45.95 90.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.234 1.017 . . . . 0.0 112.46 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -70.43 -31.82 69.15 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.239 0.472 . . . . 0.0 110.005 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -33.68 75.85 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.97 -1.081 . . . . 0.0 110.775 168.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -46.62 85.62 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -62.46 -43.53 98.6 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.571 1.186 . . . . 0.0 110.648 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 -39.61 80.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.271 0.487 . . . . 0.0 109.734 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -66.8 -38.81 87.23 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.853 -0.53 . . . . 0.0 109.867 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.06 -45.04 95.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 110.073 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.8 mt -57.99 -50.39 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.783 0.833 . . . . 0.0 109.084 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.1 -31.56 72.11 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.826 -0.546 . . . . 0.0 111.058 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -64.4 -40.63 96.17 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.492 0.587 . . . . 0.0 110.358 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.36 -36.95 85.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.751 0.705 . . . . 0.0 110.477 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -71.26 -5.1 29.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.077 0.951 . . . . 0.0 112.834 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.65 56.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.215 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -68.89 146.01 53.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.208 1.504 . . . . 0.0 107.708 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 p -125.06 -1.19 7.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 31.58 1.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.911 0.862 . . . . 0.0 111.007 175.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.11 146.99 7.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.803 0.841 . . . . 0.0 108.975 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.12 141.85 19.98 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -84.04 110.61 18.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -30.98 72.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.316 0.247 . . . . 0.0 111.483 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.15 -163.19 29.13 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.294 1.426 . . . . 0.0 109.982 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.12 159.26 32.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 169.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.5 tp -55.69 -33.03 63.8 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.86 1.264 . . . . 0.0 112.295 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -68.48 -28.68 67.24 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.112 0.565 . . . . 0.0 111.527 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.61 -39.44 22.18 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.043 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.17 134.13 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.96 26.4 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.775 1.23 . . . . 0.0 111.531 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -66.94 159.55 75.32 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 143.19 43.71 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.915 2.41 . . . . 0.0 111.707 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.14 155.76 47.6 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.96 0.904 . . . . 0.0 109.674 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.97 160.44 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.257 1.823 . . . . 0.0 108.026 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -73.4 150.03 42.03 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 169.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.104 -1.386 . . . . 0.0 110.306 172.777 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -140.09 148.58 41.94 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 108.561 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -131.0 95.4 3.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.213 1.805 . . . . 0.0 106.313 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -77.95 136.94 38.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.99 122.53 52.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -81.45 113.68 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.5 20.7 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -110.27 -169.12 1.41 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.256 -0.902 . . . . 0.0 109.714 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.62 149.49 61.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.46 -14.44 44.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.305 2.003 . . . . 0.0 112.899 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -55.22 -38.39 68.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.753 0.821 . . . . 0.0 111.372 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -69.28 -46.27 67.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.553 1.07 . . . . 0.0 109.826 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -58.65 -34.38 71.14 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 111.473 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -62.63 -39.78 94.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.507 1.123 . . . . 0.0 110.677 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -67.95 -49.67 60.43 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.385 0.993 . . . . 0.0 108.704 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.81 152.58 4.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.334 1.853 . . . . 0.0 107.548 167.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -136.95 152.38 50.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.704 1.201 . . . . 0.0 108.577 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.77 126.51 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -55.92 121.71 9.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.112 0.565 . . . . 0.0 109.682 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.67 70.64 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.222 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.25 163.14 13.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.79 1.295 . . . . 0.0 111.549 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.2 138.99 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.276 1.43 . . . . 0.0 108.394 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.82 114.86 18.11 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.037 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.72 80.94 20.45 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.639 1.575 . . . . 0.0 107.095 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.81 154.34 12.91 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.725 2.95 . . . . 0.0 113.819 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.4 tp -47.46 -36.19 9.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 113.039 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.77 -17.94 65.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.809 0.844 . . . . 0.0 113.116 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -127.75 -17.43 4.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.983 0.913 . . . . 0.0 112.174 -169.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.41 -33.03 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.119 1.368 . . . . 0.0 112.686 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.05 -25.0 65.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 112.877 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.21 -41.34 2.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.667 0.667 . . . . 0.0 110.392 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -63.53 -17.47 62.82 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.02 -37.24 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.24 0.927 . . . . 0.0 111.22 171.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.7 90.26 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.972 0.805 . . . . 0.0 111.528 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -79.41 -38.25 35.27 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.082 0.553 . . . . 0.0 110.352 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.71 78.98 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.961 0.504 . . . . 0.0 112.211 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 83.28 21.58 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.81 1.244 . . . . 0.0 107.962 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.86 -21.18 32.05 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.63 2.887 . . . . 0.0 115.129 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -131.63 95.57 3.76 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.549 1.14 . . . . 0.0 108.674 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -65.82 -5.52 9.22 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.496 1.119 . . . . 0.0 113.251 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -71.13 -21.43 62.2 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.113 0.87 . . . . 0.0 111.09 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 147.73 52.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -62.91 127.43 31.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.233 0.47 . . . . 0.0 109.765 -172.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.06 134.99 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.14 103.28 6.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.43 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.33 158.55 43.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.531 1.533 . . . . 0.0 108.562 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.5 p -144.22 -175.52 4.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.105 1.362 . . . . 0.0 107.667 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -56.76 -32.13 65.3 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.8 7.36 4.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -167.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.13 2.28 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.74 1.162 . . . . 0.0 113.416 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -59.51 -48.13 82.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.372 1.086 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.78 -24.91 58.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.052 0.842 . . . . 0.0 111.514 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -33.1 67.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 120.973 -1.08 . . . . 0.0 110.16 168.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -47.09 84.15 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.25 -45.17 95.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.166 0.983 . . . . 0.0 110.459 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.09 74.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.103 0.411 . . . . 0.0 110.797 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.84 -44.28 77.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.198 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.66 -39.5 88.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.274 1.397 . . . . 0.0 110.58 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.73 -51.18 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.866 0.866 . . . . 0.0 109.557 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.89 -34.2 76.19 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.894 -0.504 . . . . 0.0 111.147 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 19.7 m -66.09 -35.88 81.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.636 0.775 . . . . 0.0 110.0 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.85 -47.69 65.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.759 0.424 . . . . 0.0 110.152 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -68.65 -35.94 77.91 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.713 -0.661 . . . . 0.0 112.174 -170.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.88 45.18 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 CA-C-O 119.021 -0.877 . . . . 0.0 114.177 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.3 OUTLIER -55.48 159.48 2.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.661 1.23 . . . . 0.0 112.742 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.5 p -137.95 -37.01 0.6 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.893 0.877 . . . . 0.0 110.942 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -142.67 34.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.364 0.983 . . . . 0.0 111.523 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.82 141.02 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.34 144.85 38.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.601 1.561 . . . . 0.0 107.316 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -87.06 105.64 17.3 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.13 75.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.444 0.298 . . . . 0.0 111.275 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.87 -136.27 5.78 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.14 170.76 20.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 169.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.93 -39.92 91.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.728 0.811 . . . . 0.0 109.915 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -67.95 -3.69 10.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.919 1.287 . . . . 0.0 113.669 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.37 -37.33 2.03 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.289 0.949 . . . . 0.0 112.245 -169.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 mt -58.96 144.3 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.602 1.092 . . . . 0.0 110.519 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 75.42 1.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.751 1.62 . . . . 0.0 107.775 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.2 mtp -140.21 162.86 47.65 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 126.68 1.992 . . . . 0.0 107.669 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.03 143.48 40.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.965 2.444 . . . . 0.0 111.653 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -138.52 147.44 43.13 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.05 154.29 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.253 1.421 . . . . 0.0 108.408 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.6 155.92 39.53 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.006 -0.434 . . . . 0.0 110.576 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.2 145.92 36.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.623 1.169 . . . . 0.0 108.233 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -135.26 107.61 7.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -73.57 149.1 42.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mm -138.12 131.59 41.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.87 94.49 8.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.85 35.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -166.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.37 -179.78 6.88 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.465 -1.397 . . . . 0.0 108.635 -172.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -53.4 146.72 22.17 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.406 0.548 . . . . 0.0 111.999 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -10.1 14.04 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 114.465 -172.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.69 -42.6 71.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 110.939 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -35.76 69.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.941 -0.474 . . . . 0.0 111.462 178.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -58.02 -28.73 64.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.904 1.281 . . . . 0.0 110.953 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.69 -46.67 81.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.061 0.544 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.21 -45.0 43.24 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.152 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.15 152.06 12.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.074 0.852 . . . . 0.0 110.934 167.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -146.78 160.53 42.14 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.131 1.373 . . . . 0.0 108.94 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -55.65 125.82 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.052 1.341 . . . . 0.0 108.66 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -29.54 69.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 111.818 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.06 17.27 57.42 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.167 -1.352 . . . . 0.0 113.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.28 170.58 10.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.216 1.508 . . . . 0.0 112.018 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.0 pt -142.47 142.8 26.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 127.207 2.203 . . . . 0.0 107.023 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.21 116.1 19.27 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.162 0.585 . . . . 0.0 109.919 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -137.73 73.3 47.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.26 150.61 14.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.652 2.902 . . . . 0.0 113.733 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 tp -45.84 -36.16 5.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.973 1.709 . . . . 0.0 112.916 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -63.34 -18.45 63.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.018 0.927 . . . . 0.0 113.03 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -127.49 -24.17 3.37 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.293 1.037 . . . . 0.0 111.13 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -44.66 -35.63 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.407 1.883 . . . . 0.0 113.431 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -53.84 -36.48 62.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.273 0.942 . . . . 0.0 112.47 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.45 -39.14 4.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.412 0.551 . . . . 0.0 109.729 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -67.74 -16.41 64.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.686 0.795 . . . . 0.0 112.352 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.12 -32.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.478 1.035 . . . . 0.0 111.024 169.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.02 98.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.103 . . . . 0.0 110.765 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.25 -35.75 74.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.4 0.68 . . . . 0.0 111.247 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -45.3 66.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.096 0.558 . . . . 0.0 111.968 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.25 88.12 8.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.47 1.508 . . . . 0.0 107.761 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.55 -40.87 70.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.917 2.412 . . . . 0.0 113.18 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -81.22 99.08 8.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 28.5 mtmm -66.2 -8.09 22.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.62 -7.39 22.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.136 0.88 . . . . 0.0 111.597 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.92 151.17 48.09 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.941 0.791 . . . . 0.0 109.718 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 131.49 46.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.464 0.575 . . . . 0.0 109.84 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.87 129.39 75.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -126.61 86.32 2.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.04 154.72 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.54 158.5 41.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 108.08 168.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 p -133.52 -139.56 0.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.409 0.684 . . . . 0.0 110.241 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -74.32 -37.94 63.46 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.141 -0.974 . . . . 0.0 111.229 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.83 -39.31 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.52 -26.08 0.14 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.77 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.27 -62.75 1.55 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.177 1.488 . . . . 0.0 111.813 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.08 -32.64 73.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.977 0.353 . . . . 0.0 111.17 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -76.19 -33.85 59.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.582 -0.699 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.97 -46.52 93.57 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -60.4 -50.35 73.94 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.664 0.786 . . . . 0.0 109.784 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.75 78.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.68 -38.7 87.35 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.84 -39.31 87.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.313 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.48 -46.29 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.34 0.973 . . . . 0.0 109.356 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.74 -36.86 85.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.85 0.75 . . . . 0.0 110.462 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -64.44 -42.36 96.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.067 0.547 . . . . 0.0 110.305 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.63 -33.91 76.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.758 0.708 . . . . 0.0 111.126 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.3 mmm -71.28 -3.18 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.74 18.68 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.373 -0.829 . . . . 0.0 112.975 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 23.0 m-85 -66.95 157.2 33.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.719 1.259 . . . . 0.0 109.23 169.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 p -135.17 164.78 26.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.269 1.428 . . . . 0.0 108.242 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 51.99 35.34 15.78 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.4 1.08 . . . . 0.0 111.932 -169.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.18 143.54 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.48 154.04 41.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.005 1.322 . . . . 0.0 107.49 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -109.51 116.0 30.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.75 61.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.533 0.733 . . . . 0.0 111.96 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.51 -92.27 0.58 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.2 175.22 28.52 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 tp -47.95 -35.67 11.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 113.672 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -65.27 -27.62 68.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.263 0.625 . . . . 0.0 112.146 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.42 -45.65 37.57 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.831 0.741 . . . . 0.0 111.726 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 78' ' ' ILE . 4.9 mp -58.78 115.46 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.978 0.911 . . . . 0.0 110.162 -170.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.19 53.57 2.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 110.399 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.0 ptm -137.54 163.52 47.94 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 123.578 0.751 . . . . 0.0 109.72 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.07 155.85 5.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.358 3.372 . . . . 0.0 113.696 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -137.52 145.49 43.03 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.17 152.48 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 125.045 1.338 . . . . 0.0 108.618 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -68.2 162.17 25.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.034 0.534 . . . . 0.0 111.166 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.912 1.244 . . . . 0.0 110.51 172.411 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.24 149.25 41.11 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.812 1.245 . . . . 0.0 107.888 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -142.04 155.21 45.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.854 1.661 . . . . 0.0 108.164 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -137.47 148.82 46.36 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.453 1.101 . . . . 0.0 108.475 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.32 135.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -90.62 116.31 28.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 167.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.86 11.87 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -88.05 -174.81 4.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.057 1.299 . . . . 0.0 109.668 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m -58.4 152.83 41.66 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 122.67 0.388 . . . . 0.0 110.512 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.39 -17.17 58.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.727 2.285 . . . . 0.0 113.379 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -57.01 -39.2 74.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.112 0.869 . . . . 0.0 110.87 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -69.88 -35.04 74.34 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.349 0.522 . . . . 0.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -60.24 -26.71 66.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.676 1.19 . . . . 0.0 111.311 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -71.23 -46.1 61.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.683 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.9 -52.15 64.21 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.667 0.667 . . . . 0.0 109.315 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.82 157.36 8.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.655 1.582 . . . . 0.0 108.01 165.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -144.77 153.35 41.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.444 1.098 . . . . 0.0 108.634 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.68 123.31 4.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.75 68.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 0.0 111.754 -172.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.81 6.24 83.32 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.281 -1.289 . . . . 0.0 113.852 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.9 164.7 13.75 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.44 1.62 . . . . 0.0 111.16 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.7 139.02 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 126.282 1.833 . . . . 0.0 107.269 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.82 114.22 17.58 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.222 0.464 . . . . 0.0 109.779 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -141.67 89.25 9.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.44 155.64 20.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.438 2.758 . . . . 0.0 114.729 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.75 -36.17 24.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.722 2.009 . . . . 0.0 112.383 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.16 -17.53 62.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.873 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -128.12 -16.99 4.42 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.773 0.829 . . . . 0.0 112.309 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -50.0 -32.12 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.021 1.328 . . . . 0.0 112.41 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -55.33 -26.09 38.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.091 1.356 . . . . 0.0 112.969 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -116.81 -43.03 2.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.671 0.669 . . . . 0.0 109.544 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -69.57 -9.11 52.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.8 tp -53.47 -36.96 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.935 1.243 . . . . 0.0 110.408 169.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.59 96.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.351 0.978 . . . . 0.0 111.543 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -33.91 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.881 0.472 . . . . 0.0 111.042 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.89 73.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.395 0.543 . . . . 0.0 111.114 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.93 113.86 4.96 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.607 1.563 . . . . 0.0 106.995 -171.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.78 -23.87 43.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.096 2.531 . . . . 0.0 115.275 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -146.2 118.51 8.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 108.861 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.02 -12.16 7.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.824 1.249 . . . . 0.0 114.033 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.52 -20.51 59.94 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.847 0.749 . . . . 0.0 112.229 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.39 155.22 40.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.03 0.832 . . . . 0.0 108.87 168.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.41 131.16 44.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.133 0.879 . . . . 0.0 109.445 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.8 t -129.16 129.89 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.81 84.38 2.27 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 m -67.49 147.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.1 167.33 22.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.66 178.38 8.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -56.05 -35.79 67.31 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.88 5.3 6.6 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.57 -25.89 5.49 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.254 1.407 . . . . 0.0 114.891 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -64.24 -49.14 73.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.268 1.534 . . . . 0.0 110.799 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.22 -31.68 67.87 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.79 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -68.81 -31.31 70.22 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.906 1.23 . . . . 0.0 111.065 169.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.42 -50.14 64.55 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 167.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.74 -42.52 99.71 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-N 117.813 0.807 . . . . 0.0 111.745 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.66 82.91 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.849 0.75 . . . . 0.0 109.812 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -66.81 -39.46 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.232 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.48 -44.45 97.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.755 1.161 . . . . 0.0 110.827 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.71 -53.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.91 -27.39 65.73 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.047 -0.408 . . . . 0.0 110.652 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -64.44 -43.1 95.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.762 0.71 . . . . 0.0 110.624 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.71 -32.83 74.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.343 0.519 . . . . 0.0 110.258 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.9 mtp -74.3 4.15 6.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 113.114 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.56 47.15 6.49 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.972 1.26 . . . . 0.0 111.891 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.2 166.4 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.304 1.042 . . . . 0.0 113.465 173.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 p -138.47 -34.95 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.813 0.845 . . . . 0.0 111.014 167.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -138.37 32.9 2.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.178 0.899 . . . . 0.0 112.008 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -92.52 139.44 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.66 147.0 31.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.774 1.23 . . . . 0.0 108.938 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -87.83 114.58 24.58 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -51.43 65.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.779 0.432 . . . . 0.0 110.301 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.43 -164.46 27.68 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.91 170.68 40.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.9 tp -55.36 -31.07 61.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 0.0 112.7 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.66 -24.83 65.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.271 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.55 -48.45 32.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.209 0.913 . . . . 0.0 111.628 -170.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 78' ' ' ILE . 2.4 mp -61.34 115.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.27 0.628 . . . . 0.0 109.682 -169.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.38 56.48 2.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.453 1.501 . . . . 0.0 110.358 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.3 mtp -135.63 155.3 78.34 Favored Pre-proline 0 C--O 1.239 0.53 0 C-N-CA 125.3 1.44 . . . . 0.0 109.3 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.8 152.02 14.19 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.945 3.097 . . . . 0.0 112.662 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -135.94 143.29 44.83 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 m -141.16 155.51 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.991 1.316 . . . . 0.0 108.38 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.77 159.71 29.68 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.264 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.572 -1.127 . . . . 0.0 110.616 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.39 161.65 38.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 169.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -133.46 114.2 13.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.389 1.476 . . . . 0.0 107.837 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.4 141.97 48.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.5 mm -137.12 122.07 24.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.4 122.14 28.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 m -110.38 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.21 -168.43 1.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.864 -1.148 . . . . 0.0 109.701 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.52 152.37 96.29 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.078 0.551 . . . . 0.0 110.09 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.48 -21.72 14.72 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.577 2.851 . . . . 0.0 114.475 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.34 -28.99 69.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.104 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -74.73 -47.27 32.18 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 120.098 1.317 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.06 -42.96 77.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.983 0.913 . . . . 0.0 111.275 -171.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -59.0 -51.79 68.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.388 1.075 . . . . 0.0 110.904 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.71 -41.03 60.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.38 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -167.39 140.11 3.37 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.412 1.006 . . . . 0.0 109.473 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -133.86 154.45 51.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.308 1.043 . . . . 0.0 108.622 171.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.5 130.95 19.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.6 119.48 6.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.24 59.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.208 0.909 . . . . 0.0 112.695 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.62 159.94 32.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.474 1.137 . . . . 0.0 110.75 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.9 pt -136.43 141.33 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.204 1.802 . . . . 0.0 106.5 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.54 110.22 14.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -132.72 78.42 66.69 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.532 1.933 . . . . 0.0 106.131 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.91 151.35 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.818 3.012 . . . . 0.0 114.04 -170.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.1 tp -49.22 -39.58 30.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 112.468 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.91 -11.46 56.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -130.04 -15.97 3.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.351 1.06 . . . . 0.0 111.914 -172.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -51.7 -33.89 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.295 1.438 . . . . 0.0 112.101 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -53.03 -38.69 62.6 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.286 1.034 . . . . 0.0 111.908 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.52 -45.33 4.47 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.37 -21.41 66.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.582 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -57.38 -31.66 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.805 1.184 . . . . 0.0 110.988 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -22.6 63.71 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -113.46 -28.92 7.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 110.685 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.27 -41.56 94.11 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.764 0.711 . . . . 0.0 111.294 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 t -142.96 83.6 11.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.617 1.567 . . . . 0.0 107.037 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.01 -31.46 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.018 1.812 . . . . 0.0 112.482 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -80.88 94.59 6.51 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -68.03 -0.31 4.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.31 -8.47 20.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.257 0.935 . . . . 0.0 111.674 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.83 149.49 49.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.206 0.912 . . . . 0.0 109.439 170.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -65.48 141.3 58.54 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.03 -0.419 . . . . 0.0 109.918 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.47 133.74 64.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -126.26 88.99 2.93 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.04 141.68 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.57 164.24 34.08 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.343 1.057 . . . . 0.0 109.088 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -153.39 172.21 17.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.604 1.562 . . . . 0.0 107.474 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -54.16 -18.7 4.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.16 8.52 2.95 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -171.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 -43.76 1.92 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.241 1.401 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -54.05 -53.83 47.71 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.229 1.012 . . . . 0.0 112.525 -170.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -65.46 -35.86 82.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -67.52 -34.56 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.584 -0.698 . . . . 0.0 112.321 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.21 -45.6 73.32 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -65.39 -49.53 68.95 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.236 0.518 . . . . 0.0 110.359 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.67 72.04 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 122.776 0.431 . . . . 0.0 110.648 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.49 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.42 -36.59 71.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.541 -0.725 . . . . 0.0 110.977 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.62 -46.65 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.552 1.069 . . . . 0.0 109.12 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.59 -36.86 85.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.239 0.616 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 m -66.91 -37.86 85.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.537 0.335 . . . . 0.0 110.549 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.48 -36.03 81.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -69.91 0.19 6.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.757 1.223 . . . . 0.0 112.647 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.95 80.83 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.197 -0.939 . . . . 0.0 112.985 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -64.11 155.39 31.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.832 1.316 . . . . 0.0 108.907 171.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 p -131.19 164.07 26.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.984 1.314 . . . . 0.0 108.427 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.2 m80 52.65 34.44 15.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.49 144.09 10.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.99 155.62 37.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 108.292 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.31 117.47 29.17 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 168.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.3 90.89 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.411 0.444 . . . . 0.0 111.6 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.58 -26.48 2.4 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.7 1.143 . . . . 0.0 111.921 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.02 176.73 22.58 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 173.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.0 -33.66 70.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.137 0.575 . . . . 0.0 110.147 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.9 -38.51 88.62 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 110.962 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.95 -47.15 26.26 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.611 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 82.8 mt -62.54 126.36 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -171.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.01 22.48 15.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.789 1.235 . . . . 0.0 112.087 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -73.65 158.67 85.96 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 124.22 1.008 . . . . 0.0 109.126 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.8 155.55 10.6 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.587 2.858 . . . . 0.0 111.846 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -138.07 149.41 45.96 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.74 154.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.349 1.459 . . . . 0.0 108.575 -171.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.14 151.56 45.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 172.603 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.75 153.28 47.14 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.228 1.011 . . . . 0.0 109.013 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -134.36 156.32 48.71 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.259 1.824 . . . . 0.0 107.704 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -121.61 137.46 54.73 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.28 125.94 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.79 108.77 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 48' ' ' CYS 0.295 22.7 m -101.88 22.63 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.137 0.426 . . . . 0.0 111.89 -174.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.05 -177.06 3.16 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.704 -0.622 . . . . 0.0 110.464 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.08 152.84 95.62 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.221 0.608 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.81 -17.33 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.851 3.034 . . . . 0.0 115.042 171.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.08 -38.18 72.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.136 0.88 . . . . 0.0 111.461 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.93 -45.2 51.95 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.251 0.932 . . . . 0.0 109.991 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -52.85 -39.67 62.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.569 1.148 . . . . 0.0 111.699 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -54.8 -54.53 40.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.779 1.232 . . . . 0.0 111.385 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.19 -49.0 48.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.117 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.82 152.44 15.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.927 0.785 . . . . 0.0 110.635 167.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -134.19 158.32 43.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.593 1.157 . . . . 0.0 108.672 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.43 130.58 20.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 120.13 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.458 1.103 . . . . 0.0 110.101 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.63 -2.55 67.35 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.529 -1.15 . . . . 0.0 114.04 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.73 134.34 52.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.586 1.693 . . . . 0.0 109.787 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.4 130.64 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.07 113.84 12.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.567 1.076 . . . . 0.0 109.019 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.0 mt -140.79 81.62 16.44 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.59 151.97 17.58 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.661 2.907 . . . . 0.0 113.47 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.7 tp -47.75 -37.18 12.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.245 1.818 . . . . 0.0 113.216 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.86 -14.61 63.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -125.35 -19.79 4.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.836 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -50.11 -35.06 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.027 1.331 . . . . 0.0 112.465 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.69 -30.01 62.98 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.966 0.907 . . . . 0.0 112.327 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.81 -45.78 3.31 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.654 0.661 . . . . 0.0 110.102 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -63.87 -20.58 65.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.61 -34.13 34.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 0.0 111.477 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.35 97.12 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -34.71 55.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 111.137 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.39 70.84 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.429 0.559 . . . . 0.0 112.197 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.79 80.07 32.05 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.344 1.458 . . . . 0.0 107.238 -171.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.76 -1.58 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.191 2.594 . . . . 0.0 113.979 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -130.28 105.81 8.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.33 -15.0 55.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.85 -20.78 62.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.58 0.627 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.58 154.22 39.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.252 0.621 . . . . 0.0 111.619 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -76.95 135.49 38.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.625 -0.672 . . . . 0.0 109.567 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.09 90.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -72.17 131.54 42.92 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.41 143.14 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.67 163.11 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.076 0.951 . . . . 0.0 109.085 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 7' ' ' VAL . 1.7 m -144.54 -179.19 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.416 1.886 . . . . 0.0 107.735 176.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -64.19 -37.73 88.51 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.455 -0.778 . . . . 0.0 112.245 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.97 -20.06 8.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.059 0.944 . . . . 0.0 113.249 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.63 -23.72 16.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.267 0.937 . . . . 0.0 113.922 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -68.88 -41.05 78.86 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.099 1.449 . . . . 0.0 111.469 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.31 -33.37 75.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.664 0.665 . . . . 0.0 111.418 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -71.62 -31.1 66.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.749 1.159 . . . . 0.0 110.694 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.19 -47.99 77.64 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -61.75 -46.12 90.98 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.967 -0.726 . . . . 0.0 110.547 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.58 -34.97 73.39 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.026 -0.421 . . . . 0.0 111.064 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -63.0 -42.42 99.84 Favored 'General case' 0 C--N 1.335 -0.064 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.69 -44.54 93.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.72 0.691 . . . . 0.0 110.544 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.42 -51.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.3 mt -71.2 -28.05 63.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.927 -0.483 . . . . 0.0 111.587 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 m -64.88 -43.31 93.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.512 0.596 . . . . 0.0 110.134 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.97 -34.49 78.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.687 0.676 . . . . 0.0 110.813 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.74 -6.03 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.867 0.867 . . . . 0.0 112.798 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.91 58.62 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.909 170.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -72.34 122.7 21.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.124 1.462 . . . . 0.0 108.403 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -74.59 -29.95 61.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.79 1.236 . . . . 0.0 113.833 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -136.26 44.11 2.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.422 0.689 . . . . 0.0 111.123 -168.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.56 147.93 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -145.79 123.72 12.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -74.75 106.59 6.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.45 -28.27 67.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.05 0.94 . . . . 0.0 111.694 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.47 -161.68 21.53 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.265 0.936 . . . . 0.0 110.97 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.85 159.54 33.07 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.4 tp -58.01 -26.52 62.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.032 1.333 . . . . 0.0 111.875 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -69.04 -10.51 57.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.473 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.61 -33.25 3.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.877 1.271 . . . . 0.0 112.437 -170.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.16 135.8 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.504 1.502 . . . . 0.0 107.39 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.08 23.91 11.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.539 1.136 . . . . 0.0 112.16 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 75.6 mmm -68.61 160.15 78.2 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 108.765 168.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.14 155.25 62.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.659 1.573 . . . . 0.0 109.124 167.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -138.68 144.62 39.68 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.87 150.57 16.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.206 1.402 . . . . 0.0 108.66 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -65.91 161.56 20.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.837 0.455 . . . . 0.0 110.88 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.58 152.68 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.183 1.393 . . . . 0.0 107.629 173.501 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -141.33 159.42 42.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.181 1.792 . . . . 0.0 107.655 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -129.71 145.65 51.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.72 1.208 . . . . 0.0 108.148 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.9 mt -146.48 135.45 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -90.17 124.8 35.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG23 ' SG ' ' A' ' 48' ' ' CYS . 22.7 m -115.78 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.959 0.504 . . . . 0.0 112.229 -174.15 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.28 -170.56 1.77 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 m -66.68 157.36 83.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.197 0.599 . . . . 0.0 110.329 171.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -53.32 -16.75 7.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.224 3.282 . . . . 0.0 115.436 172.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.95 -41.65 46.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 111.915 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -75.44 -45.14 40.51 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.619 0.645 . . . . 0.0 109.925 174.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -54.3 -38.61 66.13 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.009 0.924 . . . . 0.0 112.289 -174.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.13 -50.68 72.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.649 1.18 . . . . 0.0 110.956 177.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -83.95 -38.5 20.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.748 -170.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.87 139.36 2.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.65 1.18 . . . . 0.0 109.359 169.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -134.79 145.7 48.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.142 1.377 . . . . 0.0 107.909 172.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.9 t -58.81 133.94 23.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.73 142.56 39.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.264 -0.273 . . . . 0.0 110.286 -178.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.13 -18.09 29.45 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.108 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.51 163.51 20.93 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.173 1.486 . . . . 0.0 110.788 172.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -145.69 138.08 20.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.652 2.381 . . . . 0.0 105.124 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -76.77 114.68 15.8 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -176.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -141.13 85.41 12.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.37 157.31 11.89 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.87 3.047 . . . . 0.0 114.506 -170.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 tp -46.8 -41.1 14.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.782 2.033 . . . . 0.0 113.215 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.53 -10.74 60.03 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -123.7 -21.46 5.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.042 1.337 . . . . 0.0 111.303 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.37 -33.19 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.396 1.478 . . . . 0.0 112.669 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.54 -43.84 72.32 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.799 1.24 . . . . 0.0 111.142 -170.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -93.78 -45.59 7.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.671 0.669 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -17.85 65.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -52.94 -36.49 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.133 0.878 . . . . 0.0 111.248 171.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.62 96.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.982 0.81 . . . . 0.0 110.954 -175.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -35.06 66.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.232 0.613 . . . . 0.0 111.11 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.5 78.61 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.406 0.548 . . . . 0.0 111.618 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.0 t -142.09 87.98 9.45 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.385 1.474 . . . . 0.0 107.306 -171.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.88 21.77 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.953 3.102 . . . . 0.0 114.107 -172.728 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -144.08 104.67 4.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 107.605 173.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.88 -10.79 52.17 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -82.42 -13.62 56.5 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.976 0.807 . . . . 0.0 111.838 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.45 154.24 40.97 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.007 0.822 . . . . 0.0 111.453 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -71.97 136.95 46.96 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.67 135.81 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -115.97 128.65 55.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.44 145.29 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.26 159.75 44.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.568 1.547 . . . . 0.0 107.754 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' HG23 ' A' ' 7' ' ' VAL . 5.5 m -157.24 167.48 30.21 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.157 1.783 . . . . 0.0 108.851 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -46.55 -30.2 2.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -176.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.42 7.97 5.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.568 1.076 . . . . 0.0 113.525 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.8 -40.95 1.88 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.045 1.307 . . . . 0.0 112.385 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -52.66 -47.96 66.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.595 1.158 . . . . 0.0 111.569 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -65.0 -37.86 89.06 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.059 0.391 . . . . 0.0 110.132 -173.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -30.98 69.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.016 172.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.64 -44.32 95.71 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 169.334 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -61.05 -49.49 77.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.803 0.802 . . . . 0.0 109.982 175.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.19 -40.41 77.34 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.86 0.3 . . . . 0.0 110.617 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.15 -37.92 87.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.71 -34.82 67.38 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.53 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.61 -47.37 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.889 1.222 . . . . 0.0 108.323 171.392 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 mt -70.49 -29.91 66.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.741 -0.6 . . . . 0.0 111.507 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.2 m -65.54 -38.04 88.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.227 0.467 . . . . 0.0 110.407 172.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.48 -36.05 81.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.821 0.737 . . . . 0.0 110.255 174.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mmm -68.93 -5.79 23.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.109 0.964 . . . . 0.0 112.579 170.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 12.0 64.48 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.425 1.012 . . . . 0.0 113.529 172.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.61 127.85 34.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.129 1.464 . . . . 0.0 107.731 175.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -89.42 -22.0 22.75 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -169.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.59 33.48 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.1 0.96 . . . . 0.0 111.551 -169.068 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.57 136.92 22.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 167.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.09 144.13 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.78 110.58 18.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -29.61 70.55 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.92 -162.08 28.84 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.239 1.399 . . . . 0.0 109.754 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.63 158.91 31.39 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 170.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -55.33 -35.62 65.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.358 1.063 . . . . 0.0 110.89 175.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.97 0.96 11.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.259 1.023 . . . . 0.0 112.735 176.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -130.9 -28.39 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.433 -169.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.71 134.99 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 120.936 1.698 . . . . 0.0 107.554 168.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.22 53.02 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.714 1.605 . . . . 0.0 108.831 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.0 mtp -133.88 158.38 75.58 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.188 1.795 . . . . 0.0 107.627 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.54 149.16 40.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.022 2.481 . . . . 0.0 113.354 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -127.85 159.17 35.71 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.202 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 100.0 t -134.82 167.83 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 127.708 2.403 . . . . 0.0 105.271 -175.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -128.71 161.61 29.3 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.798 -1.189 . . . . 0.0 109.871 -170.03 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 174.71 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.1 m80 -132.53 150.17 52.2 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.135 166.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.588 ' HZ3' ' HE2' ' A' ' 80' ' ' MET . 23.6 m95 -123.98 142.65 50.97 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.065 -1.879 . . . . 0.0 109.252 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 mm -140.0 123.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -79.86 121.7 25.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 163.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -112.28 21.35 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.937 0.79 . . . . 0.0 112.324 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.552 ' HD2' ' H ' ' A' ' 49' ' ' ASN . 7.4 ttt180 -106.3 -175.47 2.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.687 -1.258 . . . . 0.0 110.105 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 m -60.11 151.71 65.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.358 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.76 -17.14 28.12 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.221 2.614 . . . . 0.0 113.964 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -54.08 -39.87 66.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.607 1.163 . . . . 0.0 113.528 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.45 -41.74 69.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.866 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -57.54 -37.41 73.02 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.192 0.997 . . . . 0.0 111.814 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -59.96 -39.08 84.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.975 0.91 . . . . 0.0 112.319 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -87.9 -44.69 10.87 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 117.816 -1.087 . . . . 0.0 111.293 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -162.86 150.11 13.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 167.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -139.98 152.77 46.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.492 HG11 ' HE3' ' A' ' 4' ' ' TRP . 67.5 t -54.17 128.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.578 169.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.32 113.29 2.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -13.29 25.39 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.34 164.05 27.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 117.491 0.646 . . . . 0.0 110.346 171.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.58 138.25 54.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 127.084 2.154 . . . . 0.0 106.95 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.12 115.66 16.06 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 123.935 0.772 . . . . 0.0 109.592 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.41 82.78 15.96 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 126.102 1.761 . . . . 0.0 106.511 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.39 153.49 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.502 2.802 . . . . 0.0 113.791 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -49.42 -36.92 23.61 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.166 1.386 . . . . 0.0 112.457 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -67.02 -15.35 63.67 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.673 ' HB3' ' HD2' ' A' ' 32' ' ' ARG . 23.9 mt-10 -130.81 -13.61 3.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 O-C-N 124.586 1.179 . . . . 0.0 110.867 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.62 -34.15 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.342 1.057 . . . . 0.0 111.328 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -56.85 -31.36 64.7 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -105.24 -35.96 7.39 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.015 0.912 . . . . 0.0 110.482 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.673 ' HD2' ' HB3' ' A' ' 28' ' ' GLU . 5.8 mtp180 -81.2 -17.26 50.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.03 -34.39 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.56 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.48 -32.02 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.897 0.771 . . . . 0.0 111.726 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.64 -28.62 21.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.305 0.642 . . . . 0.0 111.438 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.45 -40.05 44.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.447 0.567 . . . . 0.0 111.613 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 t -142.67 82.58 12.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.41 -25.41 70.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.354 2.036 . . . . 0.0 113.84 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -101.4 100.68 11.18 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -69.34 -6.87 32.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -176.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -18.42 58.98 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 170.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -66.76 150.75 48.67 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -72.08 131.73 43.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.93 124.42 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HD2' ' HE1' ' A' ' 4' ' ' TRP . 88.5 mttt -110.34 121.04 44.33 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.04 147.02 12.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.47 163.89 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 107.975 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.8 p -154.39 -176.34 5.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.552 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 61.9 t30 -60.14 -30.68 69.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.11 1.0 7.19 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.211 -0.931 . . . . 0.0 113.101 -168.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.1 -26.57 3.79 Favored Glycine 0 C--O 1.225 -0.466 0 CA-C-O 122.611 1.117 . . . . 0.0 113.339 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.321 2.3 tpt85 -69.96 -48.16 59.43 Favored 'General case' 0 N--CA 1.426 -1.641 0 O-C-N 120.449 -1.618 . . . . 0.0 112.117 -176.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.9 -29.73 64.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.227 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -35.51 79.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.252 0.478 . . . . 0.0 111.796 167.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.86 -47.28 72.79 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -63.74 -46.01 87.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.864 0.832 . . . . 0.0 110.608 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.192 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -61.42 -41.44 97.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.86 -42.04 90.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.108 0.867 . . . . 0.0 111.255 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.3 -48.78 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 42.9 mt -64.7 -47.97 76.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.5 m -52.93 -36.26 59.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 121.761 2.073 . . . . 0.0 112.258 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -66.61 -37.93 85.92 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 41.9 mmm -68.0 -6.59 23.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.015 1.326 . . . . 0.0 113.529 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.31 28.91 13.36 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.706 -1.246 . . . . 0.0 113.866 167.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.668 ' HB3' HG23 ' A' ' 69' ' ' VAL 0.333 49.4 m-85 -68.2 151.5 46.87 Favored 'General case' 0 CA--C 1.469 -2.169 0 C-N-CA 123.686 0.794 . . . . 0.0 110.057 173.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.57 -24.44 11.77 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.711 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -138.77 47.35 1.94 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.911 1.339 . . . . 0.0 111.571 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 66' ' ' TYR . 2.1 t -90.32 148.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -147.05 134.5 20.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.629 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -78.14 110.6 13.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 163.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.53 -31.65 72.82 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.76 -147.51 19.26 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -100.52 165.56 19.26 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' HE2' ' A' ' 82' ' ' LYS . 40.3 tp -50.06 -32.81 16.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.971 1.367 . . . . 0.0 112.864 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.272 59.9 mttt -69.22 -28.45 66.36 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -86.32 -40.38 15.53 Favored 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 126.178 2.174 . . . . 0.0 107.58 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 80' ' ' MET . 2.2 mp -60.92 126.28 18.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.179 . . . . 0.0 108.806 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.85 34.24 3.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.231 1.012 . . . . 0.0 110.264 -174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.588 ' HE2' ' HZ3' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -91.24 161.47 34.85 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 123.459 0.704 . . . . 0.0 109.553 170.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -51.22 150.91 13.52 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.535 2.157 . . . . 0.0 111.519 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HE2' HD12 ' A' ' 75' ' ' LEU . 17.2 mttp -133.84 153.32 51.81 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 157.6 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.484 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -84.71 162.7 19.56 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.443 173.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.346 0 O-C-N 127.502 3.001 . . . . 0.0 111.29 170.133 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -135.28 110.98 9.26 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 107.959 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -75.95 133.02 40.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.3 mm -132.86 122.53 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -78.51 129.39 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.93 31.34 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.691 0.678 . . . . 0.0 111.991 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -120.02 -173.42 2.55 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.424 -0.797 . . . . 0.0 109.788 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.21 157.46 77.05 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.458 0.703 . . . . 0.0 110.01 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.62 -14.43 39.83 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.918 2.412 . . . . 0.0 113.649 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -47.37 -47.87 25.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.957 1.303 . . . . 0.0 111.087 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -70.61 -42.0 71.53 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 118.529 0.604 . . . . 0.0 109.957 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -57.05 -38.56 73.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.952 0.901 . . . . 0.0 111.18 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.7 -45.03 88.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.772 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -73.54 -47.26 42.16 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.542 1.065 . . . . 0.0 110.771 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.83 149.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 109.729 166.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -138.6 151.24 47.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.081 1.752 . . . . 0.0 107.991 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.96 131.55 16.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 119.18 3.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.567 1.147 . . . . 0.0 110.346 -171.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.05 76.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.626 -1.097 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.9 55.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.372 1.586 . . . . 0.0 109.424 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 mt -78.83 129.17 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -78.36 118.59 20.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.164 0.893 . . . . 0.0 109.498 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.9 mt -141.16 84.57 12.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.23 151.03 9.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.94 3.093 . . . . 0.0 113.895 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.2 tp -46.74 -42.65 17.14 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.539 1.536 . . . . 0.0 112.575 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -66.82 -12.55 59.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.745 0.818 . . . . 0.0 112.992 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.39 -9.15 4.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.739 1.216 . . . . 0.0 112.389 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 p -49.37 -42.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.735 1.152 . . . . 0.0 112.238 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -57.92 -34.95 70.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.969 0.908 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -92.77 7.57 43.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.062 0.945 . . . . 0.0 111.585 -168.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -140.94 -27.84 0.7 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.274 -0.891 . . . . 0.0 112.116 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.36 -34.81 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.687 1.131 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.39 23.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.482 1.113 . . . . 0.0 113.676 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -121.42 -27.94 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.902 1.281 . . . . 0.0 111.156 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.98 -38.54 76.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.807 0.731 . . . . 0.0 111.04 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -140.26 75.78 27.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.63 -32.88 18.21 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.34 2.026 . . . . 0.0 112.37 -172.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -79.03 97.71 6.2 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.14 -10.31 39.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -78.68 -18.99 53.52 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.686 1.13 . . . . 0.0 111.563 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.38 147.06 54.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.056 0.843 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -70.98 137.79 49.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.1 t -127.87 141.17 47.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -130.33 128.45 41.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.29 154.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.149 0.979 . . . . 0.0 108.925 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -155.92 161.76 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.593 1.957 . . . . 0.0 107.077 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.2 171.49 20.1 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.376 0.67 . . . . 0.0 109.638 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -48.32 -30.62 5.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.361 1.864 . . . . 0.0 114.545 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.75 2.05 8.17 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.52 -31.81 0.85 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.687 1.613 . . . . 0.0 113.918 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -63.57 -52.37 61.31 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.783 1.291 . . . . 0.0 111.507 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.94 -35.56 80.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.05 0.841 . . . . 0.0 110.892 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.9 p -72.04 -33.15 67.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.53 -0.732 . . . . 0.0 111.651 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.62 77.46 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -64.66 -49.2 71.92 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 117.516 0.658 . . . . 0.0 110.04 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.14 -36.63 70.94 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.443 0.297 . . . . 0.0 110.873 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.06 -42.12 97.13 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.44 -34.72 72.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.877 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -58.66 -50.45 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.323 0.965 . . . . 0.0 108.927 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.28 -34.44 78.36 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.753 -0.592 . . . . 0.0 110.825 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -63.16 -40.6 98.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.562 0.345 . . . . 0.0 110.687 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.99 -35.57 80.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.55 0.74 . . . . 0.0 110.677 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.05 -6.46 28.26 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.969 0.908 . . . . 0.0 112.415 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.631 -1.094 . . . . 0.0 113.159 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -65.93 119.26 11.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.381 1.591 . . . . 0.0 107.081 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 p -81.54 -19.86 41.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.01 76.81 1.67 Allowed 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.313 1.045 . . . . 0.0 108.441 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.76 141.99 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.25 140.87 35.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -91.74 102.99 15.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.74 76.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.743 -171.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.12 -168.3 27.1 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.53 153.63 51.78 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.8 tp -45.25 -45.09 11.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.861 1.664 . . . . 0.0 113.289 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -67.15 -25.36 66.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.13 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.56 -34.53 46.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.716 0.689 . . . . 0.0 111.574 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.77 123.93 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.06 22.9 12.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.12 0.968 . . . . 0.0 112.324 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.7 mmm -73.63 153.21 89.56 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.81 157.37 12.93 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.276 2.651 . . . . 0.0 110.948 167.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -136.43 158.0 45.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.128 0.571 . . . . 0.0 110.055 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.27 164.55 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.213 2.205 . . . . 0.0 105.186 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -147.56 172.18 14.4 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.805 -1.184 . . . . 0.0 110.648 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -173.579 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 . . . . . 0 C--O 1.236 0.387 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -140.61 163.99 31.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.574 1.55 . . . . 0.0 107.427 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -128.26 136.18 50.68 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -131.04 127.76 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -94.53 121.38 36.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 168.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.46 13.97 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -93.93 179.49 5.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.7 1.136 . . . . 0.0 110.366 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -51.9 148.09 11.17 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.76 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.56 -27.15 24.35 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.332 2.688 . . . . 0.0 113.533 171.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.73 -39.55 65.37 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.667 0.787 . . . . 0.0 111.391 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -69.83 -41.64 74.67 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.122 0.874 . . . . 0.0 110.501 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -58.1 -39.62 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.096 1.359 . . . . 0.0 110.486 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.88 -10.66 60.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.006 . . . . 0.0 113.696 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -81.69 -71.29 0.49 Allowed 'General case' 0 C--N 1.341 0.202 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 168.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.68 158.29 28.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.63 1.572 . . . . 0.0 107.702 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -143.44 152.75 41.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.527 1.131 . . . . 0.0 108.41 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.74 131.5 14.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.36 120.4 5.99 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.06 90.38 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.511 -1.161 . . . . 0.0 113.884 173.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.38 142.21 57.94 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.227 1.513 . . . . 0.0 110.005 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -87.9 127.33 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -77.18 115.33 16.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.56 81.56 23.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.133 1.773 . . . . 0.0 106.561 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.16 148.87 23.27 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.255 2.636 . . . . 0.0 112.625 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.88 -29.72 42.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.782 1.233 . . . . 0.0 112.722 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -60.08 -20.36 57.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.696 0.798 . . . . 0.0 113.049 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -128.41 -17.44 4.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.534 1.134 . . . . 0.0 112.096 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.87 -36.44 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.341 . . . . 0.0 112.765 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.65 -30.46 68.75 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.468 0.707 . . . . 0.0 112.073 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.92 -47.78 4.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.368 0.667 . . . . 0.0 109.514 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -63.89 -18.76 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.112 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -52.58 -40.55 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.43 1.014 . . . . 0.0 111.04 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.79 90.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.828 0.74 . . . . 0.0 110.917 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -71.72 -37.02 70.68 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.487 0.715 . . . . 0.0 111.063 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.87 62.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.217 0.462 . . . . 0.0 111.738 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.24 98.19 6.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 108.128 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.18 -9.76 7.01 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.088 3.192 . . . . 0.0 116.253 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -134.83 111.29 9.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.834 1.197 . . . . 0.0 110.155 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.0 -12.37 60.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.701 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -86.54 -4.17 59.13 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.151 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.74 151.03 47.9 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.362 -0.836 . . . . 0.0 108.9 168.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 m -79.62 70.21 6.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.73 0.776 . . . . 0.0 109.758 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 t -74.01 97.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -79.58 141.26 36.75 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.99 126.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -171.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.06 169.67 17.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.23 1.412 . . . . 0.0 109.307 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 p -150.11 178.45 8.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.78 -23.36 67.33 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.01 -6.81 11.97 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.63 30.13 77.08 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.661 1.119 . . . . 0.0 114.627 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -137.26 -45.8 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.012 0.906 . . . . 0.0 110.235 170.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.98 -22.38 65.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.726 0.239 . . . . 0.0 110.614 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 p -64.36 -42.21 96.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.05 -1.031 . . . . 0.0 110.95 168.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.77 -43.27 96.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.14 -40.07 96.51 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.147 1.474 . . . . 0.0 111.315 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.53 76.06 Favored 'General case' 0 C--O 1.227 -0.087 0 O-C-N 121.376 -0.828 . . . . 0.0 110.685 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.03 -39.65 83.06 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.488 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.97 -44.02 97.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.37 0.987 . . . . 0.0 109.714 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.41 -50.38 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.921 0.889 . . . . 0.0 109.688 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.05 -18.65 62.55 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.441 -0.787 . . . . 0.0 111.502 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -68.22 -36.73 79.96 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.54 -0.725 . . . . 0.0 110.126 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.12 -36.49 83.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.299 0.954 . . . . 0.0 110.052 171.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.1 mmm -73.23 -1.87 19.49 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.064 0.945 . . . . 0.0 112.796 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.08 46.05 17.78 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 119.849 1.204 . . . . 0.0 111.659 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -46.24 158.41 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.501 1.121 . . . . 0.0 113.299 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.83 -26.67 1.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.893 -1.051 . . . . 0.0 112.217 173.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -147.92 23.86 1.08 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.585 1.539 . . . . 0.0 113.845 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 144.58 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.2 128.33 16.64 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.856 0.862 . . . . 0.0 109.002 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.63 108.17 10.63 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 168.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.73 73.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.0 0.52 . . . . 0.0 110.957 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.54 -139.36 7.23 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.22 166.34 15.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.5 tp -51.03 -40.16 57.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -168.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.91 -27.61 66.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.642 0.377 . . . . 0.0 111.677 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -86.71 -36.28 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.884 0.874 . . . . 0.0 111.658 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.95 119.66 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.46 22.87 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.05 0.94 . . . . 0.0 112.468 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mmm -81.3 158.35 69.41 Favored Pre-proline 0 C--O 1.24 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 109.462 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.65 154.92 11.19 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.441 2.761 . . . . 0.0 111.754 168.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -134.41 154.34 51.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 t -130.54 141.04 47.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.59 161.0 24.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.09 0.556 . . . . 0.0 110.281 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.032 169.355 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.236 0.373 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -82.8 158.07 22.94 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.22 141.66 49.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.621 1.168 . . . . 0.0 107.998 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -139.84 136.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.89 122.24 36.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.64 20.21 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.598 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 15.8 ttt85 -109.56 -162.84 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.238 -0.914 . . . . 0.0 108.766 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 11.1 m -77.98 156.13 79.83 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.343 0.657 . . . . 0.0 109.588 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.41 -23.77 19.75 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.364 2.709 . . . . 0.0 114.029 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -26.08 64.2 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.688 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -86.2 -51.34 6.34 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 119.95 1.25 . . . . 0.0 109.142 167.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -53.25 -37.81 62.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.871 1.269 . . . . 0.0 112.992 -170.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -66.59 -45.59 78.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 0.0 111.52 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.38 -30.36 60.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.953 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.74 153.37 2.21 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.616 1.566 . . . . 0.0 109.667 166.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -146.02 146.51 31.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 t -60.15 132.67 25.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.4 149.43 16.83 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.577 0.751 . . . . 0.0 111.529 -172.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.93 -14.87 46.43 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.462 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.82 171.39 7.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.889 1.345 . . . . 0.0 111.797 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.8 mt -135.4 134.22 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -73.92 115.65 13.63 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.162 0.892 . . . . 0.0 109.031 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 mt -141.29 87.55 10.52 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.22 149.83 11.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.009 3.139 . . . . 0.0 114.027 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.49 -36.37 14.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.883 1.673 . . . . 0.0 113.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -63.88 -20.45 65.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -129.29 -11.3 4.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.93 0.892 . . . . 0.0 111.865 -169.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -50.26 -34.65 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 111.51 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.69 -33.83 56.74 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 112.609 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.54 -36.72 4.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.485 0.584 . . . . 0.0 111.211 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -69.26 -15.67 63.41 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.597 -0.689 . . . . 0.0 112.317 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.67 -35.35 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.056 169.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.08 99.43 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.385 0.993 . . . . 0.0 111.184 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -35.94 59.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.405 0.682 . . . . 0.0 111.158 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.74 75.02 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -140.66 82.47 15.78 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.994 1.718 . . . . 0.0 107.062 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.46 3.71 4.53 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.381 2.72 . . . . 0.0 114.256 -173.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.06 103.88 5.99 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.801 1.24 . . . . 0.0 107.863 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -15.78 52.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.98 -25.15 63.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.468 0.577 . . . . 0.0 111.876 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -63.66 154.7 32.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.63 0.65 . . . . 0.0 111.773 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -73.2 142.67 47.34 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.22 140.59 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -120.67 139.93 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.19 144.6 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -143.57 160.59 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.46 1.104 . . . . 0.0 109.109 170.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -130.01 -139.34 0.22 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 125.034 1.334 . . . . 0.0 107.423 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -80.53 -45.15 17.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.789 1.631 . . . . 0.0 111.89 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.87 -26.44 3.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -169.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.35 2.41 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.073 0.851 . . . . 0.0 113.933 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -66.08 -44.21 85.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.984 1.392 . . . . 0.0 112.517 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.2 -33.03 71.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.868 0.758 . . . . 0.0 110.648 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -33.39 74.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.251 -0.906 . . . . 0.0 110.648 170.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.96 -49.18 68.34 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -60.47 -46.91 88.37 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.529 0.664 . . . . 0.0 110.655 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.51 75.25 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.474 0.579 . . . . 0.0 110.791 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -65.4 -42.79 92.22 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -42.34 98.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.876 0.762 . . . . 0.0 111.111 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.84 -51.21 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.88 -24.56 59.74 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.733 -0.604 . . . . 0.0 111.858 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 m -67.38 -38.95 85.52 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.321 0.51 . . . . 0.0 110.248 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -67.26 -37.21 83.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.831 0.741 . . . . 0.0 110.256 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mmm -67.39 -12.98 61.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.688 0.795 . . . . 0.0 112.289 170.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.89 14.6 66.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.349 -1.25 . . . . 0.0 113.955 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -64.26 122.87 17.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.522 1.661 . . . . 0.0 107.716 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -68.19 -30.88 70.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -165.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.27 42.9 2.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.271 0.942 . . . . 0.0 112.213 -166.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.83 146.67 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -142.65 137.76 30.18 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.144 1.378 . . . . 0.0 108.356 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -78.5 114.37 17.35 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.38 63.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.637 0.775 . . . . 0.0 112.031 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.58 -145.7 17.71 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.93 168.99 16.02 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.98 -25.48 67.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.142 0.977 . . . . 0.0 112.234 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -78.25 -6.02 53.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.353 172.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.58 -35.09 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.311 1.044 . . . . 0.0 112.471 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.61 146.19 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 120.264 1.393 . . . . 0.0 108.615 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.97 67.14 1.34 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.471 1.508 . . . . 0.0 108.427 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.2 ptm -140.23 166.1 25.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.9 1.28 . . . . 0.0 108.543 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 147.1 33.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.231 2.621 . . . . 0.0 113.561 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.87 160.06 24.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.5 1.12 . . . . 0.0 109.029 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.56 155.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -134.86 155.86 49.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.124 0.97 . . . . 0.0 109.089 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 174.642 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -134.72 98.67 4.11 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.626 1.571 . . . . 0.0 107.149 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -72.64 147.08 46.12 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mm -140.34 124.69 18.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -79.79 114.35 18.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.4 m -106.42 18.55 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.49 -171.93 2.22 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 120.946 -1.096 . . . . 0.0 109.288 173.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.74 154.9 64.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.02 -11.11 25.7 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.059 2.506 . . . . 0.0 114.1 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -54.27 -37.26 64.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.575 1.55 . . . . 0.0 112.275 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.38 -41.85 75.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.141 0.882 . . . . 0.0 110.296 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -58.75 -31.44 68.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.945 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -64.66 -14.63 59.07 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -132.08 -36.47 1.17 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.536 1.062 . . . . 0.0 112.709 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.91 139.74 6.4 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.865 1.211 . . . . 0.0 108.256 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -141.71 154.7 45.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 170.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.39 128.8 14.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -29.68 65.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.046 0.539 . . . . 0.0 112.235 -169.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.94 22.77 36.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.241 -1.311 . . . . 0.0 113.12 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.57 163.69 17.62 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.173 1.487 . . . . 0.0 112.319 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 pt -137.36 144.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 127.053 2.141 . . . . 0.0 107.33 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.3 117.23 20.1 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.113 0.565 . . . . 0.0 109.805 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.0 mt -141.21 83.45 13.7 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.222 1.809 . . . . 0.0 106.268 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.32 152.83 24.3 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.769 2.979 . . . . 0.0 114.555 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -47.38 -36.57 9.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.651 1.981 . . . . 0.0 113.016 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -64.14 -20.06 65.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.29 -11.75 4.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.852 0.861 . . . . 0.0 112.105 -169.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -51.4 -33.75 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.763 1.225 . . . . 0.0 112.058 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -54.43 -35.75 63.28 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.577 1.151 . . . . 0.0 111.974 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.96 -42.17 5.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -66.96 -14.31 62.71 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 tp -52.18 -38.62 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.467 1.031 . . . . 0.0 111.204 170.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.76 98.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.131 0.878 . . . . 0.0 111.041 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.14 -35.63 69.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.531 0.732 . . . . 0.0 111.201 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.46 -46.27 67.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 0.0 111.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 t -143.66 101.32 5.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -171.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.17 -22.92 34.1 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.57 2.847 . . . . 0.0 115.53 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -144.43 116.63 8.44 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.305 1.042 . . . . 0.0 108.849 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -66.74 -4.56 9.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 113.088 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.62 -23.58 62.58 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.146 0.579 . . . . 0.0 111.087 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.13 150.0 45.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.07 130.17 41.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.685 -0.634 . . . . 0.0 109.416 -173.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -125.74 134.49 66.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.34 86.65 2.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.87 144.44 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -152.18 163.63 38.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.559 1.544 . . . . 0.0 108.379 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.71 170.46 21.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.466 1.106 . . . . 0.0 109.147 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -54.79 -14.98 1.6 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 -3.4 4.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.51 -30.26 0.59 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.447 1.499 . . . . 0.0 114.137 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -64.97 -49.71 69.22 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.438 1.095 . . . . 0.0 111.525 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.67 -31.35 71.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.399 0.545 . . . . 0.0 110.638 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -71.57 -30.89 66.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.173 -0.954 . . . . 0.0 111.289 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.2 -48.97 70.81 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 167.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -61.36 -44.42 97.19 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.974 -0.721 . . . . 0.0 111.166 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.06 75.46 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 118.372 0.533 . . . . 0.0 110.572 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.39 -40.38 85.66 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -64.12 -41.39 97.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.361 0.982 . . . . 0.0 110.842 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.11 -53.01 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -69.78 -23.19 63.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.927 -0.483 . . . . 0.0 111.829 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 34.9 m -63.12 -44.28 96.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.558 0.617 . . . . 0.0 110.128 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -67.22 -28.92 68.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.313 0.506 . . . . 0.0 110.884 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mmm -76.7 6.59 5.74 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.142 0.977 . . . . 0.0 112.73 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 42.51 8.55 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 119.677 1.126 . . . . 0.0 112.525 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.2 OUTLIER -53.3 161.85 0.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 175.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.33 -40.72 0.65 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 110.622 168.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -135.23 33.36 3.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.818 1.19 . . . . 0.0 112.537 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.4 t -82.42 140.67 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -147.16 143.6 28.36 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.075 0.95 . . . . 0.0 108.875 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -79.35 107.46 12.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.21 -29.29 70.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.059 0.544 . . . . 0.0 111.958 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.95 -162.12 25.21 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.05 30.83 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -58.19 -34.06 69.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 110.565 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.13 -14.66 63.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.92 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -110.7 -39.26 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.114 0.966 . . . . 0.0 111.33 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 mt -64.42 139.79 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.721 1.146 . . . . 0.0 109.498 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.06 27.39 7.18 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.022 1.329 . . . . 0.0 111.508 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.0 162.51 45.44 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.05 144.26 46.92 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.285 1.99 . . . . 0.0 110.547 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.14 153.09 51.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.609 0.764 . . . . 0.0 109.261 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.77 160.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.458 1.903 . . . . 0.0 106.725 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.47 157.05 23.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 173.508 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 . . . . . 0 C--O 1.235 0.334 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -141.12 153.37 45.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.091 1.757 . . . . 0.0 106.906 169.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -123.08 150.44 43.15 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 mm -140.04 123.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -80.87 111.18 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -103.3 20.69 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 11.6 ttt-85 -106.94 -175.48 2.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.194 -0.942 . . . . 0.0 109.61 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 4.4 m -69.14 156.86 90.72 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.185 0.594 . . . . 0.0 109.868 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.53 -14.2 4.62 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.107 3.205 . . . . 0.0 115.759 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -48.65 -38.02 19.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.099 1.36 . . . . 0.0 112.058 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.43 -48.52 12.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.227 0.467 . . . . 0.0 110.305 173.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -55.81 -38.99 70.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.129 0.971 . . . . 0.0 112.02 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -65.4 -7.8 15.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.259 1.424 . . . . 0.0 113.637 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -130.23 -29.68 2.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.657 1.117 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -167.04 143.15 4.35 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.062 1.301 . . . . 0.0 108.797 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -143.75 153.36 42.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.337 1.055 . . . . 0.0 108.217 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.44 131.58 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -33.64 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.373 0.669 . . . . 0.0 111.54 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.37 12.94 67.81 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.048 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.03 166.05 13.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.128 1.464 . . . . 0.0 112.169 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.45 142.16 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.022 2.129 . . . . 0.0 107.373 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -80.0 114.79 19.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.877 0.471 . . . . 0.0 110.231 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 mt -139.04 80.4 24.01 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.811 1.644 . . . . 0.0 107.034 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.62 153.86 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.669 2.912 . . . . 0.0 113.912 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 tp -46.61 -38.96 10.37 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 113.114 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -69.23 -13.14 62.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -126.98 -18.84 4.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.164 0.986 . . . . 0.0 111.989 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.55 -34.48 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.018 1.327 . . . . 0.0 112.813 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -57.11 -29.88 63.9 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.356 1.062 . . . . 0.0 112.476 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.18 -41.29 3.33 Favored 'General case' 0 C--N 1.334 -0.065 0 C-N-CA 123.374 0.67 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.12 -16.85 63.94 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.3 -35.16 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.662 1.119 . . . . 0.0 110.85 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.24 -7.15 28.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.931 0.893 . . . . 0.0 113.145 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 p -120.91 15.79 11.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.732 1.613 . . . . 0.0 110.512 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.74 -51.08 0.79 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.266 1.026 . . . . 0.0 110.733 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.21 67.51 21.34 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.726 1.21 . . . . 0.0 108.142 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.98 -28.92 75.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.331 2.021 . . . . 0.0 112.211 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.65 81.09 3.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -52.47 -26.4 12.78 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.934 1.294 . . . . 0.0 113.092 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -66.64 -24.33 66.28 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.172 0.989 . . . . 0.0 112.743 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.43 150.61 44.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.29 0.95 . . . . 0.0 109.8 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.35 137.78 54.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.546 -0.721 . . . . 0.0 110.221 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.7 131.57 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -125.34 90.94 3.32 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.7 144.46 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.08 162.22 38.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.706 1.202 . . . . 0.0 109.115 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.6 p -153.35 172.45 17.03 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.214 1.006 . . . . 0.0 109.603 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -51.28 -25.96 6.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.621 1.568 . . . . 0.0 115.232 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.77 -0.68 6.05 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 -36.64 0.96 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.594 1.569 . . . . 0.0 113.811 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -63.35 -44.3 95.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.902 1.351 . . . . 0.0 111.425 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -72.94 -29.07 62.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.098 0.408 . . . . 0.0 110.412 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -69.93 -32.41 70.67 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.945 -1.097 . . . . 0.0 109.961 168.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.38 -47.96 66.62 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.48 -41.8 98.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.261 1.03 . . . . 0.0 111.095 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.48 76.31 Favored 'General case' 0 CA--C 1.526 0.035 0 CA-C-N 118.802 0.728 . . . . 0.0 110.491 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.63 -41.43 79.47 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.95 -44.34 94.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.47 1.032 . . . . 0.0 110.53 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.5 -52.12 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.97 0.908 . . . . 0.0 109.431 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.09 -26.75 65.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.989 -0.444 . . . . 0.0 110.954 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 m -61.38 -39.39 90.5 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.551 -0.718 . . . . 0.0 110.627 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.91 -41.8 77.69 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.263 0.483 . . . . 0.0 110.424 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -74.41 -16.2 60.89 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.54 46.07 0.19 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.01 168.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.05 157.48 3.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.639 1.219 . . . . 0.0 112.752 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.9 -44.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 109.491 168.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.99 35.47 2.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.394 1.078 . . . . 0.0 111.359 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.76 135.68 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -140.22 146.86 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.385 1.074 . . . . 0.0 108.963 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -80.15 113.9 18.67 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.6 -31.34 71.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.469 0.708 . . . . 0.0 111.685 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.88 -165.39 24.27 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.9 160.41 31.1 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.3 tp -49.6 -34.08 16.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.014 1.725 . . . . 0.0 111.944 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -66.68 -9.8 39.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 112.53 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.88 -27.39 3.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.223 1.409 . . . . 0.0 112.751 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.03 89.88 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.572 1.533 . . . . 0.0 107.037 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.57 27.39 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.358 1.463 . . . . 0.0 113.15 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -73.13 156.37 89.48 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 123.51 0.724 . . . . 0.0 109.226 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.24 155.24 12.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.458 2.772 . . . . 0.0 111.643 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -132.87 154.64 50.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.036 0.534 . . . . 0.0 110.518 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -133.02 173.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.298 2.239 . . . . 0.0 105.652 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -125.41 146.04 49.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.986 -1.071 . . . . 0.0 109.217 -172.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 172.701 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 . . . . . 0 C--O 1.236 0.343 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -140.38 169.92 16.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.534 1.134 . . . . 0.0 108.264 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -131.11 138.39 49.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -169.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.1 mm -137.84 129.75 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.71 120.61 26.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.415 HG23 ' SG ' ' A' ' 48' ' ' CYS . 29.2 m -111.97 19.42 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 118.199 0.454 . . . . 0.0 111.617 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -98.77 -177.62 3.71 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.347 -0.846 . . . . 0.0 109.601 176.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.43 154.46 54.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.16 -19.67 12.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.568 2.846 . . . . 0.0 114.899 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -47.45 -44.83 25.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -73.0 -45.86 55.46 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.747 0.703 . . . . 0.0 110.719 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -55.29 -37.15 66.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.41 1.484 . . . . 0.0 111.37 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -67.64 -16.31 64.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.73 1.212 . . . . 0.0 113.119 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -92.51 -59.74 2.0 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -159.95 158.85 31.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.363 1.465 . . . . 0.0 107.755 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -140.19 154.36 46.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.38 141.31 13.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.49 121.56 4.61 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.385 1.074 . . . . 0.0 110.132 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.26 2.91 68.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.536 -1.147 . . . . 0.0 114.14 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 154.51 35.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.505 1.652 . . . . 0.0 110.964 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.02 127.93 73.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.39 114.36 9.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.754 0.706 . . . . 0.0 109.501 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -140.54 79.7 19.79 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.325 1.85 . . . . 0.0 106.508 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.54 151.24 24.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.951 3.1 . . . . 0.0 114.731 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -47.92 -38.92 17.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.881 2.072 . . . . 0.0 112.863 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -64.4 -20.45 66.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -129.71 -3.49 4.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.047 0.939 . . . . 0.0 112.045 -169.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 p -49.97 -40.98 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.476 1.111 . . . . 0.0 111.691 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -56.93 -38.01 72.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.802 0.841 . . . . 0.0 112.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -90.31 -3.76 57.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.591 0.757 . . . . 0.0 111.399 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -132.12 -26.54 1.91 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -59.56 -35.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.855 0.752 . . . . 0.0 110.739 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.12 96.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.559 0.618 . . . . 0.0 111.26 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -36.14 65.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.157 0.583 . . . . 0.0 111.143 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.19 -42.27 72.61 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.476 0.58 . . . . 0.0 111.705 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.28 82.36 13.16 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.37 1.468 . . . . 0.0 108.247 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.44 -37.78 93.19 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.014 2.476 . . . . 0.0 113.133 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -79.2 96.02 5.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -69.51 -3.28 13.98 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -7.12 25.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.732 1.213 . . . . 0.0 111.108 174.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.11 150.56 49.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.668 1.122 . . . . 0.0 109.327 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -73.88 131.81 41.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -130.48 96.31 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -74.62 134.36 42.07 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.01 146.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -146.25 163.16 36.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.003 1.321 . . . . 0.0 108.162 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' A' ' 7' ' ' VAL . 1.7 m -159.99 -178.59 7.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.801 1.641 . . . . 0.0 109.695 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -63.03 132.35 51.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 166.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.85 0.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.162 2.185 . . . . 0.0 116.413 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.03 -8.0 40.39 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.836 1.208 . . . . 0.0 114.252 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -63.06 -56.89 13.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.545 1.672 . . . . 0.0 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.74 -29.49 70.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.948 -170.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -76.19 -33.23 59.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.204 -0.935 . . . . 0.0 111.28 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.37 -47.4 75.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.32 -46.53 88.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.643 0.777 . . . . 0.0 110.533 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.3 73.96 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 121.719 -0.613 . . . . 0.0 111.058 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HE2' HG23 ' A' ' 69' ' ' VAL . 12.3 tmtt? -64.39 -44.75 90.35 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.24 -33.07 72.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.105 0.866 . . . . 0.0 111.215 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.32 -49.9 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.204 0.911 . . . . 0.0 108.938 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.88 -31.29 70.98 Favored 'General case' 0 C--O 1.231 0.123 0 O-C-N 121.54 -0.725 . . . . 0.0 111.378 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.94 -41.04 99.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.38 -35.91 80.28 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.78 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.86 -7.09 25.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.192 0.997 . . . . 0.0 112.318 171.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.51 12.42 59.64 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.155 -0.966 . . . . 0.0 113.328 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -68.35 148.07 51.23 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.068 1.434 . . . . 0.0 108.106 168.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.5 t -128.0 -10.29 5.4 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -128.51 34.27 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.31 1.044 . . . . 0.0 110.109 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.451 HG23 ' HE2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -79.1 143.06 13.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -146.94 128.74 15.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -76.75 104.56 7.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.21 66.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.589 0.755 . . . . 0.0 111.872 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.3 -166.54 24.96 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.983 0.801 . . . . 0.0 111.227 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.76 48.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.2 tp -44.94 -49.7 10.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 -25.35 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.305 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.74 -28.35 30.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.007 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.56 120.33 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.611 1.096 . . . . 0.0 108.884 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.5 55.54 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.563 1.545 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.0 mtp -134.53 156.14 79.04 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 124.792 1.237 . . . . 0.0 108.673 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.81 157.3 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.073 2.515 . . . . 0.0 111.434 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -134.69 128.97 34.05 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.09 139.58 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.65 155.78 28.82 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.993 -0.442 . . . . 0.0 110.805 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 168.504 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -84.32 158.39 21.19 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -133.97 122.13 22.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -123.57 126.46 73.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.04 117.19 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.275 21.5 m -114.6 52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 12.9 ttt180 -141.44 -169.92 2.97 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.508 -1.37 . . . . 0.0 110.144 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 12.0 m -58.62 153.95 37.88 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.34 -22.15 15.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.157 2.572 . . . . 0.0 114.124 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.69 -25.49 64.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.101 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -78.37 -49.86 12.78 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 120.22 1.373 . . . . 0.0 109.43 169.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.55 -40.71 75.6 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.469 1.107 . . . . 0.0 111.691 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.14 -4.76 11.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.027 1.331 . . . . 0.0 113.599 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -126.27 -34.6 2.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.941 1.246 . . . . 0.0 111.912 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -163.79 145.77 9.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.852 1.206 . . . . 0.0 109.243 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -146.75 154.87 41.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.78 1.232 . . . . 0.0 107.944 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.92 131.24 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.95 -36.5 49.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -166.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.18 2.11 83.3 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.601 0.637 . . . . 0.0 113.672 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.3 157.72 37.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.255 1.026 . . . . 0.0 113.636 -169.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.3 pt -131.52 134.44 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.14 120.87 25.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.802 0.441 . . . . 0.0 109.981 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -143.72 94.46 6.0 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.69 151.24 11.01 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.053 3.168 . . . . 0.0 114.86 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.52 -50.06 33.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.962 1.305 . . . . 0.0 112.272 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -71.75 -5.65 35.58 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -124.1 -18.95 5.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.608 1.163 . . . . 0.0 111.96 -167.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.34 -31.93 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.813 1.645 . . . . 0.0 112.452 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -52.73 -40.48 63.1 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.5 1.12 . . . . 0.0 111.802 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.26 -45.97 8.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.898 0.317 . . . . 0.0 110.543 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -73.05 -20.35 61.0 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.624 -0.672 . . . . 0.0 112.207 -168.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.54 -33.6 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.391 0.996 . . . . 0.0 110.642 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.04 -17.01 61.77 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 p -116.81 -29.31 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 110.984 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.06 72.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.68 0.673 . . . . 0.0 111.271 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.52 74.34 28.44 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.894 1.677 . . . . 0.0 106.507 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.19 -29.41 39.35 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.09 1.86 . . . . 0.0 112.435 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -79.68 95.14 5.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.435 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -62.47 -10.62 12.29 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -81.99 -19.94 39.51 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.839 1.199 . . . . 0.0 111.795 173.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.49 146.21 54.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.877 0.762 . . . . 0.0 110.635 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -70.68 145.98 50.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.139 0.976 . . . . 0.0 110.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.06 141.88 40.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -117.03 144.01 45.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.787 1.235 . . . . 0.0 107.928 171.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.75 144.34 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.367 1.067 . . . . 0.0 108.762 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -157.58 149.11 21.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.406 1.483 . . . . 0.0 109.19 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 t -149.01 174.64 12.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.989 1.716 . . . . 0.0 108.427 -168.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.13 -25.07 60.96 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.604 0.761 . . . . 0.0 112.92 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.65 140.81 41.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.596 1.159 . . . . 0.0 108.836 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.97 -28.87 72.74 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.213 0.911 . . . . 0.0 113.054 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -55.55 -46.11 77.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.483 1.141 . . . . 0.0 110.035 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -71.86 -36.89 70.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.633 0.651 . . . . 0.0 110.095 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -56.9 -44.63 82.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.268 0.485 . . . . 0.0 110.038 169.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.99 -43.04 98.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.95 1.262 . . . . 0.0 111.859 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -62.08 -43.01 99.76 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 118.445 1.123 . . . . 0.0 110.509 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.36 76.79 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-N 119.008 0.822 . . . . 0.0 110.651 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -64.07 -45.83 87.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.03 -39.45 94.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.269 0.486 . . . . 0.0 111.014 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.61 -48.04 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.975 0.807 . . . . 0.0 109.621 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.02 -29.04 66.0 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.7 m -67.11 -38.52 85.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.04 0.536 . . . . 0.0 110.61 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.1 -37.74 88.46 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.147 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.23 -3.82 18.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.841 0.856 . . . . 0.0 112.708 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.29 22.91 76.97 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.217 172.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 10.9 m-85 -65.36 124.09 21.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.175 1.487 . . . . 0.0 107.728 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -27.3 67.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.311 0.644 . . . . 0.0 112.364 -169.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -139.27 107.64 5.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.7 t -141.99 144.15 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.92 125.74 25.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -71.16 109.14 5.04 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.98 -25.09 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.862 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.04 -166.61 23.63 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.21 157.55 40.95 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 168.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.44 -41.96 86.28 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.767 -0.843 . . . . 0.0 110.462 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.3 -29.78 69.46 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.281 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.36 -39.91 31.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.15 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.0 137.79 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.579 0.627 . . . . 0.0 109.631 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.2 23.73 14.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.419 1.088 . . . . 0.0 112.296 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -72.84 154.4 91.09 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.79 152.35 17.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.715 2.943 . . . . 0.0 112.137 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -140.17 152.92 46.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.688 0.795 . . . . 0.0 109.448 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.3 158.17 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.337 1.855 . . . . 0.0 107.242 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.69 154.14 38.57 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.668 -0.645 . . . . 0.0 110.251 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 171.134 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.236 0.353 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -137.3 156.66 47.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.257 1.823 . . . . 0.0 106.773 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -128.94 139.21 52.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.4 mm -130.93 121.18 49.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -81.3 110.42 16.74 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 166.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 m -99.11 21.46 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -111.26 -172.25 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.004 -1.06 . . . . 0.0 110.381 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.75 152.59 95.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.105 0.562 . . . . 0.0 110.181 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.72 -19.63 11.05 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.625 2.883 . . . . 0.0 114.836 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.43 -28.82 67.29 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.286 -0.864 . . . . 0.0 112.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -77.41 -46.43 22.72 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.841 1.2 . . . . 0.0 109.39 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -56.43 -40.82 75.38 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.858 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -62.4 -46.99 86.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.1 0.96 . . . . 0.0 111.381 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.51 -48.23 17.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.58 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.02 142.51 7.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.125 0.875 . . . . 0.0 110.185 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -135.38 155.32 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.917 1.287 . . . . 0.0 108.198 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.68 130.18 20.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.39 114.74 3.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.58 -12.97 18.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.888 1.232 . . . . 0.0 111.942 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 164.0 24.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.307 1.054 . . . . 0.0 111.751 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.6 pt -138.84 140.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 126.53 1.932 . . . . 0.0 106.921 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.09 114.18 18.8 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.62 83.77 16.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.49 153.55 13.57 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.034 3.156 . . . . 0.0 113.378 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.9 tp -50.41 -35.6 29.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.213 1.405 . . . . 0.0 112.555 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -66.47 -15.43 63.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.672 0.789 . . . . 0.0 113.021 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -129.01 -18.44 3.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.279 1.031 . . . . 0.0 112.111 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.52 -34.05 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.014 1.326 . . . . 0.0 111.969 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.63 -11.69 46.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.125 0.97 . . . . 0.0 113.384 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -122.06 -53.42 1.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.093 0.957 . . . . 0.0 108.481 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.51 -23.19 67.29 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -56.01 -36.35 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.453 1.024 . . . . 0.0 110.884 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.68 51.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.775 0.83 . . . . 0.0 112.802 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -119.95 12.31 11.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.866 1.666 . . . . 0.0 110.813 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.08 -38.14 1.44 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.618 1.167 . . . . 0.0 111.433 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.94 71.99 48.25 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.54 -29.36 52.82 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.506 2.137 . . . . 0.0 112.607 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -78.58 96.78 5.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.65 -11.01 21.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -76.86 -17.49 58.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.258 0.935 . . . . 0.0 111.879 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.1 157.79 36.92 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.773 0.715 . . . . 0.0 111.826 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -73.79 133.67 43.29 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.76 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.78 96.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -79.01 132.28 36.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.12 135.27 64.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 123.735 0.814 . . . . 0.0 109.57 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.91 162.22 39.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.851 1.66 . . . . 0.0 108.736 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -154.64 165.81 35.36 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.399 1.48 . . . . 0.0 107.594 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -54.57 -31.98 57.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 113.009 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.87 -15.89 43.09 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.67 35.08 61.5 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.977 1.262 . . . . 0.0 112.752 -170.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -144.15 -53.87 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.666 1.186 . . . . 0.0 109.919 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.76 -27.89 68.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.27 0.628 . . . . 0.0 110.461 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -66.33 -40.06 89.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.955 1.302 . . . . 0.0 112.519 170.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.68 96.13 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -64.02 -47.12 81.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.971 0.885 . . . . 0.0 110.399 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.94 72.68 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 122.203 -0.311 . . . . 0.0 110.986 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -62.81 -45.45 92.59 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -64.05 -40.18 95.73 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.852 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.32 -53.18 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 118.947 0.794 . . . . 0.0 109.235 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.3 mt -69.31 -29.14 66.93 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.961 -0.462 . . . . 0.0 110.93 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -65.52 -40.57 93.13 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.241 0.473 . . . . 0.0 110.697 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.07 -36.67 84.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.884 0.766 . . . . 0.0 110.094 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -71.94 -3.25 21.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.04 0.936 . . . . 0.0 112.712 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 16.92 72.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.56 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -67.12 127.41 32.5 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 p -86.5 -21.83 26.75 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -131.49 35.99 3.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.763 0.825 . . . . 0.0 111.197 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.44 146.3 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.15 125.68 15.8 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -75.13 97.99 3.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.09 72.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.033 0.533 . . . . 0.0 110.679 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 -115.07 0.94 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.09 172.69 25.14 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.22 -34.46 77.69 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.002 0.521 . . . . 0.0 111.297 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.35 -36.03 80.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.823 0.449 . . . . 0.0 110.537 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.48 -41.98 31.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.509 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.91 142.91 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.859 0.754 . . . . 0.0 109.686 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.89 24.53 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.828 1.251 . . . . 0.0 111.923 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.39 165.37 49.19 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.495 1.118 . . . . 0.0 108.85 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -52.49 149.29 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.844 2.363 . . . . 0.0 111.359 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.97 148.94 45.7 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.55 149.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.42 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.1 165.02 22.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.661 0.384 . . . . 0.0 110.94 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.785 1.183 . . . . 0.0 110.625 173.355 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.237 0.404 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -140.33 161.75 36.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.849 2.06 . . . . 0.0 106.98 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -119.15 143.34 47.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -138.62 131.68 39.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.46 125.09 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.03 14.32 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -91.9 -169.18 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.397 1.453 . . . . 0.0 109.695 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -57.91 150.4 49.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.089 0.555 . . . . 0.0 109.637 167.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.47 -19.22 67.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.306 2.004 . . . . 0.0 112.624 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.08 -24.89 67.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.919 -1.113 . . . . 0.0 112.145 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -68.61 -41.18 79.92 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.517 1.053 . . . . 0.0 109.913 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -59.85 -37.34 79.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.736 1.615 . . . . 0.0 110.269 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.01 -43.49 81.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.515 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -66.39 -58.2 5.79 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -174.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -167.02 151.27 6.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.959 1.704 . . . . 0.0 107.114 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -138.53 153.61 48.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.61 126.92 12.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 96.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.51 -18.71 4.1 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.82 1.2 . . . . 0.0 111.63 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.42 162.8 25.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.146 0.973 . . . . 0.0 110.202 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -135.66 147.16 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.787 1.635 . . . . 0.0 106.831 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -80.87 116.55 20.91 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -136.92 81.52 33.36 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.48 150.45 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.5 2.8 . . . . 0.0 114.078 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -47.49 -41.54 20.99 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.671 1.989 . . . . 0.0 111.933 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.97 -15.77 57.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -129.55 -13.36 4.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.471 1.108 . . . . 0.0 112.053 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.15 -35.04 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.966 1.306 . . . . 0.0 111.735 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -56.6 -34.5 67.26 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.744 0.818 . . . . 0.0 112.234 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.4 -47.09 4.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -65.57 -22.2 66.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.673 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.66 -32.79 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.658 1.117 . . . . 0.0 111.267 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.74 60.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 112.899 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -111.39 -28.72 8.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.661 1.184 . . . . 0.0 111.01 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.55 -43.78 68.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.817 0.735 . . . . 0.0 111.546 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.94 77.11 18.89 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.036 1.334 . . . . 0.0 107.403 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.44 -36.03 93.26 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.102 2.535 . . . . 0.0 114.368 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -77.55 98.66 5.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.212 0.605 . . . . 0.0 109.484 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.15 -6.65 18.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -85.45 -14.74 45.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.184 0.902 . . . . 0.0 111.929 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.913 0.885 . . . . 0.0 110.427 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -77.98 96.44 5.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.968 0.907 . . . . 0.0 110.17 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.51 93.28 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -73.36 129.74 38.65 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -115.18 143.31 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -142.13 168.12 20.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.216 1.006 . . . . 0.0 108.355 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.3 p -153.19 178.3 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -60.31 -25.43 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.76 5.76 4.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -29.67 2.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.987 1.279 . . . . 0.0 114.532 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.5 -51.95 67.28 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.535 1.168 . . . . 0.0 111.481 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -69.01 -33.83 74.29 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.889 -171.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -68.28 -34.93 77.06 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.156 0.889 . . . . 0.0 110.974 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.3 -50.92 57.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -62.93 -46.28 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.388 0.594 . . . . 0.0 110.864 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.51 -34.38 70.88 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 110.581 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.5 94.32 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.52 -43.24 77.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.287 0.494 . . . . 0.0 110.301 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -56.93 -49.16 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.474 0.71 . . . . 0.0 109.302 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.34 -30.67 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.709 0.804 . . . . 0.0 111.313 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 m -69.81 -37.51 76.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.682 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.72 -36.66 84.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.98 0.809 . . . . 0.0 110.162 174.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mmm -69.48 -3.78 15.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.34 1.056 . . . . 0.0 112.702 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.54 78.99 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.531 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -64.54 123.56 19.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.909 1.354 . . . . 0.0 107.599 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -29.78 69.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.157 0.583 . . . . 0.0 112.362 -169.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.01 111.81 7.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -146.7 149.57 15.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.76 128.39 9.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -80.19 113.38 18.32 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.3 69.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.95 -26.23 7.6 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.368 0.985 . . . . 0.0 112.335 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.96 167.79 16.04 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.89 1.233 . . . . 0.0 110.324 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.9 tp -54.77 -33.15 60.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.129 0.972 . . . . 0.0 112.313 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.12 -29.04 69.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.599 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.79 -40.83 54.43 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.48 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -53.27 117.24 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 123.441 0.697 . . . . 0.0 111.359 -168.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 50.67 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.353 1.461 . . . . 0.0 109.72 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.1 mmm -133.42 154.48 80.92 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.477 1.511 . . . . 0.0 108.143 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.72 145.94 29.15 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.684 2.256 . . . . 0.0 110.677 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.08 147.56 33.95 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.66 154.6 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.984 0.914 . . . . 0.0 108.835 -167.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -63.46 150.19 44.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.85 0.46 . . . . 0.0 110.08 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 173.861 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.238 0.468 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -148.41 126.71 12.23 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -76.14 143.67 41.04 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -140.36 128.95 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.97 124.95 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.05 16.35 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -89.46 -176.17 4.95 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.757 -1.214 . . . . 0.0 108.636 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 m -63.9 154.34 81.64 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 121.813 -0.554 . . . . 0.0 109.51 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.3 -12.99 35.59 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.314 2.676 . . . . 0.0 114.25 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.05 -37.83 69.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.824 0.849 . . . . 0.0 111.573 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.67 -43.29 84.91 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.854 0.752 . . . . 0.0 110.128 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -57.74 -30.5 65.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.955 1.302 . . . . 0.0 111.269 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -65.87 -50.79 63.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.305 0.642 . . . . 0.0 110.856 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.97 -49.88 40.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.868 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.85 150.81 13.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.824 0.738 . . . . 0.0 110.49 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -139.07 156.03 47.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.947 1.299 . . . . 0.0 108.289 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.75 130.85 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.69 105.97 0.73 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.67 -13.48 9.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.045 1.307 . . . . 0.0 112.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.08 155.05 41.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.342 1.071 . . . . 0.0 110.191 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mm -120.09 135.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.98 116.15 16.39 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.54 81.06 17.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.611 . . . . 0.0 106.77 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.4 151.4 23.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.778 2.985 . . . . 0.0 114.31 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.8 tp -48.6 -41.66 31.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.29 1.836 . . . . 0.0 113.001 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.75 -12.0 61.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -126.15 -15.28 5.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.938 1.295 . . . . 0.0 112.051 -169.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.06 -39.79 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.769 1.627 . . . . 0.0 113.252 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -55.26 -40.93 71.52 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.575 0.75 . . . . 0.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -91.07 -2.4 57.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.219 0.607 . . . . 0.0 111.272 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.32 -15.32 1.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.79 -40.37 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.052 1.296 . . . . 0.0 111.262 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.22 -32.55 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.405 0.548 . . . . 0.0 112.13 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -10.3 58.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.909 0.883 . . . . 0.0 113.175 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 -30.4 4.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.356 0.98 . . . . 0.0 111.992 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.42 79.69 41.37 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.571 1.149 . . . . 0.0 107.994 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.98 -37.75 91.73 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.415 2.077 . . . . 0.0 112.131 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -77.51 96.76 4.81 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.134 0.974 . . . . 0.0 109.841 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.37 8.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -107.8 -6.99 16.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.671 1.188 . . . . 0.0 111.769 170.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.39 145.34 52.95 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 m -80.14 97.36 6.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 109.676 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -72.03 104.7 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -83.16 84.65 7.4 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 m -69.34 140.17 19.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -145.12 164.04 32.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.178 0.991 . . . . 0.0 108.936 171.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.02 171.25 18.66 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.281 1.432 . . . . 0.0 107.717 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -49.94 -33.22 16.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.02 -6.73 10.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.12 -31.44 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.792 1.178 . . . . 0.0 113.949 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.78 -56.48 21.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.852 1.326 . . . . 0.0 111.303 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.03 -32.4 74.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.674 0.39 . . . . 0.0 110.824 -169.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 p -71.66 -35.53 70.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.339 0.972 . . . . 0.0 111.405 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.27 -48.52 59.27 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.94 -48.4 76.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.671 0.788 . . . . 0.0 110.576 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.95 69.2 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.891 -0.506 . . . . 0.0 111.814 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -60.83 -45.0 96.18 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.92 -41.59 91.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.142 0.428 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.88 -50.53 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.6 mt -70.31 -29.01 65.64 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.554 -0.717 . . . . 0.0 111.395 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.386 0.539 . . . . 0.0 109.953 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.95 -35.78 78.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.282 0.633 . . . . 0.0 110.968 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.5 mmm -64.98 -15.48 62.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.851 0.86 . . . . 0.0 112.118 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.37 14.43 55.74 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.074 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -66.25 121.67 15.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.235 1.517 . . . . 0.0 107.37 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.5 p -75.08 -23.81 58.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.497 0.319 . . . . 0.0 111.522 -171.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -134.98 104.81 6.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.819 1.248 . . . . 0.0 107.67 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -142.16 143.33 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.39 127.17 17.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.14 111.98 9.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 166.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.55 66.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.29 -26.84 10.69 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 125.026 1.298 . . . . 0.0 110.765 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.3 174.68 13.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 124.524 1.059 . . . . 0.0 111.481 168.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 tp -60.45 -30.33 69.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 110.067 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -61.55 -18.82 60.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.748 1.619 . . . . 0.0 113.271 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -118.12 -36.93 3.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.027 0.83 . . . . 0.0 112.021 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 80' ' ' MET . 82.4 mt -57.52 141.2 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.029 0.831 . . . . 0.0 109.538 174.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.88 24.5 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.011 1.324 . . . . 0.0 111.959 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.419 ' H ' HG22 ' A' ' 78' ' ' ILE . 93.2 mmm -69.52 164.16 52.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.506 1.123 . . . . 0.0 108.596 167.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.77 147.78 30.71 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.612 2.208 . . . . 0.0 110.904 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -134.78 142.86 46.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.27 149.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.131 1.372 . . . . 0.0 108.486 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -69.08 162.19 27.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.769 0.428 . . . . 0.0 111.093 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 124.883 1.23 . . . . 0.0 110.611 172.725 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.235 0.314 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -82.69 100.66 10.36 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -73.01 145.45 46.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.9 mt -147.16 139.26 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -96.93 124.97 41.05 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.45 12.74 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.77 -174.34 4.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.172 1.351 . . . . 0.0 108.159 167.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 9' ' ' VAL . 1.6 m -57.29 156.04 16.38 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.656 0.782 . . . . 0.0 110.358 167.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.48 -14.35 43.83 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.081 2.521 . . . . 0.0 113.511 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -46.15 -49.44 16.79 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 110.82 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -69.75 -37.81 76.59 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.308 -0.245 . . . . 0.0 110.383 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -58.46 -31.22 67.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.119 1.368 . . . . 0.0 111.314 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -67.12 -39.67 86.7 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.23 0.468 . . . . 0.0 110.73 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -68.73 -54.21 17.46 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.27 152.53 4.99 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.015 1.726 . . . . 0.0 106.907 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.65 147.98 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 108.952 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.6 t -54.09 125.77 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -56.34 -24.11 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -166.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.59 -8.07 41.05 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.885 0.755 . . . . 0.0 112.764 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.81 170.3 15.61 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.223 1.011 . . . . 0.0 111.094 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.6 pt -142.95 138.92 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.661 2.384 . . . . 0.0 105.213 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.38 116.43 18.79 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.3 mt -140.67 86.98 11.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.95 153.47 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.638 2.892 . . . . 0.0 113.9 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.7 tp -51.21 -35.81 38.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.065 1.746 . . . . 0.0 112.943 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.22 -16.49 63.59 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.501 0.721 . . . . 0.0 112.775 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.76 -22.26 3.59 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.553 1.141 . . . . 0.0 111.911 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -47.42 -37.19 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.641 1.576 . . . . 0.0 112.377 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.75 -33.12 60.79 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.416 1.086 . . . . 0.0 112.301 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.52 -45.24 4.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.0 0.52 . . . . 0.0 109.951 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.91 -19.64 65.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.311 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -54.97 -34.99 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.104 0.866 . . . . 0.0 111.133 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.16 96.64 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.19 0.904 . . . . 0.0 111.273 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -37.04 45.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.463 0.705 . . . . 0.0 111.133 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.7 72.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.369 0.531 . . . . 0.0 112.057 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -139.55 79.42 24.53 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.771 1.628 . . . . 0.0 107.179 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.91 10.68 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.766 2.978 . . . . 0.0 114.502 -171.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -138.21 107.88 6.24 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.272 1.429 . . . . 0.0 107.163 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -63.25 -15.08 55.99 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.64 -15.51 58.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.73 0.695 . . . . 0.0 111.957 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -67.94 150.19 48.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.027 0.83 . . . . 0.0 110.672 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -70.24 141.87 52.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.969 0.907 . . . . 0.0 109.674 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.85 145.33 31.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -130.72 135.33 47.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.92 137.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -136.68 168.57 19.27 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 p -152.55 -175.89 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 170.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -59.18 -29.55 67.54 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.65 10.33 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -168.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.52 -29.36 2.29 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.795 1.188 . . . . 0.0 114.304 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -62.34 -50.85 69.99 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.374 1.087 . . . . 0.0 111.418 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -69.49 -31.97 70.57 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.537 0.608 . . . . 0.0 110.569 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -36.22 82.45 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 119.381 0.991 . . . . 0.0 110.734 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.24 -52.0 50.33 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -62.4 -46.24 89.48 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.486 -0.42 . . . . 0.0 111.176 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.32 74.84 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 118.222 0.465 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -63.05 -43.45 98.62 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.98 -44.78 91.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.662 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.56 -52.51 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.976 0.807 . . . . 0.0 109.072 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.15 -28.4 64.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.987 -0.446 . . . . 0.0 111.221 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.0 m -65.23 -42.16 93.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.353 0.524 . . . . 0.0 110.397 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.12 -33.92 76.49 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.879 0.763 . . . . 0.0 110.91 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -69.46 -8.75 49.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.845 0.858 . . . . 0.0 112.303 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.97 60.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.972 -0.904 . . . . 0.0 113.467 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.98 120.81 19.12 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -84.6 -17.22 39.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -167.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -133.24 38.77 3.3 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.873 0.869 . . . . 0.0 111.037 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -80.6 145.81 8.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -140.91 137.91 33.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.715 0.806 . . . . 0.0 109.139 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -72.32 106.73 4.59 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.89 79.18 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.39 -148.22 19.83 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.73 167.26 13.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.35 -34.17 66.36 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.533 1.133 . . . . 0.0 112.552 -170.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.36 -11.44 57.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.114 0.966 . . . . 0.0 113.168 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -117.1 -34.87 4.24 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.796 1.238 . . . . 0.0 111.982 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.4 127.14 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.23 24.31 8.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.484 1.113 . . . . 0.0 111.869 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.1 165.36 48.56 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 167.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.31 149.9 21.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.484 2.122 . . . . 0.0 111.688 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -131.91 158.47 41.31 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.878 0.871 . . . . 0.0 109.118 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -128.72 169.05 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -131.68 167.77 18.89 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.949 -1.094 . . . . 0.0 109.685 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 173.562 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--O 1.237 0.399 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.55 152.27 43.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.442 1.497 . . . . 0.0 107.806 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -130.04 136.13 49.03 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.591 1.156 . . . . 0.0 108.78 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.96 131.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.21 117.05 23.27 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.84 23.12 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 5.6 ttt180 -111.24 -175.5 2.72 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.8 -1.188 . . . . 0.0 110.74 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 2.7 m -60.64 150.41 75.4 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.875 0.87 . . . . 0.0 109.971 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -53.81 -23.98 29.09 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.573 2.849 . . . . 0.0 115.118 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.92 -26.35 68.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 117.428 -1.272 . . . . 0.0 113.283 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.01 -50.82 45.39 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 120.818 1.645 . . . . 0.0 109.5 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -55.91 -37.28 68.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.164 1.386 . . . . 0.0 111.373 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -61.77 -11.05 10.48 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.379 1.471 . . . . 0.0 113.985 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.16 -38.76 1.77 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.513 1.506 . . . . 0.0 112.153 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -156.48 145.32 20.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.042 1.292 . . . . 0.0 110.754 168.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -142.06 154.77 45.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 107.49 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.21 132.61 20.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -55.88 120.45 7.4 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.27 -13.51 61.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.298 0.951 . . . . 0.0 112.984 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.02 161.17 30.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.474 1.137 . . . . 0.0 111.067 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.58 137.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.9 1.68 . . . . 0.0 107.338 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.27 117.15 19.25 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -143.2 87.93 8.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -54.12 155.6 15.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.1 3.2 . . . . 0.0 114.382 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 tp -48.49 -41.93 31.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.2 1.8 . . . . 0.0 112.979 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.18 -8.38 54.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.5 -17.1 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.104 1.362 . . . . 0.0 111.829 -169.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.29 -30.42 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.314 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.6 -47.66 73.12 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.732 1.213 . . . . 0.0 111.623 -169.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -88.95 -41.82 12.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.93 0.332 . . . . 0.0 110.241 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -70.28 -15.36 62.89 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.59 -33.22 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.071 0.85 . . . . 0.0 110.851 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.11 -40.69 98.35 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.42 1.009 . . . . 0.0 111.043 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.28 -36.73 66.37 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.26 0.624 . . . . 0.0 111.168 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.43 72.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.478 0.581 . . . . 0.0 111.968 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.08 83.66 11.0 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.719 1.607 . . . . 0.0 107.425 -171.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.6 -38.12 96.17 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.875 2.383 . . . . 0.0 113.845 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -85.37 99.96 11.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.224 0.609 . . . . 0.0 109.677 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 48.6 pttt -62.81 -15.32 53.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -82.86 -11.9 57.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.024 0.829 . . . . 0.0 111.912 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.07 155.48 40.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.878 0.763 . . . . 0.0 111.191 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 140.01 54.25 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.38 140.5 43.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -123.75 147.46 28.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -150.07 164.72 34.82 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.894 1.677 . . . . 0.0 107.231 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -161.09 157.19 25.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.572 0.349 . . . . 0.0 110.167 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.93 -23.62 19.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.13 0.972 . . . . 0.0 112.72 168.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.06 105.12 7.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 170.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.99 -23.77 57.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.622 1.106 . . . . 0.0 114.215 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -57.6 -36.9 72.36 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.433 1.116 . . . . 0.0 111.778 171.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.53 -37.67 71.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.567 0.747 . . . . 0.0 110.685 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p -68.24 -26.99 65.97 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 110.824 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.36 -46.24 93.25 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -61.02 -48.7 80.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.865 0.833 . . . . 0.0 110.242 175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.14 77.13 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.819 0.282 . . . . 0.0 110.706 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.77 -39.57 92.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.42 -35.32 73.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.174 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.05 -47.99 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.749 1.159 . . . . 0.0 108.786 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.68 -33.82 76.49 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.668 -0.645 . . . . 0.0 110.861 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 m -65.56 -39.21 91.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.828 0.451 . . . . 0.0 110.656 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.12 -36.22 82.56 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.504 0.721 . . . . 0.0 110.241 175.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mmm -69.17 -3.92 15.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.189 0.995 . . . . 0.0 112.595 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.4 14.75 65.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.359 170.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 20.9 m-85 -70.0 129.14 38.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.936 1.368 . . . . 0.0 107.552 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -91.59 -18.74 23.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -167.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.88 40.47 3.36 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.323 1.049 . . . . 0.0 110.387 -169.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.78 149.45 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -143.93 142.06 30.56 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -86.33 106.8 17.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.75 66.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.872 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.53 -165.64 14.47 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.968 0.794 . . . . 0.0 112.238 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.48 151.7 52.33 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.92 30.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.255 1.822 . . . . 0.0 113.134 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -64.14 -33.19 75.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.607 0.763 . . . . 0.0 111.825 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.41 -30.03 64.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.371 0.532 . . . . 0.0 111.705 -172.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.76 91.28 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 26.43 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.851 1.261 . . . . 0.0 113.507 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.8 mtp -77.64 158.89 77.91 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.42 153.97 12.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.582 2.855 . . . . 0.0 111.703 167.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -138.97 153.9 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 108.864 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.7 p -151.84 156.69 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -68.16 152.17 45.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.796 0.839 . . . . 0.0 109.134 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.074 174.725 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.236 0.39 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -77.17 151.67 35.17 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -126.23 135.32 51.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -136.68 125.63 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.67 120.99 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.3 21.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.7 -173.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.943 -1.098 . . . . 0.0 110.216 173.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.84 152.06 77.46 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.03 -13.4 35.03 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.626 2.217 . . . . 0.0 113.371 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -55.22 -39.09 69.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.284 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -66.29 -47.85 72.31 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 120.405 1.457 . . . . 0.0 109.909 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -56.46 -37.31 70.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.948 1.299 . . . . 0.0 111.293 -172.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -58.87 -52.99 63.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.2 1.8 . . . . 0.0 110.949 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -72.32 -49.1 37.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.265 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.05 151.46 14.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.331 0.968 . . . . 0.0 111.029 167.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -139.03 153.06 48.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 170.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.44 128.4 15.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.92 106.85 1.32 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -17.69 7.49 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.933 1.254 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.18 164.75 25.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.777 0.788 . . . . 0.0 110.71 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 pt -139.88 139.0 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.263 1.825 . . . . 0.0 106.939 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -77.38 115.8 17.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.872 0.469 . . . . 0.0 109.941 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -141.2 84.09 13.13 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.11 150.73 18.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.999 3.133 . . . . 0.0 113.806 -171.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.82 -41.01 22.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.159 1.784 . . . . 0.0 112.58 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.06 -14.68 61.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.432 0.693 . . . . 0.0 112.832 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.15 -7.82 3.84 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.328 1.051 . . . . 0.0 112.369 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.8 -38.62 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.098 1.317 . . . . 0.0 110.695 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.2 -26.36 64.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.694 1.197 . . . . 0.0 112.669 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -105.48 -2.24 23.92 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.378 1.071 . . . . 0.0 111.385 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -131.48 -23.58 2.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -168.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tp -57.94 -33.94 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.355 0.979 . . . . 0.0 110.576 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -16.62 52.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 113.357 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -114.96 -28.63 6.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.657 1.183 . . . . 0.0 111.028 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.03 -38.67 72.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.733 0.697 . . . . 0.0 111.459 173.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -140.37 72.83 31.4 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.094 1.758 . . . . 0.0 107.289 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.0 -37.96 93.86 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.812 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.94 88.88 5.88 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.288 0.635 . . . . 0.0 109.84 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -65.37 -4.95 6.23 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.84 -18.69 58.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.408 1.003 . . . . 0.0 111.486 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.96 152.29 41.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.154 -0.966 . . . . 0.0 110.327 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -71.51 149.57 45.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.0 146.81 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -129.22 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.89 148.6 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -174.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -150.83 166.72 29.65 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.775 1.63 . . . . 0.0 107.379 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.0 p -161.34 172.55 16.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.563 0.745 . . . . 0.0 109.623 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.96 -52.52 62.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.7 1.2 . . . . 0.0 112.192 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.28 -35.52 61.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.337 0.255 . . . . 0.0 111.389 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.43 8.91 55.89 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.034 -0.87 . . . . 0.0 113.498 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -124.08 -23.68 4.53 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.117 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.46 -33.59 71.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.762 1.619 . . . . 0.0 110.031 169.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 p -65.99 -37.88 87.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.703 0.801 . . . . 0.0 111.587 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.41 -47.88 73.2 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 169.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -61.91 -50.97 70.03 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.872 0.869 . . . . 0.0 109.992 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.07 79.27 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.05 0.54 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -61.45 -39.76 92.01 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -35.09 69.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.068 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.19 -49.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.604 1.093 . . . . 0.0 108.648 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -66.16 -34.71 78.66 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.907 -0.495 . . . . 0.0 110.5 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -64.3 -41.56 96.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 110.746 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.12 -37.13 86.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.322 0.649 . . . . 0.0 110.195 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mtp -71.39 -3.05 18.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 112.792 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.89 16.01 68.81 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.458 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.2 124.97 22.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.217 1.509 . . . . 0.0 107.177 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.7 p -68.81 -29.05 67.31 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -166.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -150.09 106.87 3.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -173.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.22 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.19 145.94 32.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.472 0.709 . . . . 0.0 109.123 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -90.4 114.27 26.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.87 69.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.669 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.48 -158.27 14.56 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.615 1.102 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.09 162.32 35.91 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.737 0.684 . . . . 0.0 111.72 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -30.22 64.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.347 1.059 . . . . 0.0 112.869 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.66 -27.76 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.475 -0.766 . . . . 0.0 111.939 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.03 -44.73 62.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.841 0.746 . . . . 0.0 112.971 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.1 mp -55.85 119.59 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.346 0.658 . . . . 0.0 110.276 -169.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.56 52.75 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.294 1.438 . . . . 0.0 110.669 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -136.69 154.74 76.75 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.295 1.438 . . . . 0.0 109.169 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.89 155.7 10.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.644 2.896 . . . . 0.0 112.096 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -138.97 146.1 40.55 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.16 152.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.908 1.283 . . . . 0.0 108.566 -169.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.37 161.73 26.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.05 0.54 . . . . 0.0 110.149 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 124.596 1.094 . . . . 0.0 110.887 170.595 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 C--O 1.235 0.32 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -140.28 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.011 1.324 . . . . 0.0 107.701 168.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -134.43 137.91 44.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.3 133.19 58.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.28 134.21 38.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.84 33.67 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.442 1.019 . . . . 0.0 113.569 -168.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -125.15 -179.21 4.48 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.659 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.07 160.97 80.81 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.559 1.144 . . . . 0.0 111.005 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.7 -16.78 11.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.273 3.315 . . . . 0.0 116.108 175.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -50.89 -37.86 46.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.756 1.223 . . . . 0.0 112.296 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.25 -45.16 15.39 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -56.69 -37.09 70.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.919 1.288 . . . . 0.0 111.424 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -67.81 -5.36 16.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.056 1.343 . . . . 0.0 114.095 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -131.76 -33.82 1.37 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.782 1.174 . . . . 0.0 112.147 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.24 139.96 8.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.731 1.151 . . . . 0.0 108.819 166.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -142.6 148.81 38.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 166.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.57 132.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 -35.48 80.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.874 0.47 . . . . 0.0 111.124 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 -4.16 90.47 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.3 -0.722 . . . . 0.0 113.06 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.01 166.86 23.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.515 1.157 . . . . 0.0 111.075 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.6 pt -135.75 131.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -82.89 115.43 21.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.2 81.09 38.92 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.977 1.711 . . . . 0.0 106.726 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 152.81 7.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 113.706 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.23 -44.58 8.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.953 1.701 . . . . 0.0 112.359 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -67.15 -15.69 63.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -176.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -122.0 -18.86 6.83 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.405 1.082 . . . . 0.0 111.893 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.46 -32.39 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.61 1.164 . . . . 0.0 111.457 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -64.76 -8.68 15.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.14 -48.91 1.33 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.255 0.934 . . . . 0.0 109.83 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.64 -23.53 67.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.12 -32.58 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.868 0.758 . . . . 0.0 111.32 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.53 96.67 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.253 0.933 . . . . 0.0 110.655 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.67 -35.89 67.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.4 -44.58 64.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.526 0.603 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.77 85.25 9.31 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 108.018 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.63 -29.57 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.135 1.89 . . . . 0.0 112.25 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -79.68 96.63 6.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -68.84 -7.23 32.49 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.08 -6.06 39.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.664 0.786 . . . . 0.0 110.673 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.23 151.67 47.11 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -72.4 129.74 39.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.65 95.38 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -77.26 133.82 38.74 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.84 143.61 36.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.76 0.824 . . . . 0.0 108.958 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.42 159.51 44.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 109.036 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.5 p -155.52 169.6 23.91 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.728 1.611 . . . . 0.0 107.918 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -48.24 -26.2 1.86 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.24 -1.0 8.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.99 -46.75 1.52 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.413 1.482 . . . . 0.0 112.557 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 tpt85 -59.55 -45.95 90.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.234 1.017 . . . . 0.0 112.46 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -70.43 -31.82 69.15 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.239 0.472 . . . . 0.0 110.005 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -33.68 75.85 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.97 -1.081 . . . . 0.0 110.775 168.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -46.62 85.62 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -62.46 -43.53 98.6 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.571 1.186 . . . . 0.0 110.648 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 -39.61 80.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.271 0.487 . . . . 0.0 109.734 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -66.8 -38.81 87.23 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.853 -0.53 . . . . 0.0 109.867 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.06 -45.04 95.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 110.073 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.8 mt -57.99 -50.39 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.783 0.833 . . . . 0.0 109.084 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.1 -31.56 72.11 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.826 -0.546 . . . . 0.0 111.058 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -64.4 -40.63 96.17 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.492 0.587 . . . . 0.0 110.358 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.36 -36.95 85.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.751 0.705 . . . . 0.0 110.477 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -71.26 -5.1 29.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.077 0.951 . . . . 0.0 112.834 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.65 56.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.215 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -68.89 146.01 53.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.208 1.504 . . . . 0.0 107.708 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 p -125.06 -1.19 7.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 31.58 1.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.911 0.862 . . . . 0.0 111.007 175.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.11 146.99 7.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.803 0.841 . . . . 0.0 108.975 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.12 141.85 19.98 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -84.04 110.61 18.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -30.98 72.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.316 0.247 . . . . 0.0 111.483 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.15 -163.19 29.13 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.294 1.426 . . . . 0.0 109.982 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.12 159.26 32.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 169.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.5 tp -55.69 -33.03 63.8 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.86 1.264 . . . . 0.0 112.295 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -68.48 -28.68 67.24 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.112 0.565 . . . . 0.0 111.527 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.61 -39.44 22.18 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.043 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.17 134.13 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.96 26.4 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.775 1.23 . . . . 0.0 111.531 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -66.94 159.55 75.32 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 143.19 43.71 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.915 2.41 . . . . 0.0 111.707 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.14 155.76 47.6 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.96 0.904 . . . . 0.0 109.674 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.97 160.44 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.257 1.823 . . . . 0.0 108.026 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -73.4 150.03 42.03 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 169.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.104 -1.386 . . . . 0.0 110.306 172.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.235 0.32 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -131.0 95.4 3.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.213 1.805 . . . . 0.0 106.313 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -77.95 136.94 38.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.99 122.53 52.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -81.45 113.68 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.5 20.7 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -110.27 -169.12 1.41 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.256 -0.902 . . . . 0.0 109.714 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.62 149.49 61.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.46 -14.44 44.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.305 2.003 . . . . 0.0 112.899 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -55.22 -38.39 68.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.753 0.821 . . . . 0.0 111.372 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -69.28 -46.27 67.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.553 1.07 . . . . 0.0 109.826 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -58.65 -34.38 71.14 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 111.473 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -62.63 -39.78 94.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.507 1.123 . . . . 0.0 110.677 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -67.95 -49.67 60.43 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.385 0.993 . . . . 0.0 108.704 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.81 152.58 4.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.334 1.853 . . . . 0.0 107.548 167.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -136.95 152.38 50.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.704 1.201 . . . . 0.0 108.577 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.77 126.51 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -55.92 121.71 9.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.112 0.565 . . . . 0.0 109.682 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.67 70.64 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.222 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.25 163.14 13.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.79 1.295 . . . . 0.0 111.549 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.2 138.99 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.276 1.43 . . . . 0.0 108.394 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.82 114.86 18.11 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.037 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.72 80.94 20.45 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.639 1.575 . . . . 0.0 107.095 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.81 154.34 12.91 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.725 2.95 . . . . 0.0 113.819 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.4 tp -47.46 -36.19 9.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 113.039 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.77 -17.94 65.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.809 0.844 . . . . 0.0 113.116 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -127.75 -17.43 4.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.983 0.913 . . . . 0.0 112.174 -169.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.41 -33.03 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.119 1.368 . . . . 0.0 112.686 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.05 -25.0 65.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 112.877 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.21 -41.34 2.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.667 0.667 . . . . 0.0 110.392 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -63.53 -17.47 62.82 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.02 -37.24 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.24 0.927 . . . . 0.0 111.22 171.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.7 90.26 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.972 0.805 . . . . 0.0 111.528 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -79.41 -38.25 35.27 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.082 0.553 . . . . 0.0 110.352 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.71 78.98 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.961 0.504 . . . . 0.0 112.211 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 83.28 21.58 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.81 1.244 . . . . 0.0 107.962 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.86 -21.18 32.05 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.63 2.887 . . . . 0.0 115.129 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -131.63 95.57 3.76 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.549 1.14 . . . . 0.0 108.674 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -65.82 -5.52 9.22 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.496 1.119 . . . . 0.0 113.251 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -71.13 -21.43 62.2 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.113 0.87 . . . . 0.0 111.09 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 147.73 52.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -62.91 127.43 31.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.233 0.47 . . . . 0.0 109.765 -172.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.06 134.99 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.14 103.28 6.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.43 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.33 158.55 43.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.531 1.533 . . . . 0.0 108.562 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.5 p -144.22 -175.52 4.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.105 1.362 . . . . 0.0 107.667 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -56.76 -32.13 65.3 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.8 7.36 4.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -167.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.13 2.28 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.74 1.162 . . . . 0.0 113.416 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -59.51 -48.13 82.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.372 1.086 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.78 -24.91 58.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.052 0.842 . . . . 0.0 111.514 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -33.1 67.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 120.973 -1.08 . . . . 0.0 110.16 168.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -47.09 84.15 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.25 -45.17 95.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.166 0.983 . . . . 0.0 110.459 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.09 74.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.103 0.411 . . . . 0.0 110.797 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.84 -44.28 77.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.198 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.66 -39.5 88.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.274 1.397 . . . . 0.0 110.58 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.73 -51.18 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.866 0.866 . . . . 0.0 109.557 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.89 -34.2 76.19 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.894 -0.504 . . . . 0.0 111.147 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 19.7 m -66.09 -35.88 81.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.636 0.775 . . . . 0.0 110.0 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.85 -47.69 65.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.759 0.424 . . . . 0.0 110.152 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -68.65 -35.94 77.91 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.713 -0.661 . . . . 0.0 112.174 -170.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.88 45.18 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 CA-C-O 119.021 -0.877 . . . . 0.0 114.177 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.3 OUTLIER -55.48 159.48 2.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.661 1.23 . . . . 0.0 112.742 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.5 p -137.95 -37.01 0.6 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.893 0.877 . . . . 0.0 110.942 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -142.67 34.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.364 0.983 . . . . 0.0 111.523 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.82 141.02 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.34 144.85 38.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.601 1.561 . . . . 0.0 107.316 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -87.06 105.64 17.3 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.13 75.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.444 0.298 . . . . 0.0 111.275 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.87 -136.27 5.78 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.14 170.76 20.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 169.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.93 -39.92 91.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.728 0.811 . . . . 0.0 109.915 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -67.95 -3.69 10.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.919 1.287 . . . . 0.0 113.669 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.37 -37.33 2.03 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.289 0.949 . . . . 0.0 112.245 -169.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 mt -58.96 144.3 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.602 1.092 . . . . 0.0 110.519 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 75.42 1.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.751 1.62 . . . . 0.0 107.775 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.2 mtp -140.21 162.86 47.65 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 126.68 1.992 . . . . 0.0 107.669 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.03 143.48 40.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.965 2.444 . . . . 0.0 111.653 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -138.52 147.44 43.13 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.05 154.29 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.253 1.421 . . . . 0.0 108.408 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.6 155.92 39.53 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.006 -0.434 . . . . 0.0 110.576 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.235 0.342 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -135.26 107.61 7.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -73.57 149.1 42.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mm -138.12 131.59 41.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.87 94.49 8.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.85 35.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -166.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.37 -179.78 6.88 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.465 -1.397 . . . . 0.0 108.635 -172.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -53.4 146.72 22.17 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.406 0.548 . . . . 0.0 111.999 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -10.1 14.04 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 114.465 -172.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.69 -42.6 71.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 110.939 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -35.76 69.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.941 -0.474 . . . . 0.0 111.462 178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -58.02 -28.73 64.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.904 1.281 . . . . 0.0 110.953 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.69 -46.67 81.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.061 0.544 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.21 -45.0 43.24 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.152 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.15 152.06 12.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.074 0.852 . . . . 0.0 110.934 167.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -146.78 160.53 42.14 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.131 1.373 . . . . 0.0 108.94 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -55.65 125.82 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.052 1.341 . . . . 0.0 108.66 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -29.54 69.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 111.818 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.06 17.27 57.42 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.167 -1.352 . . . . 0.0 113.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.28 170.58 10.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.216 1.508 . . . . 0.0 112.018 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.0 pt -142.47 142.8 26.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 127.207 2.203 . . . . 0.0 107.023 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.21 116.1 19.27 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.162 0.585 . . . . 0.0 109.919 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -137.73 73.3 47.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.26 150.61 14.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.652 2.902 . . . . 0.0 113.733 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 tp -45.84 -36.16 5.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.973 1.709 . . . . 0.0 112.916 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -63.34 -18.45 63.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.018 0.927 . . . . 0.0 113.03 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -127.49 -24.17 3.37 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.293 1.037 . . . . 0.0 111.13 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -44.66 -35.63 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.407 1.883 . . . . 0.0 113.431 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -53.84 -36.48 62.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.273 0.942 . . . . 0.0 112.47 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.45 -39.14 4.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.412 0.551 . . . . 0.0 109.729 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -67.74 -16.41 64.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.686 0.795 . . . . 0.0 112.352 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.12 -32.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.478 1.035 . . . . 0.0 111.024 169.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.02 98.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.103 . . . . 0.0 110.765 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.25 -35.75 74.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.4 0.68 . . . . 0.0 111.247 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -45.3 66.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.096 0.558 . . . . 0.0 111.968 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.25 88.12 8.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.47 1.508 . . . . 0.0 107.761 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.55 -40.87 70.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.917 2.412 . . . . 0.0 113.18 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -81.22 99.08 8.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 28.5 mtmm -66.2 -8.09 22.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.62 -7.39 22.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.136 0.88 . . . . 0.0 111.597 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.92 151.17 48.09 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.941 0.791 . . . . 0.0 109.718 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 131.49 46.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.464 0.575 . . . . 0.0 109.84 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.87 129.39 75.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -126.61 86.32 2.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.04 154.72 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.54 158.5 41.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 108.08 168.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 p -133.52 -139.56 0.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.409 0.684 . . . . 0.0 110.241 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -74.32 -37.94 63.46 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.141 -0.974 . . . . 0.0 111.229 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.83 -39.31 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.52 -26.08 0.14 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.77 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.27 -62.75 1.55 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.177 1.488 . . . . 0.0 111.813 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.08 -32.64 73.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.977 0.353 . . . . 0.0 111.17 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -76.19 -33.85 59.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.582 -0.699 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.97 -46.52 93.57 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -60.4 -50.35 73.94 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.664 0.786 . . . . 0.0 109.784 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.75 78.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.68 -38.7 87.35 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.84 -39.31 87.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.313 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.48 -46.29 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.34 0.973 . . . . 0.0 109.356 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.74 -36.86 85.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.85 0.75 . . . . 0.0 110.462 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -64.44 -42.36 96.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.067 0.547 . . . . 0.0 110.305 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.63 -33.91 76.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.758 0.708 . . . . 0.0 111.126 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.3 mmm -71.28 -3.18 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.74 18.68 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.373 -0.829 . . . . 0.0 112.975 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 23.0 m-85 -66.95 157.2 33.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.719 1.259 . . . . 0.0 109.23 169.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 p -135.17 164.78 26.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.269 1.428 . . . . 0.0 108.242 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 51.99 35.34 15.78 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.4 1.08 . . . . 0.0 111.932 -169.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.18 143.54 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.48 154.04 41.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.005 1.322 . . . . 0.0 107.49 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -109.51 116.0 30.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.75 61.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.533 0.733 . . . . 0.0 111.96 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.51 -92.27 0.58 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.2 175.22 28.52 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 tp -47.95 -35.67 11.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 113.672 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -65.27 -27.62 68.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.263 0.625 . . . . 0.0 112.146 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.42 -45.65 37.57 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.831 0.741 . . . . 0.0 111.726 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 78' ' ' ILE . 4.9 mp -58.78 115.46 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.978 0.911 . . . . 0.0 110.162 -170.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.19 53.57 2.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 110.399 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.0 ptm -137.54 163.52 47.94 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 123.578 0.751 . . . . 0.0 109.72 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.07 155.85 5.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.358 3.372 . . . . 0.0 113.696 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -137.52 145.49 43.03 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.17 152.48 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 125.045 1.338 . . . . 0.0 108.618 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -68.2 162.17 25.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.034 0.534 . . . . 0.0 111.166 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.912 1.244 . . . . 0.0 110.51 172.411 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 C--O 1.236 0.364 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -142.04 155.21 45.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.854 1.661 . . . . 0.0 108.164 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -137.47 148.82 46.36 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.453 1.101 . . . . 0.0 108.475 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.32 135.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -90.62 116.31 28.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 167.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.86 11.87 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -88.05 -174.81 4.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.057 1.299 . . . . 0.0 109.668 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m -58.4 152.83 41.66 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 122.67 0.388 . . . . 0.0 110.512 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.39 -17.17 58.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.727 2.285 . . . . 0.0 113.379 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -57.01 -39.2 74.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.112 0.869 . . . . 0.0 110.87 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -69.88 -35.04 74.34 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.349 0.522 . . . . 0.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -60.24 -26.71 66.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.676 1.19 . . . . 0.0 111.311 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -71.23 -46.1 61.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.683 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.9 -52.15 64.21 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.667 0.667 . . . . 0.0 109.315 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.82 157.36 8.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.655 1.582 . . . . 0.0 108.01 165.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -144.77 153.35 41.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.444 1.098 . . . . 0.0 108.634 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.68 123.31 4.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.75 68.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 0.0 111.754 -172.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.81 6.24 83.32 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.281 -1.289 . . . . 0.0 113.852 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.9 164.7 13.75 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.44 1.62 . . . . 0.0 111.16 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.7 139.02 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 126.282 1.833 . . . . 0.0 107.269 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.82 114.22 17.58 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.222 0.464 . . . . 0.0 109.779 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -141.67 89.25 9.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.44 155.64 20.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.438 2.758 . . . . 0.0 114.729 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.75 -36.17 24.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.722 2.009 . . . . 0.0 112.383 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.16 -17.53 62.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.873 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -128.12 -16.99 4.42 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.773 0.829 . . . . 0.0 112.309 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -50.0 -32.12 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.021 1.328 . . . . 0.0 112.41 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -55.33 -26.09 38.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.091 1.356 . . . . 0.0 112.969 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -116.81 -43.03 2.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.671 0.669 . . . . 0.0 109.544 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -69.57 -9.11 52.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.8 tp -53.47 -36.96 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.935 1.243 . . . . 0.0 110.408 169.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.59 96.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.351 0.978 . . . . 0.0 111.543 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -33.91 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.881 0.472 . . . . 0.0 111.042 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.89 73.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.395 0.543 . . . . 0.0 111.114 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.93 113.86 4.96 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.607 1.563 . . . . 0.0 106.995 -171.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.78 -23.87 43.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.096 2.531 . . . . 0.0 115.275 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -146.2 118.51 8.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 108.861 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.02 -12.16 7.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.824 1.249 . . . . 0.0 114.033 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.52 -20.51 59.94 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.847 0.749 . . . . 0.0 112.229 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.39 155.22 40.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.03 0.832 . . . . 0.0 108.87 168.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.41 131.16 44.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.133 0.879 . . . . 0.0 109.445 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.8 t -129.16 129.89 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.81 84.38 2.27 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 m -67.49 147.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.1 167.33 22.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.66 178.38 8.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -56.05 -35.79 67.31 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.88 5.3 6.6 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.57 -25.89 5.49 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.254 1.407 . . . . 0.0 114.891 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -64.24 -49.14 73.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.268 1.534 . . . . 0.0 110.799 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.22 -31.68 67.87 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.79 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -68.81 -31.31 70.22 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.906 1.23 . . . . 0.0 111.065 169.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.42 -50.14 64.55 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 167.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.74 -42.52 99.71 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-N 117.813 0.807 . . . . 0.0 111.745 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.66 82.91 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.849 0.75 . . . . 0.0 109.812 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -66.81 -39.46 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.232 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.48 -44.45 97.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.755 1.161 . . . . 0.0 110.827 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.71 -53.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.91 -27.39 65.73 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.047 -0.408 . . . . 0.0 110.652 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -64.44 -43.1 95.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.762 0.71 . . . . 0.0 110.624 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.71 -32.83 74.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.343 0.519 . . . . 0.0 110.258 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.9 mtp -74.3 4.15 6.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 113.114 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.56 47.15 6.49 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.972 1.26 . . . . 0.0 111.891 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.2 166.4 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.304 1.042 . . . . 0.0 113.465 173.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 p -138.47 -34.95 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.813 0.845 . . . . 0.0 111.014 167.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -138.37 32.9 2.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.178 0.899 . . . . 0.0 112.008 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -92.52 139.44 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.66 147.0 31.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.774 1.23 . . . . 0.0 108.938 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -87.83 114.58 24.58 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -51.43 65.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.779 0.432 . . . . 0.0 110.301 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.43 -164.46 27.68 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.91 170.68 40.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.9 tp -55.36 -31.07 61.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 0.0 112.7 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.66 -24.83 65.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.271 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.55 -48.45 32.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.209 0.913 . . . . 0.0 111.628 -170.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 78' ' ' ILE . 2.4 mp -61.34 115.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.27 0.628 . . . . 0.0 109.682 -169.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.38 56.48 2.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.453 1.501 . . . . 0.0 110.358 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.3 mtp -135.63 155.3 78.34 Favored Pre-proline 0 C--O 1.239 0.53 0 C-N-CA 125.3 1.44 . . . . 0.0 109.3 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.8 152.02 14.19 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.945 3.097 . . . . 0.0 112.662 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -135.94 143.29 44.83 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 m -141.16 155.51 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.991 1.316 . . . . 0.0 108.38 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.77 159.71 29.68 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.264 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.572 -1.127 . . . . 0.0 110.616 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.646 0.26 . . . . 0.0 110.447 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -133.46 114.2 13.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.389 1.476 . . . . 0.0 107.837 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.4 141.97 48.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.5 mm -137.12 122.07 24.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.4 122.14 28.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 m -110.38 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.21 -168.43 1.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.864 -1.148 . . . . 0.0 109.701 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.52 152.37 96.29 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.078 0.551 . . . . 0.0 110.09 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.48 -21.72 14.72 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.577 2.851 . . . . 0.0 114.475 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.34 -28.99 69.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.104 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -74.73 -47.27 32.18 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 120.098 1.317 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.06 -42.96 77.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.983 0.913 . . . . 0.0 111.275 -171.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -59.0 -51.79 68.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.388 1.075 . . . . 0.0 110.904 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.71 -41.03 60.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.38 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -167.39 140.11 3.37 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.412 1.006 . . . . 0.0 109.473 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -133.86 154.45 51.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.308 1.043 . . . . 0.0 108.622 171.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.5 130.95 19.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.6 119.48 6.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.24 59.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.208 0.909 . . . . 0.0 112.695 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.62 159.94 32.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.474 1.137 . . . . 0.0 110.75 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.9 pt -136.43 141.33 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.204 1.802 . . . . 0.0 106.5 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.54 110.22 14.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -132.72 78.42 66.69 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.532 1.933 . . . . 0.0 106.131 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.91 151.35 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.818 3.012 . . . . 0.0 114.04 -170.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.1 tp -49.22 -39.58 30.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 112.468 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.91 -11.46 56.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -130.04 -15.97 3.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.351 1.06 . . . . 0.0 111.914 -172.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -51.7 -33.89 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.295 1.438 . . . . 0.0 112.101 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -53.03 -38.69 62.6 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.286 1.034 . . . . 0.0 111.908 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.52 -45.33 4.47 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.37 -21.41 66.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.582 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -57.38 -31.66 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.805 1.184 . . . . 0.0 110.988 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -22.6 63.71 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -113.46 -28.92 7.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 110.685 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.27 -41.56 94.11 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.764 0.711 . . . . 0.0 111.294 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 t -142.96 83.6 11.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.617 1.567 . . . . 0.0 107.037 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.01 -31.46 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.018 1.812 . . . . 0.0 112.482 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -80.88 94.59 6.51 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -68.03 -0.31 4.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.31 -8.47 20.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.257 0.935 . . . . 0.0 111.674 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.83 149.49 49.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.206 0.912 . . . . 0.0 109.439 170.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -65.48 141.3 58.54 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.03 -0.419 . . . . 0.0 109.918 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.47 133.74 64.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -126.26 88.99 2.93 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.04 141.68 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.57 164.24 34.08 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.343 1.057 . . . . 0.0 109.088 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -153.39 172.21 17.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.604 1.562 . . . . 0.0 107.474 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -54.16 -18.7 4.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.16 8.52 2.95 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -171.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 -43.76 1.92 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.241 1.401 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -54.05 -53.83 47.71 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.229 1.012 . . . . 0.0 112.525 -170.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -65.46 -35.86 82.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -67.52 -34.56 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.584 -0.698 . . . . 0.0 112.321 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.21 -45.6 73.32 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -65.39 -49.53 68.95 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.236 0.518 . . . . 0.0 110.359 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.67 72.04 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 122.776 0.431 . . . . 0.0 110.648 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.49 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.42 -36.59 71.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.541 -0.725 . . . . 0.0 110.977 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.62 -46.65 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.552 1.069 . . . . 0.0 109.12 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.59 -36.86 85.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.239 0.616 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 m -66.91 -37.86 85.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.537 0.335 . . . . 0.0 110.549 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.48 -36.03 81.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -69.91 0.19 6.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.757 1.223 . . . . 0.0 112.647 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.95 80.83 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.197 -0.939 . . . . 0.0 112.985 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -64.11 155.39 31.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.832 1.316 . . . . 0.0 108.907 171.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 p -131.19 164.07 26.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.984 1.314 . . . . 0.0 108.427 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.2 m80 52.65 34.44 15.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.49 144.09 10.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.99 155.62 37.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 108.292 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.31 117.47 29.17 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 168.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.3 90.89 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.411 0.444 . . . . 0.0 111.6 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.58 -26.48 2.4 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.7 1.143 . . . . 0.0 111.921 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.02 176.73 22.58 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 173.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.0 -33.66 70.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.137 0.575 . . . . 0.0 110.147 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.9 -38.51 88.62 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 110.962 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.95 -47.15 26.26 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.611 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 82.8 mt -62.54 126.36 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -171.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.01 22.48 15.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.789 1.235 . . . . 0.0 112.087 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -73.65 158.67 85.96 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 124.22 1.008 . . . . 0.0 109.126 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.8 155.55 10.6 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.587 2.858 . . . . 0.0 111.846 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -138.07 149.41 45.96 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.74 154.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.349 1.459 . . . . 0.0 108.575 -171.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.14 151.56 45.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 172.603 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.235 0.332 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -134.36 156.32 48.71 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.259 1.824 . . . . 0.0 107.704 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -121.61 137.46 54.73 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.28 125.94 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.79 108.77 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 48' ' ' CYS 0.295 22.7 m -101.88 22.63 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.137 0.426 . . . . 0.0 111.89 -174.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.05 -177.06 3.16 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.704 -0.622 . . . . 0.0 110.464 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.08 152.84 95.62 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.221 0.608 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.81 -17.33 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.851 3.034 . . . . 0.0 115.042 171.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.08 -38.18 72.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.136 0.88 . . . . 0.0 111.461 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.93 -45.2 51.95 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.251 0.932 . . . . 0.0 109.991 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -52.85 -39.67 62.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.569 1.148 . . . . 0.0 111.699 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -54.8 -54.53 40.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.779 1.232 . . . . 0.0 111.385 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.19 -49.0 48.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.117 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.82 152.44 15.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.927 0.785 . . . . 0.0 110.635 167.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -134.19 158.32 43.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.593 1.157 . . . . 0.0 108.672 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.43 130.58 20.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 120.13 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.458 1.103 . . . . 0.0 110.101 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.63 -2.55 67.35 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.529 -1.15 . . . . 0.0 114.04 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.73 134.34 52.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.586 1.693 . . . . 0.0 109.787 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.4 130.64 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.07 113.84 12.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.567 1.076 . . . . 0.0 109.019 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.0 mt -140.79 81.62 16.44 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.59 151.97 17.58 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.661 2.907 . . . . 0.0 113.47 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.7 tp -47.75 -37.18 12.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.245 1.818 . . . . 0.0 113.216 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.86 -14.61 63.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -125.35 -19.79 4.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.836 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -50.11 -35.06 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.027 1.331 . . . . 0.0 112.465 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.69 -30.01 62.98 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.966 0.907 . . . . 0.0 112.327 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.81 -45.78 3.31 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.654 0.661 . . . . 0.0 110.102 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -63.87 -20.58 65.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.61 -34.13 34.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 0.0 111.477 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.35 97.12 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -34.71 55.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 111.137 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.39 70.84 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.429 0.559 . . . . 0.0 112.197 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.79 80.07 32.05 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.344 1.458 . . . . 0.0 107.238 -171.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.76 -1.58 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.191 2.594 . . . . 0.0 113.979 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -130.28 105.81 8.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.33 -15.0 55.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.85 -20.78 62.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.58 0.627 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.58 154.22 39.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.252 0.621 . . . . 0.0 111.619 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -76.95 135.49 38.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.625 -0.672 . . . . 0.0 109.567 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.09 90.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -72.17 131.54 42.92 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.41 143.14 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.67 163.11 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.076 0.951 . . . . 0.0 109.085 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 7' ' ' VAL . 1.7 m -144.54 -179.19 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.416 1.886 . . . . 0.0 107.735 176.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -64.19 -37.73 88.51 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.455 -0.778 . . . . 0.0 112.245 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.97 -20.06 8.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.059 0.944 . . . . 0.0 113.249 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.63 -23.72 16.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.267 0.937 . . . . 0.0 113.922 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -68.88 -41.05 78.86 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.099 1.449 . . . . 0.0 111.469 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.31 -33.37 75.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.664 0.665 . . . . 0.0 111.418 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -71.62 -31.1 66.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.749 1.159 . . . . 0.0 110.694 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.19 -47.99 77.64 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -61.75 -46.12 90.98 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.967 -0.726 . . . . 0.0 110.547 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.58 -34.97 73.39 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.026 -0.421 . . . . 0.0 111.064 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -63.0 -42.42 99.84 Favored 'General case' 0 C--N 1.335 -0.064 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.69 -44.54 93.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.72 0.691 . . . . 0.0 110.544 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.42 -51.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.3 mt -71.2 -28.05 63.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.927 -0.483 . . . . 0.0 111.587 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 m -64.88 -43.31 93.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.512 0.596 . . . . 0.0 110.134 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.97 -34.49 78.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.687 0.676 . . . . 0.0 110.813 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.74 -6.03 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.867 0.867 . . . . 0.0 112.798 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.91 58.62 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.909 170.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -72.34 122.7 21.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.124 1.462 . . . . 0.0 108.403 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -74.59 -29.95 61.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.79 1.236 . . . . 0.0 113.833 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -136.26 44.11 2.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.422 0.689 . . . . 0.0 111.123 -168.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.56 147.93 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -145.79 123.72 12.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -74.75 106.59 6.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.45 -28.27 67.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.05 0.94 . . . . 0.0 111.694 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.47 -161.68 21.53 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.265 0.936 . . . . 0.0 110.97 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.85 159.54 33.07 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.4 tp -58.01 -26.52 62.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.032 1.333 . . . . 0.0 111.875 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -69.04 -10.51 57.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.473 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.61 -33.25 3.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.877 1.271 . . . . 0.0 112.437 -170.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.16 135.8 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.504 1.502 . . . . 0.0 107.39 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.08 23.91 11.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.539 1.136 . . . . 0.0 112.16 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 75.6 mmm -68.61 160.15 78.2 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 108.765 168.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.14 155.25 62.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.659 1.573 . . . . 0.0 109.124 167.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -138.68 144.62 39.68 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.87 150.57 16.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.206 1.402 . . . . 0.0 108.66 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -65.91 161.56 20.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.837 0.455 . . . . 0.0 110.88 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -141.33 159.42 42.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.181 1.792 . . . . 0.0 107.655 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -129.71 145.65 51.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.72 1.208 . . . . 0.0 108.148 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.9 mt -146.48 135.45 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -90.17 124.8 35.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG23 ' SG ' ' A' ' 48' ' ' CYS . 22.7 m -115.78 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.959 0.504 . . . . 0.0 112.229 -174.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.28 -170.56 1.77 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 m -66.68 157.36 83.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.197 0.599 . . . . 0.0 110.329 171.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -53.32 -16.75 7.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.224 3.282 . . . . 0.0 115.436 172.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.95 -41.65 46.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 111.915 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -75.44 -45.14 40.51 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.619 0.645 . . . . 0.0 109.925 174.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -54.3 -38.61 66.13 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.009 0.924 . . . . 0.0 112.289 -174.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.13 -50.68 72.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.649 1.18 . . . . 0.0 110.956 177.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -83.95 -38.5 20.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.748 -170.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.87 139.36 2.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.65 1.18 . . . . 0.0 109.359 169.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -134.79 145.7 48.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.142 1.377 . . . . 0.0 107.909 172.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.9 t -58.81 133.94 23.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.73 142.56 39.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.264 -0.273 . . . . 0.0 110.286 -178.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.13 -18.09 29.45 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.108 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.51 163.51 20.93 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.173 1.486 . . . . 0.0 110.788 172.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -145.69 138.08 20.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.652 2.381 . . . . 0.0 105.124 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -76.77 114.68 15.8 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -176.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -141.13 85.41 12.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.37 157.31 11.89 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.87 3.047 . . . . 0.0 114.506 -170.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 tp -46.8 -41.1 14.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.782 2.033 . . . . 0.0 113.215 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.53 -10.74 60.03 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -123.7 -21.46 5.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.042 1.337 . . . . 0.0 111.303 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.37 -33.19 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.396 1.478 . . . . 0.0 112.669 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.54 -43.84 72.32 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.799 1.24 . . . . 0.0 111.142 -170.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -93.78 -45.59 7.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.671 0.669 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -17.85 65.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -52.94 -36.49 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.133 0.878 . . . . 0.0 111.248 171.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.62 96.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.982 0.81 . . . . 0.0 110.954 -175.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -35.06 66.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.232 0.613 . . . . 0.0 111.11 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.5 78.61 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.406 0.548 . . . . 0.0 111.618 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.0 t -142.09 87.98 9.45 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.385 1.474 . . . . 0.0 107.306 -171.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.88 21.77 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.953 3.102 . . . . 0.0 114.107 -172.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -144.08 104.67 4.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 107.605 173.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.88 -10.79 52.17 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -82.42 -13.62 56.5 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.976 0.807 . . . . 0.0 111.838 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.45 154.24 40.97 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.007 0.822 . . . . 0.0 111.453 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -71.97 136.95 46.96 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.67 135.81 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -115.97 128.65 55.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.44 145.29 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.26 159.75 44.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.568 1.547 . . . . 0.0 107.754 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' HG23 ' A' ' 7' ' ' VAL . 5.5 m -157.24 167.48 30.21 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.157 1.783 . . . . 0.0 108.851 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -46.55 -30.2 2.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -176.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.42 7.97 5.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.568 1.076 . . . . 0.0 113.525 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.8 -40.95 1.88 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.045 1.307 . . . . 0.0 112.385 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -52.66 -47.96 66.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.595 1.158 . . . . 0.0 111.569 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -65.0 -37.86 89.06 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.059 0.391 . . . . 0.0 110.132 -173.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -30.98 69.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.016 172.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.64 -44.32 95.71 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 169.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -61.05 -49.49 77.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.803 0.802 . . . . 0.0 109.982 175.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.19 -40.41 77.34 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.86 0.3 . . . . 0.0 110.617 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.15 -37.92 87.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.71 -34.82 67.38 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.53 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.61 -47.37 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.889 1.222 . . . . 0.0 108.323 171.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 mt -70.49 -29.91 66.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.741 -0.6 . . . . 0.0 111.507 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.2 m -65.54 -38.04 88.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.227 0.467 . . . . 0.0 110.407 172.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.48 -36.05 81.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.821 0.737 . . . . 0.0 110.255 174.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mmm -68.93 -5.79 23.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.109 0.964 . . . . 0.0 112.579 170.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 12.0 64.48 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.425 1.012 . . . . 0.0 113.529 172.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.61 127.85 34.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.129 1.464 . . . . 0.0 107.731 175.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -89.42 -22.0 22.75 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -169.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.59 33.48 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.1 0.96 . . . . 0.0 111.551 -169.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.57 136.92 22.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 167.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.09 144.13 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.78 110.58 18.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -29.61 70.55 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.92 -162.08 28.84 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.239 1.399 . . . . 0.0 109.754 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.63 158.91 31.39 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 170.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -55.33 -35.62 65.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.358 1.063 . . . . 0.0 110.89 175.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.97 0.96 11.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.259 1.023 . . . . 0.0 112.735 176.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -130.9 -28.39 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.433 -169.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.71 134.99 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 120.936 1.698 . . . . 0.0 107.554 168.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.22 53.02 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.714 1.605 . . . . 0.0 108.831 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.0 mtp -133.88 158.38 75.58 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.188 1.795 . . . . 0.0 107.627 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.54 149.16 40.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.022 2.481 . . . . 0.0 113.354 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -127.85 159.17 35.71 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.202 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 100.0 t -134.82 167.83 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 127.708 2.403 . . . . 0.0 105.271 -175.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -128.71 161.61 29.3 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.798 -1.189 . . . . 0.0 109.871 -170.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 174.71 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.967 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -144.4 158.37 43.78 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' C ' ' CD1' ' A' ' 4' ' ' TRP . 28.1 m80 -132.53 150.17 52.2 Favored 'General case' 0 CA--C 1.484 -1.596 0 CA-C-N 113.475 -1.693 . . . . 0.0 109.135 166.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.588 ' HZ3' ' HE2' ' A' ' 80' ' ' MET . 23.6 m95 -123.98 142.65 50.97 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 113.065 -1.879 . . . . 0.0 109.252 -174.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.6 mm -140.0 123.94 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 -169.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -79.86 121.7 25.74 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 163.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.1 m -112.28 21.35 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.937 0.79 . . . . 0.0 112.324 -174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.552 ' HD2' ' H ' ' A' ' 49' ' ' ASN . 7.4 ttt180 -106.3 -175.47 2.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 120.687 -1.258 . . . . 0.0 110.105 175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 m -60.11 151.71 65.09 Favored Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.358 171.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -57.76 -17.14 28.12 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.221 2.614 . . . . 0.0 113.964 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -54.08 -39.87 66.7 Favored 'General case' 0 N--CA 1.432 -1.351 0 C-N-CA 124.607 1.163 . . . . 0.0 113.528 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -71.45 -41.74 69.07 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.866 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.5 t80 -57.54 -37.41 73.02 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 124.192 0.997 . . . . 0.0 111.814 -175.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -59.96 -39.08 84.39 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.975 0.91 . . . . 0.0 112.319 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -87.9 -44.69 10.87 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 117.816 -1.087 . . . . 0.0 111.293 -177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -162.86 150.11 13.22 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 167.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -139.98 152.77 46.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.492 HG11 ' HE3' ' A' ' 4' ' ' TRP . 67.5 t -54.17 128.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 108.578 169.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.32 113.29 2.82 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.53 -13.29 25.39 Favored Glycine 0 C--O 1.226 -0.353 0 N-CA-C 110.241 -1.143 . . . . 0.0 110.241 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.34 164.05 27.22 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 117.491 0.646 . . . . 0.0 110.346 171.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -130.58 138.25 54.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 127.084 2.154 . . . . 0.0 106.95 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.12 115.66 16.06 Favored 'General case' 0 CA--C 1.522 -0.128 0 O-C-N 123.935 0.772 . . . . 0.0 109.592 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 7.2 mt -140.41 82.78 15.96 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 126.102 1.761 . . . . 0.0 106.511 177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -52.39 153.49 13.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.502 2.802 . . . . 0.0 113.791 -171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.5 tp -49.42 -36.92 23.61 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 125.166 1.386 . . . . 0.0 112.457 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -67.02 -15.35 63.67 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.673 ' HB3' ' HD2' ' A' ' 32' ' ' ARG . 23.9 mt-10 -130.81 -13.61 3.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 O-C-N 124.586 1.179 . . . . 0.0 110.867 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.62 -34.15 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 124.342 1.057 . . . . 0.0 111.328 -176.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -56.85 -31.36 64.7 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -105.24 -35.96 7.39 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 122.015 0.912 . . . . 0.0 110.482 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.673 ' HD2' ' HB3' ' A' ' 28' ' ' GLU . 5.8 mtp180 -81.2 -17.26 50.27 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 113.211 0.819 . . . . 0.0 113.211 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.03 -34.39 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.853 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.56 174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.48 -32.02 73.47 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 118.897 0.771 . . . . 0.0 111.726 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.64 -28.62 21.74 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.305 0.642 . . . . 0.0 111.438 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.45 -40.05 44.56 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.447 0.567 . . . . 0.0 111.613 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 t -142.67 82.58 12.39 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -173.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.41 -25.41 70.89 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.354 2.036 . . . . 0.0 113.84 -175.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -101.4 100.68 11.18 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 66' ' ' TYR . 0.1 OUTLIER -69.34 -6.87 32.51 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -176.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -18.42 58.98 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 170.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -66.76 150.75 48.67 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 m -72.08 131.73 43.24 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 38.8 t -124.93 124.42 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HD2' ' HE1' ' A' ' 4' ' ' TRP . 88.5 mttt -110.34 121.04 44.33 Favored 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 106.182 -1.784 . . . . 0.0 106.182 176.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.5 m -107.04 147.02 12.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -150.47 163.89 37.29 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.828 1.251 . . . . 0.0 107.975 172.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.8 p -154.39 -176.34 5.84 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.552 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 61.9 t30 -60.14 -30.68 69.46 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -173.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.11 1.0 7.19 Favored 'General case' 0 C--O 1.225 -0.198 0 O-C-N 121.211 -0.931 . . . . 0.0 113.101 -168.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.1 -26.57 3.79 Favored Glycine 0 C--O 1.225 -0.466 0 CA-C-O 122.611 1.117 . . . . 0.0 113.339 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . 0.321 2.3 tpt85 -69.96 -48.16 59.43 Favored 'General case' 0 N--CA 1.426 -1.641 0 O-C-N 120.449 -1.618 . . . . 0.0 112.117 -176.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -71.9 -29.73 64.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.227 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 -35.51 79.07 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 118.252 0.478 . . . . 0.0 111.796 167.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.86 -47.28 72.79 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 168.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -63.74 -46.01 87.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 117.864 0.832 . . . . 0.0 110.608 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.9 78.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 119.345 -0.36 . . . . 0.0 110.192 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -61.42 -41.44 97.17 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 118.376 -0.821 . . . . 0.0 109.182 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -65.86 -42.04 90.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 119.108 0.867 . . . . 0.0 111.255 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.3 mt -57.3 -48.78 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.115 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 175.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.482 ' O ' ' HD2' ' A' ' 66' ' ' TYR . 42.9 mt -64.7 -47.97 76.39 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 64.5 m -52.93 -36.26 59.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 121.761 2.073 . . . . 0.0 112.258 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -66.61 -37.93 85.92 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 41.9 mmm -68.0 -6.59 23.19 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.015 1.326 . . . . 0.0 113.529 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.31 28.91 13.36 Favored Glycine 0 C--N 1.335 0.517 0 O-C-N 120.706 -1.246 . . . . 0.0 113.866 167.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.668 ' HB3' HG23 ' A' ' 69' ' ' VAL 0.333 49.4 m-85 -68.2 151.5 46.87 Favored 'General case' 0 CA--C 1.469 -2.169 0 C-N-CA 123.686 0.794 . . . . 0.0 110.057 173.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.57 -24.44 11.77 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 112.331 -2.213 . . . . 0.0 113.711 178.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -138.77 47.35 1.94 Allowed 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.911 1.339 . . . . 0.0 111.571 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.668 HG23 ' HB3' ' A' ' 66' ' ' TYR . 2.1 t -90.32 148.48 4.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 172.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -147.05 134.5 20.82 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.629 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -78.14 110.6 13.26 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 163.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.53 -31.65 72.82 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 113.464 0.912 . . . . 0.0 113.464 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.76 -147.51 19.26 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 107.495 -2.242 . . . . 0.0 107.495 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -100.52 165.56 19.26 Favored Glycine 0 C--O 1.22 -0.758 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 172.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD12 ' HE2' ' A' ' 82' ' ' LYS . 40.3 tp -50.06 -32.81 16.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.971 1.367 . . . . 0.0 112.864 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . 0.272 59.9 mttt -69.22 -28.45 66.36 Favored 'General case' 0 CA--C 1.482 -1.666 0 N-CA-C 115.346 1.609 . . . . 0.0 115.346 177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -86.32 -40.38 15.53 Favored 'General case' 0 N--CA 1.438 -1.063 0 O-C-N 126.178 2.174 . . . . 0.0 107.58 -171.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 80' ' ' MET . 2.2 mp -60.92 126.28 18.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 120.813 -1.179 . . . . 0.0 108.806 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -106.85 34.24 3.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.231 1.012 . . . . 0.0 110.264 -174.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.588 ' HE2' ' HZ3' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -91.24 161.47 34.85 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 123.459 0.704 . . . . 0.0 109.553 170.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -51.22 150.91 13.52 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.535 2.157 . . . . 0.0 111.519 166.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HE2' HD12 ' A' ' 75' ' ' LEU . 17.2 mttp -133.84 153.32 51.81 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.6 157.6 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.484 ' HB3' ' HE2' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -84.71 162.7 19.56 Favored 'General case' 0 CA--C 1.498 -1.041 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.443 173.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.346 0 O-C-N 127.502 3.001 . . . . 0.0 111.29 170.133 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -141.37 147.77 38.57 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.417 1.487 . . . . 0.0 107.38 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -135.28 110.98 9.26 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 124.825 1.25 . . . . 0.0 107.959 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -75.95 133.02 40.58 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.3 mm -132.86 122.53 46.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -78.51 129.39 34.8 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.93 31.34 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 118.691 0.678 . . . . 0.0 111.991 -174.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -120.02 -173.42 2.55 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.424 -0.797 . . . . 0.0 109.788 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 m -65.21 157.46 77.05 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 123.458 0.703 . . . . 0.0 110.01 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -62.62 -14.43 39.83 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.918 2.412 . . . . 0.0 113.649 176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -47.37 -47.87 25.95 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.957 1.303 . . . . 0.0 111.087 173.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -70.61 -42.0 71.53 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 118.529 0.604 . . . . 0.0 109.957 177.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -57.05 -38.56 73.41 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.952 0.901 . . . . 0.0 111.18 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.7 -45.03 88.33 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.772 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -73.54 -47.26 42.16 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 119.542 1.065 . . . . 0.0 110.771 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -173.83 149.37 1.55 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.595 1.558 . . . . 0.0 109.729 166.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -138.6 151.24 47.09 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.081 1.752 . . . . 0.0 107.991 176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.96 131.55 16.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 172.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.07 119.18 3.74 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.567 1.147 . . . . 0.0 110.346 -171.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.91 4.05 76.03 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.626 -1.097 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.2 132.9 55.15 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 119.372 1.586 . . . . 0.0 109.424 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.2 mt -78.83 129.17 37.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -78.36 118.59 20.68 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.164 0.893 . . . . 0.0 109.498 170.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.9 mt -141.16 84.57 12.75 Favored Pre-proline 0 CA--C 1.543 0.705 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -50.23 151.03 9.89 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.94 3.093 . . . . 0.0 113.895 -171.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.2 tp -46.74 -42.65 17.14 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.539 1.536 . . . . 0.0 112.575 178.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -66.82 -12.55 59.42 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.745 0.818 . . . . 0.0 112.992 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -129.39 -9.15 4.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.739 1.216 . . . . 0.0 112.389 -171.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 p -49.37 -42.24 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 119.735 1.152 . . . . 0.0 112.238 -169.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -57.92 -34.95 70.4 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.969 0.908 . . . . 0.0 112.824 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -92.77 7.57 43.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.062 0.945 . . . . 0.0 111.585 -168.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -140.94 -27.84 0.7 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.274 -0.891 . . . . 0.0 112.116 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -57.36 -34.81 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.687 1.131 . . . . 0.0 110.941 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.39 23.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.482 1.113 . . . . 0.0 113.676 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -121.42 -27.94 4.72 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.902 1.281 . . . . 0.0 111.156 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.98 -38.54 76.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.807 0.731 . . . . 0.0 111.04 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.0 t -140.26 75.78 27.59 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 -177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.63 -32.88 18.21 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.34 2.026 . . . . 0.0 112.37 -172.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -79.03 97.71 6.2 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -66.14 -10.31 39.89 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -78.68 -18.99 53.52 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.686 1.13 . . . . 0.0 111.563 171.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.38 147.06 54.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.056 0.843 . . . . 0.0 110.711 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -70.98 137.79 49.4 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -173.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 58.1 t -127.87 141.17 47.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -130.33 128.45 41.5 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.29 154.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.149 0.979 . . . . 0.0 108.925 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -155.92 161.76 40.49 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.593 1.957 . . . . 0.0 107.077 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 31.6 p -158.2 171.49 20.1 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.376 0.67 . . . . 0.0 109.638 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -48.32 -30.62 5.07 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.361 1.864 . . . . 0.0 114.545 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.75 2.05 8.17 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -173.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.52 -31.81 0.85 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.687 1.613 . . . . 0.0 113.918 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -63.57 -52.37 61.31 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 118.783 1.291 . . . . 0.0 111.507 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -62.94 -35.56 80.53 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.05 0.841 . . . . 0.0 110.892 -170.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.9 p -72.04 -33.15 67.77 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 121.53 -0.732 . . . . 0.0 111.651 172.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.65 -45.62 77.46 Favored Glycine 0 CA--C 1.531 1.075 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 168.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -64.66 -49.2 71.92 Favored 'General case' 0 CA--C 1.527 0.067 0 CA-C-N 117.516 0.658 . . . . 0.0 110.04 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.14 -36.63 70.94 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.443 0.297 . . . . 0.0 110.873 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -64.06 -42.12 97.13 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -70.44 -34.72 72.78 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 118.694 -0.669 . . . . 0.0 110.877 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.9 mt -58.66 -50.45 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 119.323 0.965 . . . . 0.0 108.927 172.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.28 -34.44 78.36 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.753 -0.592 . . . . 0.0 110.825 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.4 m -63.16 -40.6 98.01 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.562 0.345 . . . . 0.0 110.687 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.99 -35.57 80.24 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.55 0.74 . . . . 0.0 110.677 176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.0 mtp -69.05 -6.46 28.26 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.969 0.908 . . . . 0.0 112.415 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.73 11.91 63.16 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.631 -1.094 . . . . 0.0 113.159 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -65.93 119.26 11.01 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 119.381 1.591 . . . . 0.0 107.081 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 26.3 p -81.54 -19.86 41.22 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -169.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -134.01 76.81 1.67 Allowed 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.313 1.045 . . . . 0.0 108.441 -167.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.76 141.99 45.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -140.25 140.87 35.85 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 21.3 t30 -91.74 102.99 15.61 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 169.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.24 -33.74 76.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.743 -171.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.12 -168.3 27.1 Favored Glycine 0 C--N 1.337 0.628 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.53 153.63 51.78 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.8 tp -45.25 -45.09 11.7 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.861 1.664 . . . . 0.0 113.289 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -67.15 -25.36 66.13 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 119.063 -0.494 . . . . 0.0 112.13 -176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -78.56 -34.53 46.93 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 118.716 0.689 . . . . 0.0 111.574 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.77 123.93 17.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.06 22.9 12.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.12 0.968 . . . . 0.0 112.324 -176.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.7 mmm -73.63 153.21 89.56 Favored Pre-proline 0 C--O 1.241 0.613 0 C-N-CA 123.502 0.721 . . . . 0.0 109.115 169.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.81 157.37 12.93 Favored 'Trans proline' 0 C--O 1.239 0.548 0 C-N-CA 123.276 2.651 . . . . 0.0 110.948 167.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -136.43 158.0 45.47 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.128 0.571 . . . . 0.0 110.055 -174.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 97.4 t -134.27 164.55 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 127.213 2.205 . . . . 0.0 105.186 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -147.56 172.18 14.4 Favored 'General case' 0 C--O 1.235 0.341 0 O-C-N 120.805 -1.184 . . . . 0.0 110.648 -174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.968 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 -173.579 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -133.87 155.66 49.48 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.204 1.402 . . . . 0.0 107.909 176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -140.61 163.99 31.38 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.574 1.55 . . . . 0.0 107.427 171.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -128.26 136.18 50.68 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -131.04 127.76 61.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -175.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -94.53 121.38 36.02 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 168.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.6 m -108.46 13.97 8.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -93.93 179.49 5.32 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.7 1.136 . . . . 0.0 110.366 169.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -51.9 148.09 11.17 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.76 171.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -51.56 -27.15 24.35 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.332 2.688 . . . . 0.0 113.533 171.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -53.73 -39.55 65.37 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.667 0.787 . . . . 0.0 111.391 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.8 pp0? -69.83 -41.64 74.67 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 119.122 0.874 . . . . 0.0 110.501 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -58.1 -39.62 79.07 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.096 1.359 . . . . 0.0 110.486 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -70.88 -10.66 60.05 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.216 1.006 . . . . 0.0 113.696 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -81.69 -71.29 0.49 Allowed 'General case' 0 C--N 1.341 0.202 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 168.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -160.68 158.29 28.55 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.63 1.572 . . . . 0.0 107.702 168.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -143.44 152.75 41.91 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.527 1.131 . . . . 0.0 108.41 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.3 t -52.74 131.5 14.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 171.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -53.36 120.4 5.99 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.736 0.814 . . . . 0.0 109.493 -175.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.08 5.06 90.38 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.511 -1.161 . . . . 0.0 113.884 173.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.38 142.21 57.94 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.227 1.513 . . . . 0.0 110.005 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.2 mt -87.9 127.33 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 170.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -77.18 115.33 16.87 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 170.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 16.1 mt -138.56 81.56 23.87 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 126.133 1.773 . . . . 0.0 106.561 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.16 148.87 23.27 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.255 2.636 . . . . 0.0 112.625 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.88 -29.72 42.86 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.782 1.233 . . . . 0.0 112.722 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -60.08 -20.36 57.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.696 0.798 . . . . 0.0 113.049 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -128.41 -17.44 4.19 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.534 1.134 . . . . 0.0 112.096 -170.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.5 p -49.87 -36.44 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.341 . . . . 0.0 112.765 -174.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -59.65 -30.46 68.75 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 123.468 0.707 . . . . 0.0 112.073 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -103.92 -47.78 4.1 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.368 0.667 . . . . 0.0 109.514 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.8 mtp180 -63.89 -18.76 64.51 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 118.441 -0.79 . . . . 0.0 113.112 -173.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.4 tp -52.58 -40.55 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.43 1.014 . . . . 0.0 111.04 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.78 -42.79 90.36 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.828 0.74 . . . . 0.0 110.917 -173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -71.72 -37.02 70.68 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.487 0.715 . . . . 0.0 111.063 177.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.73 -43.87 62.4 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 118.217 0.462 . . . . 0.0 111.738 -177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.8 t -141.24 98.19 6.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.576 1.15 . . . . 0.0 108.128 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -58.18 -9.76 7.01 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 124.088 3.192 . . . . 0.0 116.253 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -134.83 111.29 9.78 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 119.834 1.197 . . . . 0.0 110.155 -174.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.0 -12.37 60.66 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.268 1.027 . . . . 0.0 112.701 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -86.54 -4.17 59.13 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.545 0.738 . . . . 0.0 111.151 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.74 151.03 47.9 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 121.362 -0.836 . . . . 0.0 108.9 168.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.5 m -79.62 70.21 6.06 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.73 0.776 . . . . 0.0 109.758 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 28.5 t -74.01 97.59 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -79.58 141.26 36.75 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.99 126.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -171.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -136.06 169.67 17.23 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.23 1.412 . . . . 0.0 109.307 175.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.8 p -150.11 178.45 8.95 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 169.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -63.78 -23.36 67.33 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.797 1.036 . . . . 0.0 113.797 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.01 -6.81 11.97 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 114.964 1.468 . . . . 0.0 114.964 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 64.63 30.13 77.08 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-N 119.661 1.119 . . . . 0.0 114.627 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -137.26 -45.8 0.56 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.012 0.906 . . . . 0.0 110.235 170.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.98 -22.38 65.92 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.726 0.239 . . . . 0.0 110.614 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 p -64.36 -42.21 96.33 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.05 -1.031 . . . . 0.0 110.95 168.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.77 -43.27 96.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 169.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.14 -40.07 96.51 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 119.147 1.474 . . . . 0.0 111.315 178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.36 -33.53 76.06 Favored 'General case' 0 C--O 1.227 -0.087 0 O-C-N 121.376 -0.828 . . . . 0.0 110.685 174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.03 -39.65 83.06 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.488 174.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -60.97 -44.02 97.94 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.37 0.987 . . . . 0.0 109.714 175.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 57.2 mt -56.41 -50.38 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.921 0.889 . . . . 0.0 109.688 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 90.6 mt -71.05 -18.65 62.55 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.441 -0.787 . . . . 0.0 111.502 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.8 m -68.22 -36.73 79.96 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.54 -0.725 . . . . 0.0 110.126 169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.12 -36.49 83.79 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.299 0.954 . . . . 0.0 110.052 171.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 99.1 mmm -73.23 -1.87 19.49 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.064 0.945 . . . . 0.0 112.796 177.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.08 46.05 17.78 Favored Glycine 0 CA--C 1.528 0.855 0 CA-C-N 119.849 1.204 . . . . 0.0 111.659 176.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -46.24 158.41 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.501 1.121 . . . . 0.0 113.299 169.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -134.83 -26.67 1.33 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 117.893 -1.051 . . . . 0.0 112.217 173.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -147.92 23.86 1.08 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.585 1.539 . . . . 0.0 113.845 169.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 144.58 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 168.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -145.2 128.33 16.64 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.856 0.862 . . . . 0.0 109.002 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -77.63 108.17 10.63 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 168.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.41 -40.73 73.7 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.0 0.52 . . . . 0.0 110.957 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 150.54 -139.36 7.23 Favored Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.22 166.34 15.67 Favored Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 171.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.5 tp -51.03 -40.16 57.56 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 -168.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.91 -27.61 66.79 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.642 0.377 . . . . 0.0 111.677 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -86.71 -36.28 18.77 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.884 0.874 . . . . 0.0 111.658 -177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 mp -62.95 119.66 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.46 22.87 6.49 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.05 0.94 . . . . 0.0 112.468 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.0 mmm -81.3 158.35 69.41 Favored Pre-proline 0 C--O 1.24 0.565 0 C-N-CA 124.072 0.949 . . . . 0.0 109.462 173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.65 154.92 11.19 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.441 2.761 . . . . 0.0 111.754 168.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -134.41 154.34 51.42 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 t -130.54 141.04 47.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -176.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -66.59 161.0 24.11 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 123.09 0.556 . . . . 0.0 110.281 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.658 -1.079 . . . . 0.0 111.032 169.355 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -161.4 156.96 24.47 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 125.204 1.401 . . . . 0.0 107.896 -171.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -82.8 158.07 22.94 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 171.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 53.8 m95 -132.22 141.66 49.13 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.621 1.168 . . . . 0.0 107.998 -178.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 5.0 mp -139.84 136.34 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -93.89 122.24 36.17 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 15.1 m -107.64 20.21 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -171.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.598 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 15.8 ttt85 -109.56 -162.84 0.83 Allowed 'General case' 0 N--CA 1.466 0.355 0 O-C-N 121.238 -0.914 . . . . 0.0 108.766 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 11.1 m -77.98 156.13 79.83 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 123.343 0.657 . . . . 0.0 109.588 178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -52.41 -23.77 19.75 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 123.364 2.709 . . . . 0.0 114.029 169.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -59.0 -26.08 64.2 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 117.915 -1.04 . . . . 0.0 112.688 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -86.2 -51.34 6.34 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-N 119.95 1.25 . . . . 0.0 109.142 167.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -53.25 -37.81 62.43 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.871 1.269 . . . . 0.0 112.992 -170.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -66.59 -45.59 78.7 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.75 0.82 . . . . 0.0 111.52 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -75.38 -30.36 60.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.953 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.74 153.37 2.21 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.616 1.566 . . . . 0.0 109.667 166.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -146.02 146.51 31.0 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 169.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.5 t -60.15 132.67 25.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.4 149.43 16.83 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.577 0.751 . . . . 0.0 111.529 -172.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.93 -14.87 46.43 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 118.914 -0.937 . . . . 0.0 113.462 174.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.82 171.39 7.96 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.889 1.345 . . . . 0.0 111.797 176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.8 mt -135.4 134.22 52.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 103.537 -2.764 . . . . 0.0 103.537 169.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -73.92 115.65 13.63 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.162 0.892 . . . . 0.0 109.031 173.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 32.9 mt -141.29 87.55 10.52 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -50.22 149.83 11.69 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 124.009 3.139 . . . . 0.0 114.027 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.3 tp -48.49 -36.37 14.99 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.883 1.673 . . . . 0.0 113.074 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -63.88 -20.45 65.83 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.978 0.732 . . . . 0.0 112.978 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -129.29 -11.3 4.62 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.93 0.892 . . . . 0.0 111.865 -169.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -50.26 -34.65 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.399 1.08 . . . . 0.0 111.51 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -53.69 -33.83 56.74 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 125.022 1.329 . . . . 0.0 112.609 -177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -113.54 -36.72 4.84 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 118.485 0.584 . . . . 0.0 111.211 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -69.26 -15.67 63.41 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.597 -0.689 . . . . 0.0 112.317 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -52.67 -35.35 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 118.631 -0.699 . . . . 0.0 111.056 169.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.97 -41.08 99.43 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 119.385 0.993 . . . . 0.0 111.184 -175.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.88 -35.94 59.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.405 0.682 . . . . 0.0 111.158 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.83 -35.74 75.02 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.425 0.557 . . . . 0.0 111.981 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.1 t -140.66 82.47 15.78 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.994 1.718 . . . . 0.0 107.062 -169.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.46 3.71 4.53 Favored 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 123.381 2.72 . . . . 0.0 114.256 -173.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -134.06 103.88 5.99 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 124.801 1.24 . . . . 0.0 107.863 171.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -15.78 52.07 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -69.98 -25.15 63.48 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.468 0.577 . . . . 0.0 111.876 175.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -63.66 154.7 32.14 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.63 0.65 . . . . 0.0 111.773 -174.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 m -73.2 142.67 47.34 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -138.22 140.59 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -120.67 139.93 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.8 m -127.19 144.6 36.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -143.57 160.59 40.36 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.46 1.104 . . . . 0.0 109.109 170.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -130.01 -139.34 0.22 Allowed 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 125.034 1.334 . . . . 0.0 107.423 176.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -80.53 -45.15 17.93 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.789 1.631 . . . . 0.0 111.89 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.87 -26.44 3.18 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -169.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 140.32 -29.35 2.41 Favored Glycine 0 CA--C 1.527 0.797 0 CA-C-N 119.073 0.851 . . . . 0.0 113.933 170.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -66.08 -44.21 85.14 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 118.984 1.392 . . . . 0.0 112.517 -173.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -70.2 -33.03 71.21 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.868 0.758 . . . . 0.0 110.648 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -33.39 74.56 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.251 -0.906 . . . . 0.0 110.648 170.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.96 -49.18 68.34 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 168.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -60.47 -46.91 88.37 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 117.529 0.664 . . . . 0.0 110.655 176.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.09 -36.51 75.25 Favored 'General case' 0 CA--C 1.527 0.08 0 CA-C-N 118.474 0.579 . . . . 0.0 110.791 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -65.4 -42.79 92.22 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.68 -42.34 98.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 118.876 0.762 . . . . 0.0 111.111 176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 88.2 mt -55.84 -51.21 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 175.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 65.5 mt -73.88 -24.56 59.74 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.733 -0.604 . . . . 0.0 111.858 -173.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 m -67.38 -38.95 85.52 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.321 0.51 . . . . 0.0 110.248 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -67.26 -37.21 83.1 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.831 0.741 . . . . 0.0 110.256 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.2 mmm -67.39 -12.98 61.56 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.688 0.795 . . . . 0.0 112.289 170.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.89 14.6 66.99 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 118.349 -1.25 . . . . 0.0 113.955 172.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -64.26 122.87 17.68 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.522 1.661 . . . . 0.0 107.716 176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -68.19 -30.88 70.08 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -165.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.7 m80 -138.27 42.9 2.2 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 119.271 0.942 . . . . 0.0 112.213 -166.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 t -78.83 146.67 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 170.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -142.65 137.76 30.18 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 125.144 1.378 . . . . 0.0 108.356 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -78.5 114.37 17.35 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 169.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.19 -29.38 63.93 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.637 0.775 . . . . 0.0 112.031 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.58 -145.7 17.71 Favored Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 -169.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.93 168.99 16.02 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 171.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 50.8 tp -64.98 -25.48 67.89 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.142 0.977 . . . . 0.0 112.234 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -78.25 -6.02 53.7 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 118.961 -0.543 . . . . 0.0 112.353 172.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -122.58 -35.09 3.14 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.311 1.044 . . . . 0.0 112.471 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 54.3 mt -59.61 146.19 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 120.264 1.393 . . . . 0.0 108.615 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.97 67.14 1.34 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.471 1.508 . . . . 0.0 108.427 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 19.2 ptm -140.23 166.1 25.83 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.9 1.28 . . . . 0.0 108.543 174.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -52.91 147.1 33.96 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.231 2.621 . . . . 0.0 113.561 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -120.87 160.06 24.22 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.5 1.12 . . . . 0.0 109.029 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.56 155.83 42.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.25 -2.129 . . . . 0.0 105.25 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -134.86 155.86 49.92 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.124 0.97 . . . . 0.0 109.089 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.09 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 174.642 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -140.52 145.4 36.79 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.475 1.11 . . . . 0.0 108.213 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -134.72 98.67 4.11 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.626 1.571 . . . . 0.0 107.149 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -72.64 147.08 46.12 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.8 mm -140.34 124.69 18.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -79.79 114.35 18.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 168.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.4 m -106.42 18.55 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.49 -171.93 2.22 Favored 'General case' 0 C--O 1.233 0.186 0 O-C-N 120.946 -1.096 . . . . 0.0 109.288 173.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.74 154.9 64.28 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 168.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.02 -11.11 25.7 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 123.059 2.506 . . . . 0.0 114.1 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -54.27 -37.26 64.53 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.575 1.55 . . . . 0.0 112.275 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.38 -41.85 75.93 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 119.141 0.882 . . . . 0.0 110.296 173.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -58.75 -31.44 68.34 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.097 0.959 . . . . 0.0 110.945 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 -64.66 -14.63 59.07 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -132.08 -36.47 1.17 Allowed 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.536 1.062 . . . . 0.0 112.709 -169.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.91 139.74 6.4 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 119.865 1.211 . . . . 0.0 108.256 165.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -141.71 154.7 45.47 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 170.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.5 t -54.39 128.8 14.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.17 -29.68 65.8 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.046 0.539 . . . . 0.0 112.235 -169.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.94 22.77 36.33 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.241 -1.311 . . . . 0.0 113.12 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -120.57 163.69 17.62 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 119.173 1.487 . . . . 0.0 112.319 -176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 20.9 pt -137.36 144.72 30.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 127.053 2.141 . . . . 0.0 107.33 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.3 117.23 20.1 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 123.113 0.565 . . . . 0.0 109.805 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 31.0 mt -141.21 83.45 13.7 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 126.222 1.809 . . . . 0.0 106.268 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -54.32 152.83 24.3 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.769 2.979 . . . . 0.0 114.555 -170.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.0 tp -47.38 -36.57 9.84 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.651 1.981 . . . . 0.0 113.016 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -64.14 -20.06 65.72 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.29 -11.75 4.08 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.852 0.861 . . . . 0.0 112.105 -169.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.4 p -51.4 -33.75 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 124.763 1.225 . . . . 0.0 112.058 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -54.43 -35.75 63.28 Favored 'General case' 0 C--N 1.343 0.309 0 C-N-CA 124.577 1.151 . . . . 0.0 111.974 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.96 -42.17 5.19 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -66.96 -14.31 62.71 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 tp -52.18 -38.62 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.467 1.031 . . . . 0.0 111.204 170.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.76 98.49 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.131 0.878 . . . . 0.0 111.041 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.14 -35.63 69.14 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.531 0.732 . . . . 0.0 111.201 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.46 -46.27 67.08 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.137 0.575 . . . . 0.0 111.526 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.5 t -143.66 101.32 5.05 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -171.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.17 -22.92 34.1 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.57 2.847 . . . . 0.0 115.53 -177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -144.43 116.63 8.44 Favored 'General case' 0 C--O 1.232 0.145 0 C-N-CA 124.305 1.042 . . . . 0.0 108.849 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.7 mttp -66.74 -4.56 9.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.562 1.145 . . . . 0.0 113.088 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.62 -23.58 62.58 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.146 0.579 . . . . 0.0 111.087 169.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -71.13 150.0 45.86 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 168.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -69.07 130.17 41.98 Favored 'General case' 0 CA--C 1.536 0.414 0 O-C-N 121.685 -0.634 . . . . 0.0 109.416 -173.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.7 t -125.74 134.49 66.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -129.34 86.65 2.45 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.4 m -73.87 144.44 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 176.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -152.18 163.63 38.99 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.559 1.544 . . . . 0.0 108.379 172.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 30.1 p -155.71 170.46 21.99 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.466 1.106 . . . . 0.0 109.147 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -54.79 -14.98 1.6 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.75 -3.4 4.7 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 -175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 71.51 -30.26 0.59 Allowed Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.447 1.499 . . . . 0.0 114.137 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 18.9 tpp180 -64.97 -49.71 69.22 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 124.438 1.095 . . . . 0.0 111.525 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.67 -31.35 71.28 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.399 0.545 . . . . 0.0 110.638 -174.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -71.57 -30.89 66.36 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 121.173 -0.954 . . . . 0.0 111.289 170.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.2 -48.97 70.81 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 167.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -61.36 -44.42 97.19 Favored 'General case' 0 N--CA 1.462 0.153 0 O-C-N 121.974 -0.721 . . . . 0.0 111.166 176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.56 -36.06 75.46 Favored 'General case' 0 C--N 1.338 0.071 0 CA-C-N 118.372 0.533 . . . . 0.0 110.572 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -67.39 -40.38 85.66 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -64.12 -41.39 97.26 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.361 0.982 . . . . 0.0 110.842 176.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.11 -53.01 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 70.4 mt -69.78 -23.19 63.31 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.927 -0.483 . . . . 0.0 111.829 -173.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.425 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 34.9 m -63.12 -44.28 96.05 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.558 0.617 . . . . 0.0 110.128 171.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -67.22 -28.92 68.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 118.313 0.506 . . . . 0.0 110.884 175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 93.8 mmm -76.7 6.59 5.74 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.142 0.977 . . . . 0.0 112.73 173.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.32 42.51 8.55 Favored Glycine 0 CA--C 1.528 0.848 0 CA-C-N 119.677 1.126 . . . . 0.0 112.525 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.425 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.2 OUTLIER -53.3 161.85 0.85 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 175.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.33 -40.72 0.65 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.548 1.139 . . . . 0.0 110.622 168.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.4 m80 -135.23 33.36 3.09 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.818 1.19 . . . . 0.0 112.537 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 54.4 t -82.42 140.67 16.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 167.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -147.16 143.6 28.36 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.075 0.95 . . . . 0.0 108.875 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -79.35 107.46 12.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.21 -29.29 70.09 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.059 0.544 . . . . 0.0 111.958 -177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 136.95 -162.12 25.21 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 109.011 -1.635 . . . . 0.0 109.011 -173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.06 162.05 30.83 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.81 -0.916 . . . . 0.0 110.81 172.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.5 tp -58.19 -34.06 69.95 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.403 1.081 . . . . 0.0 110.565 169.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -68.13 -14.66 63.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.92 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -110.7 -39.26 4.92 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.114 0.966 . . . . 0.0 111.33 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 26.8 mt -64.42 139.79 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.721 1.146 . . . . 0.0 109.498 176.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.06 27.39 7.18 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.022 1.329 . . . . 0.0 111.508 -176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.4 mmm -66.0 162.51 45.44 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 167.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.05 144.26 46.92 Favored 'Trans proline' 0 C--O 1.238 0.505 0 C-N-CA 122.285 1.99 . . . . 0.0 110.547 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -133.14 153.09 51.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 123.609 0.764 . . . . 0.0 109.261 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.77 160.47 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.458 1.903 . . . . 0.0 106.725 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -82.47 157.05 23.76 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 169.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 173.508 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -142.93 153.03 42.67 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.657 1.183 . . . . 0.0 108.814 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -141.12 153.37 45.37 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.091 1.757 . . . . 0.0 106.906 169.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -123.08 150.44 43.15 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.3 mm -140.04 123.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -172.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -80.87 111.18 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 167.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 m -103.3 20.69 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -176.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 11.6 ttt-85 -106.94 -175.48 2.81 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.194 -0.942 . . . . 0.0 109.61 175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 4.4 m -69.14 156.86 90.72 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.185 0.594 . . . . 0.0 109.868 175.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.53 -14.2 4.62 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 124.107 3.205 . . . . 0.0 115.759 173.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -48.65 -38.02 19.97 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.099 1.36 . . . . 0.0 112.058 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -80.43 -48.52 12.74 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.227 0.467 . . . . 0.0 110.305 173.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -55.81 -38.99 70.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.129 0.971 . . . . 0.0 112.02 -171.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -65.4 -7.8 15.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.259 1.424 . . . . 0.0 113.637 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -130.23 -29.68 2.01 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 119.657 1.117 . . . . 0.0 112.607 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -167.04 143.15 4.35 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 120.062 1.301 . . . . 0.0 108.797 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -143.75 153.36 42.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.337 1.055 . . . . 0.0 108.217 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.44 131.58 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 173.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -58.46 -33.64 69.98 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.373 0.669 . . . . 0.0 111.54 -173.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.37 12.94 67.81 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 118.296 -1.28 . . . . 0.0 113.048 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -119.03 166.05 13.37 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 119.128 1.464 . . . . 0.0 112.169 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.7 pt -142.45 142.16 27.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 127.022 2.129 . . . . 0.0 107.373 -170.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -80.0 114.79 19.17 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.877 0.471 . . . . 0.0 110.231 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 13.8 mt -139.04 80.4 24.01 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.811 1.644 . . . . 0.0 107.034 177.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.62 153.86 17.51 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.669 2.912 . . . . 0.0 113.912 -171.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 47.7 tp -46.61 -38.96 10.37 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.537 1.935 . . . . 0.0 113.114 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -69.23 -13.14 62.24 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -126.98 -18.84 4.55 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.164 0.986 . . . . 0.0 111.989 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.55 -34.48 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 125.018 1.327 . . . . 0.0 112.813 -176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -57.11 -29.88 63.9 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.356 1.062 . . . . 0.0 112.476 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.18 -41.29 3.33 Favored 'General case' 0 C--N 1.334 -0.065 0 C-N-CA 123.374 0.67 . . . . 0.0 109.945 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.12 -16.85 63.94 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.3 -35.16 29.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 119.662 1.119 . . . . 0.0 110.85 169.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.24 -7.15 28.06 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.931 0.893 . . . . 0.0 113.145 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.1 p -120.91 15.79 11.71 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.732 1.613 . . . . 0.0 110.512 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.74 -51.08 0.79 Allowed 'General case' 0 C--N 1.343 0.291 0 C-N-CA 124.266 1.026 . . . . 0.0 110.733 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 t -142.21 67.51 21.34 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.726 1.21 . . . . 0.0 108.142 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.98 -28.92 75.26 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.331 2.021 . . . . 0.0 112.211 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.65 81.09 3.3 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 169.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -52.47 -26.4 12.78 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.934 1.294 . . . . 0.0 113.092 -173.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -66.64 -24.33 66.28 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.172 0.989 . . . . 0.0 112.743 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -71.43 150.61 44.78 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.29 0.95 . . . . 0.0 109.8 174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.35 137.78 54.88 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.546 -0.721 . . . . 0.0 110.221 -171.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.9 t -130.7 131.57 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 176.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -125.34 90.94 3.32 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -173.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.6 m -75.7 144.46 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.08 162.22 38.41 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.706 1.202 . . . . 0.0 109.115 171.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.6 p -153.35 172.45 17.03 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.214 1.006 . . . . 0.0 109.603 174.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -51.28 -25.96 6.57 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.621 1.568 . . . . 0.0 115.232 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.77 -0.68 6.05 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.34 -36.64 0.96 Allowed Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.594 1.569 . . . . 0.0 113.811 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -63.35 -44.3 95.24 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.902 1.351 . . . . 0.0 111.425 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -72.94 -29.07 62.82 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.098 0.408 . . . . 0.0 110.412 -172.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -69.93 -32.41 70.67 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.945 -1.097 . . . . 0.0 109.961 168.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.38 -47.96 66.62 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 166.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -63.48 -41.8 98.57 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.261 1.03 . . . . 0.0 111.095 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.48 76.31 Favored 'General case' 0 CA--C 1.526 0.035 0 CA-C-N 118.802 0.728 . . . . 0.0 110.491 176.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.63 -41.43 79.47 Favored 'General case' 0 C--O 1.227 -0.107 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.95 -44.34 94.45 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 119.47 1.032 . . . . 0.0 110.53 175.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 53.7 mt -58.5 -52.12 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 123.97 0.908 . . . . 0.0 109.431 176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 88.6 mt -69.09 -26.75 65.08 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.989 -0.444 . . . . 0.0 110.954 -175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 45.1 m -61.38 -39.39 90.5 Favored 'General case' 0 N--CA 1.456 -0.154 0 O-C-N 121.551 -0.718 . . . . 0.0 110.627 172.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.91 -41.8 77.69 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.263 0.483 . . . . 0.0 110.424 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.7 ppp? -74.41 -16.2 60.89 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.54 46.07 0.19 Allowed Glycine 0 C--N 1.34 0.773 0 CA-C-O 118.828 -0.984 . . . . 0.0 114.01 168.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.05 157.48 3.31 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.639 1.219 . . . . 0.0 112.752 178.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.9 -44.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.986 1.314 . . . . 0.0 109.491 168.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -135.99 35.47 2.83 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.394 1.078 . . . . 0.0 111.359 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.9 t -84.76 135.68 24.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -140.22 146.86 39.21 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.385 1.074 . . . . 0.0 108.963 177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -80.15 113.9 18.67 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 168.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.6 -31.34 71.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.469 0.708 . . . . 0.0 111.685 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.88 -165.39 24.27 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -172.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.9 160.41 31.1 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 34.3 tp -49.6 -34.08 16.95 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.014 1.725 . . . . 0.0 111.944 176.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.0 mttp -66.68 -9.8 39.96 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.707 1.603 . . . . 0.0 112.53 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -124.88 -27.39 3.62 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.223 1.409 . . . . 0.0 112.751 -171.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.0 mp -71.03 89.88 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 120.572 1.533 . . . . 0.0 107.037 168.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.57 27.39 0.21 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.358 1.463 . . . . 0.0 113.15 -176.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.3 mtp -73.13 156.37 89.48 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 123.51 0.724 . . . . 0.0 109.226 171.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.24 155.24 12.54 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 123.458 2.772 . . . . 0.0 111.643 168.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -132.87 154.64 50.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.036 0.534 . . . . 0.0 110.518 -174.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.5 t -133.02 173.9 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 C-N-CA 127.298 2.239 . . . . 0.0 105.652 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -125.41 146.04 49.79 Favored 'General case' 0 C--O 1.235 0.325 0 O-C-N 120.986 -1.071 . . . . 0.0 109.217 -172.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 172.701 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -144.19 146.69 32.87 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.542 1.137 . . . . 0.0 108.797 179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -140.38 169.92 16.77 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.534 1.134 . . . . 0.0 108.264 168.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 2.4 m-90 -131.11 138.39 49.49 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -169.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.1 mm -137.84 129.75 39.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.71 120.61 26.6 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 169.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.415 HG23 ' SG ' ' A' ' 48' ' ' CYS . 29.2 m -111.97 19.42 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 118.199 0.454 . . . . 0.0 111.617 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -98.77 -177.62 3.71 Favored 'General case' 0 C--O 1.232 0.174 0 O-C-N 121.347 -0.846 . . . . 0.0 109.601 176.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -60.43 154.46 54.16 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -53.16 -19.67 12.67 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.568 2.846 . . . . 0.0 114.899 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -47.45 -44.83 25.33 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.233 1.413 . . . . 0.0 112.192 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -73.0 -45.86 55.46 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.747 0.703 . . . . 0.0 110.719 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -55.29 -37.15 66.96 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.41 1.484 . . . . 0.0 111.37 -177.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -67.64 -16.31 64.1 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.73 1.212 . . . . 0.0 113.119 177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 38.7 mm-40 -92.51 -59.74 2.0 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 171.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -159.95 158.85 31.46 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.363 1.465 . . . . 0.0 107.755 177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -140.19 154.36 46.9 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.38 141.31 13.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.49 121.56 4.61 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.385 1.074 . . . . 0.0 110.132 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 75.26 2.91 68.5 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.536 -1.147 . . . . 0.0 114.14 174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.4 154.51 35.36 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 119.505 1.652 . . . . 0.0 110.964 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.6 mt -124.02 127.93 73.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -71.39 114.36 9.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.754 0.706 . . . . 0.0 109.501 176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -140.54 79.7 19.79 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.325 1.85 . . . . 0.0 106.508 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -53.54 151.24 24.89 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.951 3.1 . . . . 0.0 114.731 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 57.6 tp -47.92 -38.92 17.59 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 126.881 2.072 . . . . 0.0 112.863 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -64.4 -20.45 66.15 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -129.71 -3.49 4.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.047 0.939 . . . . 0.0 112.045 -169.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.1 p -49.97 -40.98 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.476 1.111 . . . . 0.0 111.691 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -56.93 -38.01 72.28 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.802 0.841 . . . . 0.0 112.546 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -90.31 -3.76 57.56 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.591 0.757 . . . . 0.0 111.399 -170.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 94.7 mtt-85 -132.12 -26.54 1.91 Allowed 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -167.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 tp -59.56 -35.97 62.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 118.855 0.752 . . . . 0.0 110.739 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.12 96.1 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.559 0.618 . . . . 0.0 111.26 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.52 -36.14 65.68 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.157 0.583 . . . . 0.0 111.143 175.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.19 -42.27 72.61 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.476 0.58 . . . . 0.0 111.705 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.28 82.36 13.16 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 125.37 1.468 . . . . 0.0 108.247 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -58.44 -37.78 93.19 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.014 2.476 . . . . 0.0 113.133 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -79.2 96.02 5.78 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -69.51 -3.28 13.98 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -7.12 25.21 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.732 1.213 . . . . 0.0 111.108 174.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.11 150.56 49.0 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 119.668 1.122 . . . . 0.0 109.327 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.4 m -73.88 131.81 41.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.1 t -130.48 96.31 2.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -74.62 134.36 42.07 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 170.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.5 m -120.01 146.99 23.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 169.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -146.25 163.16 36.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.003 1.321 . . . . 0.0 108.162 176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.415 ' SG ' HG23 ' A' ' 7' ' ' VAL . 1.7 m -159.99 -178.59 7.13 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.801 1.641 . . . . 0.0 109.695 -176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -63.03 132.35 51.67 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 166.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 53.85 0.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.162 2.185 . . . . 0.0 116.413 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.03 -8.0 40.39 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.836 1.208 . . . . 0.0 114.252 176.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -63.06 -56.89 13.07 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 119.545 1.672 . . . . 0.0 109.799 178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -64.74 -29.49 70.47 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.948 -170.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 p -76.19 -33.23 59.3 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.204 -0.935 . . . . 0.0 111.28 172.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.37 -47.4 75.82 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 168.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.32 -46.53 88.29 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.643 0.777 . . . . 0.0 110.533 176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.55 -35.3 73.96 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 121.719 -0.613 . . . . 0.0 111.058 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.451 ' HE2' HG23 ' A' ' 69' ' ' VAL . 12.3 tmtt? -64.39 -44.75 90.35 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -69.24 -33.07 72.71 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.105 0.866 . . . . 0.0 111.215 178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 84.8 mt -59.32 -49.9 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 119.204 0.911 . . . . 0.0 108.938 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.88 -31.29 70.98 Favored 'General case' 0 C--O 1.231 0.123 0 O-C-N 121.54 -0.725 . . . . 0.0 111.378 -176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 20.2 m -62.94 -41.04 99.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 173.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -67.38 -35.91 80.28 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.635 -0.666 . . . . 0.0 110.78 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.6 mmm -67.86 -7.09 25.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.192 0.997 . . . . 0.0 112.318 171.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.51 12.42 59.64 Favored Glycine 0 CA--C 1.527 0.84 0 O-C-N 121.155 -0.966 . . . . 0.0 113.328 172.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -68.35 148.07 51.23 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.068 1.434 . . . . 0.0 108.106 168.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.5 t -128.0 -10.29 5.4 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -128.51 34.27 4.55 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.31 1.044 . . . . 0.0 110.109 173.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.451 HG23 ' HE2' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -79.1 143.06 13.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 168.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -146.94 128.74 15.3 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -177.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -76.75 104.56 7.32 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 168.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.36 -29.21 66.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.589 0.755 . . . . 0.0 111.872 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.3 -166.54 24.96 Favored Glycine 0 C--N 1.339 0.746 0 C-N-CA 123.983 0.801 . . . . 0.0 111.227 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.91 155.76 48.4 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 169.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 24.2 tp -44.94 -49.7 10.94 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.866 1.266 . . . . 0.0 112.833 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 -25.35 66.7 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 119.011 -0.519 . . . . 0.0 112.305 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.74 -28.35 30.48 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 118.268 -0.872 . . . . 0.0 112.007 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 mp -57.56 120.33 3.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 119.611 1.096 . . . . 0.0 108.884 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.5 55.54 3.55 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.563 1.545 . . . . 0.0 110.139 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 81.0 mtp -134.53 156.14 79.04 Favored Pre-proline 0 C--O 1.24 0.594 0 C-N-CA 124.792 1.237 . . . . 0.0 108.673 176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.81 157.3 10.45 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.073 2.515 . . . . 0.0 111.434 168.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -134.69 128.97 34.05 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.4 t -97.09 139.58 19.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.65 155.78 28.82 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.993 -0.442 . . . . 0.0 110.805 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.185 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 168.504 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.1 pm0 -160.02 161.21 33.97 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.171 1.388 . . . . 0.0 107.729 -172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.7 m80 -84.32 158.39 21.19 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 169.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -133.97 122.13 22.63 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 -174.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -123.57 126.46 73.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -84.04 117.19 23.25 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . 0.275 21.5 m -114.6 52.53 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.434 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 12.9 ttt180 -141.44 -169.92 2.97 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.508 -1.37 . . . . 0.0 110.144 170.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 12.0 m -58.62 153.95 37.88 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 172.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -52.34 -22.15 15.22 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 123.157 2.572 . . . . 0.0 114.124 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.69 -25.49 64.81 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.968 -1.015 . . . . 0.0 113.101 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -78.37 -49.86 12.78 Favored 'General case' 0 C--N 1.346 0.413 0 CA-C-N 120.22 1.373 . . . . 0.0 109.43 169.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -56.55 -40.71 75.6 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.469 1.107 . . . . 0.0 111.691 -174.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -67.14 -4.76 11.02 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.027 1.331 . . . . 0.0 113.599 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -126.27 -34.6 2.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.941 1.246 . . . . 0.0 111.912 176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -163.79 145.77 9.31 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.852 1.206 . . . . 0.0 109.243 167.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -146.75 154.87 41.9 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.78 1.232 . . . . 0.0 107.944 169.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -47.92 131.24 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 168.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -51.95 -36.5 49.51 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -166.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.18 2.11 83.3 Favored Glycine 0 CA--C 1.535 1.302 0 CA-C-N 118.601 0.637 . . . . 0.0 113.672 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.3 157.72 37.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 122.255 1.026 . . . . 0.0 113.636 -169.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.3 pt -131.52 134.44 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 168.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -81.14 120.87 25.4 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 122.802 0.441 . . . . 0.0 109.981 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -143.72 94.46 6.0 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.69 151.24 11.01 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 124.053 3.168 . . . . 0.0 114.86 -170.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.52 -50.06 33.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.962 1.305 . . . . 0.0 112.272 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -71.75 -5.65 35.58 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -124.1 -18.95 5.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.608 1.163 . . . . 0.0 111.96 -167.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -55.34 -31.93 28.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.813 1.645 . . . . 0.0 112.452 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -52.73 -40.48 63.1 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.5 1.12 . . . . 0.0 111.802 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.26 -45.97 8.72 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.898 0.317 . . . . 0.0 110.543 -176.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -73.05 -20.35 61.0 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 121.624 -0.672 . . . . 0.0 112.207 -168.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.9 tp -55.54 -33.6 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 119.391 0.996 . . . . 0.0 110.642 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.04 -17.01 61.77 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 p -116.81 -29.31 6.08 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.715 1.206 . . . . 0.0 110.984 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.0 -37.06 72.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.68 0.673 . . . . 0.0 111.271 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 t -140.52 74.34 28.44 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.894 1.677 . . . . 0.0 106.507 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.19 -29.41 39.35 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.09 1.86 . . . . 0.0 112.435 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -79.68 95.14 5.86 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.435 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 0.0 OUTLIER -62.47 -10.62 12.29 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 -179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -81.99 -19.94 39.51 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.839 1.199 . . . . 0.0 111.795 173.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -67.49 146.21 54.19 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.877 0.762 . . . . 0.0 110.635 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.8 m -70.68 145.98 50.22 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.139 0.976 . . . . 0.0 110.19 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.9 t -136.06 141.88 40.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -117.03 144.01 45.1 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 124.787 1.235 . . . . 0.0 107.928 171.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.0 m -132.75 144.34 36.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.367 1.067 . . . . 0.0 108.762 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -157.58 149.11 21.85 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.406 1.483 . . . . 0.0 109.19 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.1 t -149.01 174.64 12.07 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.989 1.716 . . . . 0.0 108.427 -168.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -58.13 -25.07 60.96 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.604 0.761 . . . . 0.0 112.92 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.65 140.81 41.07 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.596 1.159 . . . . 0.0 108.836 175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.97 -28.87 72.74 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.213 0.911 . . . . 0.0 113.054 -173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 tpm_? -55.55 -46.11 77.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.483 1.141 . . . . 0.0 110.035 171.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -71.86 -36.89 70.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.633 0.651 . . . . 0.0 110.095 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 m -56.9 -44.63 82.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.268 0.485 . . . . 0.0 110.038 169.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.99 -43.04 98.55 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.95 1.262 . . . . 0.0 111.859 175.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -62.08 -43.01 99.76 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 118.445 1.123 . . . . 0.0 110.509 177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.36 76.79 Favored 'General case' 0 C--N 1.338 0.076 0 CA-C-N 119.008 0.822 . . . . 0.0 110.651 175.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -64.07 -45.83 87.02 Favored 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -63.03 -39.45 94.78 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.269 0.486 . . . . 0.0 111.014 177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.61 -48.04 90.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 118.975 0.807 . . . . 0.0 109.621 176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 23.2 mt -70.02 -29.04 66.0 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 121.535 -0.728 . . . . 0.0 111.078 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.7 m -67.11 -38.52 85.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.04 0.536 . . . . 0.0 110.61 172.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -65.1 -37.74 88.46 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 123.647 0.779 . . . . 0.0 110.147 174.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 98.7 mmm -70.23 -3.82 18.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.841 0.856 . . . . 0.0 112.708 171.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.29 22.91 76.97 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-O 118.749 -1.028 . . . . 0.0 113.217 172.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.435 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 10.9 m-85 -65.36 124.09 21.32 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.175 1.487 . . . . 0.0 107.728 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.55 -27.3 67.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.311 0.644 . . . . 0.0 112.364 -169.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -139.27 107.64 5.82 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.7 t -141.99 144.15 25.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -135.92 125.74 25.68 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -71.16 109.14 5.04 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 167.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.98 -25.09 52.34 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 119.16 -0.448 . . . . 0.0 111.862 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 133.04 -166.61 23.63 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.21 157.55 40.95 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 168.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.44 -41.96 86.28 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.767 -0.843 . . . . 0.0 110.462 175.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -67.3 -29.78 69.46 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.317 -0.373 . . . . 0.0 111.281 177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -79.36 -39.91 31.48 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 119.077 -0.487 . . . . 0.0 111.15 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 68.4 mt -63.0 137.79 23.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 118.579 0.627 . . . . 0.0 109.631 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.2 23.73 14.06 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.419 1.088 . . . . 0.0 112.296 -175.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -72.84 154.4 91.09 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.79 152.35 17.44 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.715 2.943 . . . . 0.0 112.137 169.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -140.17 152.92 46.43 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 123.688 0.795 . . . . 0.0 109.448 -178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.3 158.17 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.337 1.855 . . . . 0.0 107.242 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -74.69 154.14 38.57 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.668 -0.645 . . . . 0.0 110.251 170.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 171.134 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -140.77 148.75 41.14 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.526 1.131 . . . . 0.0 108.382 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -137.3 156.66 47.98 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.257 1.823 . . . . 0.0 106.773 169.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.2 m-90 -128.94 139.21 52.22 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.4 mm -130.93 121.18 49.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -81.3 110.42 16.74 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 166.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.3 m -99.11 21.46 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -111.26 -172.25 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 O-C-N 121.004 -1.06 . . . . 0.0 110.381 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 m -66.75 152.59 95.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 123.105 0.562 . . . . 0.0 110.181 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -52.72 -19.63 11.05 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.625 2.883 . . . . 0.0 114.836 172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.43 -28.82 67.29 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 118.286 -0.864 . . . . 0.0 112.14 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -77.41 -46.43 22.72 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.841 1.2 . . . . 0.0 109.39 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -56.43 -40.82 75.38 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.211 1.004 . . . . 0.0 111.858 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 94.1 mm-40 -62.4 -46.99 86.1 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.1 0.96 . . . . 0.0 111.381 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.51 -48.23 17.56 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.58 -175.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -164.02 142.51 7.45 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.125 0.875 . . . . 0.0 110.185 169.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -135.38 155.32 50.77 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.917 1.287 . . . . 0.0 108.198 170.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.4 t -57.68 130.18 20.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -62.39 114.74 3.68 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 115.58 -12.97 18.26 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.888 1.232 . . . . 0.0 111.942 -178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.31 164.0 24.45 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 118.307 1.054 . . . . 0.0 111.751 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 22.6 pt -138.84 140.91 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 126.53 1.932 . . . . 0.0 106.921 175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.09 114.18 18.8 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.62 83.77 16.54 Favored Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.49 153.55 13.57 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 124.034 3.156 . . . . 0.0 113.378 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.9 tp -50.41 -35.6 29.14 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.213 1.405 . . . . 0.0 112.555 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -66.47 -15.43 63.35 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.672 0.789 . . . . 0.0 113.021 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -129.01 -18.44 3.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.279 1.031 . . . . 0.0 112.111 -169.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -50.52 -34.05 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 C-N-CA 125.014 1.326 . . . . 0.0 111.969 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -65.63 -11.69 46.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.125 0.97 . . . . 0.0 113.384 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -122.06 -53.42 1.94 Allowed 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.093 0.957 . . . . 0.0 108.481 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -63.51 -23.19 67.29 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -170.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -56.01 -36.35 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 119.453 1.024 . . . . 0.0 110.884 176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.19 -11.68 51.24 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.775 0.83 . . . . 0.0 112.802 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.7 p -119.95 12.31 11.99 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.866 1.666 . . . . 0.0 110.813 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -130.08 -38.14 1.44 Allowed 'General case' 0 C--N 1.342 0.263 0 C-N-CA 124.618 1.167 . . . . 0.0 111.433 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -137.94 71.99 48.25 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -65.54 -29.36 52.82 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.506 2.137 . . . . 0.0 112.607 -170.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -78.58 96.78 5.56 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -63.65 -11.01 21.8 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -76.86 -17.49 58.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.258 0.935 . . . . 0.0 111.879 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -70.1 157.79 36.92 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.773 0.715 . . . . 0.0 111.826 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.7 m -73.79 133.67 43.29 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.767 -0.583 . . . . 0.0 109.76 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 44.5 t -131.78 96.75 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -79.01 132.28 36.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.12 135.27 64.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 123.735 0.814 . . . . 0.0 109.57 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -147.91 162.22 39.73 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.851 1.66 . . . . 0.0 108.736 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.7 p -154.64 165.81 35.36 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.399 1.48 . . . . 0.0 107.594 174.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -54.57 -31.98 57.72 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.986 -1.071 . . . . 0.0 113.009 176.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -84.87 -15.89 43.09 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -175.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.67 35.08 61.5 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.977 1.262 . . . . 0.0 112.752 -170.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -144.15 -53.87 0.34 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.666 1.186 . . . . 0.0 109.919 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -60.76 -27.89 68.31 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.27 0.628 . . . . 0.0 110.461 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 p -66.33 -40.06 89.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.955 1.302 . . . . 0.0 112.519 170.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -40.68 96.13 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -64.02 -47.12 81.48 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 117.971 0.885 . . . . 0.0 110.399 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.94 72.68 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 122.203 -0.311 . . . . 0.0 110.986 176.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -62.81 -45.45 92.59 Favored 'General case' 0 N--CA 1.461 0.094 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -64.05 -40.18 95.73 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 118.809 -0.615 . . . . 0.0 110.852 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 73.7 mt -57.32 -53.18 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 118.947 0.794 . . . . 0.0 109.235 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 53.3 mt -69.31 -29.14 66.93 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.961 -0.462 . . . . 0.0 110.93 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.2 m -65.52 -40.57 93.13 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.241 0.473 . . . . 0.0 110.697 172.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -64.07 -36.67 84.76 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.884 0.766 . . . . 0.0 110.094 175.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.9 mtp -71.94 -3.25 21.53 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.04 0.936 . . . . 0.0 112.712 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.27 16.92 72.92 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 118.908 -0.94 . . . . 0.0 113.56 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -67.12 127.41 32.5 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 p -86.5 -21.83 26.75 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.8 m80 -131.49 35.99 3.8 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.763 0.825 . . . . 0.0 111.197 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.44 146.3 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 168.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -143.15 125.68 15.8 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -75.13 97.99 3.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 168.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.22 -33.09 72.93 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.033 0.533 . . . . 0.0 110.679 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 -115.07 0.94 Allowed Glycine 0 C--N 1.337 0.608 0 N-CA-C 107.232 -2.347 . . . . 0.0 107.232 174.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.09 172.69 25.14 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.6 tp -63.22 -34.46 77.69 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.002 0.521 . . . . 0.0 111.297 -173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -67.35 -36.03 80.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.823 0.449 . . . . 0.0 110.537 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -78.48 -41.98 31.04 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.509 -175.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 76.8 mt -61.91 142.91 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 118.859 0.754 . . . . 0.0 109.686 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.89 24.53 6.45 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.828 1.251 . . . . 0.0 111.923 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.39 165.37 49.19 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 124.495 1.118 . . . . 0.0 108.85 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -52.49 149.29 24.11 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.844 2.363 . . . . 0.0 111.359 168.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -137.97 148.94 45.7 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.55 149.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 125.238 1.415 . . . . 0.0 108.42 -171.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -70.1 165.02 22.87 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.661 0.384 . . . . 0.0 110.94 174.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 C-N-CA 124.785 1.183 . . . . 0.0 110.625 173.355 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -139.21 158.91 43.33 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.826 0.85 . . . . 0.0 110.036 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -140.33 161.75 36.93 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 126.849 2.06 . . . . 0.0 106.98 168.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -119.15 143.34 47.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 174.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -138.62 131.68 39.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -88.46 125.09 34.57 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 169.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.4 m -114.03 14.32 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -91.9 -169.18 2.19 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.397 1.453 . . . . 0.0 109.695 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -57.91 150.4 49.54 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 123.089 0.555 . . . . 0.0 109.637 167.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.47 -19.22 67.46 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.306 2.004 . . . . 0.0 112.624 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.08 -24.89 67.38 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.919 -1.113 . . . . 0.0 112.145 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -68.61 -41.18 79.92 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.517 1.053 . . . . 0.0 109.913 172.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -59.85 -37.34 79.01 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.736 1.615 . . . . 0.0 110.269 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -57.01 -43.49 81.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.417 -0.801 . . . . 0.0 111.515 173.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 56.8 mm-40 -66.39 -58.2 5.79 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -174.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -167.02 151.27 6.95 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.959 1.704 . . . . 0.0 107.114 167.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -138.53 153.61 48.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.61 126.92 12.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.99 96.71 1.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 134.51 -18.71 4.1 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.82 1.2 . . . . 0.0 111.63 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.42 162.8 25.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.146 0.973 . . . . 0.0 110.202 173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.3 pt -135.66 147.16 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 125.787 1.635 . . . . 0.0 106.831 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -80.87 116.55 20.91 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -176.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.5 mm -136.92 81.52 33.36 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 105.431 -2.063 . . . . 0.0 105.431 179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -53.48 150.45 27.17 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.5 2.8 . . . . 0.0 114.078 -169.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -47.49 -41.54 20.99 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 126.671 1.989 . . . . 0.0 111.933 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -62.97 -15.77 57.16 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -129.55 -13.36 4.3 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.471 1.108 . . . . 0.0 112.053 -169.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 p -52.15 -35.04 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 124.966 1.306 . . . . 0.0 111.735 -174.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 tttt -56.6 -34.5 67.26 Favored 'General case' 0 C--N 1.341 0.239 0 C-N-CA 123.744 0.818 . . . . 0.0 112.234 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -102.4 -47.09 4.59 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.1 mtp180 -65.57 -22.2 66.67 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.673 -173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 tp -57.66 -32.79 43.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.658 1.117 . . . . 0.0 111.267 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.62 -18.74 60.7 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.522 0.729 . . . . 0.0 112.899 -178.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -111.39 -28.72 8.09 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.661 1.184 . . . . 0.0 111.01 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.55 -43.78 68.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.817 0.735 . . . . 0.0 111.546 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -141.94 77.11 18.89 Favored Pre-proline 0 CA--C 1.543 0.699 0 C-N-CA 125.036 1.334 . . . . 0.0 107.403 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.44 -36.03 93.26 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.102 2.535 . . . . 0.0 114.368 -173.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -77.55 98.66 5.44 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.212 0.605 . . . . 0.0 109.484 176.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.15 -6.65 18.6 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -85.45 -14.74 45.21 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 119.184 0.902 . . . . 0.0 111.929 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.913 0.885 . . . . 0.0 110.427 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 m -77.98 96.44 5.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.968 0.907 . . . . 0.0 110.17 -178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.9 t -80.51 93.28 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.4 mttm -73.36 129.74 38.65 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.9 m -115.18 143.31 25.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 174.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.7 p90 -142.13 168.12 20.5 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.216 1.006 . . . . 0.0 108.355 170.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 25.3 p -153.19 178.3 9.89 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 168.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -60.31 -25.43 65.78 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.76 5.76 4.3 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -169.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.71 -29.67 2.03 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 124.987 1.279 . . . . 0.0 114.532 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -60.5 -51.95 67.28 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 118.535 1.168 . . . . 0.0 111.481 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -69.01 -33.83 74.29 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-O 118.97 -0.538 . . . . 0.0 110.889 -171.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 p -68.28 -34.93 77.06 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 119.156 0.889 . . . . 0.0 110.974 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.3 -50.92 57.63 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -62.93 -46.28 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.388 0.594 . . . . 0.0 110.864 178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.51 -34.38 70.88 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 122.734 0.414 . . . . 0.0 110.581 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 -42.5 94.32 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -68.52 -43.24 77.21 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.287 0.494 . . . . 0.0 110.301 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 87.1 mt -56.93 -49.16 80.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 C-N-CA 123.474 0.71 . . . . 0.0 109.302 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 64.6 mt -68.34 -30.67 69.69 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.709 0.804 . . . . 0.0 111.313 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.6 m -69.81 -37.51 76.28 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 119.268 -0.396 . . . . 0.0 110.682 173.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -65.72 -36.66 84.24 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.98 0.809 . . . . 0.0 110.162 174.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 95.5 mmm -69.48 -3.78 15.97 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.34 1.056 . . . . 0.0 112.702 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.7 19.54 78.99 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.946 -0.919 . . . . 0.0 113.531 171.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -64.54 123.56 19.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.909 1.354 . . . . 0.0 107.599 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.07 -29.78 69.65 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.157 0.583 . . . . 0.0 112.362 -169.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -139.01 111.81 7.79 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 -171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.9 t -146.7 149.57 15.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -153.76 128.39 9.35 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -80.19 113.38 18.32 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.96 -28.3 69.72 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 118.95 -26.23 7.6 Favored Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.368 0.985 . . . . 0.0 112.335 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.96 167.79 16.04 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 124.89 1.233 . . . . 0.0 110.324 172.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.9 tp -54.77 -33.15 60.95 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.129 0.972 . . . . 0.0 112.313 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -66.12 -29.04 69.27 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.947 -0.549 . . . . 0.0 111.599 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -75.79 -40.83 54.43 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.48 -175.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 mm -53.27 117.24 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 123.441 0.697 . . . . 0.0 111.359 -168.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.73 50.67 2.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.353 1.461 . . . . 0.0 109.72 177.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 93.1 mmm -133.42 154.48 80.92 Favored Pre-proline 0 C--O 1.238 0.48 0 C-N-CA 125.477 1.511 . . . . 0.0 108.143 -178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.72 145.94 29.15 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.684 2.256 . . . . 0.0 110.677 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -144.08 147.56 33.95 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -147.66 154.6 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 C-N-CA 123.984 0.914 . . . . 0.0 108.835 -167.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -63.46 150.19 44.29 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 122.85 0.46 . . . . 0.0 110.08 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 173.861 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.89 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -138.67 158.0 45.06 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.986 0.914 . . . . 0.0 109.528 -177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -148.41 126.71 12.23 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 173.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 28.3 m-90 -76.14 143.67 41.04 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.3 mm -140.36 128.95 25.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 105.84 -1.911 . . . . 0.0 105.84 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.97 124.95 32.27 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.2 m -116.05 16.35 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -89.46 -176.17 4.95 Favored 'General case' 0 N--CA 1.464 0.251 0 O-C-N 120.757 -1.214 . . . . 0.0 108.636 169.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 m -63.9 154.34 81.64 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 121.813 -0.554 . . . . 0.0 109.51 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.3 -12.99 35.59 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.314 2.676 . . . . 0.0 114.25 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -56.05 -37.83 69.77 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.824 0.849 . . . . 0.0 111.573 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -66.67 -43.29 84.91 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.854 0.752 . . . . 0.0 110.128 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -57.74 -30.5 65.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.955 1.302 . . . . 0.0 111.269 -174.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -65.87 -50.79 63.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.305 0.642 . . . . 0.0 110.856 177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -70.97 -49.88 40.54 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 118.807 -0.616 . . . . 0.0 109.868 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.85 150.81 13.81 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 118.824 0.738 . . . . 0.0 110.49 167.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.0 p-80 -139.07 156.03 47.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.947 1.299 . . . . 0.0 108.289 170.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.75 130.85 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.69 105.97 0.73 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 121.67 -13.48 9.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.045 1.307 . . . . 0.0 112.134 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.08 155.05 41.04 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 118.342 1.071 . . . . 0.0 110.191 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.6 mm -120.09 135.31 60.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 104.081 -2.563 . . . . 0.0 104.081 169.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -75.98 116.15 16.39 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 11.9 mt -140.54 81.06 17.81 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 125.729 1.611 . . . . 0.0 106.77 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -53.4 151.4 23.5 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.778 2.985 . . . . 0.0 114.31 -169.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.8 tp -48.6 -41.66 31.5 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.29 1.836 . . . . 0.0 113.001 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -70.75 -12.0 61.29 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -126.15 -15.28 5.82 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.938 1.295 . . . . 0.0 112.051 -169.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -47.06 -39.79 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 125.769 1.627 . . . . 0.0 113.252 -173.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -55.26 -40.93 71.52 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.575 0.75 . . . . 0.0 112.333 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -91.07 -2.4 57.63 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.219 0.607 . . . . 0.0 111.272 -169.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -136.32 -15.32 1.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -166.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.0 tp -57.79 -40.37 75.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 120.052 1.296 . . . . 0.0 111.262 -178.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.22 -32.55 72.33 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.405 0.548 . . . . 0.0 112.13 -176.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -10.3 58.13 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.909 0.883 . . . . 0.0 113.175 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.1 -30.4 4.67 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 119.356 0.98 . . . . 0.0 111.992 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.2 t -136.42 79.69 41.37 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.571 1.149 . . . . 0.0 107.994 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.98 -37.75 91.73 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.415 2.077 . . . . 0.0 112.131 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -77.51 96.76 4.81 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 124.134 0.974 . . . . 0.0 109.841 -178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -70.37 8.76 0.73 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -107.8 -6.99 16.46 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.671 1.188 . . . . 0.0 111.769 170.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -69.39 145.34 52.95 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.7 m -80.14 97.36 6.85 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.897 0.879 . . . . 0.0 109.676 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.1 t -72.03 104.7 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -83.16 84.65 7.4 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 m -69.34 140.17 19.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 172.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -145.12 164.04 32.47 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.178 0.991 . . . . 0.0 108.936 171.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 26.4 p -153.02 171.25 18.66 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.281 1.432 . . . . 0.0 107.717 173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -49.94 -33.22 16.87 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.02 -6.73 10.46 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -169.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.12 -31.44 3.73 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 119.792 1.178 . . . . 0.0 113.949 -176.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.78 -56.48 21.62 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.852 1.326 . . . . 0.0 111.303 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -65.03 -32.4 74.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.674 0.39 . . . . 0.0 110.824 -169.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.7 p -71.66 -35.53 70.38 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.339 0.972 . . . . 0.0 111.405 171.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.27 -48.52 59.27 Favored Glycine 0 CA--C 1.532 1.112 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -63.94 -48.4 76.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.671 0.788 . . . . 0.0 110.576 177.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.84 -28.95 69.2 Favored 'General case' 0 C--N 1.34 0.16 0 O-C-N 121.891 -0.506 . . . . 0.0 111.814 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -60.83 -45.0 96.18 Favored 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.92 -41.59 91.22 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.142 0.428 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.8 mt -58.88 -50.53 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 177.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.6 mt -70.31 -29.01 65.64 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.554 -0.717 . . . . 0.0 111.395 -176.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.1 m -62.46 -42.14 99.26 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.386 0.539 . . . . 0.0 109.953 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.95 -35.78 78.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.282 0.633 . . . . 0.0 110.968 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.5 mmm -64.98 -15.48 62.3 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.851 0.86 . . . . 0.0 112.118 171.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.37 14.43 55.74 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.762 -1.021 . . . . 0.0 113.074 174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -66.25 121.67 15.75 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.235 1.517 . . . . 0.0 107.37 169.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.5 p -75.08 -23.81 58.08 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 122.497 0.319 . . . . 0.0 111.522 -171.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -134.98 104.81 6.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.819 1.248 . . . . 0.0 107.67 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.5 t -142.16 143.33 26.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -143.39 127.17 17.16 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.14 111.98 9.83 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 166.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.71 -23.55 66.19 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.29 -26.84 10.69 Favored Glycine 0 C--N 1.338 0.682 0 C-N-CA 125.026 1.298 . . . . 0.0 110.765 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.3 174.68 13.44 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 124.524 1.059 . . . . 0.0 111.481 168.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.2 tp -60.45 -30.33 69.59 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.641 0.776 . . . . 0.0 110.067 170.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -61.55 -18.82 60.9 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.748 1.619 . . . . 0.0 113.271 172.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -118.12 -36.93 3.47 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.027 0.83 . . . . 0.0 112.021 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 80' ' ' MET . 82.4 mt -57.52 141.2 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 119.029 0.831 . . . . 0.0 109.538 174.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.88 24.5 7.62 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.011 1.324 . . . . 0.0 111.959 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.419 ' H ' HG22 ' A' ' 78' ' ' ILE . 93.2 mmm -69.52 164.16 52.43 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.506 1.123 . . . . 0.0 108.596 167.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.77 147.78 30.71 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.612 2.208 . . . . 0.0 110.904 167.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -134.78 142.86 46.82 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.9 m -142.27 149.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.131 1.372 . . . . 0.0 108.486 -169.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -69.08 162.19 27.45 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 122.769 0.428 . . . . 0.0 111.093 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 124.883 1.23 . . . . 0.0 110.611 172.725 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 121.204 0.526 . . . . 0.0 110.666 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.22 162.22 36.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 126.012 1.725 . . . . 0.0 108.785 -178.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -82.69 100.66 10.36 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -73.01 145.45 46.65 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 169.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.9 mt -147.16 139.26 18.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -96.93 124.97 41.05 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 m -112.45 12.74 8.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.77 -174.34 4.25 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.172 1.351 . . . . 0.0 108.159 167.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 9' ' ' VAL . 1.6 m -57.29 156.04 16.38 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.656 0.782 . . . . 0.0 110.358 167.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -64.48 -14.35 43.83 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.081 2.521 . . . . 0.0 113.511 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -46.15 -49.44 16.79 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.467 1.507 . . . . 0.0 110.82 173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -69.75 -37.81 76.59 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 122.308 -0.245 . . . . 0.0 110.383 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -58.46 -31.22 67.59 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.119 1.368 . . . . 0.0 111.314 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -67.12 -39.67 86.7 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.23 0.468 . . . . 0.0 110.73 176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -68.73 -54.21 17.46 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -175.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.27 152.53 4.99 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.015 1.726 . . . . 0.0 106.907 172.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -145.65 147.98 32.59 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 108.952 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.6 t -54.09 125.77 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 171.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 pp0? -56.34 -24.11 41.75 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -166.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.59 -8.07 41.05 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 123.885 0.755 . . . . 0.0 112.764 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.81 170.3 15.61 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 122.223 1.011 . . . . 0.0 111.094 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 13.6 pt -142.95 138.92 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 127.661 2.384 . . . . 0.0 105.213 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -78.38 116.43 18.79 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 41.3 mt -140.67 86.98 11.71 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.95 153.47 25.29 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.638 2.892 . . . . 0.0 113.9 -171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.7 tp -51.21 -35.81 38.46 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.065 1.746 . . . . 0.0 112.943 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.22 -16.49 63.59 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.501 0.721 . . . . 0.0 112.775 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -127.76 -22.26 3.59 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.553 1.141 . . . . 0.0 111.911 -168.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -47.42 -37.19 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 125.641 1.576 . . . . 0.0 112.377 -178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -54.75 -33.12 60.79 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.416 1.086 . . . . 0.0 112.301 -179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -104.52 -45.24 4.69 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.0 0.52 . . . . 0.0 109.951 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -66.91 -19.64 65.77 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.311 -173.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.3 tp -54.97 -34.99 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 119.104 0.866 . . . . 0.0 111.133 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.87 -40.16 96.64 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.19 0.904 . . . . 0.0 111.273 -176.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.27 -37.04 45.93 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.463 0.705 . . . . 0.0 111.133 177.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.93 -35.7 72.34 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.369 0.531 . . . . 0.0 112.057 -177.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.4 t -139.55 79.42 24.53 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.771 1.628 . . . . 0.0 107.179 -169.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.91 10.68 1.03 Allowed 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.766 2.978 . . . . 0.0 114.502 -171.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -138.21 107.88 6.24 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 125.272 1.429 . . . . 0.0 107.163 171.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 pttt -63.25 -15.08 55.99 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.64 -15.51 58.42 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.73 0.695 . . . . 0.0 111.957 176.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -67.94 150.19 48.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 119.027 0.83 . . . . 0.0 110.672 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.9 m -70.24 141.87 52.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.969 0.907 . . . . 0.0 109.674 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 47.2 t -135.85 145.33 31.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -130.72 135.33 47.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 174.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.0 m -121.92 137.54 55.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -136.68 168.57 19.27 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 168.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 29.9 p -152.55 -175.89 5.48 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 170.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -59.18 -29.55 67.54 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -134.65 10.33 3.68 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 -168.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.52 -29.36 2.29 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.795 1.188 . . . . 0.0 114.304 175.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -62.34 -50.85 69.99 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 118.374 1.087 . . . . 0.0 111.418 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.1 mm100 -69.49 -31.97 70.57 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.537 0.608 . . . . 0.0 110.569 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.23 -36.22 82.45 Favored 'General case' 0 C--O 1.227 -0.083 0 CA-C-N 119.381 0.991 . . . . 0.0 110.734 169.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.24 -52.0 50.33 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -62.4 -46.24 89.48 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.486 -0.42 . . . . 0.0 111.176 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.16 -34.32 74.84 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 118.222 0.465 . . . . 0.0 110.862 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.7 tmtt? -63.05 -43.45 98.62 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -63.98 -44.78 91.67 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 118.562 -0.732 . . . . 0.0 110.662 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 78.0 mt -54.56 -52.51 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-N 118.976 0.807 . . . . 0.0 109.072 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 48.0 mt -71.15 -28.4 64.25 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.987 -0.446 . . . . 0.0 111.221 -172.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.0 m -65.23 -42.16 93.69 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.353 0.524 . . . . 0.0 110.397 171.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -67.12 -33.92 76.49 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 118.879 0.763 . . . . 0.0 110.91 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.6 mmm -69.46 -8.75 49.63 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.845 0.858 . . . . 0.0 112.303 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.16 17.97 60.06 Favored Glycine 0 CA--C 1.529 0.93 0 CA-C-O 118.972 -0.904 . . . . 0.0 113.467 172.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -72.98 120.81 19.12 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.7 p -84.6 -17.22 39.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -167.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -133.24 38.77 3.3 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.873 0.869 . . . . 0.0 111.037 -169.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.9 t -80.6 145.81 8.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 169.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -140.91 137.91 33.48 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.715 0.806 . . . . 0.0 109.139 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -72.32 106.73 4.59 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.89 79.18 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 145.39 -148.22 19.83 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.73 167.26 13.05 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 168.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 59.0 tp -56.35 -34.17 66.36 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.533 1.133 . . . . 0.0 112.552 -170.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -67.36 -11.44 57.68 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.114 0.966 . . . . 0.0 113.168 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -117.1 -34.87 4.24 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.796 1.238 . . . . 0.0 111.982 -171.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.8 mp -65.4 127.14 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 169.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.23 24.31 8.83 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.484 1.113 . . . . 0.0 111.869 -174.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 90.3 mtp -71.1 165.36 48.56 Favored Pre-proline 0 CA--C 1.539 0.537 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 167.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.31 149.9 21.49 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.484 2.122 . . . . 0.0 111.688 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -131.91 158.47 41.31 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.878 0.871 . . . . 0.0 109.118 -177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 93.4 t -128.72 169.05 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -131.68 167.77 18.89 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 120.949 -1.094 . . . . 0.0 109.685 -169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 173.562 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -142.83 153.75 43.51 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.685 1.594 . . . . 0.0 106.797 172.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -141.55 152.27 43.95 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.442 1.497 . . . . 0.0 107.806 174.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.9 m95 -130.04 136.13 49.03 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 124.591 1.156 . . . . 0.0 108.78 -173.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.9 mp -136.96 131.39 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -84.21 117.05 23.27 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.1 m -104.84 23.12 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -174.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' A' ' 9' ' ' VAL . 5.6 ttt180 -111.24 -175.5 2.72 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.8 -1.188 . . . . 0.0 110.74 175.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 2.7 m -60.64 150.41 75.4 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.875 0.87 . . . . 0.0 109.971 175.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -53.81 -23.98 29.09 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.573 2.849 . . . . 0.0 115.118 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.92 -26.35 68.13 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 117.428 -1.272 . . . . 0.0 113.283 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -69.01 -50.82 45.39 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 120.818 1.645 . . . . 0.0 109.5 169.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -55.91 -37.28 68.69 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.164 1.386 . . . . 0.0 111.373 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 -61.77 -11.05 10.48 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.379 1.471 . . . . 0.0 113.985 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.16 -38.76 1.77 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 120.513 1.506 . . . . 0.0 112.153 175.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -156.48 145.32 20.19 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 120.042 1.292 . . . . 0.0 110.754 168.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -142.06 154.77 45.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.137 1.375 . . . . 0.0 107.49 169.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.4 t -56.21 132.61 20.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -55.88 120.45 7.4 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.27 -13.51 61.58 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.298 0.951 . . . . 0.0 112.984 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.02 161.17 30.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.474 1.137 . . . . 0.0 111.067 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.58 137.74 50.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.9 1.68 . . . . 0.0 107.338 179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -78.27 117.15 19.25 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 26.3 mt -143.2 87.93 8.38 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -54.12 155.6 15.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.1 3.2 . . . . 0.0 114.382 -170.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.7 tp -48.49 -41.93 31.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.2 1.8 . . . . 0.0 112.979 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -72.18 -8.38 54.41 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.5 -17.1 4.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.104 1.362 . . . . 0.0 111.829 -169.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.29 -30.42 40.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 125.26 1.424 . . . . 0.0 112.314 -177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -54.6 -47.66 73.12 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 124.732 1.213 . . . . 0.0 111.623 -169.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -88.95 -41.82 12.17 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.93 0.332 . . . . 0.0 110.241 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.3 mtt85 -70.28 -15.36 62.89 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -168.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 tp -56.59 -33.22 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.071 0.85 . . . . 0.0 110.851 169.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.11 -40.69 98.35 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-N 119.42 1.009 . . . . 0.0 111.043 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -73.28 -36.73 66.37 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.26 0.624 . . . . 0.0 111.168 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.24 -42.43 72.24 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.478 0.581 . . . . 0.0 111.968 -178.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.5 t -143.08 83.66 11.0 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.719 1.607 . . . . 0.0 107.425 -171.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -56.6 -38.12 96.17 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.875 2.383 . . . . 0.0 113.845 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -85.37 99.96 11.52 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.224 0.609 . . . . 0.0 109.677 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 48.6 pttt -62.81 -15.32 53.61 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -82.86 -11.9 57.85 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.024 0.829 . . . . 0.0 111.912 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -70.07 155.48 40.55 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.878 0.763 . . . . 0.0 111.191 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 140.01 54.25 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 59.2 t -136.38 140.5 43.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -129.14 135.76 49.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -123.75 147.46 28.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.543 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -150.07 164.72 34.82 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.894 1.677 . . . . 0.0 107.231 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 48.8 t -161.09 157.19 25.65 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.572 0.349 . . . . 0.0 110.167 -172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -54.93 -23.62 19.8 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.13 0.972 . . . . 0.0 112.72 168.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.06 105.12 7.51 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 170.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.99 -23.77 57.41 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 124.622 1.106 . . . . 0.0 114.215 -169.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.0 ptt-85 -57.6 -36.9 72.36 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.433 1.116 . . . . 0.0 111.778 171.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -71.53 -37.67 71.13 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.567 0.747 . . . . 0.0 110.685 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 p -68.24 -26.99 65.97 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.389 0.995 . . . . 0.0 110.824 169.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.36 -46.24 93.25 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 167.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -61.02 -48.7 80.56 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.865 0.833 . . . . 0.0 110.242 175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.14 77.13 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.819 0.282 . . . . 0.0 110.706 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -61.77 -39.57 92.1 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -70.42 -35.32 73.33 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.425 -0.798 . . . . 0.0 111.174 177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.05 -47.99 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.749 1.159 . . . . 0.0 108.786 172.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 10.7 mt -66.68 -33.82 76.49 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.668 -0.645 . . . . 0.0 110.861 -177.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 21.9 m -65.56 -39.21 91.41 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.828 0.451 . . . . 0.0 110.656 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -66.12 -36.22 82.56 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.504 0.721 . . . . 0.0 110.241 175.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.4 mmm -69.17 -3.92 15.49 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.189 0.995 . . . . 0.0 112.595 171.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.4 14.75 65.46 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.895 -0.947 . . . . 0.0 113.359 170.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.423 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 20.9 m-85 -70.0 129.14 38.66 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.936 1.368 . . . . 0.0 107.552 172.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 35.6 p -91.59 -18.74 23.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -167.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -131.88 40.47 3.36 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.323 1.049 . . . . 0.0 110.387 -169.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 t -79.78 149.45 5.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 171.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -143.93 142.06 30.56 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 169.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -86.33 106.8 17.64 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 168.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.34 -25.75 66.15 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.872 -177.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.53 -165.64 14.47 Favored Glycine 0 C--N 1.34 0.769 0 C-N-CA 123.968 0.794 . . . . 0.0 112.238 174.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -67.48 151.7 52.33 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.98 -44.92 30.93 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.255 1.822 . . . . 0.0 113.134 -169.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -64.14 -33.19 75.22 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.607 0.763 . . . . 0.0 111.825 -178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -72.41 -30.03 64.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 118.371 0.532 . . . . 0.0 111.705 -172.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.76 91.28 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 172.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.27 26.43 0.12 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.851 1.261 . . . . 0.0 113.507 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.8 mtp -77.64 158.89 77.91 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 123.942 0.897 . . . . 0.0 109.654 172.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -52.42 153.97 12.49 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.582 2.855 . . . . 0.0 111.703 167.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -138.97 153.9 48.23 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.779 0.832 . . . . 0.0 108.864 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.7 p -151.84 156.69 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -68.16 152.17 45.88 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 123.796 0.839 . . . . 0.0 109.134 171.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.075 -1.403 . . . . 0.0 110.074 174.725 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.086 0.47 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -152.21 164.16 37.92 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.851 1.66 . . . . 0.0 108.075 177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -77.17 151.67 35.17 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -126.23 135.32 51.44 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -136.68 125.63 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -173.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -84.67 120.99 27.03 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 167.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.3 21.85 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -175.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.7 -173.65 2.34 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.943 -1.098 . . . . 0.0 110.216 173.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.9 m -61.84 152.06 77.46 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 175.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.03 -13.4 35.03 Favored 'Trans proline' 0 CA--C 1.534 0.485 0 C-N-CA 122.626 2.217 . . . . 0.0 113.371 176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -55.22 -39.09 69.28 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.767 -1.111 . . . . 0.0 111.284 173.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -66.29 -47.85 72.31 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 120.405 1.457 . . . . 0.0 109.909 172.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -56.46 -37.31 70.13 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.948 1.299 . . . . 0.0 111.293 -172.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -58.87 -52.99 63.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.2 1.8 . . . . 0.0 110.949 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -72.32 -49.1 37.04 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 118.494 -0.765 . . . . 0.0 110.265 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -163.05 151.46 14.09 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.331 0.968 . . . . 0.0 111.029 167.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.1 p-80 -139.03 153.06 48.06 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.829 1.252 . . . . 0.0 108.326 170.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.3 t -55.44 128.4 15.59 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -64.92 106.85 1.32 Allowed 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 124.19 -17.69 7.49 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.933 1.254 . . . . 0.0 111.525 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.18 164.75 25.36 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 117.777 0.788 . . . . 0.0 110.71 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.2 pt -139.88 139.0 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.263 1.825 . . . . 0.0 106.939 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -77.38 115.8 17.45 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 122.872 0.469 . . . . 0.0 109.941 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -141.2 84.09 13.13 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 175.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -52.11 150.73 18.32 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.999 3.133 . . . . 0.0 113.806 -171.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 55.9 tp -47.82 -41.01 22.74 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 126.159 1.784 . . . . 0.0 112.58 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -65.06 -14.68 61.07 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.432 0.693 . . . . 0.0 112.832 -178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -131.15 -7.82 3.84 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.328 1.051 . . . . 0.0 112.369 -173.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 p -53.8 -38.62 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 120.098 1.317 . . . . 0.0 110.695 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -59.2 -26.36 64.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.694 1.197 . . . . 0.0 112.669 178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -105.48 -2.24 23.92 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.378 1.071 . . . . 0.0 111.385 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -131.48 -23.58 2.34 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -168.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.6 tp -57.94 -33.94 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.355 0.979 . . . . 0.0 110.576 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.98 -16.62 52.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.094 0.958 . . . . 0.0 113.357 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.7 p -114.96 -28.63 6.96 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.657 1.183 . . . . 0.0 111.028 178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.03 -38.67 72.59 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 118.733 0.697 . . . . 0.0 111.459 173.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.2 t -140.37 72.83 31.4 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.094 1.758 . . . . 0.0 107.289 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -58.0 -37.96 93.86 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.333 2.022 . . . . 0.0 112.812 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -80.94 88.88 5.88 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 123.288 0.635 . . . . 0.0 109.84 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -65.37 -4.95 6.23 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 -178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -76.84 -18.69 58.21 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.408 1.003 . . . . 0.0 111.486 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -72.96 152.29 41.45 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.154 -0.966 . . . . 0.0 110.327 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.8 m -71.51 149.57 45.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 174.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.0 146.81 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -129.22 145.31 51.36 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.0 m -129.89 148.6 33.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 -174.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -150.83 166.72 29.65 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.775 1.63 . . . . 0.0 107.379 176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.0 p -161.34 172.55 16.37 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.563 0.745 . . . . 0.0 109.623 173.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -54.96 -52.52 62.77 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.7 1.2 . . . . 0.0 112.192 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.28 -35.52 61.31 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.337 0.255 . . . . 0.0 111.389 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.43 8.91 55.89 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.034 -0.87 . . . . 0.0 113.498 176.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 53.8 ptt85 -124.08 -23.68 4.53 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.117 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -59.46 -33.59 71.49 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.762 1.619 . . . . 0.0 110.031 169.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.9 p -65.99 -37.88 87.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.703 0.801 . . . . 0.0 111.587 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.41 -47.88 73.2 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 169.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -61.91 -50.97 70.03 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.872 0.869 . . . . 0.0 109.992 178.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -37.07 79.27 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.05 0.54 . . . . 0.0 111.146 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.6 tmtt? -61.45 -39.76 92.01 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.81 -35.09 69.85 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 118.39 -0.814 . . . . 0.0 111.068 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.2 mt -58.19 -49.74 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 119.604 1.093 . . . . 0.0 108.648 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -66.16 -34.71 78.66 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.907 -0.495 . . . . 0.0 110.5 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.5 m -64.3 -41.56 96.8 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 122.864 0.466 . . . . 0.0 110.746 175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -65.12 -37.13 86.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.322 0.649 . . . . 0.0 110.195 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mtp -71.39 -3.05 18.71 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 112.792 172.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.89 16.01 68.81 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 118.664 -1.076 . . . . 0.0 113.458 171.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.2 124.97 22.28 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.217 1.509 . . . . 0.0 107.177 169.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.7 p -68.81 -29.05 67.31 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -166.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -150.09 106.87 3.54 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -173.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.2 t -138.22 144.25 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.19 145.94 32.4 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.472 0.709 . . . . 0.0 109.123 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -90.4 114.27 26.36 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 172.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.41 -29.87 69.48 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.701 0.4 . . . . 0.0 111.669 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 116.48 -158.27 14.56 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.615 1.102 . . . . 0.0 110.941 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.09 162.32 35.91 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 123.737 0.684 . . . . 0.0 111.72 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.12 -30.22 64.2 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.347 1.059 . . . . 0.0 112.869 -175.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -68.66 -27.76 66.28 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.475 -0.766 . . . . 0.0 111.939 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.03 -44.73 62.91 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 118.841 0.746 . . . . 0.0 112.971 -168.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 78' ' ' ILE . 3.1 mp -55.85 119.59 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.346 0.658 . . . . 0.0 110.276 -169.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.56 52.75 1.95 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.294 1.438 . . . . 0.0 110.669 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.9 mtp -136.69 154.74 76.75 Favored Pre-proline 0 C--O 1.24 0.555 0 C-N-CA 125.295 1.438 . . . . 0.0 109.169 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.89 155.7 10.6 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.644 2.896 . . . . 0.0 112.096 169.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -138.97 146.1 40.55 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.16 152.28 19.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.908 1.283 . . . . 0.0 108.566 -169.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -68.37 161.73 26.88 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.05 0.54 . . . . 0.0 110.149 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.084 0 C-N-CA 124.596 1.094 . . . . 0.0 110.887 170.595 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -145.91 146.97 31.28 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.214 1.006 . . . . 0.0 109.242 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -140.28 168.1 20.59 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.011 1.324 . . . . 0.0 107.701 168.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -134.43 137.91 44.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.3 133.19 58.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 -173.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -95.28 134.21 38.32 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.84 33.67 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.442 1.019 . . . . 0.0 113.569 -168.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -125.15 -179.21 4.48 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.235 -0.916 . . . . 0.0 111.659 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -71.07 160.97 80.81 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 124.559 1.144 . . . . 0.0 111.005 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.7 -16.78 11.82 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.273 3.315 . . . . 0.0 116.108 175.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -50.89 -37.86 46.15 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.756 1.223 . . . . 0.0 112.296 -178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -82.25 -45.16 15.39 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.162 -0.311 . . . . 0.0 110.162 173.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -56.69 -37.09 70.41 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.919 1.288 . . . . 0.0 111.424 -171.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 66.3 mm-40 -67.81 -5.36 16.09 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.056 1.343 . . . . 0.0 114.095 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -131.76 -33.82 1.37 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.782 1.174 . . . . 0.0 112.147 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -162.24 139.96 8.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 119.731 1.151 . . . . 0.0 108.819 166.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -142.6 148.81 38.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 166.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t -60.57 132.21 25.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 -35.48 80.96 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.874 0.47 . . . . 0.0 111.124 -170.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.48 -4.16 90.47 Favored Glycine 0 CA--C 1.532 1.108 0 CA-C-O 119.3 -0.722 . . . . 0.0 113.06 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.01 166.86 23.0 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.515 1.157 . . . . 0.0 111.075 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.6 pt -135.75 131.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 168.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -82.89 115.43 21.76 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.6 mt -136.2 81.09 38.92 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 125.977 1.711 . . . . 0.0 106.726 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.21 152.81 7.63 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 123.959 3.106 . . . . 0.0 113.706 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -44.23 -44.58 8.0 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 125.953 1.701 . . . . 0.0 112.359 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -67.15 -15.69 63.86 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -176.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -122.0 -18.86 6.83 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.405 1.082 . . . . 0.0 111.893 -169.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.46 -32.39 13.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.61 1.164 . . . . 0.0 111.457 178.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 57.2 tttt -64.76 -8.68 15.83 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -128.14 -48.91 1.33 Allowed 'General case' 0 C--O 1.232 0.153 0 CA-C-N 119.255 0.934 . . . . 0.0 109.83 175.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -63.64 -23.53 67.41 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 tp -59.12 -32.58 48.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 118.868 0.758 . . . . 0.0 111.32 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.53 96.67 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.253 0.933 . . . . 0.0 110.655 -174.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.67 -35.89 67.8 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.63 0.772 . . . . 0.0 111.22 175.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.4 -44.58 64.66 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.526 0.603 . . . . 0.0 111.938 -177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.77 85.25 9.31 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 125.3 1.44 . . . . 0.0 108.018 -172.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.63 -29.57 15.87 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.135 1.89 . . . . 0.0 112.25 -177.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -79.68 96.63 6.28 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 172.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -68.84 -7.23 32.49 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.08 -6.06 39.47 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.664 0.786 . . . . 0.0 110.673 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -67.23 151.67 47.11 Favored 'General case' 0 C--O 1.236 0.387 0 O-C-N 121.049 -1.032 . . . . 0.0 109.51 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 m -72.4 129.74 39.08 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 -176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.0 t -131.65 95.38 2.23 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -77.26 133.82 38.74 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 172.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.1 m -123.84 143.61 36.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 123.76 0.824 . . . . 0.0 108.958 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -151.42 159.51 44.19 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.799 1.64 . . . . 0.0 109.036 177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 21.5 p -155.52 169.6 23.91 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.728 1.611 . . . . 0.0 107.918 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -48.24 -26.2 1.86 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.24 -1.0 8.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -170.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.99 -46.75 1.52 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.413 1.482 . . . . 0.0 112.557 -175.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.5 tpt85 -59.55 -45.95 90.3 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 118.234 1.017 . . . . 0.0 112.46 -172.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -70.43 -31.82 69.15 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.239 0.472 . . . . 0.0 110.005 -174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.24 -33.68 75.85 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.97 -1.081 . . . . 0.0 110.775 168.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -46.62 85.62 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 168.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -62.46 -43.53 98.6 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 118.571 1.186 . . . . 0.0 110.648 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 -39.61 80.77 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 118.271 0.487 . . . . 0.0 109.734 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -66.8 -38.81 87.23 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 121.853 -0.53 . . . . 0.0 109.867 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -62.06 -45.04 95.28 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.702 0.801 . . . . 0.0 110.073 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 82.8 mt -57.99 -50.39 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 C-N-CA 123.783 0.833 . . . . 0.0 109.084 176.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 40.2 mt -67.1 -31.56 72.11 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.826 -0.546 . . . . 0.0 111.058 -176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 m -64.4 -40.63 96.17 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.492 0.587 . . . . 0.0 110.358 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -64.36 -36.95 85.8 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.751 0.705 . . . . 0.0 110.477 175.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 97.5 mtp -71.26 -5.1 29.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.077 0.951 . . . . 0.0 112.834 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.36 21.65 56.15 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 118.757 -1.024 . . . . 0.0 113.215 174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -68.89 146.01 53.18 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 119.208 1.504 . . . . 0.0 107.708 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.7 p -125.06 -1.19 7.77 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.32 31.58 1.72 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.911 0.862 . . . . 0.0 111.007 175.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.11 146.99 7.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 123.803 0.841 . . . . 0.0 108.975 169.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.12 141.85 19.98 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -84.04 110.61 18.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 169.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.53 -30.98 72.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.316 0.247 . . . . 0.0 111.483 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.15 -163.19 29.13 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 125.294 1.426 . . . . 0.0 109.982 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.12 159.26 32.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 169.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 47.5 tp -55.69 -33.03 63.8 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.86 1.264 . . . . 0.0 112.295 -174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 mtmt -68.48 -28.68 67.24 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.112 0.565 . . . . 0.0 111.527 177.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -82.61 -39.44 22.18 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.39 0.676 . . . . 0.0 111.043 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 mp -62.17 134.13 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -124.96 26.4 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.775 1.23 . . . . 0.0 111.531 -175.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 99.2 mtp -66.94 159.55 75.32 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 167.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.25 143.19 43.71 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.915 2.41 . . . . 0.0 111.707 172.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.14 155.76 47.6 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 123.96 0.904 . . . . 0.0 109.674 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -142.97 160.44 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 126.257 1.823 . . . . 0.0 108.026 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -73.4 150.03 42.03 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 169.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.104 -1.386 . . . . 0.0 110.306 172.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -140.09 148.58 41.94 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.554 1.142 . . . . 0.0 108.561 176.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -131.0 95.4 3.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 126.213 1.805 . . . . 0.0 106.313 173.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 3.6 m-90 -77.95 136.94 38.08 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.8 mm -130.99 122.53 52.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -81.45 113.68 19.68 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 166.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 m -106.5 20.7 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ttt180 -110.27 -169.12 1.41 Allowed 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.256 -0.902 . . . . 0.0 109.714 171.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 m -58.62 149.49 61.95 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 168.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.46 -14.44 44.25 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.305 2.003 . . . . 0.0 112.899 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -55.22 -38.39 68.38 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.753 0.821 . . . . 0.0 111.372 176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -69.28 -46.27 67.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.553 1.07 . . . . 0.0 109.826 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -58.65 -34.38 71.14 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.949 1.699 . . . . 0.0 111.473 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 tp60 -62.63 -39.78 94.9 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.507 1.123 . . . . 0.0 110.677 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -67.95 -49.67 60.43 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.385 0.993 . . . . 0.0 108.704 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -169.81 152.58 4.55 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 126.334 1.853 . . . . 0.0 107.548 167.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -136.95 152.38 50.1 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.704 1.201 . . . . 0.0 108.577 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -54.77 126.51 11.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 170.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -55.92 121.71 9.9 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.112 0.565 . . . . 0.0 109.682 -171.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -2.67 70.64 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.911 -0.938 . . . . 0.0 113.222 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.25 163.14 13.35 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 118.79 1.295 . . . . 0.0 111.549 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 27.6 pt -133.2 138.99 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.276 1.43 . . . . 0.0 108.394 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -78.82 114.86 18.11 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.519 0.728 . . . . 0.0 110.037 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 14.8 mt -139.72 80.94 20.45 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.639 1.575 . . . . 0.0 107.095 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.81 154.34 12.91 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.725 2.95 . . . . 0.0 113.819 -173.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.4 tp -47.46 -36.19 9.71 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.173 1.789 . . . . 0.0 113.039 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -66.77 -17.94 65.12 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.809 0.844 . . . . 0.0 113.116 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -127.75 -17.43 4.51 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.983 0.913 . . . . 0.0 112.174 -169.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 p -49.41 -33.03 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 125.119 1.368 . . . . 0.0 112.686 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -60.05 -25.0 65.0 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.185 0.994 . . . . 0.0 112.877 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -122.21 -41.34 2.43 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 118.667 0.667 . . . . 0.0 110.392 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -63.53 -17.47 62.82 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 tp -54.02 -37.24 33.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 119.24 0.927 . . . . 0.0 111.22 171.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.7 90.26 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.972 0.805 . . . . 0.0 111.528 -173.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.9 p -79.41 -38.25 35.27 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.082 0.553 . . . . 0.0 110.352 179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.13 -38.71 78.98 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.961 0.504 . . . . 0.0 112.211 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.6 t -138.37 83.28 21.58 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.81 1.244 . . . . 0.0 107.962 -174.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -55.86 -21.18 32.05 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.63 2.887 . . . . 0.0 115.129 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -131.63 95.57 3.76 Favored 'General case' 0 C--N 1.339 0.133 0 C-N-CA 124.549 1.14 . . . . 0.0 108.674 176.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -65.82 -5.52 9.22 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.496 1.119 . . . . 0.0 113.251 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -71.13 -21.43 62.2 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.113 0.87 . . . . 0.0 111.09 170.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -67.07 147.73 52.8 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 167.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -62.91 127.43 31.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 118.233 0.47 . . . . 0.0 109.765 -172.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.0 t -120.06 134.99 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.14 103.28 6.41 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.5 m -90.43 134.26 29.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -140.33 158.55 43.85 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.531 1.533 . . . . 0.0 108.562 170.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 18.5 p -144.22 -175.52 4.65 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.105 1.362 . . . . 0.0 107.667 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -56.76 -32.13 65.3 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.8 7.36 4.06 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.316 1.599 . . . . 0.0 115.316 -167.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.97 -40.13 2.28 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.74 1.162 . . . . 0.0 113.416 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.2 tpm_? -59.51 -48.13 82.85 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.372 1.086 . . . . 0.0 110.606 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -74.78 -24.91 58.75 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 119.052 0.842 . . . . 0.0 111.514 -173.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.08 -33.1 67.65 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 120.973 -1.08 . . . . 0.0 110.16 168.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.22 -47.09 84.15 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 167.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -61.25 -45.17 95.64 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.166 0.983 . . . . 0.0 110.459 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.43 -35.09 74.99 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 118.103 0.411 . . . . 0.0 110.797 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -67.84 -44.28 77.56 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.198 175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.66 -39.5 88.61 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 120.274 1.397 . . . . 0.0 110.58 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 61.1 mt -56.73 -51.18 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 123.866 0.866 . . . . 0.0 109.557 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.89 -34.2 76.19 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.894 -0.504 . . . . 0.0 111.147 -176.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 66' ' ' TYR . 19.7 m -66.09 -35.88 81.7 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.636 0.775 . . . . 0.0 110.0 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -68.85 -47.69 65.35 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.759 0.424 . . . . 0.0 110.152 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -68.65 -35.94 77.91 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.713 -0.661 . . . . 0.0 112.174 -170.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.88 45.18 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 CA-C-O 119.021 -0.877 . . . . 0.0 114.177 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.414 ' CD1' ' HA ' ' A' ' 62' ' ' SER . 0.3 OUTLIER -55.48 159.48 2.8 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 118.661 1.23 . . . . 0.0 112.742 175.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.5 p -137.95 -37.01 0.6 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.893 0.877 . . . . 0.0 110.942 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -142.67 34.87 1.43 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.364 0.983 . . . . 0.0 111.523 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.82 141.02 15.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.34 144.85 38.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.601 1.561 . . . . 0.0 107.316 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -87.06 105.64 17.3 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 168.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.88 -33.13 75.27 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.444 0.298 . . . . 0.0 111.275 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.87 -136.27 5.78 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -129.14 170.76 20.12 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.272 -1.931 . . . . 0.0 108.272 169.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -60.93 -39.92 91.29 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 123.728 0.811 . . . . 0.0 109.915 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -67.95 -3.69 10.72 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.919 1.287 . . . . 0.0 113.669 176.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -127.37 -37.33 2.03 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 119.289 0.949 . . . . 0.0 112.245 -169.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.1 mt -58.96 144.3 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 119.602 1.092 . . . . 0.0 110.519 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.16 75.42 1.1 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.751 1.62 . . . . 0.0 107.775 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 92.2 mtp -140.21 162.86 47.65 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 126.68 1.992 . . . . 0.0 107.669 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -52.03 143.48 40.62 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.965 2.444 . . . . 0.0 111.653 169.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -138.52 147.44 43.13 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.05 154.29 17.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 125.253 1.421 . . . . 0.0 108.408 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.9 mttm -72.6 155.92 39.53 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.006 -0.434 . . . . 0.0 110.576 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -141.2 145.92 36.26 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.623 1.169 . . . . 0.0 108.233 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -135.26 107.61 7.29 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -73.57 149.1 42.38 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mm -138.12 131.59 41.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -93.87 94.49 8.52 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 34.8 m -98.85 35.86 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -166.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.37 -179.78 6.88 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.465 -1.397 . . . . 0.0 108.635 -172.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -53.4 146.72 22.17 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 118.406 0.548 . . . . 0.0 111.999 -173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -80.0 -10.1 14.04 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.254 2.636 . . . . 0.0 114.465 -172.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.69 -42.6 71.63 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.828 0.851 . . . . 0.0 110.939 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.15 -35.76 69.15 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.941 -0.474 . . . . 0.0 111.462 178.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -58.02 -28.73 64.73 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.904 1.281 . . . . 0.0 110.953 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -64.69 -46.67 81.39 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.061 0.544 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -75.21 -45.0 43.24 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 118.585 -0.721 . . . . 0.0 110.152 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.15 152.06 12.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.074 0.852 . . . . 0.0 110.934 167.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.3 p-80 -146.78 160.53 42.14 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.131 1.373 . . . . 0.0 108.94 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 t -55.65 125.82 11.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 C-N-CA 125.052 1.341 . . . . 0.0 108.66 175.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -60.76 -29.54 69.46 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.885 0.474 . . . . 0.0 111.818 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.06 17.27 57.42 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.167 -1.352 . . . . 0.0 113.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -124.28 170.58 10.64 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 119.216 1.508 . . . . 0.0 112.018 -176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 14.0 pt -142.47 142.8 26.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 127.207 2.203 . . . . 0.0 107.023 -177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.21 116.1 19.27 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 123.162 0.585 . . . . 0.0 109.919 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 18.3 mm -137.73 73.3 47.67 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -51.26 150.61 14.29 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.652 2.902 . . . . 0.0 113.733 -169.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 tp -45.84 -36.16 5.05 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.973 1.709 . . . . 0.0 112.916 174.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -63.34 -18.45 63.66 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.018 0.927 . . . . 0.0 113.03 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -127.49 -24.17 3.37 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.293 1.037 . . . . 0.0 111.13 -170.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.2 p -44.66 -35.63 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 126.407 1.883 . . . . 0.0 113.431 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -53.84 -36.48 62.6 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 119.273 0.942 . . . . 0.0 112.47 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.45 -39.14 4.75 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 118.412 0.551 . . . . 0.0 109.729 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -67.74 -16.41 64.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.686 0.795 . . . . 0.0 112.352 -174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.12 -32.06 43.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 119.478 1.035 . . . . 0.0 111.024 169.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.3 -41.02 98.92 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.103 . . . . 0.0 110.765 -177.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -70.25 -35.75 74.01 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.4 0.68 . . . . 0.0 111.247 174.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.26 -45.3 66.71 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.096 0.558 . . . . 0.0 111.968 -177.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 t -143.25 88.12 8.26 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 125.47 1.508 . . . . 0.0 107.761 -174.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -58.55 -40.87 70.19 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.917 2.412 . . . . 0.0 113.18 177.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -81.22 99.08 8.39 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' HA ' ' CE2' ' A' ' 66' ' ' TYR . 28.5 mtmm -66.2 -8.09 22.24 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -174.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -101.62 -7.39 22.76 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.136 0.88 . . . . 0.0 111.597 178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -66.92 151.17 48.09 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 118.941 0.791 . . . . 0.0 109.718 171.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -65.91 131.49 46.38 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 118.464 0.575 . . . . 0.0 109.84 -174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.87 129.39 75.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -126.61 86.32 2.5 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -72.04 154.72 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.6 p90 -153.54 158.5 41.36 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.109 1.364 . . . . 0.0 108.08 168.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 19.3 p -133.52 -139.56 0.18 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.409 0.684 . . . . 0.0 110.241 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -74.32 -37.94 63.46 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.141 -0.974 . . . . 0.0 111.229 172.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -151.83 -39.31 0.11 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.52 -26.08 0.14 Allowed Glycine 0 CA--C 1.528 0.904 0 CA-C-O 118.879 -0.956 . . . . 0.0 114.77 175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.27 -62.75 1.55 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 119.177 1.488 . . . . 0.0 111.813 -176.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -62.08 -32.64 73.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 117.977 0.353 . . . . 0.0 111.17 -173.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.0 p -76.19 -33.85 59.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 121.582 -0.699 . . . . 0.0 112.106 175.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.97 -46.52 93.57 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -60.4 -50.35 73.94 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 123.664 0.786 . . . . 0.0 109.784 176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -38.75 78.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 122.253 0.221 . . . . 0.0 110.961 178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.68 -38.7 87.35 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -66.84 -39.31 87.57 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.68 -0.676 . . . . 0.0 110.313 174.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 96.9 mt -58.48 -46.29 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 119.34 0.973 . . . . 0.0 109.356 173.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 7.2 mt -63.74 -36.86 85.26 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.85 0.75 . . . . 0.0 110.462 -178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -64.44 -42.36 96.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.067 0.547 . . . . 0.0 110.305 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -66.63 -33.91 76.71 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.758 0.708 . . . . 0.0 111.126 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.3 mmm -71.28 -3.18 19.07 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.577 1.151 . . . . 0.0 112.515 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.74 18.68 74.88 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 121.373 -0.829 . . . . 0.0 112.975 173.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE2' ' HA ' ' A' ' 40' ' ' LYS . 23.0 m-85 -66.95 157.2 33.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.719 1.259 . . . . 0.0 109.23 169.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.0 p -135.17 164.78 26.92 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.269 1.428 . . . . 0.0 108.242 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 51.99 35.34 15.78 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.4 1.08 . . . . 0.0 111.932 -169.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.3 t -86.18 143.54 11.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 171.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.48 154.04 41.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.005 1.322 . . . . 0.0 107.49 172.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -109.51 116.0 30.98 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 171.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.75 61.79 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.533 0.733 . . . . 0.0 111.96 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 115.51 -92.27 0.58 Allowed Glycine 0 C--N 1.334 0.448 0 N-CA-C 107.969 -2.052 . . . . 0.0 107.969 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -149.2 175.22 28.52 Favored Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.1 tp -47.95 -35.67 11.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.185 1.394 . . . . 0.0 113.672 -169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -65.27 -27.62 68.77 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.263 0.625 . . . . 0.0 112.146 -177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.42 -45.65 37.57 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 118.831 0.741 . . . . 0.0 111.726 -172.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.601 ' H ' HD12 ' A' ' 78' ' ' ILE . 4.9 mp -58.78 115.46 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 123.978 0.911 . . . . 0.0 110.162 -170.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.19 53.57 2.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.194 1.398 . . . . 0.0 110.399 -179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.0 ptm -137.54 163.52 47.94 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 123.578 0.751 . . . . 0.0 109.72 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -51.07 155.85 5.7 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 124.358 3.372 . . . . 0.0 113.696 176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -137.52 145.49 43.03 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -177.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.7 m -141.17 152.48 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 125.045 1.338 . . . . 0.0 108.618 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -68.2 162.17 25.5 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.034 0.534 . . . . 0.0 111.166 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 124.912 1.244 . . . . 0.0 110.51 172.411 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.24 149.25 41.11 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.812 1.245 . . . . 0.0 107.888 175.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -142.04 155.21 45.39 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 125.854 1.661 . . . . 0.0 108.164 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 22.1 m-90 -137.47 148.82 46.36 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.453 1.101 . . . . 0.0 108.475 -176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.8 mp -144.32 135.96 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -90.62 116.31 28.4 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 167.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.86 11.87 7.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -88.05 -174.81 4.84 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.057 1.299 . . . . 0.0 109.668 171.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.0 m -58.4 152.83 41.66 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 122.67 0.388 . . . . 0.0 110.512 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.39 -17.17 58.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.727 2.285 . . . . 0.0 113.379 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -57.01 -39.2 74.29 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.112 0.869 . . . . 0.0 110.87 178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -69.88 -35.04 74.34 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 118.349 0.522 . . . . 0.0 110.319 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -60.24 -26.71 66.64 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.676 1.19 . . . . 0.0 111.311 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 -71.23 -46.1 61.84 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-O 118.529 -0.748 . . . . 0.0 111.683 -177.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.9 -52.15 64.21 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 118.667 0.667 . . . . 0.0 109.315 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.82 157.36 8.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.655 1.582 . . . . 0.0 108.01 165.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -144.77 153.35 41.57 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.444 1.098 . . . . 0.0 108.634 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.9 t -53.68 123.31 4.5 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 169.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.59 -31.75 68.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.005 0.522 . . . . 0.0 111.754 -172.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.81 6.24 83.32 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.281 -1.289 . . . . 0.0 113.852 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.9 164.7 13.75 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 119.44 1.62 . . . . 0.0 111.16 -176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.7 139.02 47.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 126.282 1.833 . . . . 0.0 107.269 -173.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -78.82 114.22 17.58 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 118.222 0.464 . . . . 0.0 109.779 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.6 mt -141.67 89.25 9.23 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -55.44 155.64 20.09 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.438 2.758 . . . . 0.0 114.729 -170.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.75 -36.17 24.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.722 2.009 . . . . 0.0 112.383 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -63.16 -17.53 62.48 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.696 0.798 . . . . 0.0 112.873 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -128.12 -16.99 4.42 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.773 0.829 . . . . 0.0 112.309 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -50.0 -32.12 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 125.021 1.328 . . . . 0.0 112.41 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -55.33 -26.09 38.61 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.091 1.356 . . . . 0.0 112.969 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -116.81 -43.03 2.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.671 0.669 . . . . 0.0 109.544 176.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -69.57 -9.11 52.67 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -174.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.8 tp -53.47 -36.96 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 119.935 1.243 . . . . 0.0 110.408 169.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -40.59 96.31 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.351 0.978 . . . . 0.0 111.543 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -71.74 -33.91 69.08 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.881 0.472 . . . . 0.0 111.042 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.82 -45.89 73.44 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.395 0.543 . . . . 0.0 111.114 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.93 113.86 4.96 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 125.607 1.563 . . . . 0.0 106.995 -171.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -55.78 -23.87 43.87 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.096 2.531 . . . . 0.0 115.275 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -146.2 118.51 8.4 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.203 1.001 . . . . 0.0 108.861 -178.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -60.02 -12.16 7.49 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.824 1.249 . . . . 0.0 114.033 178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -74.52 -20.51 59.94 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.847 0.749 . . . . 0.0 112.229 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -68.39 155.22 40.25 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 119.03 0.832 . . . . 0.0 108.87 168.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.1 m -68.41 131.16 44.82 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.133 0.879 . . . . 0.0 109.445 -177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.8 t -129.16 129.89 67.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -124.81 84.38 2.27 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 106.762 -1.569 . . . . 0.0 106.762 -177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.5 m -67.49 147.41 12.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.1 167.33 22.38 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.1 p -148.66 178.38 8.69 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 167.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -56.05 -35.79 67.31 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -174.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.88 5.3 6.6 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.57 -25.89 5.49 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.254 1.407 . . . . 0.0 114.891 170.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.5 tpm_? -64.24 -49.14 73.09 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.268 1.534 . . . . 0.0 110.799 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -71.22 -31.68 67.87 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 118.812 -0.613 . . . . 0.0 110.79 -172.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -68.81 -31.31 70.22 Favored 'General case' 0 C--O 1.227 -0.1 0 CA-C-N 119.906 1.23 . . . . 0.0 111.065 169.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.42 -50.14 64.55 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 167.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -62.74 -42.52 99.71 Favored 'General case' 0 N--CA 1.46 0.053 0 CA-C-N 117.813 0.807 . . . . 0.0 111.745 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.66 82.91 Favored 'General case' 0 C--O 1.227 -0.13 0 CA-C-N 118.849 0.75 . . . . 0.0 109.812 176.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 12.5 tmtt? -66.81 -39.46 87.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 118.398 -0.811 . . . . 0.0 109.232 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -61.48 -44.45 97.07 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 119.755 1.161 . . . . 0.0 110.827 175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.71 -53.03 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 96.9 mt -68.91 -27.39 65.73 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.047 -0.408 . . . . 0.0 110.652 -173.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 44.9 m -64.44 -43.1 95.38 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 118.762 0.71 . . . . 0.0 110.624 171.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -63.71 -32.83 74.45 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.343 0.519 . . . . 0.0 110.258 176.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.9 mtp -74.3 4.15 6.23 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.317 1.047 . . . . 0.0 113.114 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.56 47.15 6.49 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 119.972 1.26 . . . . 0.0 111.891 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -54.2 166.4 0.4 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.304 1.042 . . . . 0.0 113.465 173.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.7 p -138.47 -34.95 0.61 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.813 0.845 . . . . 0.0 111.014 167.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -138.37 32.9 2.31 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 119.178 0.899 . . . . 0.0 112.008 -176.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.9 t -92.52 139.44 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 171.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -145.66 147.0 31.53 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.774 1.23 . . . . 0.0 108.938 -178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -87.83 114.58 24.58 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 169.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.62 -51.43 65.26 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 122.779 0.432 . . . . 0.0 110.301 178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 144.43 -164.46 27.68 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.309 -1.117 . . . . 0.0 110.309 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.91 170.68 40.13 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 169.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.9 tp -55.36 -31.07 61.44 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 0.0 112.7 -177.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -67.66 -24.83 65.47 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.271 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -73.55 -48.45 32.94 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 119.209 0.913 . . . . 0.0 111.628 -170.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 78' ' ' ILE . 2.4 mp -61.34 115.37 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 123.27 0.628 . . . . 0.0 109.682 -169.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.38 56.48 2.92 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.453 1.501 . . . . 0.0 110.358 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 97.3 mtp -135.63 155.3 78.34 Favored Pre-proline 0 C--O 1.239 0.53 0 C-N-CA 125.3 1.44 . . . . 0.0 109.3 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -51.8 152.02 14.19 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.945 3.097 . . . . 0.0 112.662 172.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.9 mttp -135.94 143.29 44.83 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 -179.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 4.3 m -141.16 155.51 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.991 1.316 . . . . 0.0 108.38 -173.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -67.77 159.71 29.68 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.066 0.546 . . . . 0.0 110.264 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.915 0 CA-C-O 118.572 -1.127 . . . . 0.0 110.616 169.707 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.922 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.39 161.65 38.46 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.668 -0.645 . . . . 0.0 110.447 169.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.8 m80 -133.46 114.2 13.37 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.389 1.476 . . . . 0.0 107.837 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -72.4 141.97 48.71 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 168.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.5 mm -137.12 122.07 24.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -83.4 122.14 28.1 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.3 m -110.38 15.36 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.5 ttt180 -100.21 -168.43 1.59 Allowed 'General case' 0 N--CA 1.465 0.324 0 O-C-N 120.864 -1.148 . . . . 0.0 109.701 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.0 m -67.52 152.37 96.29 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.078 0.551 . . . . 0.0 110.09 177.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.48 -21.72 14.72 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.577 2.851 . . . . 0.0 114.475 172.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.34 -28.99 69.62 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.063 -0.97 . . . . 0.0 112.104 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -74.73 -47.27 32.18 Favored 'General case' 0 C--N 1.347 0.482 0 CA-C-N 120.098 1.317 . . . . 0.0 109.095 169.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -56.06 -42.96 77.44 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.983 0.913 . . . . 0.0 111.275 -171.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -59.0 -51.79 68.56 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.388 1.075 . . . . 0.0 110.904 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -74.71 -41.03 60.93 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.38 -173.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -167.39 140.11 3.37 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.412 1.006 . . . . 0.0 109.473 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -133.86 154.45 51.03 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.308 1.043 . . . . 0.0 108.622 171.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -56.5 130.95 19.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 172.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.6 119.48 6.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.24 59.59 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.208 0.909 . . . . 0.0 112.695 177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.62 159.94 32.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.474 1.137 . . . . 0.0 110.75 173.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.9 pt -136.43 141.33 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.204 1.802 . . . . 0.0 106.5 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -79.54 110.22 14.66 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 17.4 mm -132.72 78.42 66.69 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 126.532 1.933 . . . . 0.0 106.131 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -52.91 151.35 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.818 3.012 . . . . 0.0 114.04 -170.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.1 tp -49.22 -39.58 30.5 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.703 1.601 . . . . 0.0 112.468 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.91 -11.46 56.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -130.04 -15.97 3.71 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.351 1.06 . . . . 0.0 111.914 -172.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 p -51.7 -33.89 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.295 1.438 . . . . 0.0 112.101 -176.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -53.03 -38.69 62.6 Favored 'General case' 0 C--N 1.342 0.254 0 C-N-CA 124.286 1.034 . . . . 0.0 111.908 178.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -105.52 -45.33 4.47 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -65.37 -21.41 66.68 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 118.631 -0.699 . . . . 0.0 112.582 -174.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 tp -57.38 -31.66 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 119.805 1.184 . . . . 0.0 110.988 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -60.49 -22.6 63.71 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -113.46 -28.92 7.37 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 110.685 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.27 -41.56 94.11 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.764 0.711 . . . . 0.0 111.294 173.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.1 t -142.96 83.6 11.18 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 125.617 1.567 . . . . 0.0 107.037 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.01 -31.46 23.8 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.018 1.812 . . . . 0.0 112.482 -175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -80.88 94.59 6.51 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -68.03 -0.31 4.32 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -175.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -103.31 -8.47 20.27 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.257 0.935 . . . . 0.0 111.674 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.83 149.49 49.82 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 119.206 0.912 . . . . 0.0 109.439 170.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.9 m -65.48 141.3 58.54 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.03 -0.419 . . . . 0.0 109.918 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.47 133.74 64.77 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -126.26 88.99 2.93 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.6 m -77.04 141.68 15.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -147.57 164.24 34.08 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.343 1.057 . . . . 0.0 109.088 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 28.4 p -153.39 172.21 17.43 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 125.604 1.562 . . . . 0.0 107.474 171.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -54.16 -18.7 4.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 -178.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.16 8.52 2.95 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 -171.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.67 -43.76 1.92 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 125.241 1.401 . . . . 0.0 113.652 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -54.05 -53.83 47.71 Favored 'General case' 0 CA--C 1.521 -0.172 0 C-N-CA 124.229 1.012 . . . . 0.0 112.525 -170.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -65.46 -35.86 82.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 p -67.52 -34.56 77.36 Favored 'General case' 0 N--CA 1.456 -0.161 0 O-C-N 121.584 -0.698 . . . . 0.0 112.321 171.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -54.21 -45.6 73.32 Favored Glycine 0 CA--C 1.531 1.046 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 169.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -65.39 -49.53 68.95 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 117.236 0.518 . . . . 0.0 110.359 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.59 -36.67 72.04 Favored 'General case' 0 C--O 1.226 -0.178 0 C-N-CA 122.776 0.431 . . . . 0.0 110.648 -178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.89 -41.49 97.95 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.42 -36.59 71.37 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.541 -0.725 . . . . 0.0 110.977 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 81.5 mt -58.62 -46.65 90.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 119.552 1.069 . . . . 0.0 109.12 173.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 16.5 mt -63.59 -36.86 85.21 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.239 0.616 . . . . 0.0 110.923 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.2 m -66.91 -37.86 85.13 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 122.537 0.335 . . . . 0.0 110.549 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -66.48 -36.03 81.73 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.644 0.778 . . . . 0.0 110.494 174.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -69.91 0.19 6.28 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.757 1.223 . . . . 0.0 112.647 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 74.63 14.95 80.83 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 121.197 -0.939 . . . . 0.0 112.985 174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -64.11 155.39 31.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.832 1.316 . . . . 0.0 108.907 171.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 p -131.19 164.07 26.34 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.984 1.314 . . . . 0.0 108.427 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.2 m80 52.65 34.44 15.91 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.278 1.031 . . . . 0.0 111.598 -168.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.49 144.09 10.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.416 -1.328 . . . . 0.0 107.416 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -152.99 155.62 37.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.617 1.167 . . . . 0.0 108.292 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -118.31 117.47 29.17 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 168.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.66 -39.3 90.89 Favored 'General case' 0 CA--C 1.536 0.408 0 O-C-N 123.411 0.444 . . . . 0.0 111.6 -176.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.58 -26.48 2.4 Favored Glycine 0 C--N 1.337 0.625 0 C-N-CA 124.7 1.143 . . . . 0.0 111.921 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.02 176.73 22.58 Favored Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 173.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.0 -33.66 70.96 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.137 0.575 . . . . 0.0 110.147 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -61.9 -38.51 88.62 Favored 'General case' 0 C--N 1.342 0.258 0 C-N-CA 123.592 0.757 . . . . 0.0 110.962 175.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -75.95 -47.15 26.26 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 119.19 -0.433 . . . . 0.0 110.611 -175.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 82.8 mt -62.54 126.36 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 -171.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -108.01 22.48 15.89 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.789 1.235 . . . . 0.0 112.087 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 96.6 mmm -73.65 158.67 85.96 Favored Pre-proline 0 C--O 1.24 0.581 0 C-N-CA 124.22 1.008 . . . . 0.0 109.126 169.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.8 155.55 10.6 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.587 2.858 . . . . 0.0 111.846 168.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -138.07 149.41 45.96 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.74 154.91 16.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 125.349 1.459 . . . . 0.0 108.575 -171.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.14 151.56 45.3 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.983 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 172.603 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.75 153.28 47.14 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.228 1.011 . . . . 0.0 109.013 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -134.36 156.32 48.71 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.259 1.824 . . . . 0.0 107.704 170.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -121.61 137.46 54.73 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mm -133.28 125.94 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 -177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -83.79 108.77 17.03 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 167.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 48' ' ' CYS 0.295 22.7 m -101.88 22.63 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 118.137 0.426 . . . . 0.0 111.89 -174.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -110.05 -177.06 3.16 Favored 'General case' 0 C--N 1.341 0.196 0 O-C-N 121.704 -0.622 . . . . 0.0 110.464 174.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.08 152.84 95.62 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 123.221 0.608 . . . . 0.0 110.4 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.81 -17.33 10.17 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 123.851 3.034 . . . . 0.0 115.042 171.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.08 -38.18 72.96 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 119.136 0.88 . . . . 0.0 111.461 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -73.93 -45.2 51.95 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 119.251 0.932 . . . . 0.0 109.991 171.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -52.85 -39.67 62.76 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.569 1.148 . . . . 0.0 111.699 -173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -54.8 -54.53 40.93 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.779 1.232 . . . . 0.0 111.385 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -71.19 -49.0 48.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 118.746 -0.645 . . . . 0.0 110.117 -178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -162.82 152.44 15.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.927 0.785 . . . . 0.0 110.635 167.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -134.19 158.32 43.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.593 1.157 . . . . 0.0 108.672 169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.43 130.58 20.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 169.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.96 120.13 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.458 1.103 . . . . 0.0 110.101 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 78.63 -2.55 67.35 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.529 -1.15 . . . . 0.0 114.04 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.73 134.34 52.97 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 119.586 1.693 . . . . 0.0 109.787 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.4 130.64 35.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.07 113.84 12.87 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.567 1.076 . . . . 0.0 109.019 170.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 15.0 mt -140.79 81.62 16.44 Favored Pre-proline 0 CA--C 1.542 0.643 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -52.59 151.97 17.58 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.661 2.907 . . . . 0.0 113.47 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 50.7 tp -47.75 -37.18 12.81 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.245 1.818 . . . . 0.0 113.216 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.5 mmtm -68.86 -14.61 63.14 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -125.35 -19.79 4.97 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.312 1.045 . . . . 0.0 111.836 -172.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.9 p -50.11 -35.06 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.027 1.331 . . . . 0.0 112.465 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -56.69 -30.01 62.98 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 123.966 0.907 . . . . 0.0 112.327 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -111.81 -45.78 3.31 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 118.654 0.661 . . . . 0.0 110.102 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -63.87 -20.58 65.93 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 tp -55.61 -34.13 34.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 118.81 0.732 . . . . 0.0 111.477 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.35 97.12 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.186 0.903 . . . . 0.0 111.456 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -34.71 55.2 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.533 0.733 . . . . 0.0 111.137 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.46 -35.39 70.84 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 118.429 0.559 . . . . 0.0 112.197 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.6 t -137.79 80.07 32.05 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.344 1.458 . . . . 0.0 107.238 -171.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.76 -1.58 10.6 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.191 2.594 . . . . 0.0 113.979 -173.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -130.28 105.81 8.15 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -63.33 -15.0 55.96 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -171.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -70.85 -20.78 62.5 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.58 0.627 . . . . 0.0 111.954 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.58 154.22 39.34 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.252 0.621 . . . . 0.0 111.619 -175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -76.95 135.49 38.74 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.625 -0.672 . . . . 0.0 109.567 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.9 t -130.09 90.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -72.17 131.54 42.92 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 170.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.41 143.14 36.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -141.67 163.11 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.076 0.951 . . . . 0.0 109.085 174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.46 ' SG ' HG23 ' A' ' 7' ' ' VAL . 1.7 m -144.54 -179.19 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.416 1.886 . . . . 0.0 107.735 176.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -64.19 -37.73 88.51 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 121.455 -0.778 . . . . 0.0 112.245 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.97 -20.06 8.27 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.059 0.944 . . . . 0.0 113.249 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 111.63 -23.72 16.94 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.267 0.937 . . . . 0.0 113.922 169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -68.88 -41.05 78.86 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 119.099 1.449 . . . . 0.0 111.469 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -66.31 -33.37 75.59 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.664 0.665 . . . . 0.0 111.418 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -71.62 -31.1 66.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.749 1.159 . . . . 0.0 110.694 171.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -56.19 -47.99 77.64 Favored Glycine 0 CA--C 1.534 1.263 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 167.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -61.75 -46.12 90.98 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 121.967 -0.726 . . . . 0.0 110.547 177.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.58 -34.97 73.39 Favored 'General case' 0 CA--C 1.528 0.107 0 O-C-N 122.026 -0.421 . . . . 0.0 111.064 177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -63.0 -42.42 99.84 Favored 'General case' 0 C--N 1.335 -0.064 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.69 -44.54 93.39 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.72 0.691 . . . . 0.0 110.544 177.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 92.5 mt -55.42 -51.37 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 36.3 mt -71.2 -28.05 63.93 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.927 -0.483 . . . . 0.0 111.587 -174.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 36.3 m -64.88 -43.31 93.34 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.512 0.596 . . . . 0.0 110.134 171.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -65.97 -34.49 78.22 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 118.687 0.676 . . . . 0.0 110.813 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 91.8 mmm -71.74 -6.03 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.867 0.867 . . . . 0.0 112.798 172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.99 15.91 58.62 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.903 -0.943 . . . . 0.0 113.909 170.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -72.34 122.7 21.61 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 119.124 1.462 . . . . 0.0 108.403 175.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.2 m -74.59 -29.95 61.51 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.79 1.236 . . . . 0.0 113.833 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -136.26 44.11 2.45 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.422 0.689 . . . . 0.0 111.123 -168.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -73.56 147.93 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -145.79 123.72 12.02 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -74.75 106.59 6.37 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 168.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -67.45 -28.27 67.74 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 124.05 0.94 . . . . 0.0 111.694 -178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.47 -161.68 21.53 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.265 0.936 . . . . 0.0 110.97 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -85.85 159.54 33.07 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 174.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 54.4 tp -58.01 -26.52 62.52 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.032 1.333 . . . . 0.0 111.875 177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -69.04 -10.51 57.93 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.768 0.827 . . . . 0.0 112.473 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -123.61 -33.25 3.23 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 124.877 1.271 . . . . 0.0 112.437 -170.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 mp -58.16 135.8 22.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-N 120.504 1.502 . . . . 0.0 107.39 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -117.08 23.91 11.55 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.539 1.136 . . . . 0.0 112.16 -175.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 75.6 mmm -68.61 160.15 78.2 Favored Pre-proline 0 CA--C 1.537 0.442 0 C-N-CA 124.118 0.967 . . . . 0.0 108.765 168.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.14 155.25 62.43 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.659 1.573 . . . . 0.0 109.124 167.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 80.4 mttt -138.68 144.62 39.68 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -171.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.87 150.57 16.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 125.206 1.402 . . . . 0.0 108.66 -172.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -65.91 161.56 20.98 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 122.837 0.455 . . . . 0.0 110.88 174.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.007 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.445 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -141.58 152.68 44.25 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.183 1.393 . . . . 0.0 107.629 173.501 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -141.33 159.42 42.25 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.181 1.792 . . . . 0.0 107.655 173.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -129.71 145.65 51.52 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 124.72 1.208 . . . . 0.0 108.148 -179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 51.9 mt -146.48 135.45 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -90.17 124.8 35.14 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 168.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG23 ' SG ' ' A' ' 48' ' ' CYS . 22.7 m -115.78 21.07 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 122.959 0.504 . . . . 0.0 112.229 -174.15 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.28 -170.56 1.77 Allowed 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 171.334 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 m -66.68 157.36 83.66 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.197 0.599 . . . . 0.0 110.329 171.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -53.32 -16.75 7.62 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 124.224 3.282 . . . . 0.0 115.436 172.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -49.95 -41.65 46.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.97 1.308 . . . . 0.0 111.915 178.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -75.44 -45.14 40.51 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.619 0.645 . . . . 0.0 109.925 174.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -54.3 -38.61 66.13 Favored 'General case' 0 C--O 1.233 0.234 0 C-N-CA 124.009 0.924 . . . . 0.0 112.289 -174.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -60.13 -50.68 72.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.649 1.18 . . . . 0.0 110.956 177.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -83.95 -38.5 20.94 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.183 -0.913 . . . . 0.0 111.748 -170.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -168.87 139.36 2.37 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.65 1.18 . . . . 0.0 109.359 169.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -134.79 145.7 48.64 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.142 1.377 . . . . 0.0 107.909 172.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 95.9 t -58.81 133.94 23.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 107.243 -1.391 . . . . 0.0 107.243 173.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -56.73 142.56 39.88 Favored 'General case' 0 C--O 1.234 0.276 0 O-C-N 122.264 -0.273 . . . . 0.0 110.286 -178.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.13 -18.09 29.45 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 118.756 -1.024 . . . . 0.0 113.108 -179.483 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.51 163.51 20.93 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.173 1.486 . . . . 0.0 110.788 172.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.7 pt -145.69 138.08 20.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 127.652 2.381 . . . . 0.0 105.124 -179.455 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -76.77 114.68 15.8 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.695 -0.484 . . . . 0.0 109.695 -176.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 38.8 mt -141.13 85.41 12.12 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 176.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -54.37 157.31 11.89 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.87 3.047 . . . . 0.0 114.506 -170.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 tp -46.8 -41.1 14.91 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.782 2.033 . . . . 0.0 113.215 -179.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -73.53 -10.74 60.03 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -177.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -123.7 -21.46 5.2 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.042 1.337 . . . . 0.0 111.303 -169.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 p -51.37 -33.19 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.396 1.478 . . . . 0.0 112.669 -178.002 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -54.54 -43.84 72.32 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.799 1.24 . . . . 0.0 111.142 -170.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.9 mp0 -93.78 -45.59 7.6 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.671 0.669 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -17.85 65.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -169.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.5 tp -52.94 -36.49 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 119.133 0.878 . . . . 0.0 111.248 171.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.51 -41.62 96.3 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.982 0.81 . . . . 0.0 110.954 -175.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -35.06 66.66 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.232 0.613 . . . . 0.0 111.11 176.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.47 -42.5 78.61 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.406 0.548 . . . . 0.0 111.618 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 21.0 t -142.09 87.98 9.45 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.385 1.474 . . . . 0.0 107.306 -171.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.88 21.77 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 123.953 3.102 . . . . 0.0 114.107 -172.728 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -144.08 104.67 4.16 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.212 1.405 . . . . 0.0 107.605 173.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -66.88 -10.79 52.17 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -175.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -82.42 -13.62 56.5 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 118.976 0.807 . . . . 0.0 111.838 174.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.45 154.24 40.97 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.007 0.822 . . . . 0.0 111.453 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.2 m -71.97 136.95 46.96 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -137.67 135.81 46.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -115.97 128.65 55.91 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 m -120.44 145.29 27.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.26 159.75 44.21 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.568 1.547 . . . . 0.0 107.754 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.471 ' SG ' HG23 ' A' ' 7' ' ' VAL . 5.5 m -157.24 167.48 30.21 Favored 'General case' 0 C--N 1.334 -0.089 0 C-N-CA 126.157 1.783 . . . . 0.0 108.851 -177.08 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -46.55 -30.2 2.15 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.366 1.617 . . . . 0.0 115.366 -176.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.42 7.97 5.41 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.568 1.076 . . . . 0.0 113.525 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.8 -40.95 1.88 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 125.045 1.307 . . . . 0.0 112.385 178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 -52.66 -47.96 66.78 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.595 1.158 . . . . 0.0 111.569 -179.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -65.0 -37.86 89.06 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.059 0.391 . . . . 0.0 110.132 -173.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.16 -30.98 69.32 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 121.46 -0.775 . . . . 0.0 112.016 172.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.64 -44.32 95.71 Favored Glycine 0 CA--C 1.53 1.024 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 169.334 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -61.05 -49.49 77.16 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.803 0.802 . . . . 0.0 109.982 175.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.19 -40.41 77.34 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.86 0.3 . . . . 0.0 110.617 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.0 tmtt? -62.15 -37.92 87.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -178.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -72.71 -34.82 67.38 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.318 -0.848 . . . . 0.0 111.53 177.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 90.3 mt -57.61 -47.37 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 119.889 1.222 . . . . 0.0 108.323 171.392 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 52.5 mt -70.49 -29.91 66.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.741 -0.6 . . . . 0.0 111.507 -177.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.2 m -65.54 -38.04 88.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.227 0.467 . . . . 0.0 110.407 172.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.48 -36.05 81.79 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.821 0.737 . . . . 0.0 110.255 174.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 94.9 mmm -68.93 -5.79 23.58 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.109 0.964 . . . . 0.0 112.579 170.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.93 12.0 64.48 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 124.425 1.012 . . . . 0.0 113.529 172.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -67.61 127.85 34.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.129 1.464 . . . . 0.0 107.731 175.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.1 p -89.42 -22.0 22.75 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -169.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -132.59 33.48 3.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.1 0.96 . . . . 0.0 111.551 -169.068 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -79.57 136.92 22.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 167.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -145.09 144.13 30.78 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -83.78 110.58 18.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.98 -29.61 70.55 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.92 -162.08 28.84 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 125.239 1.399 . . . . 0.0 109.754 -179.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.63 158.91 31.39 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 170.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -55.33 -35.62 65.36 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.358 1.063 . . . . 0.0 110.89 175.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -73.97 0.96 11.92 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.259 1.023 . . . . 0.0 112.735 176.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -130.9 -28.39 1.99 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 117.547 -1.216 . . . . 0.0 113.433 -169.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mp -56.71 134.99 20.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 120.936 1.698 . . . . 0.0 107.554 168.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.22 53.02 1.1 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.714 1.605 . . . . 0.0 108.831 -174.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 95.0 mtp -133.88 158.38 75.58 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 126.188 1.795 . . . . 0.0 107.627 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.54 149.16 40.42 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.022 2.481 . . . . 0.0 113.354 -176.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -127.85 159.17 35.71 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.202 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 100.0 t -134.82 167.83 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 127.708 2.403 . . . . 0.0 105.271 -175.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -128.71 161.61 29.3 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 120.798 -1.189 . . . . 0.0 109.871 -170.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 174.71 . . . . . . . . 0 0 . 1 stop_ save_